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ABSTRACT 
 
Graphene is the elementary structure of graphite, being a one carbon atom thick sheet, composed 
of sp2 carbon atoms arranged in a flat honeycomb structure. Due to its unique characteristics, 
graphene has unmatched electronic, mechanical, optical, and thermal properties, amongst others. 
In 2010, Geim and Novoselov were awarded the Nobel prize "for groundbreaking experiments 
regarding the two-dimensional material graphene". Since then significant financial and human 
investment has been made on graphene applications in the most diverse forms. This means that 
graphene tends to become widespread. However, only a small fraction of the research focuses on 
the biological field. 
Poly(lactic acid) (PLA) is an aliphatic polyester derived from renewable sources, which has 
several applications in various areas. In bioengineering, PLA is used for production of 
bioresorbable artificial ligaments, hernia repair meshes, scaffolds, screws, surgical plates, and 
suture yarns. To make this material more effective in several applications some properties can be 
improved, being mechanical performance usually the most relevant. Reinforcement with small 
amounts of nanofillers, as graphene/based materials (GBMs) is an interesting option because it 
allows improvement of target properties without changing PLA’s main characteristics. 
Since GBMs have several potential applications in biomedical engineering and biotechnology, 
this thesis is focused in understanding their biointeractions, and which sort of physical-chemical 
features have impact on their biocompatibility. It also studies GBMs as fillers for PLA, and the 
way by which they improve PLA properties and affect biocompatibility. 
An extensive literature review is presented on the key issues regarding GBMs biocompatibility, 
namely production methods, physical-chemical properties, concentrations, time of exposure, and 
encapsulation in polymer matrices. In this thesis, the biological properties of GBMs dispersed in 
liquid media are studied in in vitro assays, as well as how they are affected by the materials’ 
morphology, degree of oxidation, and surface modification with polymers. Human fibroblasts are 
used as an in vitro model to characterize GBMs biocompatibility, in terms of induction of reactive 
oxygen species production, metabolic activity changes, effect on cell morphology, evaluation of 
membrane damages, and particles internalization. Smaller graphene nanoplatelets (GNP) are 
observed to be generally more biocompatible than larger sized ones, which tend to cause 
membrane damages. Also, complete oxidation of GNP folds its sharp edges, therefore preventing 
toxicity. Surface adsorption of poly(vinyl alcohol) increases GNP size, preventing its 
internalization, therefore improving its biocompatibility. These results are relevant for the 
materials’ use in biomedical applications. 
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Literature on composites of PLA with carbon-based nanomaterials is also reviewed in depth. 
Usually, GBMs are reported to improve several PLA properties, namely thermal, electrical, 
mechanical, and biological properties. However, GBMs physico-chemical properties, composites 
production methods, and ideal incorporation amounts vary between studies. 
In this thesis, the production of PLA/GNP composites is explored by two different methods: 
solvent mixing followed by doctor blading, and melt-blending followed by compression 
moulding. Optimization of both methods is performed, in order to improve PLA physical-
chemical properties. GNP improves the mechanical properties of PLA, and reduces the decay of 
its mechanical performance after 6 months degradation in physiological conditions. In addition, 
the composites have stable behaviour under cyclic creep-relaxation testing, while PLA exhibits 
significant cumulative permanent strain, and ruptures after a few cycles. This is particularly 
relevant in the context of PLA uses in orthopedics, or other implantable materials that need to 
have a suitable mechanical performance along time when inside the body. 
Improvements in biological properties are also observed, namely increase in cell proliferation for 
PLA/graphene oxide composites, and decrease of platelets activation for PLA/graphene 
nanoplatelets composites, both produced by solvent mixing. Composites produced by melt-
blending, and their degradations products, do not affect cell metabolic activity and morphology. 
Finally, the above-mentioned results are discussed in the light of the most recently available 
literature reports, and new research perspectives are pointed out. In vivo characterization of the 
PLA/GNP composites is being performed, since they present outstanding mechanical 
performance after degradation in biological conditions, and lack of in vitro toxicity, which 
perspectives them as a promising material for biomedical applications. 
 
 
Keywords 
graphene; poly(lactic acid); biocompatibility; biomaterials; biodegradation; composites; 
mechanical properties. 
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RESUMO 
 
O grafeno é a estrutura elementar da grafite, sendo uma folha com a espessura de um átomo de 
carbono, composta por átomos de carbono com hibridização sp2, ordenados numa estrutura de 
colmeia 2D. Devido a estas características únicas, o grafeno possui ímpares propriedades 
eletrónicas, mecânicas, óticas, térmicas, entre outras. Em 2010, o prémio Nobel da Física foi 
atribuído a Geim e Novoselov “por experiências revolucionárias com o material bidimensional 
grafeno”. Desde então, tem sido feito um significativo investimento financeiro e humano nas 
aplicações do grafeno nas mais diversas formas. Isto significa que o grafeno tende a estar 
disseminado, no entanto, apenas uma pequena parte da investigação na área está focada no campo 
biológico. 
O ácido poliláctico (PLA) é um poliéster alifático derivado de fontes renováveis, que tem 
aplicações em diversas áreas. Em bioengenharia, o PLA é usado para produção de ligamentos 
artificiais bioabsorvíveis, redes para reparação de hérnias, estruturas para regeneração de tecidos, 
parafusos e placas cirúrgicas e fios de sutura. Para tornar este material mais eficaz para várias 
aplicações, algumas propriedades podem ser melhoradas, sendo o desempenho mecânico 
normalmente a mais relevante. O reforço com pequenas quantidades de nano-cargas, como os 
materiais com base em grafeno (GBMs) é uma opção interessante, pois permite a melhoria das 
propriedades alvo sem modificar as principais características do PLA. 
Como os GBMs têm várias potenciais aplicações em engenharia biomédica e biotecnologia, esta 
tese está focada na compreensão das suas bio-interações e no tipo de características físico-
químicas que têm impacto na sua biocompatibilidade. Também estuda os GBMs como cargas 
para incorporação em PLA e a forma como melhoram as propriedades do PLA e afetam a sua 
biocompatibilidade. 
É apresentada uma extensa revisão bibliográfica dos pontos-chaves da biocompatibilidade dos 
GBMs, nomeadamente métodos de produção, propriedades físico-químicas, concentrações, 
tempos de exposição e encapsulação em matrizes poliméricas. Nesta tese, as propriedades 
biológicas dos GBMs quando dispersos em meio líquido, são estudadas em ensaios in vitro, assim 
como a forma como estas são afetadas pela morfologia dos materiais, grau de oxidação e 
modificação superficial com polímeros. Fibroblastos humanos são usados como modelo in vitro 
para caracterizar a biocompatibilidade dos GBMs, em termos de indução de espécies reativas de 
oxigénio, alterações na atividade metabólica, efeito na morfologia celular, avaliação de danos na 
membrana e internalização de partículas. Foi observado que nanoplaquetas de grafeno (GNP) 
mais pequenas, no geral são mais biocompatíveis que as de tamanho maior, que tendem a causar 
danos nas membranas celulares. Para além disso, a oxidação completa das GNP dobra as suas 
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extremidades afiadas, prevenindo assim a sua toxicidade. A adsorção superficial de álcool 
polivinílico aumenta o tamanho das GNP, impedindo a sua internalização e assim melhorando a 
sua biocompatibilidade. Estes resultados são relevantes tendo em conta as aplicações biomédicas 
destes materiais. 
A literatura sobre materiais compósitos de PLA com nanomateriais com base em carbono também 
é revista em profundidade. É descrito que normalmente os GBMs melhoram várias propriedades 
do PLA, nomeadamente térmicas, elétricas, mecânicas e biológicas. No entanto, as propriedades 
físico-químicas dos GBMs, os métodos de produção dos compósitos e quantidades de GBMs 
incorporadas variam entre os estudos. 
Nesta tese, a produção de compósitos de PLA/GBMs é explorada usando dois métodos diferentes: 
1) mistura em solvente, seguida de doctor blading; 2) mistura em fundido, seguida de moldagem 
por compressão. É realizada otimização de ambos os métodos, de forma a melhorar as 
propriedades físico-químicas do PLA. As GNP melhoram as propriedades mecânicas do PLA e 
reduzem o decaimento do seu desempenho mecânico após degradação em condições fisiológicas 
durante 6 meses. Para além disso, os compósitos apresentam comportamento estável sob testes 
cíclicos de fluência-relaxamento, enquanto que o PLA apresenta deformação cumulativa 
constante e rompe após poucos ciclos. Isto é particularmente relevante tendo em conta as 
aplicações do PLA em ortopedia ou noutros materiais implantáveis que necessitem de ter um 
desempenho mecânico adequado ao longo do tempo quando no interior do corpo. 
São observadas melhorias nas propriedades biológicas, nomeadamente aumento da proliferação 
celular à superfície de filmes compósitos de PLA/óxido de grafeno e decréscimo da ativação de 
plaquetas para PLA/nanoplaquetas de grafeno, ambos produzidos por mistura em solvente. É 
observado que os compósitos produzidos por mistura em fundido e os seus produtos de 
degradação não afetam a atividade metabólica nem a morfologia celular. 
Finalmente, os resultados acima mencionados são discutidos à luz da literatura mais recente e 
novas perspetivas de investigação apontadas. Está a ser realizada caracterização in vivo dos 
compósitos de PLA/GNP, uma vez que apresentam um desempenho mecânico notável após 
degradação em condições biológicas e não são tóxicos in vitro, o que os torna um material 
promissor para aplicações biomédicas. 
 
Palavras-chave 
grafeno; ácido polilático; biocompatibilidade; biomateriais; biodegradação; compósitos; 
propriedades mecânicas. 
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1 INTRODUCTION 
1.1 Scope 
 
The present chapter starts by introducing some of the key concepts intimately related to the work 
in the chapters presented later in this thesis. 
Since historical basis usually provides the motivation to do research within a certain scope, 
sometimes it is hard to dissociate between the two. However, a separate section, entitled 
motivation and scope, was introduced to explain the events and conditions that made this work 
possible and that directed it along the last years. 
Finally, an outline of the chapters in this thesis is presented, with the relations between them 
pointed out and their contents briefly explained. 
 
1.2 Key concepts 
1.2.1 Biomaterials and biocompatibility 
 
The use of biomaterials can be traced back to the origins of civilization, in parallel with the 
invention and application of instruments and tools. Ranging from Mesoamerica to Asia, including 
Mexico, Rome, Athens, Egypt, and India, findings of antient artificial limbs, eyes, ears, teeth, and 
noses took place. This states the early concern of mankind to augment or repair the body, using 
materials available in nature such as wood, glue, rubber, manufactured materials such as iron, 
gold, zinc, and glass, and even tissues from living origins. [1-6] Materials were tested, selected, and 
modified for medical applications along the ages with early concepts starting to arise, however it 
was only in the late 17th century with advancements in the field of surgery, the usage of aseptic 
techniques, and radiography that a more accurate use and scientific understanding of biomaterials 
was possible. [2, 5, 7, 8] In the late 19th and early 20th centuries, previous knowledge and concepts 
resulted in the advent of today’s routinely used biomaterials in for example, intraocular lenses, 
orthopedic prostheses, dental implants, kidney dialysis machines, catheters, pacemakers, heart 
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valves, stents, and breast implants. [1, 2, 9] Every day, advances on biomaterials field result in 
improvement of the quality of life and life expectancy. The refinement of the production methods, 
along with the improvement of existent materials, and the arising of new ones, as synthetic 
polymers, ceramics, and metal alloys, increased the application range of biomaterials. Also, the 
1970s advances in molecular biology and 1990-2000s in genomics and proteomics, allowed the 
study and understanding of biological interactions at the interface with materials. The possibility 
of using methods or molecules to modify biomaterials interactions with the body or even using 
living tissue as a biomaterial itself, revolutionized the field to a point in which it is already hard to 
define the main terms commonly used. [1, 9] For that reason, the definition of “biomaterial” has 
been evolving and adapting to new insights along the past decades. One of the first definitions 
was resultant from the National Institutes of Health (NIH) consensus development conferences in 
1982, and describes biomaterial as “any substance (other than a drug) or combination of 
substances synthetic or natural in origin, which can be used for any period of time, as a whole or 
part of a system which treats, augments, or replaces tissue, organ, or function of the body.” [2, 5, 10, 
11] Some years later, at the 1986 consensus conference of the European Society for Biomaterials 
in Chester, England, several key definitions within the scope of biomaterials science were debated 
with some consistency being achieved. [8, 12, 13] Consensual definitions for artificial organ, 
bioactive material, bioadhesion, bioattachment, biocompatibility, biomaterial, bioprosthesis, host 
response, hybrid artificial organ, implant, medical device, prosthesis, and thrombogenicity were 
published in the proceedings. [14] The definition agreed for biomaterial was “a non viable material 
used in a medical device, intended to interact with biological systems.” [1, 8, 12, 13, 15] The success 
of the first consensus conference led to a second meeting in the same place in 1991, in which the 
past definitions were further discussed and perfected. For example, in the case of biomaterial 
definition, the reference to non-viability was removed. [13, 16] Further reflection and refinement of 
the concepts was published in a contextual dictionary of biomaterials science published in 1999. 
[17] The most recent refinement of the definition of biomaterial in literature was published in 
2009, in which after a methodical discussion the following conclusion was stated, “a biomaterial 
is a substance that has been engineered to take a form which, alone or as part of a complex 
system, is used to direct, by control of interactions with components of living systems, the course 
of any therapeutic or diagnostic procedure, in human or veterinary medicine.’’ [12] 
Another key term that has been discussed along the years in biomaterials science is 
“biocompatibility”. [1, 8, 13, 18, 19] Despite papers studying tissue reaction to implanted biomaterials 
appearing since 1940s, only by 1970 the word “biocompatible” was used. [8] The most widespread 
concept for it was originated at the 1986 consensus conference on biomaterials held in Chester. 
There, biocompatibility is defined as “the ability of a material to perform with an appropriate host 
response in a specific application”. [1, 8, 18]  
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This simple and at the same time broad definition reminds us that a biomaterial should not elicit a 
deleterious host response, but leaves questions open regarding the criteria to evaluate if that 
response is acceptable or not. In a comprehensive leading opinion article, the previous definition 
was updated to, “biocompatibility refers to the ability of a biomaterial to perform its desired 
function with respect to a medical therapy, without eliciting any undesirable local or systemic 
effects in the recipient or beneficiary of that therapy, but generating the most appropriate 
beneficial cellular or tissue response in that specific situation, and optimising the clinically 
relevant performance of that therapy.” This definition reaffirms the importance of biomaterials 
safety in a more specific manner, and adds that the material should exert beneficial effects to the 
host. [18] However, it is still being a qualitative definition, because it doesn’t specify the criteria to 
judge the “undesirable local or systemic effects”. Absolute absence of undesirable effects with 
desirable biological actions can be considered the ultimate goal of biomaterials. However, while 
that is not achieved a risk/benefit approach on accessing biocompatibility can be taken. An 
interesting term found in literature is “biomaterial performance”. It consists of characterizing 
biomaterials using many qualitative, semi-quantitative, and/or quantitative observations or 
measurements. Some of these observations can be data in surface corrosion, changes in bulk and 
surface properties, and histological and biological analysis of inflammation. [19] Here, physico-
chemical characterization of the biomaterial is important because it can impact on its 
performance, both by leading to “undesirable effects” or changing/preventing “the clinically 
relevant performance”. Also, the application of this concept requires the support of well-
documented reference standards of materials, methods, and responses. [19] In vitro studies allow a 
first understanding of tissues and cells interactions with a biomaterial. Also, low levels of 
endotoxins and no measurable leachables are a predictor of better performance after implantation. 
In vivo studies allow the assessment of the body’s overall response towards a biomaterial, and 
allow the understanding of how the immune system reacts to it, which can be done by evaluating 
a possible foreign body reaction and its extent. [8, 19]  Usually, a biomaterial that elicits the 
formation of a thin, stable foreign body capsule and only low levels of cellular reaction at the 
implant site is accepted as biocompatible by physicians, regulatory agencies, and standards 
organizations. However, the evolution on materials science field led to “the ability of a material to 
locally trigger and guide non-fibrotic wound healing, reconstruction and tissue integration”, and 
this is the latest proposed definition for biocompatibility, regarding biomaterials to which it is 
applicable. Thus, “the ability of a material to reside in the body for long periods of time with only 
low degrees of inflammatory reaction” should be considered biotolerability. [8] The definitions of 
biomaterial and biocompatibility have been evolving since they first started to be found in 
literature around 1970. Since then, their use has been growing as can be noticed in Figure 1.1. As 
the biomaterials science field expand new insights keep arising, that creates a pressing need for 
reflection and constant adjustment of the definitions, so those should be regarded as dynamic 
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instead of dogmatic. Also, the definitions can be subdivided according to the context, because for 
example the concept of biocompatibility regarding an implant is surely different from when 
considering a polymer-nucleotide conjugate, and the attempt to make a definition that comprises 
such different biomaterials, can result in a hollow one. 
 
Figure 1.1: Evolution of the number of publications mentioning biomaterials and 
biocompatibility from 1970 to 2016. Source: Scopus; keywords searched: “biomaterial” - 
“biocompatibility”; search date: 30/12/2016. 
 
1.2.2 Graphene-based materials 
 
Carbon has been observed since prehistoric times in the form of soot, charcoal, graphite and 
diamond. For example, the usage of graphite has been traced to before 4000 BC, when the 
Marican, Boian, and Gumelniţa cultures in Europe used it to paint pottery. [20-24] Obviously, 
ancient cultures did not realize, that these substances were different forms of the same element, 
[23, 24] because the identification of carbon as an element only millennia after was worked out step 
by step by R.-A.-F. de Reaumur, H.-L. Duhamel du Monceau, Torbern Bergman, C. W. Scheele, 
C.-L. Berthollet, A.-L. Lavoisier, and others. [24] In 1789, A-. L. Lavoisier listed “Carbone” in his 
“Traité Elémentaire de Chimie” as one of the newly identified chemical elements, whose 
versatility was already known since it had been shown that it was the elementary component of 
both diamond and graphite. [25, 26]  Since then, more allotropes of carbon have been discovered 
and studied, ranging from amorphous carbon, to fullerenes (0 D), graphene (1D), and nanotubes 
(2 D). [26-28] Graphite ore has been found and mined in England since the 16th century. One of its 
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uses was to mark sheep, and because of that in 1789 A. G. Verner named it after the Greek word 
“graphein”, which means “to write”. [21, 29] Since the development of the pencil industry in the 
18th century, graphite has been one of the most widely used materials to write. [21] Due to its 
layered structure when mechanical friction occurs between the paper and graphite in the pencil, 
graphite flakes are delaminated becoming attached to the paper. Thus by the simple act of writing, 
we have been on the way between graphite and graphene since centuries ago, but that only started 
to be considered recently, due to the importance that graphene has been achieving. [30] Reviews 
on graphene history [29, 31] report the firstly produced monolayer graphene-based material (GBM) 
to be graphene oxide (GO). Since around 1840, Schafhaeutl, Brodie, Staudenmaier, and others 
were studying the intercalation (insertion of small molecules in between the graphite layers) and 
exfoliation of graphite with strong oxidizing acids (Figure 1.2). [29] In 1948, G. Ruess and F. 
Vogt, observed few nanometers flakes of GO by transmission electron microscopy (TEM), being 
these studies continued by the group of Ulrich Hofmann, which in 1962, together with Hanns-
Peter Boehm identified some GO fragments as monolayers. [31] The later, proposed the term 
graphene for the first time in 1962 in the following terms, “The ending -ene is used for fused 
polycyclic aromatic hydrocarbons, even when the root of the name is of trivial origin, e.g. 
naphthalene, anthracene, tetracene, coronene, ovalene. A single carbon layer of the graphitic 
structure would be the final member of infinite size of this series. The term graphene layer should 
be used for such a single carbon layer.” [32] In 1997, IUPAC recognized graphene by including the 
following recommendations into their Compendium of Chemical Technology, “previously, 
descriptions such as graphite layers, carbon layers or carbon sheets have been used for the term 
graphene. Because graphite designates that modification of the chemical element carbon, in which 
planar sheets of carbon atoms, each atom bound to three neighbours in a honeycomb-like 
structure, are stacked in a three-dimensional regular order, it is not correct to use for a single layer 
a term which includes the term graphite, which would imply a threedimensional structure. The 
term graphene should be used only when the reactions, structural relations or other properties of 
individual layers are discussed [emphasis added].” In 1999 Ruoff and co-workers 
micromechanically exfoliated graphite into thin lamellae comprising multiple graphene layers. In 
this method, lithographic patterning of highly ordered pyrolytic graphite was combined with 
oxygen-plasma etching to create pillars, which were converted into the thin lamellae by rubbing. 
[29] In 2004, Geim, Novoselov, and co-workers using a similar micromechanical approach, 
followed by repeated peeling of flakes from graphite with scotch tape, finally achieved a single 
layer – graphene, which could be located by optical and electron microscopy and its electric-field 
effects characterized. [33]  
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Figure 1.2: Timeline of selected events in the history of the preparation, isolation, and 
characterization of graphene. Reprinted from reference 29, with permission from Wiley, 
Copyright (2016). 
 
Graphene’s outstanding electronic, mechanical, and thermal properties, amongst others, surprised 
researchers and started a whole new field of research that has been growing ever since, due to its 
vast potential applications. [34-38] Around 2009 several technological companies, like IBM, 
Samsung, and Fujitsu, started investing on graphene-based technology. [21] In 2010, Geim and 
Novoselov were awarded the Nobel prize "for groundbreaking experiments regarding the two-
dimensional material graphene". [39] Realizing the potential of graphene, several governmental 
agencies started investing in graphene from 2011 on. The outputs of industry and governmental 
investment have been arising in the most diverse forms up to date, as for example graphene-based 
inks, water desalinators, transistors, batteries, supercapacitors, sensors, and displays, amongst 
others. [21]  This means that currently and each time more, graphene will be widespread in the 
environment, however, it can be observed from Figure 1.3, that only a tiny fraction of the research 
on graphene field is focused on the biological field. The first publication regarding graphene 
biocompatibility that could be traced, was from 2008, and shown that mouse fibroblasts presented 
a normal morphology and grew at the same rate on top of a graphene paper, as at the surface of 
tissue culture polystyrene. [40] However, graphene-based materials (GBMs) can also be dispersed 
in solution, present different dimensions, degree of oxidation and functionalizations. With the 
arise of new studies of graphene-based materials biological properties, it could be concluded 
that most studies report cell viability decreases inferior to 20% after exposure to GBMs 
concentrations around 10 μg mL−1 during 24 h or longer. Also, the in vivo effect of GBMs 
depends on their physical–chemical properties, concentration, time of exposure, and 
administration route, and also on the characteristics of the animals used. Most studies report no 
occurrence of adult animal death [41], with an exception for the death of a mice due to intravenous 
administration of 0.4 mg GO [42]. However, there are some reports of GBMs accumulation and 
histological findings associated with inflammation, and, more rarely, fibrosis. Small sized GBMs 
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present fast elimination. Existing information on in vivo toxicity mechanisms is still scarce, and 
more studies are needed to support safe biological applications of these materials. Little is known 
about long-term toxicity of GBMs. This is an issue that merits consideration in future studies. 
Also, the effect of GBMs on cell signaling is being studied, and more information should become 
available soon. [41] More detailed information regarding GBMs biological effects can be found on 
Chapter 2. However, in the scope of this thesis, it is important to note that, encapsulation of 
GBMs in a matrix reduces potential toxicity. In addition, incorporation of hydrophilic forms 
improves cell adhesion at the biomaterials surface. Also, some reports of antibacterial properties 
and improved hemocompatibility of GBMs-based composites offer interesting perspectives for 
future research and developments. [41] 
 
 
Figure 1.3: Evolution of the number of publications mentioning graphene and graphene + 
biocompatibility from 2004 to 2016. Source: Scopus; keywords searched: “graphene” - 
“graphene; biocompatibility”; search date: 31/12/2016. The number of “graphene; 
biocompatibility” publications was subtracted from “graphene” ones in the graph. Labels 
on top of the bars show the number of “graphene + biocompatibility” publications. 
 
1.2.3 Poly(lactic acid) 
 
The basic building block for poly(lactic acid) (PLA) is lactic acid, which was first isolated from 
sour milk by Scheele, in 1780, and started to be produced for commercial purposes in 1881. [43] 
PLA was firstly obtained in 1845 by Pelouze, which condensed lactic acid by distillation of water. 
[44, 45] However, because each step of polymerization forms water that degrades the polymer that is 
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being produced, and no method to remove it was known by then, only low molecular weight PLA 
was obtained, which had few or no commercial interest. [46] For that reason, for almost a century, 
research on PLA was focused in trying to produce a polymer with high molecular weight by a 
method with industrial applicability. [45] The most widely used method to obtain PLA, ring-
opening polymerization (ROP) of lactide, was first demonstrated by Carothers in 1932, but high 
molecular weights were not obtained until in 1954, when the purification techniques of lactide 
were developed by Dupont. [44, 46, 47] Due to the high cost of high molecular weight PLA 
production, its use was limited to the biomedical field, as for example in the development of 
sutures, implants, and drug delivery systems. In 1990s, Cargill Inc. found a commercially viable 
lactide ring opening reaction and, in 1997, Cargill Dow LLC was formed between Cargill Inc. and 
The Dow Chemical Company, beginning to significant commercialize high molecular weight 
PLA under the trade name NatureWorks™. [44, 45, 47] Due to its suitable mechanical properties and 
biodegradability, PLA has been regarded as a promising material to replace non-degradable oil-
based polymers. For that reason, it has been used to produce coatings, flexible packaging films, 
rigid packaging containers, cold drink cups, bottles, and injection- and extrusion-moulds, textiles, 
automotive materials, amongst others. [44]   
Despite the existence of the abovementioned early research on PLA’s medical applications, it was 
only after the year 2000, with the beginning of PLA’s widespread commercialization, that the 
outputs of the research on this field increased considerably, as can be observed from Figure 1.4. 
Several PLA-based products are now approved for biomedical applications and contact with body 
fluids by Food and Drug Administration (FDA). This polymer has several applications in 
bioengineering, like the production of bioresorbable artificial ligaments, hernia repair meshes, 
scaffolds, screws, surgical plates, and suture yarns. PLA can also be used in the production of 
drug delivery systems, and in the packaging of pharmaceutical products. To make this material 
more effective in several applications, namely orthopaedic, some properties can be improved, 
being mechanical performance usually the most relevant. Approaches like adjustment of 
crystallinity, incorporation of plasticizers, blends with other polymers and addition of nanofillers 
have been tested. Reinforcement with small amounts of nanofillers is an interesting option 
because it allows improvement of target properties without changing PLA’s main characteristics. 
[48, 49] More detailed information on the subject can be found on Chapters 5-8. 
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Figure 1.4: Evolution of the number of publications mentioning PLA and PLA + medical 
from 1975 to 2016. Source: Scopus; keywords searched: “PLA” - “PLA; medical”; search 
date: 31/12/2016. The number of “PLA; medical” publications was subtracted from “PLA” 
ones in the graph. Labels on top of the bars show the number of “PLA + medical” 
publications. 
 
 
1.3 Motivation and Scope 
 
In 2010, the same year in which Geim and Novoselov were awarded the Nobel prize "for 
groundbreaking experiments regarding the two-dimensional material graphene", we started our 
study on GBMs and GBMs composites, at the Faculty of Engineering of the University of Porto 
research unit LEPABE (Laboratory for Process Engineering, Environment, Biotechnology and 
Energy). The work was initially focused on understanding the physicochemical properties of the 
composites, in particular using PLA as the polymer matrix. About 1 year later, informal 
cooperation in this area started with INEB (National Institute of Biomedical Engineering), 
allowing to extend the work to the study of the materials biocompatibility. A joint application for 
a PhD grant to Foundation for Science and Technology (FCT) – Portuguese Ministry of 
Education and Science, was accepted and Artur Pinto became a PhD research fellow 
(SFRH/BD/86974/2012) since January 2013, with a working plan focused on "Production and 
characterization of composite bioabsorbable biomaterials". 
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When this PhD work started, little information was available regarding GBMs and 
GBMs/composites biocompatibility. However, observing the abovementioned recent findings on 
graphene production methods, properties and potential applications, and early investments of 
several companies on the field, there was no doubt that soon GBMs would play a key role on state 
of the art technology in the most diverse fields.  
Within the scope of an on-going research project (PTDC/EME-PME/114808/2009), led by prof. 
Rui Guedes (FEUP), which goal was the production of bioabsorbable artificial ligaments, PLA 
was being studied as a biomaterial, but its excessive fatigue/creep that leads to laxity was a 
problem. [50] Previously, the base knowledge from work developed at LEPABE on GBMs for 
different applications, and on polymer/nanofillers composites, set the roots for preliminary testing 
of GBMs as fillers to improve the properties of PLA. These studies were regarded with broad 
scope due to this biodegradable polymer having several potential applications (see above). Results 
revealed that PLA performance was improved with incorporation of GBMs, namely in terms of 
mechanical, thermal and gas permeation properties. [51] Thus, our previously acquired knowledge 
on the potential of GBMs as fillers for PLA further strengthened the decision to continue working 
with these fillers to reinforce PLA for biomedical applications. 
The lack of knowledge regarding GBMs biocompatibility, and reports on the toxicity of other 
nanomaterials, [52-54] including the most similar known structures, carbon nanotubes, [55, 56] 
motivated the study of GBMs biocompatibility, both when dispersed in culture media, to allow 
free contact with cells, and when integrated in a PLA matrix, to assure the safety of the 
biocomposite and its viability for biomedical applications. 
For those reasons, this research was focused on developing original work that could contribute 
with pertinent advancements on the field. It started with the production and characterization of 
PLA/GBMs composites, whose methods were further explored and improved, in parallel with the 
characterization of GBMs biological properties when dispersed in liquid media, and the effect of 
their morphology, degree of oxidation, and surface modification with polymers. This work is 
presented in this dissertation, whose outline can be found below. 
 
 
1.4 Dissertation Outline 
 
This thesis is divided into 8 chapters. Chapter 1 is the present introduction, Chapters 2-4 and 6-8 
are based on articles published in peer-reviewed international indexed journals, and Chapter 5 is 
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based on the content of a manuscript in preparation. Figure 1.5, shows a schematic diagram 
illustrating the different topics covered in this thesis and their articulation. 
 
 
Figure 1.5: Schematic diagram illustrating the different topics covered in this thesis and 
their articulation. 
 
• Chapter 2 presents a review of published data regarding the biocompatibility of GBMs 
in order to provide a critical overview of the state of the art. Firstly, the distinct 
physico–chemical nature of the GBMs available is clarified, as well as the production 
methods involved. This chapter also discusses the available in vitro (with bacterial and 
mammalian cells) and in vivo studies concerning evaluation of GBMs biocompatibility, 
as well as existing hemocompatibility studies. The biocompatibility issues concerning 
composite materials that incorporate GBMs are also addressed, since encapsulation in a 
polymer matrix modifies biological interactions. The most pertinent questions that 
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should be addressed in the scope of this work and regarding future works on the field 
are also highlighted. 
 
• Information gathered on Chapter 2 shows that GBMs have recognized potential for 
biomedical applications, but also that different production methods and treatments 
originate divergent biocompatibility. For that reason, Chapter 3 reports the study of two 
commercially available graphene nanoplatelets (GNP), differing in platelet size, GNP-C 
(with 1–2 μm) and GNP-M (with 5 μm). Also, GNP-M was oxidized in different extents 
so that an in vitro study of the effect of oxidation and size on biocompatibility could be 
made. 
 
• Chapter 4 reports further manipulation of GNP biocompatibility, by adsorbing different 
polymers onto its surface. Graphene nanoplatelets (GNP-C) were modified with 
poly(vinyl alcohol), hydroxyethyl cellulose, polyethylene glycol, poly(vinyl 
pyrrolidone), and  glycosaminoglycans (chondroitin, glucosamine, and hyaluronic acid). 
The obtained materials were characterized in terms of physicochemical properties and 
their in vitro biocompatibility is studied. 
 
• Chapter 5 reviews existing information on PLA reinforced with two types of carbon-
based nanofillers (CBNs): carbon nanotubes (CNTs) and graphene-based materials 
(GBMs). It describes the composites production methods, and the effects of CBNs on 
PLA properties, namely mechanical, thermal, electrical and biological properties. 
 
• Chapter 6 presents the production, by solvent casting followed by doctor blading, of 
thin PLA films and composite PLA films incorporating two GBMs – graphene oxide 
(GO) and GNP-M. These films were characterized regarding not only biocompatibility, 
but also mechanical performance, surface topography, chemistry, and wettability.  
Studies on platelet adhesion and activation on PLA and PLA/GBMs films surface are 
also presented. 
 
• Chapter 7 explores a solvent free method (melt blending) to incorporate different 
loadings of GNP-C (0.1–0.5 wt%) in PLA. The effect of varying mixing time and 
mixing intensity is reported and the best conditions identified. An analysis of the 
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physical-chemical properties, with focus on mechanical performance is presented, along 
with the study of the PLA and PLA/GNP-C composites in vitro biocompatibility. 
 
• Chapter 8 complements the work presented in chapter 7. It presents a study on the 
hydrolytic degradation along 6 months, in phosphate-buffered saline at 37 °C, of 
PLA/GNP-C and PLA/GNP-M composites produced by melt-blending at 0.25 wt.% 
loading. Physico-chemical characterization is performed before and after degradation, 
and biocompatibility of the degradation products tested in vitro. 
 
 
• Finally, chapter 9 and 10 present a brief general discussion of the most relevant results, 
in the light of the most recently available literature reports, and the general conclusions 
withdrawn from the work presented in this thesis. Also, ongoing, and future work is 
presented and proposed. 
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2 GBMS BIOCOMPATIBILITY – LITERATURE 
REVIEW 
2.1 Scope 
 
The present chapter focuses on graphene-based materials (GBMs) potential applications in 
biomedical engineering and biotechnology. It presents a review of published data in order to 
provide a critical overview of the state of the art. Firstly, the distinct physical–chemical nature of 
the GBMs available is clarified, as well as the production methods involved. Then it discusses the 
available in vitro (with bacterial and mammalian cells) and in vivo studies concerning evaluation 
of GBMs biocompatibility, as well as existing hemocompatibility studies. The biocompatibility 
issues concerning composite materials that incorporate GBMs are addressed in a separate section, 
since encapsulation in a polymer matrix modifies biological interactions. The most pertinent 
questions that should be addressed in future works are also emphasized. 
 
2.2 State of the art 
2.2.1 Introduction 
 
Graphene, the elementary structure of graphite, is an atomically thick sheet composed of sp2 
carbon atoms arranged in a flat honeycomb structure. It possesses very high mechanical strength, 
surface area and thermal and electrical conductivity. [1-9] However, graphene is hydrophobic and, 
consequently, stable dispersions in polar solvents can only be obtained with addition of proper 
surfactants. [10, 11] Graphene oxide (GO) is similar to graphene, but presents oxygen-containing 
functional groups. [12-17] The presence of these polar and reactive groups reduces the thermal 
stability of the nanomaterial, but may be important to promote interaction and compatibility with 
polar solvents or with a particular polymer matrix. [1, 2, 18-20] Both graphene and GO can be 
modified in order to obtain other graphene-based materials (GBMs) with suitable properties to 
GBMs biocompatibility – literature review  
22                                                                                                       Artur M. Pinto – Jan 2017 
specific applications. [21-28] Some examples of chemical modifications, which will be mentioned 
in this review, are shown in Figure 2.1.  
 
Figure 2.1: Simplified scheme showing graphene and graphene oxide structures and some 
examples of functionalization for both materials. 
 
In the last years there has been a surge in research work on GBMs, with applications in fields as 
diverse as nanoelectronics [29-32], energy technology [33, 34], sensors [35, 36], and composite 
materials [37-39]. Several biomedical applications have also been studied, like 
biosensing/bioimaging [21], drug delivery [18], cancer photothermal therapy [40], and antibacterial 
materials [18]. Furthermore, approaches for applications in biomedical engineering [41, 42], 
regenerative medicine [41, 42], and biotechnology [43] are under study. Some examples of the 
reported advantages of GBMs are: (a) improvement of biomaterials mechanical/electrical 
properties, (b) increase of cellular attachment and growth at biomaterials surface, and (c) 
production of more efficient biosensors. 
In view of the growing interest in using GBMs in medical applications, the issue of 
biocompatibility has gained relevance. This is evidenced in Figure 1.3, which shows the evolution 
in the number of scientific publications mentioning the term “graphene biocompatibility” between 
2004 and 2016. It must be noted that existing information on other carbon-based materials is not 
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necessarily valid for GBMs, due to differences in production methodologies, particle morphology, 
and surface chemistry. For instance, contrary to carbon nanotubes, metal catalysis is not usually 
employed in the synthesis of GBMs, thus, cytotoxicity and inflammation caused by residual 
metals can be avoided. [44, 45] 
GBMs biocompatibility depends on their intrinsic physical–chemical properties. These are 
dependent on the raw materials and production methods used. Sometimes GBMs obtained from 
different sources and/or methods are described using identical designations. [1, 2] 
 
Table 2.1: GBMs and respective production methods. 
Material Production Refs. 
Graphite (Gt) 
Raw material (commercial product) usually from 
different suppliers and with different characteristics 
(e.g. size, purity) 
[54-56, 60-64] 
 
Graphite oxide (GtO) Modified Hummers Method (MHM) [54] 
Graphene oxide (GO) 
MHM 
[54, 55, 60, 61, 
63-69, 73, 74, 
77-79, 85] 
MHM + 7 days dialysis [56] 
Refluxing with sulfuric and nitric acid mixture [86] 
Ultrasonically separated from graphite and modified by 
chloroacetic acid 
[87] 
Ultra small (nGO) 
MHM + functionalization with six-arm branched PEG 
– poly(ethylene glycol) (10 kDa) 
[80] 
(G2xO) Doubly-oxidized 
graphene oxide 
GO lyophilization + Modified Hummers method [64] 
GO–Pluronic hydrogel 
GO 0.5 wt.% solution (Angstrom Materials, OH, USA) 
(46 wt.% C and O) 
 
GO and Pluronic solutions were refrigerated to make 
sol-state solutions placed at 37 °C to make hydrogels 
[82] 
GO functionalized with 
carboxylic groups (GO-COOH) 
(information only available in Chinese) [87] 
PEGylated nano-graphene 
oxide (NGO-SS-mPEG) 
MHM + conjugation of amino-terminated PEG to 
carboxylated NGO sheets via a disulfide bond 
[70] 
Reduced graphene oxide (rGO) MHM + hydrazine reduction (Hr) [54, 55] 
GO nanosheets functionalized 
with fetal bovine serum (FBS) 
MHM + 10% FBS in cell culture medium (adsorption 
by electrostatic and hydrophobic interactions) 
[73] 
Reduced graphene oxide 
(RGO) 
GO rapid thermal heating (>2000 °C min−1, to 
1100 °C) 
[85, 86] 
RGO-PEG 
GO + Hr + PEG-grafted poly (maleic anhydride-alt-1-
octadecene) (C18PMHePEG) non-covalent 
functionalization 
[80] 
nRGO-PEG nGO + Hr + (C18PMHePEG) non-covalent [80] 
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For this reason, it is often difficult to extract general conclusions from existing literature. The 
present work presents a review of the literature available until the current date, regarding the 
evaluation of GBMs biocompatibility, taking care in distinguishing the particular types of 
functionalization 
Polydopamine adhered RGO 
(pRGO) 
GO and dopamine hydrochloride were dispersed in 
PBS by sonication and stirred at 60 °C for 12 h, 
followed by centrifugation and dialysis 
[74] 
Heparin/bovine serum albumin 
grafted pRGO (Hep/BSA-g-
pRGO) 
pRGO was dispersed in PBS by sonication and pristine 
heparin or BSA was added and stirred at 25 °C, 24 h, 
followed by centrifugation and dialysis 
[80] 
1-Naphthalenesulfonate 
functionalized rGO (NA-rGO) 
MHM + NA direct sonication + Hr [57] 
Brilliant blue functionalized 
rGO (BB-rGO) 
MHM + BB direct sonication + Hr [58] 
Graphene sheets (GS) 
Hydrothermal processing of GO in deionized water 
(pH ≈ 3) 
[61] 
Pristine graphene (p-G) Chemical oxidation of graphite + thermal exfoliation [62] 
 
Arc-Discharge Method [84] [83] 
COOH-functionalized graphene 
(f-G) 
Chemical oxidation of p-G [62] 
Functionalized graphene (f-G) Chemical oxidation of p-G [83] 
Graphene dispersed in Pluronic 
aqueous solution (G-Pluronic) 
Natural graphite flakes ultrasonication in Pluronic 
aqueous solution followed by ultracentrifugation 
[78] 
Aggregated graphene (aG) Flocculation with isopropyl alcohol 4:1 of G-Pluronic [78] 
Magnetic multifunctional 
graphene (MFG) 
Magnetic graphene (MG) obtained by GO and 
ferrocene microwave irradiation 
 
MG modified with poly(acrylic acid) and 
fluorescein o-methacrylate (sonication + microwaves) 
[66] 
(PEG-NGS) Poly(ethylene 
glycol) functionalized 
nanographene sheets 
MHM + conjugation via amide formation with amine 
terminated PEG 
[76] 
Amine-modified graphene (G-
NH2) 
GO stirring in SOCl2 and dimethylformamide (DMF), 
dispersing the product in sodium azide and DMF (40 h, 
room temperature) 
[86] 
Methanol derived graphene 
(MDG) 
Sodium hydroxide and methanol supersaturated 
solution 
heating (under flow of argon) 
[59] 
(GNP) Graphene nanoplatelets 
Graphite rapid microwave heating + ultrasonic 
treatment 
[63] 
Graphene oxide nanoplatelets 
(GONP) 
MHM [72] 
Polyethylenimine-grafted 
graphene nanoribbon (PEI-g-
GNR) 
Unzipping of multiwalled carbon nanotubes by a 
MHM 
[71] 
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materials tested. Table 2.1 congregates the GBMs types mentioned along the text, together with a 
succinct description of the corresponding production methods. 
This review focuses on in vitro studies performed with bacterial and mammalian cell models, and 
on in vivo studies performed with animals and embryos. The issue of GBMs hemocompatibility is 
also analyzed. Finally, the existing studies on biocompatibility of GBMs incorporated in 
composite materials are also presented. 
It is relevant to mention that part of the available data regarding GBMs toxicity (mostly in vitro) 
is obtained from studies on its potential use as vehicle in drug delivery. In some cases the authors 
characterize the toxicity of GBMs in conjugation with the drug. [46-50] These studies were not 
included in this review, due to the impossibility in isolating the biological effect of the GBM 
material alone. 
Some studies have been recently published concerning the effect of GBMs on cell signaling. [51-
53] However, this subject is not within the scope of this work. We believe that due to the 
complexity of this topic, it should be reviewed at a later date, when more data are available. 
 
 
2.2.2 In vitro biocompatibility studies 
2.2.2.1 Bacterial cells 
 
The effect of GBMs on bacteria structure, metabolism and viability has been shown to depend on 
the materials’ concentration, time of exposure, and physical–chemical properties, as well as on the 
characteristics of bacteria used in the tests. [54-59] Table 2.2 presents the main results of current 
available studies regarding the effect of GBMs on bacterial cells. Most works report bacterial 
viability decrease after exposure to GBMs. [54-59] Moreover, viability was observed to decrease 
with increase of contact time [54] and GBMs concentration. [54, 55, 59] Some authors consider that 
viability decrease is associated with GBMs causing physical damage on bacterial membranes 
upon direct contact, resulting in the release of intracellular contents. This rupture is originated by 
the blade-like action of low thickness GBMs (a few nanometers) having sharp edges (like GO, 
rGO [54, 55], and BB-rGO [58]). 
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Table 2.2: Effect of GBMs on bacteria viability and membrane integrity. 
Ref Material Particle size Bacterial model Cell viability 
Membrane 
damage 
Liu et 
al. [54] 
GtO 
Length 
(l) ≈ 6.28 μm 
Escherichia 
coli (E. coli) 
GtO ≈ 85%, Gt ≈ 74%, 
rGO ≈ 54%, GO ≈ 31% 
(80 μg mL−1, 2 h) 
Decreases with incubation 
time (results not shown), 
concentration increase and 
size decrease 
Not studied 
(n/s) 
Gt l ≈ 6.87 μm n/s 
rGO l ≈ 2.75 μm Yes 
GO 
Thickness 
(t) <≈0.31 μm 
Yes 
Hu et 
al. [55] 
GO t ≈ 1.1 nm E. coli DH5α 
≈70% (20 μg mL−1, 2 h) 
≈13% (85 μg mL−1, 2 h) 
Yes 
rGO t ≈ 1 nm 
 
≈24% (85 μg mL−1, 2 h) 
Ruiz et 
al. [56] 
GO n/s E. coli 
Cell proliferation: 130% 
(25 μg mL−1, 16 h) 
n/s 
Cai et 
al. [57] 
NA-rGO t ≈ 0.5 nm 
E. coli ≈7.5% (≈100 μg mL−1, 6 h) 
n/s Staphylococcus 
aureus (S. aureus) 
≈11.2% (≈100 μg mL−1, 
6 h) 
Cai et 
al. [58] 
BB-rGO n/s 
E. coli ≈50% (1.2 μg mL−1, 24 h) 
Yes 
S. aureus ≈50% (0.8 μg mL−1, 24 h) 
Pandey 
et al. [59] 
MDG t ≈ 3.5 nm E. coli 
≈70% (20 μg mL−1, 2 h) 
≈55% (40 μg mL−1, 2 h) n/s 
 
Additionally, Liu et al. [54] observed GBMs-induced oxidative stress, in terms of strong time and 
concentration dependent oxidization capacity toward glutathione (GSH), an endogenous 
antioxidant. They also found that when in direct contact with cells, reduced graphene oxide (rGO) 
and graphite (Gt) originate more intense oxidative stress than GO (graphene oxide) and GtO 
(graphite oxide). This is explained taking into account that the reduced forms of graphene are 
good electrical conductors. These authors also asserted that GBMs containing higher density of 
functional groups, and that are smaller in size, have more chances to interact with bacterial cells. 
This results in deposition on cellular surfaces, leading to more pronounced decreases in viability. 
Contrasting to what is suggested in most studies, Ruiz et al. [56] reported increase of E. coli 
proliferation after exposure to GO. The GO used was dialyzed during 7 days after being produced 
by modified Hummer's method. Increase in proliferation was attributed to GO acting as a support 
for bacterial growth. 
It must be noted that purification of the materials used is essential to assure removal of toxic 
contaminants. Information on the procedures adopted in this context is often absent from 
published works. This may mask the effect of contaminations on the results. 
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2.2.2.2 Mammalian cells 
 
Table 2.3 presents the main results of currently available studies regarding the effect of GBMs on 
mammalian cell structure, metabolism and viability. Most studies report cell viability decreases 
inferior to 20% after exposure to GBMs concentrations around 10 μg mL−1 during 24 h or longer 
[57, 60-62, 64, 66, 69, 71-74]. Moreover, most of the studies that considered both the effects of contact 
time [60, 66, 73] and GBMs concentration [57, 60-64, 66, 68, 69, 72-74] conclude that increasing these 
variables leads to a decrease in cell viability. 
Hydrophilic and small GBMs usually penetrate the cell membrane [60, 62, 71-73]. After 
internalization, these materials can lead to cytoplasmatic [60, 73], perinuclear [60, 62] or nuclear 
accumulation [60]. On the other hand, hydrophobic materials are hindered from penetrating into 
the cell membrane due to repulsive interactions or to presenting large hydrodynamic diameters, 
since they tend to agglomerate in physiological medium. [62] Despite not entering the cell, 
hydrophobic GBMs have been reported to cause membrane deformation, destabilize the 
cytoskeleton, and trigger intracellular stress, which may lead to apoptosis. [62] Hydrophilic 
materials may originate similar effects [57, 60], but no relevant toxicity was observed in some 
cases, even after internalization [62, 71]. 
It has been shown that both hydrophobic [61] and hydrophilic [66] GBMs generate reactive oxygen 
species (ROS). This is one of the major factors leading to lipid peroxidation, DNA damage, and 
caspase activation followed by chromatin condensation which eventually leads to cell death via 
apoptosis. 
Additional studies are needed to clarify the effect of the GBMs degree of oxidation on 
biocompatibility. The tendency of hydrophilic (oxidized) materials to penetrate cell membranes 
can be counteracted by physical or chemical functionalization with polymers, in order to increase 
hydrophobicity. As abovementioned, this sort of modification might improve GBMs 
biocompatibility. [71, 74] This issue is discussed further in Section 2.2.5. 
Peng et al. [65] observed that a small decrease in cell viability caused by GO was reversed by 
incubation with fresh medium. Further studies on the fate of GBMs after cell uptake, combined 
with the resultant long term effects of the materials internalization, should be performed. An 
interesting aspect that is lacking from existing studies has to do with the effect of particle size 
(length and thickness) on the biocompatibility of GBMs with similar chemical properties. In 
addition, there are no references in the literature regarding the effect of GBMs surface charge on 
biocompatibility. These have been shown to be relevant issues for cell adhesion and proliferation 
on biomaterial surfaces. [75] 
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Several authors [57, 64, 65-71] employ cancer cell lines to evaluate GBMs cytotoxicity. It is observed 
that in most cases cell viability decrease is lower for this type of cells (Table 2.3). This might 
occur due to cancer cell lines being more resistant to possible damages or metabolic impairment. 
This fact may imply some restraint regarding the significance of the obtained results and of the 
conclusions that may be withdrawn. Furthermore, studies by Rana et al. [68] revealed that GO 
caused different cell viability decreases in two different cancer cell models, for equal 
concentrations. Biocompatibility results may therefore be biased by the cell line used. Care should 
be taken in evaluating the suitability of the cell models. 
 
2.2.3 In vivo biocompatibility studies 
 
There are few in vivo studies concerning the biocompatibility of GBMs (Table 2.4). In the works 
available, radioactive labels are usually used to track GBMs in vivo and study its distribution in 
the body. Histological analysis of the tissues of most relevant organs is often performed, and in 
some cases inflammatory cells and cytokine levels are evaluated. The in vivo effect of GBMs was 
observed to depend on their physical–chemical properties, concentration, exposure time, 
administration route, and on the characteristics of the animals used in the assays [60, 66, 72, 76-82].
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Table 2.3: Effect of GBMs on mammalian cell structure, metabolism and viability. 
Ref Material Particle size Cellular model Cell viability Cell Morphology/Integrity GBMs location 
Wang et 
al. 
[60]
 
GO t ≈ 1 nm Human fibroblasts 
≈80% (<20 μg mL−1, 6d) 
≈60%, cell floating and 
apoptosis (>50 μg mL−1, 6d) 
Decreases with time 
Cells rounded up, detached and 
displayed apoptotic morphology 
(100 μg mL−1, 24 h) 
Membrane vesicles, fragmentation 
and unclear cell boundary 
(20 μg mL−1, 72 h) 
GO appeared in cell 
cytoplasm, around 
nucleus, and a few inside 
nucleus 
Liao et 
al. 
[61]
 
GO 
(HD) Hydrodynamic 
diameter (in 
PBS) ≈ 1.3 μm 
Human skin fibroblasts 
≈80% (200 μg mL−1, 24 h) 
n/s n/s 
GS 
HD (in phosphate 
buffered saline – 
PBS) ≈ 4.3 μm 
≈80% (12.5 μg mL−1, 24 h) 
≈20% (200 μg mL−1, 24 h) 
Sasidharan 
et al. 
[62]
 
p-G 
t ≈ 0.8 nm Vero cells 
≈90% (10 μg mL−1, 24 h) 
≈40% (300 μg mL−1, 24 h) 
Membrane deformation 
Destabilization of F-actin 
alignment 
Aggregation outside 
membrane 
f-G 
≈100% (until 300 μg mL−1, 
24 h) 
Normal Perinuclear concentration 
Pinto et 
al. 
[63]
 
GO 
(O at.% ≈ 22) 
Diameter (d) ≈ 500 nm 
(wrinkled due to hydrogen 
bonds) 
Mouse embryo 
fibroblasts 3T3 
≈70% (1 μg mL−1, 48 h) 
≈50% (10 μg mL−1, 48 h) 
n/s n/s 
GNP 
(O at.% ≈ 8) 
t ≈ 6–8 nm 
l ≈ 5 μm 
Hong et 
al. 
[64]
 
GO 
(O at.% ≈ 38) 
HD (75 mM NaCl, 
48 h) ≈ 200 nm 
Human cervical cancer 
cells Hela 
≈85% (10 μg mL−1, 48 h) 
≈75% (100 μg mL−1, 48 h) 
n/s n/s 
G2xO 
(O at.% ≈ 54)   
≈95% (10 μg mL−1, 48 h) 
≈75% (100 μg mL−1, 48 h) 
Peng et 
al. 
[65]
 
GO t ≈ 0.9 nm HeLa cells 
≈80% (40 μg mL−1, 6 h) 
≈95% (refreshed medium, 
40 μg mL−1, 24 h) 
n/s n/s 
Gollavelli et 
al. 
[66]
 
GO 
t ≈ 1–3 nm 
l ≈ 40–60 nm 
HeLa cells 
≈85% (10 μg mL−1, 48 h) 
≈65% (100 μg mL−1, 48 h) 
Decreases with time 
Lactate dehydrogenase (LDH) 
release increased ≈ 80% 
Apoptotic and necrotic cell death 
<8% (200 μg mL−1, 24 h) 
n/s 
Yang et 
al. 
[67]
 
GO n/s HeLa cells ≈90% (50 μg mL−1, 24 h) n/s n/s 
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Rana et 
al. 
[68]
 
GO t ≈ 1 nm 
CEM 
(human lymphoblastic 
leukemia) 
≈80% (10 μg mL−1, 5 d) 
≈30% (400 μg mL−1, 5d) 
n/s n/s 
  
MCF7-human breast 
cancer 
≈50% (10 μg mL−1, 5 d) 
≈30% (400 μg mL−1, 5 d) 
Yang et 
al. 
[69]
 
GO 
t ≈ 0.8–1 nm 
l < 200 nm 
HeLa cells 
≈100% (10 μg mL−1, 24 h) 
≈80% (500 μg mL−1, 24 h) 
n/s n/s 
Cai et 
al. 
[57]
 
NA-rGO t ≈ 0.5 nm CNE1 cells 
≈90% (10 μg mL−1, 24 h) 
≈80% (100 μg mL−1, 24 h) 
Cell shape became 
irregular (500 μg mL−1, 24 h) 
n/s 
Wen et 
al. 
[70]
 
NGO-SS-
mPEG 
t ≈ 0.87 nm 
d ≈ 220 nm 
HeLa cells 
>100% (50–1000 μg mL−1, 
24 h) 
n/s n/s 
Dong et 
al. 
[71]
 
PEI-g-GNR l ≈ 220–400 nm HeLa cells >95% (24 μg mL−1, 12 h) Apoptotic ratio = 8.8% Enter the cells 
Zhan et 
al. 
[72]
 
GONP 
(labeled 
with 99mT) 
Irregular shape (big 
particle size ≈200 nm) 
ARPE-19 cells (human 
retinal pigment 
epithelium) 
>80% (10 μg mL−1, 72 h) 
>60% (100 μg mL−1, 72 h) 
LDH release 
<5% (100 μg mL−1, 72 h) and 
decreases with time 
Apoptosis rate ≈ 1.5% (similar to 
control) 
Enter the cells (until 
50 μg mL−1, 
≈50 μg mL−1is too 
aggregated) 
Hu et 
al. 
[73]
 
GO 
nanosheets 
t ≈ 1 nm 
A549 (adenocarcinomic 
human alveolar basal 
epithelial) 
≈80%, (20 μg mL−1, 24 h) 
≈50% (100 μg mL−1, 24 h) 
Decreases with time 
Destroys cell membrane and 
directly induces cell death 
Predominantly inside cell 
membrane 
GO 
nanosheets-
FBS 
  
Increased ≈ 30% comparing to 
GO nanosheets (20 and 
100 μg mL−1, 24 h) 
FBS formed a protein corona on 
GO nanosheets surface 
preventing direct interaction 
with the cells 
Normal cells 
Few inside cell 
membrane 
Cheng et 
al. 
[74]
 
GO 
t ≈ 1.038 nm 
d (PBS) ≈ 1429.1 nm 
HUVECS (human 
umbilical vein 
endothelial cells) 
≈95%, (20 μg mL−1, 24 h) 
≈60% (100 μg mL−1, 24 h) 
n/s n/s 
pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1596.8 nm  
≈100%, (20 μg mL−1, 24 h) 
≈70% (100 μg mL−1, 24 h) 
Normal cells n/s 
Hep-g-pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1241.5 nm  
≈110%, (20 μg mL−1, 24 h) 
≈95% (100 μg mL−1, 24 h) 
Normal cells n/s 
BSA-g-pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1131.7 nm  
≈105%, (20 μg mL−1, 24 h) 
≈75% (100 μg mL−1, 24 h) 
Normal cells n/s 
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Most studies report no occurrence of adult animal's death, even for GBMs doses up to 20 mg kg−1. 
[76-82] However, Wang et al. [60] observed that almost half mice population died after intravenous 
(i.v.) administration of GO. When administered by i.v. route, GBMs generally accumulate in MPS 
(mononuclear phagocyte system) – mainly in liver and spleen – and in lung [60, 72, 76-78]. These 
materials are reported to have mostly fecal elimination via bile when accumulated in MPS, and 
renal elimination when particles have sufficiently small sizes [60, 76-78]. Small size GBMs (single 
sheets with diameter of 10 nm or less) present t1/2 (elimination half-life) close to 0.4 h, while t1/2 
for GBMs with larger sizes can be superior to 5 h. [76, 77] There is only one study that reports 
possible long term degradation, using PEG-NGS (PEG-functionalized nanographene sheets). [76] 
Some studies report dose and time dependent inflammation, usually in lung and liver, with cell 
infiltration and in few cases fibrosis [60, 77, 78]. However, Yang et al. [76] did not observe 
appreciable inflammation with PEG-NGS. 
Yang et al. [80] observed that few hours after being administered by oral route, nGO-PEG, RGO-
PEG and nRGO-PEG were present in high quantities in stomach and intestine, but not in other 
major organs. However, after 1 day only low levels were detected in the organs, and no trace was 
detected after 1 week. Thus, these GBMs seem to be poorly adsorbed in gastrointestinal tract, 
presenting fast excretion. Yan et al. [81] reported no clear clinical evidence of ocular changes 
caused by GO intravitreal injection. When subcutaneously injected, a GO-Pluronic hydrogel 
caused mild inflammation after 3 weeks, which reverted later [82]. Finally, Dutch et al. [78] tested 
three different GBMs (GO, G-Pluronic – graphene dispersed in Pluronic aqueous solution, and aG 
– aggregated graphene) by intratracheal administration. They observed that GO caused persistent 
lung inflammation, which was attributed to its ability to increase the rate of mitochondrial 
respiration, and the generation of reactive oxygen species in cells, activating inflammatory and 
apoptotic pathways. Opposingly, mice treated with hydrophobic G-Pluronic presented no signs of 
fibrosis. However, aG, which probably presented larger particle sizes, persisted in the medium or 
small airways of the lung, and induced peribronchial inflammation and mild fibrosis. Li et al. [79] 
also observed that GO caused acute lung injury and mild to severe fibrosis. 
Gollavelli and Ling [66] evaluated the embryotoxicity of GO and MFG (magnetic multifunctional 
graphene) injected in the pole region of Danio rerio and observed minute drop in survival 
comparing to control. The authors also found that both GO and MFG distributed from head to tail, 
despite being observed mainly in the yolk sac region, where they caused edema. Additionally, 
mutations were observed, occurring probably due to interactions with some specific proteins and 
biomolecules. 
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Table 2.4: GBMs in vivo biocompatibility. 
Ref Material Particle size Animal model Animals survival Toxicokinetics Histology 
Wang et 
al. 
[60]
 
GO t ≈ 1 nm 
Kunming mice 
(female, 28–
30 g, 4–5 
weeks old) 
100% (0.1 and 0.25 mg 
per mouse) 
66% (0.4 mg per 
mouse) 
(deaths occurred: 1, 7d) 
(i.v. administration) 
Biodistribution: mainly to lungs, liver and 
spleen 
Not present in brain 
Few in kidney (probably excreted in bile) 
Dose-dependent lung 
inflammatory response 
(neutrophils and foamy alveolar 
macrophage) 
After 7 d: lesions surrounded GO 
After 30 d: Multifocal 
macrophage-containing 
granulomas 
GO in hepatic macrophage 
phagosome 
Yang et 
al. 
[76]
 
PEG-NGS 
(labeled 
with 125I) 
t ≈ 1 nm 
 
l ≈ 10–30 nm 
Balb/c mice 
(female) 
100%, no significant 
body weight drop 
(20 mg kg−1, 3–90 d) 
(i.v. administration) 
t1/2 ≈ 0.4 h (smaller particles) and 7 h 
AUC0–∞ ≈ 4.6 mg min mL−1 
Biodistribution: mainly accumulated on MPS 
(liver and spleen) 
Elimination: renal (small size – single 
sheets d < 10 nm), fecal via bile (accumulated in 
MPS), possible long term degradation by 
oxidative metabolic pathways 
No obvious organ damage 
Liver and spleen turned brown 
(NGS accumulation) 
Reverted after 20 d 
Zhang et 
al. 
[77]
 
GO (labeled 
with 188R) 
t ≈ 1 nm 
 
l = 10–800 nm 
Kunming mice 
100%, no body weight 
drop (1 and 10 mg kg−1, 
14 d) 
(i.v. administration) 
t1/2 ≈ 5 h 
Biodistribution: (48 h) mainly accumulated in 
lungs (≈26% injected dose per gram of tissue 
(%ID/g)) and MPS – liver (≈3%ID/g) and 
spleen (≈2.5%ID/g) 
Elimination: renal – small GO particles, large 
size GO accumulated in lungs 
1 mg kg−1, 14 days: n pathological 
changes (lungs, liver, spleen, 
kidney) 
10 mg kg−1, 14 days: 
granulomatous lesions, pulmonary 
edema, inflammatory cell 
infiltration, and fibrosis 
throughout the lung 
Zhan et 
al. 
[72]
 
GONP 
(labeled 
with 99mT) 
Irregular shape (big 
particle size ≈200 nm) 
Kunming mice 
(female, 15–
18 g) 
100%, no body weight 
drop 
Biodistribution: 
0.3 mL 99mT-GONP 
Histology: 1 mg of 
GONP/mouse 
(i.v. administration) 
Biodistribution; (24 h) Mainly accumulated in 
MPS – liver (≈15%ID/g) and spleen (≈5%ID/g) 
and lungs (≈3%ID/g) 
Elimination: ≈  0.5%, 24 h (feces + urine) 
Observed in stomach (by eyes) 
and in transmission electron 
microscopy (TEM) of chyme and 
gastric tissues 
2 h post i.v.: accumulated in liver 
and phagocytosed by Kupffer 
cells, little observed in lung/spleen 
Duch et GO 
t = 0.5–2 nm 
 
C57BL/6 mice 
(8–12 week 
100%, no body weight 
drop (50 μg/mouse in 
(Intratracheal administration) 
Leakage of protein into the alveolar space, 
After 21 d: 
Persistent lung inflammation 
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al. 
[78]
 Area 
(90%) ≤ 25,000 nm2 
old, 20–25 g, 
male) 
50 μL, 24 h) bronchoalveolar lavage (BAL) fluid 
pleiocytosis, ↑pro inflammatory cytokines, 
hyaline membrane formation 
Induction of prothrombotic state 
Increase in apoptosis 
ROS after uptake into macrophages 
Little evidence of lung fibrosis 
G-Pluronic 
t = 1.2–5 nm 
Areas 
(90%) ≤ 25,000 nm2 
  
Contains more macrophages with a black 
cytoplasm than aG (better distribution in lung) 
No evidence of fibrosis (21 days) 
aG n/s   
Persisted in medium/small airways 
Macrophages with black cytoplasm 
Induced peribronchial 
inflammation and mild fibrosis (21 
days) 
Li et 
al. 
[79]
 
GO (labeled 
with 125I) 
t ≈ 1 nm 
 
d = 10–800 nm 
KunMing mice 100% 
(Intratracheal administration) 
(10 mg kg−1, 24 h) 
Biodistribution: (10 min) ≈ 70% remained in 
lung, (2 h) ≈ 20% remained in lung, (6 h) NGO 
may pass through the air–blood barrier and be 
delivered to other organs mainly liver and 
intestine. 
Elimination: higher concentration in urine 
observed within 6 h 
Sheets with small sizes can penetrate the 
alveolar–capillary barrier and be quickly 
eliminated by a renal route 
Acute lung injury with the greatest 
severity at 48 h being then 
alleviated 
1 week: fibroproliferation and 
organization of lung tissue – 
emergence of lung fibrosis 
1–3 months: consolidation of the 
lung and an accumulation of 
alveolar macrophages 
Yang et 
al. 
[80]
 
(labeled 
with 125I) 
GO 
t ≈ 0.94 nm 
d = 450 nm 
Female balb/c 
mice 
100% 
(Oral route) (4 mg kg−1) 
4 h: high levels of nGO-PEG, RGO-PEG and 
nRGO-PEG in stomach and intestine, but not in 
other major organs; 1 day: low levels in all 
organs; 1 week: undetectable. 
(Intraperitoneal injection) (4 mg kg−1) 
1 and 7 days: high accumulation in liver and 
spleen, RGO-PEG with larger sizes showed 
nearly 2 fold RES uptake compared to smaller 
nGO-PEG and nRGO-PEG at day 7 
(Oral route) (100 mg kg−1) 
30 days: PEGylated GO 
derivatives were not adsorbed by 
organs and were rapidly excreted 
(Intraperitoneal injection) 
(50 mg kg−1) 
30 days: PEGylated GO 
derivatives (but not GO) were not 
engulfed by phagocytes in the 
RES system (size and surface 
coating) 
Long-term retention occurred for 
injected GO and PEGylated GO 
No significant toxicity was noticed 
nGO-PEG 
t ≈ 1.22 nm 
d = 25 nm 
RGO-PEG 
t ≈ 4.43 nm 
d = 50 nm 
nRGO-PEG 
t ≈ 5.66 nm 
d = 27 nm 
Yan et 
al. 
[81]
 
GO t ≈ 1  nm 
Japanese white 
rabbits 
100%, no body weight 
drop (0.1, 0.2 and 
(Intravitreal injection) 
No clear clinical evidence of ocular changes 
Very small amount of residue in 
the eye 
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(2−3 kg) 0.3 mg GO in 0.1 mL 
BBS) 
No influence on IOP 
Negligible ERG changes 
No apparent damage to retinal 
morphology 
Sahu et 
al. 
[82]
 
GO-Pluronic 
hydrogel 
Single layer 
d < 500 nm 
Female 
BALB/c mice 
(female, 6–7 
weeks) 
100%, no body weight 
drop (do not refer 
which quantity is 
injected) 
(Subcutaneous injection) 
No noticeable degradation was observed 
No signs of acute inflammation, 
tissue necrosis, hemorrhaging or 
hyperemia 
After 3 weeks: Migration of a few 
macrophages into the gel – suggest 
mild chronic inflammation 
After 8 weeks: the number of 
macrophages indicated a time 
dependent healing of the early sign 
of inflammation 
Gollavelli 
et al. 
[66]
 
GO 
t ≈ 1–3 nm 
l ≈ 40–60 nm 
Wild-type AB 
strains of 
zebrafish 
embryos 
Drop in survival was 
relatively minute 
comparing to control 
(n = 50) 
Effects were evaluated 
until 72 h post-
fertilization (hpf) 
(10 nl volume was microinjected into the pole 
region, stages 1–3) 
For 0.05 ng nl−1: 4% yolk sac 
edema and 6% tail or spinal cord 
flexure 
For 0.1 ng nl−1: 6% yolk sac 
edema and 2% of cardiac 
malfunction 
MFG 
t ≈ 4–6 nm 
l ≈ 40–60 nm 
(Same conditions as for GO) 
Distribution: from head to tail. Mainly observed 
in the yolk sac region, blood vessels, brain 
ventricle, and other organs 
For 0.05 ng nl−1: 9% yolk sac 
edema and 8% tail flexure 
For 0.1 ng nl−1: 12% yolk sac 
edema and 6% of cardiac 
malfunction 
Mutations occur 
i.v., intravenous; t1/2, elimination half-life; AUC0–∞, area under the curve after a single dose; MPS, mononuclear phagocyte system; %ID/g, percent injected dose per gram 
of wet tissue; BBS, balanced buffer solution; IOP, intraocular pressure; ERG, electroretinography; hpf, hours post-fertilization; RES - reticuloendothelial system. 
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As abovementioned, there are not many studies concerning in vivo biocompatibility of GBMs. 
More detailed characterization and mechanistic toxicity studies are essential for safer design and 
production of GBMs, in order to optimize potential biological applications of these materials with 
minimal risks for health. 
 
2.2.4 Hemocompatibility 
 
Several biomedical applications are being studied for GBMs (e.g. drug delivery, contrast imaging, 
cancer thermal ablation, biosensors, implants). [36, 37, 41-43] In this context, hemocompatibility 
studies are necessary to assess if intravenous administration or implantation of GBMs is safe. 
Even so, there is a relatively low number of studies on this subject (Table 2.5). Most of the 
available literature considers GBMs to be hemocompatible. These materials are described as not 
causing hemolysis, platelet activation, and changes in coagulation or hematological markers 
abnormalities. [76, 77, 83, 87]. However, Singh et al. [85, 86] reported that GO caused strong platelet 
aggregation and extensive thromboembolism in mice. Interestingly, much less platelet 
aggregation occurred with RGO. [86] Moreover, amine-modified graphene (G-NH2) did not show 
stimulatory effects on human platelets or thromboembolism and did not induce erythrocyte lysis. 
[86] Sasidaram et al. [83] observed that peripheral blood mononuclear cells (PBMCs) treated with 
p-G expressed more IL-8 and IL-6 than PBMCs exposed to f-G. These results oppose those 
obtained by Singh et al. [86], mentioned before, where GO revealed lower hemocompatibility than 
RGO. Additionally, high GO concentrations (>100 μg mL−1) were shown to cause erythrocyte 
lysis, while with low concentrations (<10 μg mL−1) no effect was observed. [74, 77] In our 
unpublished work, GNP and GNP oxidized by modified Hummers method did not cause lysis of 
red blood cells when incubated in concentrations up to 200 μg mL−1. The effect of GBMs 
physical–chemical properties and concentration on hemocompatibility deserves further attention, 
in order to clarify conflicting results and pending questions. 
 
2.2.5 Biocompatibility of composite materials containing 
GBMs 
 
GBMs can be incorporated in different polymer matrices in order to improve relevant properties, 
namely mechanical [88-89], thermal [88-89], and electrical [90]. 
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Table 2.5: GBMs hemocompatibility. 
Reference Material Particle size Hemocompatibility 
Sasidharan 
et al. [83] 
p-G t ≈ 0.4 nm 
Hemolysis: both (p-G and f-G) did not interfered with 
RBC membrane integrity 
Platelet activation/aggregation: both did not interfere 
with natural platelet functioning 
Coagulation studies: both did not interfere with 
intrinsic or extrinsic pathways of coagulation 
f-G (n/s) 
Pro-inflammatory cytokines: p-G treated peripheral 
blood mononuclear cells (PBMCs) express relatively 
higher levels of IL-8 and IL-6, comparing to f-G treated 
PBMCs 
Singh et 
al. [85] 
GO 
Single or few layer 
d ≈ 0.2–5 μm 
GO caused strong aggregatory response in platelets 
through activation of Src kinases and release of calcium 
from intracellular stores 
GO i.v. administration induced extensive pulmonary 
thromboembolism in mice (Swiss, 8–12 weeks, male) 
RGO (n/s) RGO was much less effective in aggregating platelets 
Singh et 
al. [86] 
G-NH2 
Single and few layer 
l ≈ 2 μm 
No platelet aggregation (2 μg mL−1) 
No effect on [Ca2+]i (intracellular free calcium) 
(10 μg mL−1) 
Did not evoked cytosolic proteins or tyrosine 
phosphorylation 
Did not increased ROS (2 μg mL−1) 
Did not evoked significant lysis of erythrocytes 
(50 μg mL−1) 
(i.v., 250 μg kg−1) No pulmonary thromboembolism in 
mice (Swiss male mice, 8–12 weeks old) 
GO 
Size distribution similar to G-
NH2and RGO (flow 
cytometry) 
≈90% platelet aggregation (2 μg mL−1) 
[Ca2+]i ↑4× (2 μg mL−1) 
Evoked strong tyrosine phosphorylation 
ROS ↑2× (2 μg mL−1) 
Evoked significant concentration dependent lysis of 
erythrocytes (2–10 μg mL−1) 
(i.v., 250 μg kg−1) Occlusion of large number of lung 
vessels with platelet thrombi 
RGO Similar to G-NH2and GO 
≈15% platelet aggregation (2 μg mL−1) 
[Ca2+]i ↑2× (2 μg mL−1) 
Zhang et 
al. [77] 
GO (labeled 
with 188R) 
t ≈ 1 nm 
l = 10–800 nm 
Little effect on erythrocyte morphology and membrane 
integrity (10 μg mL−1 for 1 and 4 h) 
A part of erythrocyte membranes were ruptured and 
ghost cells were observed (80 μg mL−1 for 4 h) 
No significant difference was found between RBC 
exposure to PBS and GO (10–80 μg mL−1 for 1 h) 
Yang et 
al. [76] 
PEG-NGS 
(labeled with 
Cy7) 
t ≈ 1 nm 
l ≈ 10–30 nm 
Normal hematology markers (20 mg kg−1, unlabeled, 3, 
40, and 90d p.i.) 
Dong et 
al. [87] 
GO 
GO-COOH 
(information only available in 
Chinese) 
GO-COOH recalcification time increased 11 min 
(1.25 μg mL−1) 
GO-COOH hematolysis ratio was less than 5% (0.5–
100 μg mL−1) 
GO-COOH anti-clotting properties better than GO, due 
to direct complexation between carboxyl group and 
clotting factors 
Cheng et 
al. [74] 
GO 
t ≈ 1.038 nm 
d (PBS) ≈ 1429.1 nm 
Hemolysis: GO hemolysis ratio of 2.3% (5 mg mL−1) 
and 78.5% (200 mg mL−1) 
pRGO, Hep/BSA-g-pRGO hemolysis ratio < 2% 
(200 mg mL−1) 
Activated partial thromboplastin time (APTT): slightly 
increases in presence of GO (attributed to COOH) 
gradually increases with Hep-g-pRGO concentration 
pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1596.8 nm 
Hep-g-pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1241.5 nm 
BSA-g-pRGO 
t ≈ 1 nm 
d (PBS) ≈ 1131.7 nm 
 
Table 2.6 introduces the composite types mentioned in the existing biocompatibility studies. In 
the case of biomedical applications, the incorporation of GBMs should not decrease 
 GBMs biocompatibility – literature review 
Artur M. Pinto – Jan 2017                                                                                                                                  37 
biocompatibility, and desirably would inhibit bacterial growth on the surfaces and reduce 
thrombogenicity. These issues are addressed below. 
 
Table 2.6: Types of GBMs composites used in biocompatibility studies and respective 
production methods. 
Type of 
composite 
Matrix GBM filler 
GBM 
production 
method 
Composite 
production 
method 
Ref 
PLGA/GO 
nanofibers 
PLGA – Poly(D,L-
lactic-co-glycolic 
acid, 1:1) 
GO MHM Electrospinning 
Yoon 
et 
al. [91] 
PLGA/GO 
films 
PLGA GO MHM Spin coating 
Yoon 
et 
al. [92] 
PLA/HA/GO 
nanofibers 
PLA – poly(lactic 
acid) 
Mw = 26,000 g mol
−1 
GO and 
hydroxyapatite 
(HA, 99% 
purity d = 20–
40 nm) 
MHM Electrospinning 
HaiBi
n et 
al. [93] 
PLA/GO and 
GNP films 
PLA (96% L-
lactide) 
Mw = 121,400 g mo
l−1 
GO (O 
at.% ≈ 22) 
MHM 
Solvent 
casting + doctor 
blading 
Pinto 
et 
al. [63] 
GNP (O 
at.% ≈ 8) 
XG Sciences, 
USA 
(commercial 
product) 
UHMWPE/G
NP films 
Ultra-high 
molecular weight 
poly (ethylene) – 
UHMWPE 
films d = 20−30 μm 
GNP 
XG Sciences, 
USA 
(commercial 
product) 
Electrostatic 
powder coating 
Lahiri 
et 
al. [94] 
CS/N-GS 
films 
Chitosan (CS) 
degree of 
deacetylation 
(DD) > 90% 
N-doped 
graphene sheets 
(N-GS) 
Arc-discharge 
[96] using 
NH3 as one of 
the buffer 
gases 
Solvent casting 
Fan et 
al. [95] 
CS/GO 
scaffolds 
CS 50 kDa 
DD = 80% 
GO Not mentioned 
Solvent casting 
(GO –COOH 
cross-linking with 
CS –NH2) + freeze-
drying 
Depan 
et 
al. [97] 
PVA/GO 
scaffolds 
PVA – Poly(vinyl 
alcohol) 
GO MHM 
Solvent 
casting + freeze-
drying 
Zang 
et 
al. [98] 
PVA/GO and 
R-PVA/GO 
films 
PVA Mw ≈ 80,000 
GO MHM 
Solvent casting self 
assembling of PVA 
coated onto GO 
sheets 
Li et 
al. [99] RGO 
Films reduced 
with 
hydroiodic 
acid 
RGO/CL 
papers 
Cellulose (CL) GO MHM 
Solvent mixing of 
GO with cellulose; 
reduction of GO by 
cellulose with the 
assistance of 1-
butyl-3 
methylimidazolium 
chloride + filtration 
Peng 
et 
al. [10
0] 
GO and 
graphene/PAN
Polyaniline (PANI) GO 
Pre-oxidation 
of 
Preparation of GO 
papers by 
Yan 
et 
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I papers graphite + MH
M 
filtration + immersi
on of GO papers in 
an aniline solution 
in which a 
polymerization 
reaction was 
recently induced 
al. [10
1] 
Graphene 
Hr of GO-
PANI paper 
PVK/GNP 
composites 
and films 
poly(N-
vinylcarbazole) – 
PVK 
GNP 
XG Sciences, 
USA 
(commercial 
product) 
Solvent 
mixing + PVK/GN
P composites 
electrodeposition at 
indium tin oxide 
(ITO) surfaces 
Spin coating of 
ITO surfaces with 
pristine GNP 
(control) 
Santo
s et 
al. [10
2] 
GO/rGO-DS-
PLL and PET-
GO-DS-PLL 
films 
(poly-L-lysine) – 
PLL Mw = 30,000–
70,000 
GO MHM Functionalization 
of GO and rGO 
with benzene 
diazonium salt 
(DS) to generate 
more -COOH 
groups 
+ 
composites with 
PLL prepared by 
mixing in aqueous 
solution 
+ 
spin coating of 
glass cover slips 
with 100 μL of 
1 mg mL−1 
dispersions 
 
Pre-plasma treated 
PET coated with 
250 μL of 
1 mg mL−1GO-DS-
PLL 
Some 
et 
al. [10
3] 
rGO Not mentioned 
Solid culture 
mediums with 
GBMs 
composites 
CS 
Small area GO 
(sGO) 
Obtained from 
graphite 
powder 
(MHM) 
Solvent casting 
(1.0 wt% chitosan 
solution added with 
0.3 wt% GBMs) 
+ 
preparation of 
broth solutions 
with 2% GBMs 
Petri dish: 100 μl 
broth 
solution + 15 mL 
trypticase soy agar 
Lim 
et 
al. [10
4] 
Large area GO 
(hGO) 
Obtained from 
graphite flakes 
by a simplified 
hummers 
method [105] 
rGO 
NaOH, 80 °C, 
overnight 
Polyurethane 
(PU)/functiona
l graphene 
oxide 
nanocomposit
e films 
(PU/GO-g-
pMPC) 
PU 
Graphene oxide 
functionalized 
with 2-
(methacryloylox
y) ethyl 
phosphorylcholi
ne 
 
(GO-g-pMPC) 
GO was 
obtained from 
graphite 
powder by 
Modified 
Brodie 
Method [107] a
nd GO-g-
pMPC was 
GO-g-pMPC 
powders were 
dispersed in 
dimethylformamide 
(DMF) by 
sonication and then 
dispersed in a PU 
dispersion by the 
same method 
Su-
xing 
et 
al. [10
6] 
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synthesized by 
reverse atom 
transfer radical 
polymerization 
in alcoholic 
media using 
peroxide 
groups as 
initiator 
PU and PU/GO-g-
pMPC films were 
obtained by solvent 
evaporation at 
100 °C 
Cotton-GO 
fabrics 
Cotton GO MHM 
Adsorption 
(Cotton-GO), 
radiation-induced 
crosslinking 
(Cotton-rx-GO) 
and chemical 
crosslinking 
(Cotton-cx-GO) 
Zhao 
et 
al. [10
8] 
 
2.2.5.1 Mammalian cells 
 
Table 2.7 presents several studies in which the biocompatibility of GBM-based composites is 
assessed. Most studies show that the toxic effect of the fillers is reduced when incorporated in 
biomaterials [63, 100-102], due to minimization of direct biological interactions with the 
encapsulated materials. GO usually increases surface hydrophilicity of the biocomposites [63, 91-
93], therefore improving biocompatibility [63, 91, 92] by providing potential adhesion sites, like 
hydroxyl groups [97]. Additionally, incorporation of GO may create a more favorable surface 
topography toward cell adhesion [93]. Hydrophobic GBMs have been reported to not change [63] or 
cause reduction [96] of cell proliferation at the surface of biocomposites. 
 
Table 2.7: Biocompatibility of GBMs composites. 
Ref Material Size Biocompatibility 
Yoon et 
al. [91] 
PLA/GO 1 and 
2 wt.% nanofibers 
GO (t = 1.5 nm, l ≈ 1 μm) 
Nanofibers (length = 11–
14 μm) 
Cell proliferation: (PLGA = 100%, 
PLGA/GO 1 wt.% ≈ 102%, PLGA/GO 
2 wt.% ≈ 108%, 48 h) 
(PC 12 cells) 
Yoon et 
al. [92] 
PLGA/GO films 
GO (not mentioned) 
Films (t ≈ 5 μm) 
Cell proliferation: small increase (≈10%) 
comparing to PLGA for PLGA/GO 2 wt.% 
(48 h) (Hela cells) 
HaiBin 
et 
al. [93] 
PLA/HA 
(10 wt.%)/GO 
nanofibers 
GO (few layer) 
PLA/HA/GO (d = 0.3–
1.3 μm) 
Cell proliferation: 1, 2 and 5 wt.% GO ↑cell 
proliferation, comparing to PLA/HA (24 h) 
Only nanofibers with 5 wt.% GO presented 
higher proliferation than PLA/HA (48 h) 
(MC3T3-E1 cells) 
Pinto et 
al. [63] 
PLA/GO films 
(0.4 wt.%) 
d ≈ 500 nm 
Films (t = 25–65 μm) 
Cell proliferation: no variations until 48 h, 
except for PLA/GO after 24 h (more 13% 
than pristine PLA) 
(mouse embryo fibroblasts 3T3 – ATCC 
CCL-164) 
Hemocompatibility: less platelets activated in 
PLA/GNP films 
(0.4 wt.%) 
GNP (t ≈ 6–
8 nm, l ≈ 5 μm) 
Films (t = 25–65 μm) 
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PLA/GNP comparing with PLA in presence 
of plasma proteins (human platelets 
concentrate) 
Lahiri 
et 
al. [94] 
UHMWPE/GNP 
films 
GNP (t = 6–
8 nm, l = 5 μm) 
Films (t = 200 μm) 
Cell proliferation: UHMWPE/GNP 0.1 wt.% 
↓6, 14 and 17%, UHMWPE/GNP 1 wt.% 
↓43, 69 and 87% comparing to pristine 
polymer after, respectively, 1, 3 and 5 d. 
(osteoblasts, ATCC) 
Fan et 
al. [95] 
CS/N-GS films 
Films (t = not mentioned) 
GS (2–6 
layers, l ≈ 500 nm) 
Cell proliferation: = for CS and CS/N-GS 
0.1–0.6 wt.% (24 and 48 h) 
Cell adhesion: completed at 6 h for CS/N-GS 
0–0.3 wt.%, at 9 h for 0.6 wt.%, at 12 h was 
similar for every concentration and reached 
80% 
Morphology: no differences for every 
concentration (24 h) (L929 fibroblasts) 
Depan 
et 
al. [97] 
CS/GO 1 and 
3 wt.% scaffolds 
GO (t = 1.3 nm, d ≈ 2μm) 
Pore diameter = 100–
120 μm 
 
Porosity 84–91% 
Cell adhesion: ↑CS/GO than CS (7 d) 
Cell viability: ↑CS/GO than CS scaffolds (9 
and 21d) 
Degradation products: cell viability was 
higher after 48 h (mouse pre-osteoblast 
MC3T3-E1, ATCC) 
Zhang 
et 
al. [98] 
PVA/GO 0–1 wt.% 
scaffolds 
PVA (any information) 
GO (t = several layers) 
Cell adhesion: 1 d – most adhered to PVA 
and PVA/GO 0.4%, PVA/GO 1% – did not 
adhere and appear spherical; 3 d – almost 
completely flat and spread out and fewer cells 
are observed for all samples; 5 d – no 
differences in the cell morphology or the 
number of cells. (osteoblasts) 
Li et 
al. [99] 
PVA/GO films 
 
Reduced (R)-
PVA/GO films 
GO (t = 1.3–
1.7 nm, l = several 
hundred nm to several 
μm) 
PVA/GO films 
(t ≈ 10 μm) 
R-PVA/GO films 
(t ≈ 7.5 μm) 
Cell adhesion: 2.5 h – 56% adhered to R-
PVA/GO films, 49% adhered to common 
tissue culture polystyrene (TCPS) 
Cell viability: 72 h – ↑PVA R-PVA/GO films 
than on TCPS (human umbilical vein 
endothelial cells – HUVECs) 
Peng et 
al. [100] 
RGO (24 wt.%)/CL 
papers 
GO (t = 1 nm) 
 
RGO/CL papers 
(t = 1.9 nm) 
Cell viability: very few necrotic cells on 
RGO/CL, necrosis in RGO (24 h) (HeLa 
cells) 
Yan et 
al. [101] 
GO/PANI paper 
 
Graphene/PANI 
paper 
Both papers (t = 4–5 μm, 
distance between 
layers = 100–200 nm) 
Cell viability: 2 d – 71% GO, 77% GO/PANI, 
75% graphene, 84% graphene/PANI; 4 d: 
92% GO, 97% GO/PANI, 92% graphene, 
100% graphene-PANI. (Fibroblasts L-929 
cells) 
Santos 
et 
al. [102] 
PVK/GNP 
composites 
 
PVK/GNP films 
 
PVK films 
 
GNP films 
GNP (t = 1.8 nm, l = 10–
20 μ) 
Films (t = 150 nm) 
Cell viability: GNP ≈ 60%, PVK ≈ 90%, 
PVK/GNP 3 wt.% composites ≈ 80%; 
concentrations of 1.0 mg mL−1 in culture 
medium (NIH 3T3 Fibroblasts, Univ. 
Wisconsin-Madison) 
Antibacterial properties: (E. coli and B. 
subtilis) 
Cell viability: after 1 h – PVK > 85%, 
GNP < 30% (concentrations of 
1.0 mg mL−1 in culture medium), PVK/GNP 
3 wt.% composites <90%, <90%, <20%, 
<10%, respectively for 0.01, 0.05, 0.5 and 
1 mg mL−1 in culture medium. 
Biofilm formation: inhibited at PVK/GNP 
and GNP films surfaces 
Some et GO/rGO-DS-PLL 
 
Cell proliferation: ↑GO-PLL, GO-DS-PLL 
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al. [103] films 
 
PET-GO-DS-PLL 
films 
and rGO-DS-PLL than PLL and GO (non-
small cell lung carcinoma A549 and human 
adipose derived stem cells) 
Antibacterial properties (E. coli DH5-α): 
 
Live dead: control 4%, GO-DS-PLL 97% 
dead cells (25 μg mL−1) 
Cell viability: E. coli = 100% (control), GO-
PLL, rGO-DS-PLL, GO-DS-PLL ≈ 0; 
PLL ≈ 43%, rGO-PLL ≈ 52%, GO-DS 78%, 
rGO 87%, GO 96%, rGO-DS 104% 
(25 μg mL−1) 
Biofilm formation: PET-PLL presented 
bacterial growth contrarily to PET-GO-DS-
PLL. 
Lim et 
al. [104] 
Solid culture 
mediums with 
GBMs composites 
sGO (l = 5 μm) 
hGO (l = 100 μm) 
Cell viability: P. aeruginosa = 0% CS/srGO 
and hrGO; for CS/sGO and hGO growth was 
not suppressed 
Su-xing 
et 
al. [106] 
PU/GO-g-pMPC 
films 
GO-g-pMPC (t ≈ 1 nm) 
Hemocompatibility: PU/GO-g-pMPC films 
(in plasma) showed improved resistance to 
nonspecific protein adsorption and platelet 
adhesion (comparing with PU) 
Zhao et 
al. [108] 
Cotton-GO 
Cotton-rx-GO 
Cotton-cx-GO 
t ≈ 1.1 nm 
Bacteria: E. coli and B. subtilis ≈ 0% (4 h, 
37 °C), membrane damage occurred in E. 
coli, it was not studied for B. cereus 
Rabbits: no evidence of significant irritation 
in a skin irritation test until 72 h 
 
The composite production method may influence biocompatibility. Cell proliferation at the 
surface of graphene nanoplatelets (GNP) composites produced by electrostatic powder coating 
decreased due to leaching of the filler [94], which was shown to be toxic [63]. However, for 
materials produced by solvent mixing no changes in cell proliferation were observed, since GNP 
was effectively embedded in the polymer matrix [63]. Hydrophilic GO released by degradation of 
chitosan (CS) scaffolds was found to be non-toxic [97]. 
 
2.2.5.2 Bacterial cells 
 
Since it has been reported that some GBMs have antibacterial properties, it is relevant to address 
if incorporation of GBMs in polymer matrices decreases bacterial proliferation at the composite 
surface. This is an important issue because infection is frequent in biomaterial implantation 
procedures. [109] 
In a few studies, the incorporation of both hydrophilic and hydrophobic GBMs (GO, rGO, GNP) 
in polymer matrixes [PLL – poly-l-lysine, CS, PVK – poly(N-vinylcarbazole)] was shown to 
decrease bacterial cell viability. [102-104] This was explained by GBMs causing direct damage [102, 
104] on cell membrane and/or by oxidative stress. [104] This effect was enhanced in the reduced 
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form of the materials, due to stronger interaction between the more sharpened edges of the sheets 
and the bacteria's cell membrane and/or better charge transfer between the bacteria and the edge 
of the GBMs. [104] 
The ideal biocomposite should inhibit bacterial growth at the surface, while promoting cell 
attachment and proliferation. [104] However, conjugation of these two effects is not evident and 
must be evaluated for each case. As an example, Santos et al. [102] observed that incorporation of 
GNP on PVK matrix decreased biofilm growth but simultaneously caused a slight decrease in cell 
viability. Additionally, Zhao et al. [108] observed that cotton fabrics modified with GO inhibit 
almost completely bacteria proliferation and that the fabrics caused no irritation to rabbit skin 
after 72 h contact. 
 
2.2.5.3 Hemocompatibility 
 
Hemocompatibility studies are relevant to assess whether implantation of composites with GBMs 
is safe (see Section 2.2.4). In our previous study [63] the hemocompatibility of PLA composite 
films was evaluated. Results showed that less adherent platelets were activated in PLA/GNP films 
comparing with pristine PLA films, in the presence of plasma proteins. Hydrophobic GNP 
seemed to favor albumin adsorption, which blocked platelet activation. Su-xing et al. [106], 
observed that PU/GO-g-pMPC films showed improved resistance to nonspecific protein 
adsorption and platelet adhesion, in the presence of plasma proteins, comparing with pristine PU 
films. 
These results suggest that incorporation of GBMs in biomaterials may decrease their 
thrombogenicity. However, further studies are needed to clarify whether these fillers can indeed 
be used to prevent thrombus formation associated with implantation procedures. 
 
2.3 Conclusions 
 
Most existing works report bacterial viability decrease after exposure to GBMs. Often, 
physical damages occur upon direct contact of bacterial membranes with sharp edges of 
graphene sheets. Additionally, oxidative stress has been observed. GBMs with small particle 
size and in oxidized state seem to present higher antibacterial effect. 
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Studies frequently show that mammalian cell viability decreases slightly after exposure to 
GBMs. These materials were shown to induce oxidative stress and apoptosis. The most 
hydrophilic forms of GBMs were found to penetrate the cellular membrane. Even so, these 
materials were found to be generally less toxic than hydrophobic forms, which accumulate 
on cell membrane surfaces. One issue that has not yet been addressed is the effect of particle 
size on cell viability, for the same type of GBMs. 
The in vivo effect of GBMs depends on their physical–chemical properties, concentration, 
time of exposure, and administration route, and also on the characteristics of the animals 
used. Most studies report no occurrence of adult animal death. However, there are some 
reports of GBMs accumulation and histological findings associated with inflammation, and, 
more rarely, fibrosis. Small sized GBMs present fast elimination. Existing information on in 
vivo toxicity mechanisms is still scarce, and more studies are needed to support safe 
biological applications of these materials. 
Most of the available literature considers GBMs to be hemocompatible, but, again, further 
work is needed for confirmation. 
Encapsulation of GBMs in a matrix reduces potential toxicity. In addition, incorporation of 
hydrophilic forms improves cell adhesion at the biomaterials surface. Some reports of 
antibacterial properties and improved hemocompatibility in GBM-based composites offer 
interesting perspectives for future research and developments. 
Little is known about long-term toxicity of GBMs. This is an issue that merits consideration 
in future studies. Also, the effect of GBMs on cell signaling has just started being studied, 
and more information should become available soon. 
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3 GBMS BIOCOMPATIBILITY – EFFECT OF 
PARTICLE SIZE AND DEGREE OF 
OXIDATION 
3.1 Scope 
 
Graphene-based materials (GBMs) have recognized potential for biomedical applications, 
however different production methods and treatments originate divergent biocompatibility. In this 
chapter, two commercially available graphene nanoplatelets (GNP) were studied, differing in 
platelet size. The effect of oxidation is known to change GBMs physico-chemical properties, thus 
affecting its biointeractions. For those reasons, the effect of oxidation and size on 
biocompatibility was evaluated in vitro. GBMs biocompatibility was studied in terms of 
hemolysis potential, induction of reactive oxygen species production, metabolic activity changes, 
effect on cell morphology, evaluation of membrane damages and particles internalization. The 
studies were performed using two different cell models, human fibroblasts, and pulmonary 
microvascular endothelial cells.  
 
3.2 State of the art 
 
Graphene is a single layer of sp2 carbon atoms arranged in a honeycomb structure. It possesses 
very high mechanical strength, specific surface area and high thermal and electrical conductivity. 
[1-9] Strong oxidizing agents can be used to produce oxidized forms of graphene, designated as 
graphene oxide (GO). Also, graphite can be directly oxidized to produce graphite oxide, which 
can then be exfoliated originating GO. [4] The presence of polar and reactive oxygen-containing 
functional groups in graphene oxide [10-15] reduces its thermal stability, but may be important to 
promote interaction and compatibility with polar solvents and with some polymer matrices. [4, 8, 
16-18] 
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Several biomedical applications have been studied for graphene-based materials (GBMs), like 
biosensing/bioimaging [19], drug delivery [18], cancer photothermal therapy [20], regenerative 
medicine [21-22], and antibacterial materials [18]. Examples of GBMs functions in some of the 
mentioned fields are: a) improvement of biomaterials mechanical/electrical properties, b) 
adsorption and targeted delivery of drugs, c) strong optical absorption of near infrared radiation, 
d) increase of cellular attachment and growth at biomaterials surface, and e) induction of selective 
damages in bacteria. In view of the growing interest in using GBMs in medical applications, it is 
relevant to evaluate their biocompatibility. From existent studies it can be concluded that 
generally GBMs induce a decrease on cell viability above a concentration of 10 μg mL−1 after 24 
h incubation, with cell viability often decreasing with time and concentration. GBMs interaction 
with cells depends on their intrinsic physical––chemical properties (e.g. size, hydrophilicity), 
which are related to the raw materials and production methods used. However, few studies are 
available and some contradictory results can be found in literature. This subject was recently 
reviewed by Pinto et al. [23-24]. There is still the need to perform a comprehensive characterization 
for the different GBMs available, in terms of both physical–chemical properties and 
biocompatibility. Also, since several biomedical applications under study for GBMs imply 
contact with blood, hemocompatibility studies are necessary to assess the clinic safety of 
intravenous administration or implantation of GBMs [23-24]. Some GBMs have been reported to 
induce cell death by different mechanisms: a) generation of reactive oxygen species (ROS), which 
leads to lipid peroxidation, denaturation of proteins, DNA degradation, and activation of 
apoptosis, b) direct damage on cell membrane by a blade-like action of the particles sharp edges 
[25], c) decrease of free cell surface area modifying metabolic changes with the cell medium, 
leading to poor nutrient absorption and inefficient waste release, or affecting cell–cell interaction. 
[26] Thus, careful characterization of each particular GBM is needed to assure their 
biocompatibility. 
The present work studies a commercially available product, with reduced cost comparing with 
single layer graphene: graphene nanoplatelets (GNP). Each particle is constituted by at least 2 
stacked graphene layers, possessing oxygen-containing functional groups at the edges. Since this 
is a commercial product, there is the advantage of material consistency and availability. 
Moreover, GNP has been reported to display good results as biopolymers fillers, improving 
mechanical performance [24] and biocompatibility, namely reducing platelets activation without 
increasing toxicity. [24] In this work, the biocompatibility of GNP is studied for different sizes and 
oxidation states. Namely, evaluating hemolysis, effects on cell viability, proliferation, 
mitochondrial membrane potential and morphology, and ROS production. 
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3.3 Materials and methods 
3.3.1 Graphene-based materials oxidation 
Graphene nanoplatelets (GNP) grades M5 and C750, were acquired from XG Sciences (Lansing, 
USA), with the following characteristics: Grade M5 (GNP-M) – average thickness of 6–8 nm, 
maximum length 5 μm, and surface area between 120 and 150 m2 g−1; Grade C750 (GNP-C) – 
average thickness lower than 2 nm and surface area of 750 m2 g−1. The sizes of a typical grade C 
sample has a distribution that ranges from very small flakes (diameter below 100 nm) up to larger 
flakes (1–2 μm). According to the manufacturer, GNP production is based on exfoliation of 
sulphuric acid-based intercalated graphite by rapid microwave heating, followed by ultrasonic 
treatment. [27] 
GNP-M was oxidized by modified Hummers method (MHM), as described in our previous work. 
[24] Briefly, 50 mL of H2SO4 were added to 2 g of GNP-M at room temperature and the solution 
was cooled using an ice bath, followed by gradual addition of KMnO4, 6 g for GNP-M-ox-1:3 and 
12 g for GNP-M-ox-1:6. Then 300 mL of distilled water were added, followed by addition of 
H2O2 until oxygen release stopped. GNP-M-ox-1:3 and 1:6 were washed 5 times with water by 
centrifugation at 4000 rpm during 15 min. The solids were dispersed in 500 mL of water by 
sonication (Bandelin Sonorex R K512 H) during 5 h, frozen at −80 °C and lyophilized for 72 h. 
3.3.2 GBMs physical-chemical characterization 
3.3.2.1 GBMs physical characterization 
3.3.2.1.1 Scanning electron microscopy (SEM) 
The morphology of GBMs was observed using SEM (FEI Quanta 400FEG, with acceleration 
voltage of 3 kV). Powders of the nanomaterials were applied on conductive carbon strips for 
visualization. 
3.3.2.1.2 Dynamic light scattering 
Particle sizes and distributions of the materials were determined with an LS230 laser particle 
analyzer (Coulter, USA). GBMs were dispersed in water at a concentration of 100 μg mL−1 and 
sonicated for 1 h. Just before sample testing, 10 min sonication was performed to redisperse 
agglomerates using a Bandelin Sonorex R K512 H ultrasound bath. Data were collected 
performing 3 scans of 60 s, including polarization intensity differential scattering and using 
Fraunhofer's model. This model assumes spherical shape for the particles in suspension. The 
obtained size distributions must therefore be considered as relative evaluations of the degree of 
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deagglomeration of the different materials in water, and not as precise estimations of particle 
sizes. Li et al. [28] used a similar approach to evaluate graphene oxide particle size distribution in 
water by dynamic light scattering. 
3.3.2.2 GBMs chemical characterization 
3.3.2.2.1 X-ray photoelectron spectroscopy (XPS) 
The XPS analysis of GBMs powders tablets (d = 10 mm) was performed at CEMUP (Centro de 
Materiais da Universidade do Porto) using a ESCALAB 200A, VG Scientific (UK) with PISCES 
software for data acquisition and analysis. For analysis, an achromatic Al (Kα) X-ray source 
(1486.6 eV) operating at 15 kV (300 W) was used, and the spectrometer, calibrated with reference 
to Ag 3d5/2 (368.27 eV), was operated in constant analyser energy mode with a pass energy of 20 
eV for regions of interest, and 50 eV in survey. The core levels for O 1s and C 1s were analyzed. 
The photoelectron take-off angle (the angle between the surface of the sample and the axis of the 
energy analyzer) was 90°. The electron gun used focused on the specimen in an area close to 100 
mm2. Data acquisition was performed with a pressure lower them 1 × 106 Pa. The effect of the 
electric charge was corrected by the reference of the carbon peak (285 eV). The deconvolution of 
spectra was performed with the XPSPEAK41 program, in which a peak fitting was performed 
using Gaussian–Lorentzian peak shape and Shirley type background subtraction. 
3.3.2.2.2 Raman spectroscopy 
The unpolarized Raman spectra of GNP-C, GNP-M, GNP-M-ox-1:3 and GNP-M-ox-1:6 powders 
were obtained under ambient conditions, in several positions for each sample. The linear 
polarized 514.5 nm line of an Ar+ laser was used as excitation. The Raman spectra were recorded 
in a backscattering geometry by using a confocal Olympus BH-2 microscope with a 50× 
objective. The spatial resolution is about 2 μm, and laser power was 15 mW. The scattered 
radiation was analysed using a Jobin–Yvon T64000 triple spectrometer, equipped with a charge-
coupled device. The analysis diameter was 10 μm and spectral resolution was better than 4 cm−1. 
The spectra were quantitatively analysed by fitting a sum of damped oscillator to the experimental 
data, according to the equation: 
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Here ),( Tn   is the Bose-Einstein factor: ojA , oj  and oj  are the strength, wave number 
and damping coefficient of the j-th oscillator, respectively, and )(B  is the background. In this 
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work, the background was well simulated by a linear function of the frequency, which enable us 
to obtain reliable fits of equation (1) to the experimental data. The fitting procedure was 
performed for all Raman bands collected from the same sample, but in different positions. This 
procedure allows us to determine the average and standard deviation (SD) values of the phonon 
parameters, namely the wave number and intensity. [29] 
3.3.2.2.3 Thermogravimetric analysis (TGA) 
Thermal stability of samples was determined with a Netzsh STA 449 F3 Jupiter device. Sample 
amounts ranged from 10 to 12 mg. The thermograms were recorded between 50 and 800 °C at a 
heating rate of 10 °C min−1 under nitrogen flow. 
3.3.3 GBMs biocompatibility 
GBMs were sterilized in ethanol by dispersion and sonication during 20 min (Bandelin Sonorex 
RK 512 H). Materials were dried in a vacuum oven overnight at 50 °C under sterile conditions. 
GBMs were redispersed in appropriate volume of phosphate buffered saline (PBS, pH 7.4) or cell 
culture medium. 
3.3.3.1 Hemolysis assay 
Red blood cells (RBCs) were isolated from buffy coats (obtained from Immunohemotherapy 
Service, Hospital S. João, Porto, Portugal), as described previously. [30] Briefly, RBCs were 
centrifuged over density gradient with Histopaque-1077 (Sigma–Aldrich) according to the 
manufacturer's instructions. After removal of the plasma upper layer, the lower layer containing 
RBC was washed three times in PBS. The purified RBCs were diluted to a concentration of 2 × 
108 cells mL−1 and 100 μL of RBCs were placed in round bottom 96 wells polypropylene 
microtiter plates. Next, 100 μL of GNP dispersions were added to the wells and incubated for 3 h 
at 37 °C and 80 rpm. Afterwards, 96-well plates were centrifuged at 4000 rpm for 15 min to 
collect supernatant, which was transferred (80 μL) from each well to black polypropylene 96 
wells microtiter plates for absorbance reading. Absorbance was read at 380, 415, and 450 nm 
using a micro-plate reader spectrophotometer (Bioteck Plate Reader, Synergy MX). The amount 
of hemoglobin (Hb) is calculated as follows: Hb value of sample (mg dL−1) = [[2 × A415 − (A380 
+ A450)] × 1000 × Dilution factor]/(E), where A415, A380, A450 are the absorbance values at 
415, 380, and 450 nm, respectively. A415 is the Soret band absorption of Hb and A380, A450 are 
correction factors of uroporphyrin whose absorption falls under the same wavelength range. E is 
the molar absorptivity of oxyhemoglobin at 415 nm, which is 79.46. The hemolytic potential of 
GNP was calculated as follows: Hemolysis (%) = Hb value of sample/Total Hb value × 100, 
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where total Hb value corresponds to 100% hemolysis with Triton 1% (Sigma Aldrich, X100). [31] 
GBMs concentrations tested were 100, 200 and 500 μg mL−1. Controls with PBS (lysis negative 
control) and Triton 1% in PBS (positive control for 100% hemolysis) were performed. 
Additionally, controls with only GBMs in PBS were performed for each concentration tested. All 
assays were performed in triplicate and repeated 3 times. 
3.3.3.2 Biocompatibility with cell line 
Human foreskin fibroblasts HFF-1 (from ATCC) where grown in DMEM+ (Dulbecco's modified 
Eagle's medium (DMEM, Gibco) supplemented with 10% (V/V) foetal bovine serum (Gibco) and 
1% (V/V) penicillin/streptomycin (biowest) at 37 °C, in a fully humidified air containing 5% 
CO2. The media were replenished every 3 days. When reaching 90% confluence, cells were 
rinsed with PBS (37 °C) and detached from culture flasks (TPP®) using 0.25% (w/V) trypsin 
solution (Sigma Aldrich) in PBS. For all assays, HFF-1 cells were seeded at a density of 2 × 104 
cells mL−1 in 96 well plates or in 8 chamber Lab-Tek-II. Upon subconfluence (24 h), DMEM+ 
was removed and cells incubated with increasing concentrations of GBMs in DMEM+ (1–100 μg 
mL−1) for 24, 48, and 72 h. At indicated time-points, cells were observed in an inverted 
fluorescence microscope (Carl Zeiss – Axiovert 200) and phase contrast images were acquired. 
All experiments were performed using cells between passages 10 to 14. 
HPMEC-ST1.6R cells (from ATCC) were cultured in culture flasks (TPP®) treated with 0.2% 
gelatine (Sigma) in medium M199+ (M199 medium (Sigma–Aldrich) supplemented (M199+) 
with 20% (V/V) foetal bovine serum (FBS), 2 mM Glutamax I, 100 U/100 μg mL−1 Pen/Strep, 
(all Gibco Invitrogen), 25 μg mL−1 sodium heparin (Sigma–Aldrich), 25 μg mL−1 endothelial cell 
growth supplement (ECGS, Becton Dickinson), and 50 μg mL−1 G-418 (Gibco, Invitrogen). For 
resazurin assay, HPMEC cells were seeded at a density of 2 × 104 cells mL−1 in 96 well plates 
coated with 0.2% gelatine. Upon subconfluence (24 h), M199+ was removed and cells incubated 
with increasing concentrations of GBMs in M199+ (10–100 μg mL−1) for 24, and 72 h. At 
indicated time-points, cells were observed in an inverted fluorescence microscope (Carl Zeiss – 
Axiovert 200) and phase contrast images were acquired. All experiments were performed using 
cells between passages 26 to 37. 
3.3.3.2.1 Cytotoxicity assays 
Cell metabolic activity was quantified by resazurin assay at 24, 48, and 72 h of incubation. 
Briefly, 20 μL (1 mg mL−1) resazurin (Sigma Aldrich) solution in PBS was added to each well. 
Cells were incubated for 3 h and fluorescence (λex/em = 530/590 nm) read in a micro-plate reader 
spectrophotometer. Negative control for metabolic activity decrease was performed incubating 
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cells with DMEM+ and positive control incubating with Triton 0.1 wt.%. Cell metabolic activity 
(%) was calculated as follows: Fluorescence of sample/Fluorescence of negative control * 100. 
Controls were performed with materials only (without cells) dispersed in DMEM+, for all 
concentrations tested. All assays were performed in sextuplicate and repeated 3 times. 
Cell viability/membrane integrity was evaluated by LIVE/DEAD assay. Hoechst 33342 permeates 
membrane and stains nucleic acids. Calcein also permeates membrane and is metabolized in 
cytoplasm by intracellular esterases originating a green highly fluorescent derivative. Cell 
membrane has residual permeability to propidium iodide, which only enters cells whose 
membrane integrity is compromised, staining nucleic acids. At 24, 48 and 72 h DMEM+ was 
removed and cells incubated with Hoechst 33342 (Molecular Probes) and Calcein (Molecular 
Probes), both at 2.5 μg mL−1 in PBS for 15 min, at 37 °C in the dark. Then, propidium iodide (PI) 
(Sigma Aldrich) in PBS was added to each well to a final concentration of 1.25 μg mL−1 and 
images acquired in an inverted fluorescence microscope (Carl Zeiss – Axiovert 200). Cell death 
(%) was calculated as follows: number of cells stained with PI/number of cells stained with 
Hoechst 33342 * 100. All assays were performed in triplicate and repeated 3 times. 
TMRE (tetramethylrhodamine, ethyl ester) Mitochondrial Membrane Potential (MMP) Assay Kit 
(Abcam, ab113852) was used to measure MMP of HFF-1 cells according to manufacturer's 
instructions. HFF-1 cells were seeded in 96-well plates and exposed to GBMs at concentrations 
from 10 to 100 μg mL−1, for 48 h. Then, cells were rinsed 3× with DMEM+ to assure no 
interference from materials in fluorescence determination and were loaded with 500 nM TMRE in 
DMEM+ for 30 min at 37 °C. Cells were rinsed once with BSA 0.2 wt.% in PBS and fluorescence 
(λex/em = 549/575 nm) read in a micro-plate reader spectrophotometer. Negative control for 
MMP decrease was performed with cells cultured in culture medium (DMEM+), as positive 
control for MMP decrease cells were exposed to carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) 20 μM for 15 min. MMT (%) was calculated as follows: Fluorescence of 
sample/Fluorescence of negative control for MMP decrease * 100. Controls were performed with 
materials only (without cells) dispersed in DMEM+ for all concentrations tested and revealed 
similar fluorescence to DMEM+. All assays were performed in triplicate and repeated 3 times. 
Cells were prepared for image acquisition in an inverted fluorescence microscope (Carl Zeiss – 
Axiovert 200), following the same procedure, but incubating with 500 nM TMRE and Hoechst 
33342 (2.5 μg mL−1), to allow observation of cell nuclei on cells with decreased MMP. 
3.3.3.2.2 Intracellular ROS evaluation 
Chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) is a chloromethyl 
derivative of H2DCFDA, useful as an indicator for reactive oxygen species (ROS) in cells. It 
passively diffuses into cells, where its acetate groups are cleaved by intracellular esterases 
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originating a highly fluorescent derivative (DCF) and its thiol-reactive chloromethyl group reacts 
with intracellular glutathione and other thiols. The fluorescence intensity is proportional to the 
ROS levels within the cell cytosol. 
HFF-1 cells were seeded as previously described and, after reaching a state of subconfluence (24 
h), washed with PBS at 37 °C and incubated 45 min at 37 °C with 95 μL CM-DCFH-DA 
(Molecular Probes) at a concentration of 2 μg mL−1. The reagent was removed and cells incubated 
at 37 °C for 1 h, with 150 μL GBMs dispersed in PBS (1, 10, and 50 μg mL−1). Finally, 100 μL 
Triton 1% in PBS was added to each well and fluorescence (λex/em = 480/530 nm) read in a 
micro-plate reader spectrophotometer. Controls were performed with GBMs dispersed in PBS, for 
all concentrations tested, incubated with the same amount of CM-H2DCFDA, in wells without 
cells. PBS was used as negative control and H2O2 (Merck) 100 mM as positive control for 
intracellular ROS levels increase. ROS levels were calculated as follows: ROS levels (%) = 
Fluorescence of the sample/Fluorescence of negative control * 100. All assays were performed in 
triplicate and repeated 3 times. 
3.3.3.2.3 Immunocytochemistry 
Cells in each well exposed to 50 μg mL−1 of GBMs (at 100 μg mL−1 GBMs interfere with staining 
and images had worse quality) were washed with PBS. Then, fixation was performed with 
paraformaldehyde (PFA – Merck) 4 wt.% in PBS for 15 min. PFA was removed, cells washed 
with PBS and stored at 4 °C. Cell cytoskeletal filamentous actin can be visualized by binding of 
fluorescent phalloidin and the nucleus can be stained with 4′,6-Diamidino-2-phenylindole 
dihydrochloride (DAPI) that intercalates with nucleic acids. Cell membrane was permeabilized 
with Triton 0.1 wt.% at 4 °C for 5 min. Washing was done with PBS and incubation performed 
with phalloidin (Alexa Fluor 488; Molecular Probes) solution in PBS in a 1:80 dilution for 20 min 
in the dark. After rinsing with PBS, DAPI (Sigma Aldrich) solution at 3  μg mL−1 was added to 
each well and incubated for 15 min in the dark. Finally, cells were washed and kept in PBS to 
avoid drying. Plates with adherent cells were observed in an inverted fluorescence microscope 
(Carl Zeiss – Axiovert 200). 
For evaluation of cell proliferation, Ki-67 immunocytochemistry was performed. Fixed and 
permeabilized cells were incubated with a blocking solution 4 wt.% BSA and 1% (V/V) FBS for 
1 h, and subsequently incubated with rabbit anti-Ki67 primary antibody (1:100) from Abcam 
(ab15580) overnight. Cells were further incubated with the secondary antibody goat anti-rabbit 
IgG Alexa Fluor® 488 (1:800) from Invitrogen (a11070) for 1 h. Nuclei were stained with 
Nuclear Mask (Invitrogen, H10294). In order to identify possible nonspecific labelling, a negative 
control was performed excluding the incubation with primary antibody. Images were acquired 
using the In cell analyser 2000 6E Healthcare, equipped with an Nikon 10×/0.45 Plan Apo. Image 
analysis/Ki67 quantification was performed using the software In cell investigator developer toll 
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box (GE Healthcare). Ki67 positive (Ki67+) cells percentage were calculated as follows: 
Ki67+(%) = Ki67+ cells/total cell number × 100. 
3.3.3.2.4 Transmission electron microscopy (TEM) 
After 72 h incubation, cells exposed to 100 μg mL−1 GBMs in Lab-Tek-II were fixed in 2% 
glutaraldehyde (Electron Microscopy sciences, Hatfield, USA) and 4% PFA in cacodylate Buffer 
0.1 M (pH 7.4), dehydrated and embedded in Epon resin (TAAB, Berks, England). Ultrathin 
sections (40–60 nm thickness) were prepared on a Leica Reichert SuperNOVA Ultramicrotome 
(Germany) using diamond knives (DDK, Wilmington, DE, USA). The sections were mounted on 
200 mesh copper or nickel grids, stained with uranyl acetate and lead citrate for 15 min each, and 
examined under a JEOL JEM 1400 TEM (Tokyo, Japan). Images were digitally recorded using a 
CCD digital camera Orious 1100W (Tokyo, Japan) at the HEMS – Institute for Molecular and 
Cell Biology (IBMC) of the University of Porto. 
3.3.4 Statistical analysis 
Statistical analysis was performed using the software Statistical Package for the Social Sciences 
(SPSS 20, IBM, USA) performing Kruskal–Wallis one-way analysis of variance. Resazurin 
assays were analysed performing parametric analysis of variance (ANOVA) followed by post hoc 
tests Tamhane, Dunnett, and Games-Howell. Multiple means comparison were performed 
between samples to identify significant differences, which were considered for p < 0.05. 
3.4 Results 
3.4.1 GBMs physical-chemical characterization 
3.4.1.1 Physical characterization 
SEM imaging of the powders (Figure 3.1) shows that GNP-C is constituted by platelets with a 
length bellow 2 μm and small flakes (<0.5 μm) that form agglomerates (Fig. 3.1(A and B)). The 
larger platelets have planar conformation, being constituted by few single layer sheets, while 
small flakes are wrinkled and possess folded edges (Fig. 3.1(B)). This probably occurs due to the 
flakes short dimensions allowing the oxygen-containing functional groups at the edges to form 
hydrogen bonds, distorting the sheets. GNP-M (Fig. 3.1(C and D)) is also constituted by 
agglomerated platelets. However, some agglomerates can be redispersed in liquid medium. Each 
platelet is formed by stacks of few individual “graphene” sheets, assuming planar conformations 
and presenting sharp edges. These platelets have a length of about 5 μm (Fig. 3.1(E and F)). 
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Figure 3.1: SEM images of dry powders of GNP-C at (A) 500×, (B) 100000×; GNP-M at (C) 
500×, (E) 4000×, (F) 20000×, and (D) 100000×; GNP-M-ox-1:3 at (G) 4000×, and (H) 
20000×; and of GNP-M-ox-1:6 at (I) 4000×, and (J) 20000×. Scale bars are 1 (B, D), 5 (F, H, 
J), 30 (E, G, I), and 200 µm (A, C). 
 
Oxidation of GNP-M changes its morphology. Both GNP-M-ox-1:3 (Fig. 3.1(G and H)) and 
GNP-M-ox-1:6 (Fig. 3.1(I and J)) powders have sizes similar to GNP-M, however oxidized 
platelets are more wrinkled and exhibit folded edges, due to formation of hydrogen bonds 
between intra-platelet oxygen-containing functional groups. 
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Figure 3.2 reveals that GNP-C is constituted by considerably smaller particle sizes than GNP-M, 
showing two narrow peaks at 0.5 and 2 μm, while GNP-M has broad peaks at 20, 35 and 60 μm, 
with a particle size distribution ranging from few μm to 70 μm. GNP-M-ox-1:3 and 1:6 display 
broad distributions, almost unimodal, with particle sizes ranging from few to about 100 μm in the 
first case and 70 μm in the second. These results suggest that GNP-C is effectively exfoliated in 
water, presenting two populations of platelets with sizes below 2 μm, which is consistent with the 
SEM images. GNP-M is significantly agglomerated in water. Both, GNP-M-ox-1:3 and 1:6 are 
also agglomerated, despite the oxidation treatment, which may be due to formation of inter-
particle hydrogen bonds that do not dissociate in aqueous medium. 
 
 
Figure 3.2: Particle size distributions of GNP-C, GNP-M and GNP-M-ox-1:3 and 1:6 
dispersed in water at a concentration of 100 μg mL−1. 
 
3.4.1.1.1 Chemical characterization 
 
XPS results (Figure 3.3(A)) show that both GNP-M and GNP-C have a low degree of oxidation 
(atomic percentage of oxygen – O 1s (at.%) < 4%). This was expected since GNP are obtained 
from graphite by microwave and ultrasonic treatment (see section 3.3.1), and its hexagonal carbon 
structure should unveil defects, in the form of oxygen-containing groups, mostly at the platelet 
edges. XPS data also reveal that oxidation of GNP-M by modified Hummer's method, to produce 
GNP-M-ox-1:3 and GNP-M-ox-1:6, increases the O 1s (at.%) in the final products by about 20% 
(Fig. 3.3(A)). 
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Figure 3.3: A) Table shows atomic composition of GBMs and content of C 1s chemical 
groups resulting from spectra fitting (*fitting for oxygen groups of GNP-C and M could not 
be performed due to having low content); B) XPS spectra for the core level C 1s for GNP-C, 
M, GNP-M-ox-1:3 and 1:6; C, D, E) spectra fitting for GNP-M, GNP-M-ox-1:3 and 1:6, 
respectively. Deconvoluted peaks shown correspond to: 1) C=C (sp2), 2) C-C (sp3), 3) C-OH, 
4) C-O-C, 5) C=O, and 6) O-C=O. 
 
Sulphuric acid (H2SO4) forms some epoxy groups (C–O–C) in alkenes double bonds in GNP 
honeycomb structure, mostly at the edges and surface defects. [11] Potassium permanganate 
(KMnO4) also reacts with alkene double bonds (C=C) forming diols (HO-C-C-OH). However, the 
principal mechanism proposed for graphene oxidation by modified Hummers method is through 
the formation of manganese heptoxide (Mn2O7), which is more reactive than potassium 
permanganate. This strong oxidant forms carbonyls (C=O) by cleavage of alkenes double bonds. 
Moreover, carboxyls (HO-C=O) can be formed by further oxidation of aldehydes (H-C=O). [11] In 
the formation of manganese heptoxide, sulphuric acid was used in excess and potassium 
permanganate was the limiting reagent. GNP-M-ox-1:6 was oxidized in presence of 2 fold the 
KMnO4 amount comparing to GNP-M-ox-1:3. This caused strong oxidation of GNP-M-ox-1:6, 
probably leading to preferential formation of carboxyls (O-C=O) and hydroxyls (C–OH) (Figure 
3.3(A)). For GNP-M-ox-1:3, the oxidation was milder, with mostly epoxy (C–O–C) and carbonyl 
(C=O) groups being formed. XPS results also show that the total C–C (sp2 + sp3) is lower for 
GNP-M-ox-1:6, despite the total C at.% being similar for both materials. This suggests that in 
GNP-M-ox-1:6 the oxygen-containing functional groups are distributed by more carbon atoms 
than in GNP-M-ox-1:3. This statement is in agreement with what is observed in Raman results 
(see below), which show that GNP-M-ox-1:6 is more homogeneously oxidized than GNP-M-ox-
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1:3. This may be due to oxidation in GNP-M-ox-1:3 having occurred predominantly at the 
platelets edges. For GNP-M-ox-1:6, due to excess manganese heptoxide, oxygen-containing 
functional groups were also produced throughout the platelets surfaces, despite this being less 
sterically favourable than edge oxidation. [11] 
The ratio between C sp2 and sp3 is lower for GNP-M than for GNP-C (Fig. 3.3(A)), because it has 
higher thickness, thus more electronic delocalization trough parallel single carbon sheets. This 
ratio also decreases with oxidation [32], due to the induction of defects at platelets surface by 
cleavage of alkene double bonds and aldehydes oxidation to form carboxyls. Moreover, stronger 
oxidation, as observed for GNP-M-ox-1:6, leads to the lowest sp2/sp3 ratio. This is in agreement 
with this material being more homogenously oxidized. 
As seen in Figure 3.4(A), Raman spectra obtained for GBMs powders are similar. D-band, 
located between 1270 and 1450 cm−1, is assigned to the carbon lattice disorder typical of crystal 
edges and defects in the graphene network. G-band close to 1580 cm−1, is associated with the sp2 
hybridization. [33, 34] From the fitting procedure, we have calculated the intensity of the observed 
Raman bands. It is well established that the ratio between the intensities of the D- and G-bands, 
ID/G, is widely used for characterizing the defects degree in graphene materials and to evaluate 
multilayered graphene crystallite size. [33] Usually, the D band is absent or week in the surface of 
graphene sheets and intense in their edges. [34] For this reason, the ratio between the D- and G-
bands is higher for GNP-C, because it exhibits a smaller mean diameter than GNP-M, having 
more edges in the analysis volume. 
The oxidation of GNP-M lead to an increase of D-band intensity (Fig. 3.4(B)), due to disruption 
of sp2 hybridization in the interior of graphene sheets due to introduction of oxygen containing 
functional groups and also due to weakening of π interactions between individual sheets and 
particles. [8-35] GNP-M-ox-1:3 has a lower ID/G ratio, comparing with GNP-M-ox-1:6, because in 
some spectra acquired, D-band was intense but in other cases, this band presented an intensity 
similar to non oxidized GNP-M. This points out for a non-uniform oxidization when a ratio of 
GNP-M 1:3 KMnO4 is used, as it was discussed previously (see section 3.3.3.1.2). Opossingly, all 
spectra of GNP-M-ox-1:6 present an intense D-band and a broader G-band, evidencing both 
homogeneous and large degree of oxidation. Moreover, G band width slightly increases for both 
oxidized materials comparing with non-oxidized GNP-M and D band width is higher for the more 
oxidized GNP-M-ox-1:6 (Fig. 3.4(B)). 
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Figure 3.4: Representative unpolarized Raman spectra for GNP-C, GNP-M, GNP-M-ox-1:3, 
and GNP-M-ox-1:6 powders, acquired at ambient conditions. B) Intensity ratio of the (D/G) 
bands of GBMs powders. Results are presented as mean and standard deviation (n = 3). C) 
TGA curves and weight loss for GBMs powders. 
 
Thermograms for GBMs are shown in Fig. 3.4(C). GNP-C and GNP-M display similar behaviour 
along heating ramp, having small weight losses (GNP-C = 13.8 wt.%, GNP-M = 20.7 wt.%) 
mostly above 400 °C. GNP-M-ox-1:3 shows 55.5 wt.% weight loss and GNP-M-ox-1:6 68.3 
wt.% after heating up to 800 °C, more 34.8 and 47.6 wt.% than pristine GNP-M, respectively. 
This confirms that oxidation occurred to a higher degree in GNP-M-ox-1:6 than for GNP-M-ox-
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1:3. Also, GNP-M-ox-1:3 earlier occurring weight loss points out the predominant location of 
thermolabile oxygen-containing groups at sheets edges. [36-37] 
 
3.4.2 GBMs biocompatibility 
3.4.2.1 Hemolysis evaluation 
 
Figure 3.5 shows that both GNP-M (2.5%) and GNP-C (1.7%) induce low hemolysis even in 
concentrations up to 500 μg mL−1. Despite being dark-coloured, GBMs did not interfere with 
measurements in Hb absorption wavelength for all concentrations tested. Materials were washed 
or centrifuged in order to assure the removal of possible contaminants from production/storage, 
however these procedures revealed unnecessary, because hemolysis was not decreased (Figure A1 
– see Appendix A). 
 
 
Figure 3.5: Percentage of RBCs lysis after 3 h incubation at 37 °C with PBS (negative 
control), and different concentrations of GBMs (100, 200 and 500 μg mL−1). Positive control 
(Triton 1% in PBS) resulted in 100% hemolysis. Results are presented as mean and 
standard deviation (n = 3). Greek symbols represent statistically significant differences 
between samples within the same concentrations (p < 0.05). No significant differences were 
observed between PBS and GBMs for all concentrations tested (p > 0.05). 
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No significant differences in hemolysis were observed between GNP-M and GNP-C for all 
concentrations tested (p > 0.05). The oxidation of GNP-M, significantly reduced hemolysis ratio 
for both GNP-M-ox-1:3 and 1:6 for the higher concentrations tested of 200 and 500 μg mL−1 (Fig. 
3.5). As an example, for 500 μg mL−1, GNP-M hemolysis was 2.5%, GNP-M-ox-1:3 0.04% and 
1:6 0.08%. This can be explained by the presence of oxygen-containing functional groups at 
sheets edges causing folding, therefore reducing the occurrence of physical damages to cells. 
 
3.4.2.2 Biocompatibility with fibroblasts 
 
After verifying that the materials do not show relevant toxic effects towards RBCs, further assays 
were performed to evaluate their effect when in direct contact with human foreskin fibroblasts 
(HFF-1). Phase contrast images were obtained for each time and concentration tested, 
representative images are shown in Figure A2. Further characterization was performed and 
described below. 
 
3.4.2.2.1 Cytotoxicity 
 
Considering that a sample has cytotoxic potential if its metabolic activity is reduced to less than 
70% comparing to negative control for metabolic activity decrease (cells incubated with 
DMEM+) [ISO 10993-5:2009(E)], it can be observed from Figure 3.6(A) that both GNP-M and 
GNP-C are potentially non-toxic up to a concentration of 20 μg mL−1, until 72 h. GNP-C is toxic 
at 24 h for concentrations above 20 μg mL−1. However, cell metabolic activity recovered over 
time, and at 48 h toxicity is only present above 50 μg mL−1. At 72 h the results show toxicity only 
slightly above the limit of 70% for 100 μg mL−1. For GNP-M, toxicity occurs at 24 h above 50 μg 
mL−1. At 48 and 72 h, toxicity is observed above 20 μg mL−1. These results are in agreement with 
conclusions from our previous review on graphene-based materials (GBMs) biocompatibility, in 
which most analysed studies reported cell viability decreases inferior to 20% after exposure to 
GBMs concentrations around 10 μg mL−1 during 24 h or longer. [23] 
GNP-M-ox-1:3 unveils a toxicity profile similar to GNP-M, while GNP-M-ox-1:6 
biocompatibility is greatly improved. This occurs because GNP-M-ox-1:3 oxidization was not as 
uniform as for GNP-M-ox-1:6, which is only slightly toxic (viability ≈ 69%, SD = 5.1%) at 24 h 
for 100 μg mL−1, however at 48 and 72 h of incubation, no toxicity is observed. Controls 
performed with materials dispersed in DMEM+ without cells, for all concentrations tested, 
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presented similar values to DMEM+, suggesting that the materials tested did not interfere with 
fluorescence determinations. 
 
Figure 3.6: A) HFF-1 cells viability after incubation with GBMs in DMEM+, at 24, 48 and 
72 h. Cell metabolic activity is represented as percentage in comparison with cells cultured 
in DMEM+ (100%). Results are presented as mean and standard deviation (n = 6). The red 
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line at 70%, marks the toxicity limit, according to ISO 10993-5:2009(E). Statistical analysis 
is presented in Table A1. B) Percentage of HFF-1 cell death after 72 h of incubation with 
GBMs. Cell death percentage was corrected by subtraction of the value for cells cultured in 
DMEM+ (negative control for cell death). Results are presented as mean and standard 
deviation (n = 3). Statistically significant differences, analysed within each concentration 
between all GBMs are represented by c – GNP-C, m – GNP-M, 1:3 – GNP-M-ox-1:3 
(differences were only found comparing with GNP-M-ox-1:6); Differences comparing with 
DMEM+ are represented by Ø. Symbols not underlined represent p < 0.05, for p < 0.01 
signs are underlined. 
 
Results are also presented in terms of fluorescence intensity values, so that the increase of cell 
metabolic activity over time can be observed in Figure A3. It also provides images of the cells 
incubated with culture medium and GBMs for a concentration of 100 μg mL−1, showing an 
increase of cell density from 24 to 72 h. 
For evaluation of cell proliferation, Ki-67 assay was performed. Ki-67 is a nuclear antigen present 
at all stages of the cell cycle, except G0 when cells are in the resting state. [38, 39] Results 
presented in Figure A5 revealed that there is significant decrease in cell proliferation for GNP-C 
100 μg mL−1 at 24 h comparing with control (p < 0.05), followed by a recovery of the 
proliferative capacity of the cells at 48 h and 72 h. These results are in agreement with the 
metabolic activity assay obtained for this condition. Importantly, as for the other conditions 
tested, an increase of cell proliferation has been observed from 24 to 72 h for 50 and 100 μg mL−1 
concentrations. 
Resazurin assay was also performed with HPMEC (Human Pulmonary Microvascular Endothelial 
Cells). The results showed the same trend as for HFF-1, with GNP-M and GNP-M-ox-1:3 being 
the most toxic materials, while GNP-M-ox-1:6 showed no toxicity. Also, GNP-C presented initial 
mild toxicity which was recovered over time. Detailed results are presented as supplementary data 
in Figure A7. 
Figure A4 show example images for HFF-1 cells fluorescently labelled for LIVE/DEAD assay. 
As expected, positive control of cell death (cells incubated with Triton 0.1 wt.% in DMEM+ for 
72 h) unveils 100% cell death. Negative control was performed incubating cells with DMEM+, 
presenting mostly live cells with scarce dead cells. 
Fig. 3.6(B) shows that cell death is below 11% for all materials tested. The resazurin assays 
showed larger metabolic activity decreases. A possible explanation for this difference is that 
metabolic activity decreased in some cells, despite possessing intact membranes, avoiding being 
stained by PI. GNP-M exhibits higher cell death values than GNP-C for all concentrations tested, 
but no significant differences were observed (p > 0.05). However, GNP-C only reveals 
significantly higher cell death than DMEM+ for 100 μg mL−1 (p < 0.05), while GNP-M presents it 
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for 20, 50 and 100 μg mL−1 (p < 0.01), thus exhibiting higher toxicity. Also, GNP-M-ox-1:3 (8%) 
exhibits similar cell death (p > 0.05) to GNP-M (10%) for 100 μg mL−1. However, GNP-M-ox-
1:3 is equivalent to DMEM+ bellow this concentration (p > 0.05), contrary to GNP-M. GNP-M-
ox-1:6 (0%) unveils no cell death for 100 μg mL−1, being similar to DMEM+ for all 
concentrations tested (p > 0.05) and significantly less toxic than GNP-M for 20 g mL−1 (p < 0.05), 
50 and 100 μg mL−1 (p < 0.01). It is also less toxic than GNP-M-ox 1:3 (p < 0.05) and GNP-C (p 
< 0.01) for 50 μg mL−1, and GNP-M-ox-1:3 for 100 μg mL−1 (p < 0.01). These results are in 
agreement with those observed in the cell metabolic activity assays. The fact that GNP-M-ox-1:6 
is homogeneously oxidized, presenting less sharp edges than GNP-M, suggests that less physical 
damages are induced by oxidized material, explaining the lower number of cell stained with PI 
and higher cell viability observed in resazurin assay. 
Figure 3.7, shows that for 10 μg mL−1 GNP-C increases ROS production by 2.8 fold, being 
significantly higher (p < 0.01) than GNP-M, GNP-M-ox-1:3 (1 fold) and GNP-M-ox-1:6 (1.6 
fold, p < 0.05). Also, GNP-M-ox-1:6 is significantly higher than GNP-M and GNP-M-ox-1:3 (p < 
0.05). For 50 μg mL−1, GNP-C (4.4 fold) induces significantly more ROS production than GNP-
M (1.5 fold, p < 0.05) and GNP-M-ox-1:6 (1.6 fold, p < 0.01). 
 
Figure 3.7: Intracellular reactive oxygen species levels (ROS) induced by GNP-C, GNP-M, 
GNP-M-ox-1:3, and GNP-M-ox-1:6 (1, 10, 50 μg mL−1), when incubated with HFF-1 cells 
for 1 h. Negative control for ROS levels increase is PBS (considered 100%) and positive 
control H2O2 100 mM. Results are presented as mean and standard deviation (n = 3). 
Statistically significant differences, analysed within each concentration are represented by c 
– GNP-C, m – GNP-M, 1:3 – GNP-M-ox-1:3, 1:6 – GNP-M-ox-1:6. Symbols represented 
above a sample concentration indicate that sample is different from samples represented by 
the symbols for that concentration. Symbols are not underlined when p < 0.05 and 
underlined when p < 0.01. Above 10 μg mL−1 all samples are different from PBS (p < 0.01). 
 
These results indicate that size is the main factor leading to ROS formation, because smaller 
GNP-C penetrates cell membrane more easily than GNP-M, GNP-M-ox-1:3, and GNP-M-ox-1:6, 
inducing higher intracellular ROS formation. 
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Controls performed with GBMs dispersed in PBS, incubated with CM-H2DCFHDA in wells 
without cells, present similar values to PBS only, incubated with the indicator. Thus, GBMs do 
not interfere in ROS quantification method used. 
Mitochondrial membrane potential (MMP) was evaluated for GBMs at concentrations between 10 
and 100 μg mL−1, with 48 h incubation. It was observed to be decreased for both GNP-M and 
GNP-M-ox-1:3 for concentrations above 10 μg mL−1 and for GNP-C above 50 μg mL−1. For 
GNP-M-ox-1:6 no significant differences in MMP were perceptible (p > 0.05) comparing with 
cells cultured in DMEM+. Detailed results are presented in Figure A6. 
 
3.4.2.2.2 Cell morphology and interaction with GBMs 
 
After the resazurin assays, cells exposed to 50 μg mL−1 of GBMs were stained and observed (at 
100 μg mL−1 GBMs interfere with staining and images had lower quality). Immunofluorescence 
images (Figure 3.8) show that for toxicity positive control (Triton 0.1% in DMEM+), cells 
cytoskeleton was disassembled. A control was performed with cells cultured in DMEM+, which 
exhibited the typical “spindle” like shape of fibroblasts. After 72 h of incubation with 50 μg mL−1 
GNP-C, cells exhibit a normal morphology, similar to negative control. For GNP-M, the cell 
density is lower, with some cells showing altered morphology and being weakly attached to the 
bottom of the well. Similar images were obtained for GNP-M-ox-1:3. However, for GNP-M-ox-
1:6, cell morphology is normal and similar to cell cultured in DMEM+. As expected, these results 
are in agreement with those observed in cell viability assays results (see section 3.3.3.2.2.1) at 72 
h for all materials.  
TEM images (Figure 3.9(B)) show that GNP-C interacts with plasma membrane, being 
internalized without causing membrane damages, probably by pinocytosis. GNP-C is found often 
in cytoplasm, being able to interact with mitochondria (Fig. 3.9(C)), which may induce ROS 
production (see section 3.3.3.2.2.1). Sometimes, GNP-M causes cell membrane damage (Fig. 
3.9(D)), entering cells and being found inside plasma membrane (Fig. 3.9(E)). However, this 
seems to be less frequent than for GNP-C. It is not clear if internalization always occurs by 
membrane rupture or other mechanism. GNP-M-ox-1:3 interacts with plasma membrane, being 
internalized and forming vesicles in cytoplasm. The internalization process occurs both with and 
without causing membrane damages (Fig. 3.9(F)). GNP-M-ox-1:6 was found not to cause 
membrane damages (Fig. 3.9(G)), probably do to having less sharp edges. However, it was found 
inside cells in some cases (Fig. 3.9(H)). For all materials, the internalized particles had sizes from 
hundreds of nanometres to 5 μm. Internalized agglomerated particles have therefore not been 
observed. 
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Figure 3.8: Representative immunofluorescence images of HFF-1 cells after 72 h incubation 
with 50 μg mL−1 of GNP-C, GNP-M, GNP-M-ox-1:3 and GNP-M-ox-1:6. Triton 0.1% in 
DMEM+ was used as positive control for changed morphology and cells grown in DMEM+ 
as negative control. Cells were stained with DAPI (nuclei) – blue and Phalloidin (F-actin in 
cytoskeleton) – green. Scale bar represents 200 μm. 
 
 
Figure 3.9: TEM images of HFF-1 cells incubated for 72 h with 100 μg mL−1 GBMs. A, B – 
DMEM+, C – GNP-C (a – particle interacting with plasma membrane (pm), b – particle 
internalized and in contact with plasma membrane, c – particle inside a vesicle (vs) in 
cytoplasm), D – GNP-C particles spread in cytoplasm and interaction with a mitochondria 
(mt), E − Membrane rupture (white arrow) and cytoplasmic content leakage caused by 
GNP-M particle, F – GNP-M in cytoplasm (nc – nucleus), G – GNP-M-ox-1:3 (a – 
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interacting with plasma membrane, b – entering through plasma membrane, c – vesicle 
containing an internalized particle), H – GNP-M-ox-1:6 particle in contact with plasma 
membrane causing no damages, I – GNP-M-ox-1:6 inside cytoplasm. Scale bar represents 
0.5 μm for all images except for image A, in which it represents 2 μm. 
 
3.5 Discussion 
 
The particle size distribution of GBMs dispersed in water was determined to evaluate their 
agglomeration state in conditions similar to those used in the biocompatibility assays. After 
sonication, agglomerated fractions were identified for all materials except GNP-C. The oxidation 
of GNP-M to GNP-M-ox-1:3 and 1:6 slightly reduced agglomeration, as expected due to 
increased hydrophilicity. However, it was observed by optical microscopy that over time all 
materials sediment on the bottom of the wells contacting with the cells. This can be explained by 
the presence of more oxygen-containing functional groups, allowing hydrogen bonds between 
GNP particles. Despite agglomerates with considerable size being present, TEM images show that 
only small platelets and agglomerates, with diameters bellow 5 μm, are internalized. 
To our knowledge, a complete characterization of the in vitro biological effect of materials 
oxidized to different degrees, comparing with the base GBM, has not been performed until date. 
For this reason, the oxidation degree of the materials and the functional groups present were 
studied with particular attention. GNP-M-ox-1:6 was oxidized in higher extension and more 
homogeneously than GNP-M-ox-1:3, because of the higher amount of KMnO4 used. Also, more 
sp2 disruption is observed for GNP-M-ox-1:6 due to more effective introduction of oxygen-
containing functional groups in GNP-M surface. GNP-M-ox-1:3 was preferentially oxidized in 
platelets edges, because peripheral oxidation demands lower amount of KMnO4. Finally, different 
amounts of oxygen-containing functional groups were introduced in both materials, GNP-M-ox-
1:3 presenting mostly epoxides and carbonyls and GNP-M-ox-1:6 carboxyls and hydroxyls. 
No toxicity (0.1% lysis) was caused by both oxidized materials in RBCs, while for the original 
GNP-M, 2.5% hemolysis occurred after 3 h incubation with high concentrations of 500 μg mL−1. 
The published literature on this topic is scarce and shows that hemocompatibility is dependent on 
the particular GBMs considered. Dong et al. observed that functionalization of GO with 
carboxylic groups improved its hemocompatibility. [40] Sasidharan et al. reported that both 
pristine bilayer graphene (p-G) obtained by chemical oxidation of graphite and thermal 
exfoliation, and carboxyl-functionalized graphene (f-G) by mild chemical oxidation were 
nonhemolytic (hemolysis ≈ 0.2%) up to a tested concentration of 75 μg mL−1 with incubations of 
3 h at room temperature. [31] Liao et al. [41] performed hemolysis assays for GO (C at.% 2:1 O 
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at.%) obtained by a MHM from graphite and GS – graphene sheets (C at.% 7:1 O at.%) obtained 
from GO by hydrothermal treatment. They observed that GO caused about 80% hemolysis and 
graphene sheets (GS) about 15%, for the higher concentration tested of 200 μg mL−1, for the same 
incubation time. 
Metabolic activity of two cell lines (HFF-1 and HPMEC) exposed to different concentrations of 
GBMs over time was evaluated. These models were chosen because they are human non-
cancerous cell lines, from tissues that may be exposed to GBMs in case of either dermal contact 
or inhalation, respectively for HFF-1 and HPMEC. To the best of our knowledge, 
biocompatibility of HPMEC exposed to GBMs has never been reported. The results show similar 
toxicological profile for GBMs in contact with both cell lines. GNP-M-ox-1:3 causes a decrease 
of HFF-1 cells metabolic activity similar to the base material GNP-M. However, the more 
homogeneously oxidized GNP-M-ox-1:6 is biocompatible up to the highest concentration tested 
(100 μg mL−1). Hong et al. [42] observed that GO (produced by MHM from graphite (1:3 
KMnO4), O at.% = 38%, hydrodynamic diameter (HD) = 200 nm) caused a decrease in HeLa 
cells metabolic activity of about 15% and 25%, respectively for 48 h incubations with 10 and 100 
μg mL−1. When this material was re-oxidized by the same method (G2xO – O at.% of 54%, HD = 
200 nm), the metabolic activity decreased about 5% and 25% for 10 and 100 μg mL−1 (48 h), 
respectively. Comparing with our work, GO and G2xO are nanometric, while GNP-M, GNP-M-
ox-1:3 and 1:6 are in the micrometer range. Thus, the biologic relevance of oxidation may be 
different. 
GNP-M-ox-1:6 causes no metabolic activity decrease, contrary to GNP-M-ox-1:3. With a more 
extensive and homogeneous oxidation, GNP-M sharp edges fold, by formation of intra-platelet 
hydrogen bonds, causing much less damage to cell membrane and structures. However, GNP-M-
ox-1:6 is also found inside cells, pointing out to a non-disruptive internalization mechanism. 
These results are in agreement with immunocytochemistry observations of normal cell 
morphology for GNP-M-ox-1:6, contrarily to GNP-M and GNP-M-ox-1:3. Also, LIVE/DEAD 
assay shows lower cell death for GNP-M-ox-1:6, comparing with GNP-M. The fact that GNP-M-
ox-1:6 causes no damage on cell structure was confirmed by a non-reduced cell metabolic activity 
at all concentrations, comparing with cells cultured in DMEM+, contrary to GNP-M and GNP-M-
ox-1:3, which revealed decreases for concentrations above 10 μg mL−1. Sasidharan et al. [43] 
observed Vero cells in contact with f-G to have higher cell metabolic activity (comparing to 
control with culture medium) than the originally toxic hydrophobic material (p-G), which 
presented a metabolic activity of 60% for a concentration 100 μg mL−1 and 24 h incubation. Also, 
Liao et al. [41] studied the biocompatibility of a hydrophilic and a hydrophobic GBM using human 
skin fibroblasts. They tested GO with an HD in deionized water of about 0.7 μm and GS with 3 
μm. It should be noted that as in our work, the same GBM presented larger HD in the reduced 
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form in relation to the oxidized material, due to agglomeration. Using the WST assay, the 
metabolic activity values for GO were of 88% and for GS of 20% for 24 h incubations with 50 μg 
mL−1 concentrations. Thus, based on the current studies, it can be concluded that the oxidation of 
a hydrophobic GBM often improves its biocompatibility. Actually, GNP-M-ox-1:6 has increased 
metabolic activity, comparing with negative control (cells cultured in DMEM+) at 24 h for 100 μg 
mL−1, and at 72 h for 50 μg mL−1 and above. This suggests a favourable effect on cell 
proliferation. Such was confirmed by evaluating cell proliferation, which showed to significantly 
increase (p < 0.05), not only for GNP-M-ox-1:6, but for all GBMs at 72 h, for the higher 
concentration – 100 μg mL−1, comparing with DMEM+. This points out that GNP-M-ox-1:6 is 
not toxic at higher concentrations, opposing to other GBMs. Interestingly, Ruiz et al. [44] 
observed that mammalian colorectal adenocarcinoma HT-29 cells attached and proliferated more 
efficiently in GO coated glass slides, than in control (glass slides). 
An interesting aspect that is lacking from existing studies on GBMs biocompatibility has to do 
with the effect of particle size on the biocompatibility of hydrophobic GBMs. For this reason, 
biocompatibility tests were also performed for GNP-C, which exhibits smaller size than GNP-M 
and completely exfoliates in aqueous medium in particles with HDs of about 0.5 and 2 μm. GNP-
C seems to lead to lower (1.7%) Hb leakage from RBCs than GNP-M (2.5%) for 3 h incubation 
with a high concentration of 500 μg mL−1. However, these differences are not statistically 
significant (p > 0.05). Liau et al. [41] compared the hemolytic activity of GO with different sizes, 
produced by ultrasounds fragmentation of the base GO. They conclude that after 30 min 
sonication, GO decreased size by half to about 0.8 μm and caused higher hemolysis than the 
original material, which was already hemolytic. Liau et al. [41] also observed that no hemolysis 
was observed after coating the most hemolytic GO with chitosan, due to prevention of toxic 
interactions of RBCs with materials. Thus, polymer coating is a method that can be tried to 
improve GBMs biocompatibility. 
Higher decreases on cell metabolic activity were observed for GNP-C at 24 h than for GNP-M. 
However, at 48 and 72 h GNP-M decreases metabolic activity more than GNP-C. This can be 
explained by GNP-C inducing more ROS production than GNP-M in the initial contact with cells 
(1 h incubation), causing early toxicity at 24 h, from which cells recover over time. Sasidharan et 
al. observed highly increased ROS levels in Vero cells for p-G, unfortunately f-G was not tested. 
However, Liao et al. [41] observed a 9-fold increase (control: cells with no GBMs) in ROS 
production for GO, comparing to GS (about 1.3 fold). For GNP-M, metabolic activity decreases 
with incubation time, because physical damages are caused on cell membranes, by the platelets' 
sharp edges. LIVE/DEAD results show that GNP-M causes 3-fold more cell death than GNP-C. 
Additionally, immunocytochemistry images show that cells incubated with GNP-C display 
normal cell morphology, as opposed to cells incubated with GNP-M. In fact, the latter particles 
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were found to cause cell membrane rupture by TEM. GNP-C particles, on the other hand, were 
found inside cells, in higher quantities, without evidence of damages, despite an observed 
occurrence of interaction with cell membrane. To our knowledge it is the first time different types 
of GBMs interaction, internalization and effects in non-phagocytic or cancer line cells is shown in 
TEM images. Lamel et al. [25] observed that graphene oxide (GO) and carboxyl graphene 
nanoplatelets (CXYG) penetrate through the plasma membrane of Hep G2 (human hepatocellular 
carcinoma) cells into the cytosol, are concentrated and encapsulated in intracellular vesicles. They 
also observed that exposure to GO (HD ≈ 0.4 μm) and CXYG (HD ≈ 1.7 μm) nanoplatelets 
results in high intracellular ROS levels by perturbation of mitochondrial structure and function. 
GNP-C (HD ≈ 0.5 and 2 μm) caused high increases of ROS levels and was found spread in 
cytoplasm close to mitochondria. However, as mentioned above, this material did not cause 
membrane damages. GNP-M-ox-1:6, which was internalized, did not cause observable membrane 
damages, despite having a particle size distribution around 35 μm. It must be noted, however, that 
only particles bellow 5 μm were found in cytoplasm for all materials tested. 
Since GNP-C induces higher ROS production than the other materials and was found close to 
mitochondria, mitochondrial membrane potential (MMP) was evaluated. However, since a 
decrease on MMP was observed not only for GNP-C, but also for GNP-M and GNP-M-ox-1:3, 
another mechanism besides ROS formation is involved in MMP decrease, such as direct 
mitochondrial damage. Lamel et al. [25] also proposed that MMP disruption can be caused by 
physical interaction with mitochondria, besides being induced indirectly through ROS resultant 
from GBMs biointeraction. The collapse of the MMP coincides with the opening of the 
mitochondrial permeability transition pores, leading to the release of cytochrome c into the 
cytosol, which in turn triggers other downstream events in the apoptotic cascade. [45] MMP is 
decreased for both GNP-M and GNP-M-ox-1:3 for concentrations above 10 μg mL−1 and for 
GNP-C above 50 μg mL−1, pointing out apoptosis induced by these GBMs. For GNP-M-ox-1:6 no 
significant differences in MMP were perceptible (p > 0.05) comparing with cells cultured in 
DMEM+. These results are in agreement with above discussed data regarding cell death 
(LIVE/DEAD assay). 
 
3.6 Conclusions 
 
The biocompatibility of GNPs with different platelet sizes and oxidation degrees was 
evaluated in vitro. GNP-C, which exhibited smaller sizes, was shown to be generally more 
biocompatible than GNP-M. The sharper and longer edges of GNP-M platelets cause 
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membrane damages on cells being cytotoxic above 20 μg mL−1. GNP-C, despite being 
internalized without causing membrane damages, increases ROS levels being toxic above 
50 μg mL−1. 
The complete oxidation of GNP-M (GNP-M-ox-1:6) folds its sharp edges, assuring 
biocompatibility until the highest concentration tested (100 μg mL−1). GNP-M-ox-1:6 has an 
oxygen content of 24% (mostly carboxyls and hydroxyls) and is dispersible in water by 
sonication, revealing potential to be used for biomedical purposes. 
Generally, oxidation was found to be more important than size, since more oxidized GNP-M 
performed better than smaller GNP-C. 
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4 GBMS BIOCOMPATIBILITY – EFFECT OF 
POLYMER SURFACE ADSORPTION 
4.1 Scope 
 
The biointeractions of graphene-based materials depend on their physico-chemical properties. 
Thus, these properties can be manipulated in order to understand and improve GBMs 
biocompatibility. This chapter presents a study on the biocompatibility of graphene nanoplatelets 
modified by surface adsorption of several water-soluble polymers. In addition to biocompatibility, 
the materials produced were characterized by scanning electron microscopy, dynamic light 
scattering, X-ray photoelectron spectroscopy, Raman spectroscopy, and thermogravimetric 
analysis. 
 
4.2 State of the art 
 
Excellent physico-mechanical properties have been extensively reported in the literature 
concerning graphene and graphene-based materials (GBMs), such as high mechanical strength, 
specific surface area and high thermal and electrical conductivity. [1-9] Several biomedical 
applications have been studied, including biosensing/bioimaging [10], drug delivery [11], cancer 
photothermal therapy [12], regenerative medicine [13-14], and antibacterial materials [11]. In view of 
the growing interest in using GBMs in this context, it is paramount to evaluate their 
biocompatibility. Existing studies indicate that GBMs generally induce a decrease in cell viability 
above a concentration of 10 μg mL−1 after 24 h of incubation, with cell viability often decreasing 
as time and concentration increase. However, it is expected that cell interactions will be 
dependent on the physical-chemical properties of GBMs (e.g., size, hydrophilicity), which are 
related to the raw materials and production methods used. However, the number of available 
studies is still relatively low, and some contradictory results can be found. This subject was 
recently reviewed by Pinto et al. [15]. The relationship between the physical-chemical properties 
of GBMs and their biocompatibility is still not clearly established and has to be evaluated in each 
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case. In addition, because intravenous administration or implantation of GBMs is often 
considered, haemocompatibility studies must be included. [15-16] 
Covalent and non-covalent surface modification with polymers is a strategy to overcome possible 
toxicity of GBMs. Regarding covalent modification, GBMs biocompatibility has been shown to 
be improved by functionalization with 2-methacryloyloxyethyl phosphorylcholine [17], and 
crosslinked poly(N-isopropylacrylamide)-g-poly(ethylene oxide) [18]. A limitation of some 
reported works that describe chemical functionalization in the context of drug delivery 
applications is that the biocompatibility of only the modified GBMs conjugated with drugs is 
reported, without comparison to the polymer-functionalized material. [19-21] The approach of non-
covalent modification has been less fully explored, with few biocompatibility studies available. 
The only such reports concern surface adsorption of polyethylene glycol (PEG) [22] and 
poly(ethylene imine) − PEI [23], with biocompatibility improvements being observed. A main 
advantage of this strategy is that it can usually be performed in aqueous medium. Covalent 
functionalization, on the other hand, often implies using toxic solvents as reaction medium. In 
addition, the procedures for non-covalent surface modification are simple and easily up-scaled. 
The present work studies a commercially available product, graphene nanoplatelets (GNP), with 
reduced cost compared to single layer graphene. Each particle of GNP-C consists of 2 or more 
stacked graphene layers, possessing oxygen-containing functional groups at the edges, which may 
interact with solvent or polymers. Because this is a commercial product, it has the advantage of 
material consistency and availability. Moreover, GNP has been reported to display good results as 
a biopolymer filler, improving mechanical performance [24] and biocompatibility, namely 
reducing platelet activation without increasing toxicity [24]. In this work, the biocompatibility of 
GNP was studied, as were the effects of non-covalent surface modification with several 
biocompatible polymers, namely poly(vinyl alcohol) (PVA), poly(ethylene glycol) (PEG), 
poly(vinyl pyrrolidone) (PVP), hydroxyethyl cellulose (HEC), and glycosaminoglycans: 
chondroitin (CON), glucosamine (GLU) and hyaluronic acid (HA). [25-28] Polymers such as PVA, 
PEG, PVP, and HEC are often used in biomedical applications themselves or as modifying agents 
to improve the biocompatibility of materials. [29] Glycosaminoglycans are a significant component 
of proteoglycans, and they do not elicit immune response and have been used extensively for 
tissue engineering applications. [30] As an example, HA has been used for surface modification of 
carbon nanotubes and GO. [31] Wu et al. [32] observed that GO functionalized with adipic acid and 
covalently conjugated with HA was biocompatible with HeLa and L929 cells and non-toxic to 
mice up to high concentrations. 
In the present work, biocompatibility was evaluated in terms of hemolysis, effects on cell 
viability, morphology and membranes, and ROS production. 
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4.3 Materials and methods 
4.3.1 Materials preparation 
 
Graphene nanoplatelets (GNP) grade C750 were acquired from XG Sciences (Lansing, USA), 
presenting an average thickness lower than 2 nm and surface area of 750 m2 g−1. GNP-C has a 
size distribution that ranges from very small flakes (diameter below 100 nm) up to larger flakes 
(1–2 μm). According to the manufacturer, GNP production is based on exfoliation of sulphuric 
acid-based intercalated graphite by rapid microwave heating, followed by ultrasonic 
treatment. [39] 
GNP-C were modified by surface adsorption with: a) poly(vinyl alcohol) − PVA, b) hydroxyethyl 
cellulose − HEC, c) poly(ethylene glycol) − PEG, d) poly(vinyl pyrrolidone) − PVP e) 
chondroitin sulfate potassium − CON, f) d-glucosamine sulfate potassium − GLU and g) 
hyaluronic acid − HA. HEC − WeKcelo 300 was acquired from WeiKem Chemical Co., China; 
according to manufacturer, the polymer has a particle size of 180 μm (98,5%) and ?̅? w 
= 3000000 g mol−1. PVA − Mowiol 47-88, ?̅?w = 205000 g mol−1, hydrolysis degree (HD) = 88% 
− was purchased from Clariant. CON (?̅?w = 463.3 g mol−1), GLU (?̅?w = 277.2 g mol−1) and HA 
( ?̅? w = 1450000 g mol−1) were acquired from PureBulk, USA. PVP-K30 ( ?̅? w = 40000–
80000 g mol−1) was purchased from Alfa Aesar. PEG-bioultra (?̅?w = 16000–24000 g mol−1) was 
acquired from Sigma Aldrich. Polymers and GNP-C (1:1 w/w ratio) were dispersed in water, 
performing sonication with a Hielsher UIP 1000 probe for 5 min. Next, the dispersion was 
centrifuged at 4000 rpm for 15 min and supernatant discarded, assuring removal of excess 
polymer. The precipitate was dried at 60 °C for 1 week. Controls were performed by washing 
GNP-C with 5 L distilled water by filtration, and this material was designated GNP-C-w. GNP-C 
was centrifuged at 4000 rpm for 15 min, and the precipitate was recovered and tested. This 
material was designated GNP-C-c. [37] 
 
4.3.2 Physical-chemical characterization 
 
Dynamic light scattering particle sizes and distributions of the materials were determined with an 
LS230 laser particle analyzer (Coulter, USA). GBMs were dispersed in water at a concentration 
of 100 μg mL−1 and sonicated for 20 min. Just before sample testing, a 10 min sonication was 
performed to redisperse agglomerates. Data were collected performing 3 scans of 60 s, including 
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polarization intensity differential scattering and using Fraunhofer’s model. This model assumes 
spherical shape for the particles in suspension. The obtained size distributions must therefore be 
considered as relative evaluations of the degree of deagglomeration of the different materials in 
water and not as precise estimations of particle sizes. Li et al. [40] used a similar approach to 
evaluate graphene oxide particle size distribution in water by dynamic light scattering. 
 
4.3.3 Biocompatibility evaluation 
 
GBMs were sterilized in ethanol by sonication for 20 min (Bandelin Sonorex RK512H). The 
materials were dried in a vacuum oven at 50 °C under sterile conditions. GBMs were redispersed 
in appropriate volume of phosphate buffered saline (PBS, pH 7.4) or Dulbecco’s modified Eagle’s 
medium (DMEM, Gibco) supplemented with 10% (V/V) newborn calf serum (Gibco) and 1% 
(V/V) penicillin/streptomycin (biowest) (DMEM +). 
4.3.3.1 Hemolysis assay 
Red blood cells (RBCs) were isolated from buffy coats (obtained from Immunohemotherapy 
Service, Hospital S. João, Porto, Portugal) as described previously. [41] Briefly, RBCs were 
centrifuged over a density gradient with Histopaque-1077 (Sigma-Aldrich) according to 
manufacturer's instructions. The lower layer containing RBCs was washed three times in PBS. 
The purified RBCs were diluted to a concentration of 2 × 108 cells mL−1, and 100 μL of RBCs 
were placed in round bottom 96-well polypropylene microtiter plates. Next, 100 μL of GBMs 
dispersion was added to the wells and incubated for 3 h at 37 °C and 80 rpm. Afterwards, the 96-
well plates were centrifuged at 4000 rpm for 15 min to collect supernatant, which was transferred 
(80 μL) from each well to black polypropylene 96-well microtiter plates. Absorbance was read at 
380, 415, and 450 nm using a micro-plate reader spectrophotometer (Bioteck Plate Reader, 
Synergy MX). The haemolytic potential of GBMs was calculated as follows: Hemolysis (%) = Hb 
value of sample/Total Hb value × 100, where total Hb value corresponds to 100% hemolysis with 
1% Triton X-100. [34] The GBMs concentrations tested were 100, 200 and 500 μg mL−1. Controls 
with PBS (lysis negative control) and 1% Triton (Sigma Aldrich, X100) in PBS (positive control 
for 100% hemolysis) were performed. Additionally, controls with only GBMs in PBS were 
performed for each concentration tested. All assays were performed in triplicate and repeated 3 
times. 
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4.3.3.2 Biocompatibility with fibroblasts 
In vitro assays were performed using HFF-1 (from ATCC), grown in DMEM+ at 37 °C, in fully 
humidified air containing 5% CO2. The medium was replenished every 3 days and cells were 
detached from T75 flasks upon reaching 90% confluence. For all assays, HFF-1 cells were seeded 
at a density of 2 × 104 cells mL−1 in 96-well plates or an 8-well chamber slide system Lab-Tek-II. 
Upon confluence (24 h), the DMEM+ was removed and cells were incubated with increasing 
concentrations of GBMs in DMEM+ (1–100 μg mL−1) for 24, 48, and 72 h. At the indicated time-
points, cells were observed in an inverted fluorescence microscope (Carl Zeiss − Axiovert 200) 
and phase contrast images were acquired. All experiments were performed using cells between 
passages 10 and 14. 
4.3.3.3 Cytotoxicity assays 
Cell mitochondrial metabolic activity was quantified by resazurin assay at 24, 48, and 72 h of 
incubation. Briefly, 20 μL (1 mg mL−1) of resazurin (Sigma Aldrich) solution in PBS was added 
to each well. Cells were incubated for 3 h and fluorescence (λex/em = 530/590 nm) read in a micro-
plate reader spectrophotometer. The negative control for metabolic activity decrease was 
performed by incubating cells with DMEM+ and the positive control by incubating with triton 
0.1 wt.%. Cell metabolic activity (%) was calculated as follows: Fluorescence of 
sample/Fluorescence of negative control x 100. Controls were performed with materials only 
(without cells) dispersed in DMEM+ for all concentrations tested. All assays were performed in 
sextuplicate and repeated 3 times. 
Cell viability/membrane integrity was evaluated by LIVE/DEAD assay. At 72 h, the medium was 
removed and cells incubated with Hoechst 33342 (Molecular Probes) and Calcein (Molecular 
Probes), both at 2.5 μg mL−1 in PBS for 15 min at 37 °C in the dark. Then, propidium iodide (PI) 
(Sigma Aldrich) in PBS was added to each well to a final concentration of 1.25 μg mL−1 and 
images were acquired in a Carl Zeiss − Axiovert 200. Cell death (%) was calculated as follows: 
number of cells stained with PI/number of cells stained with Hoechst 33342 * 100. All assays 
were performed in triplicate and repeated 3 times. 
 
4.3.3.4 Intracellular ROS evaluation 
HFF-1 cells were seeded as previously described and, after reaching a state of subconfluence 
(24 h), washed with PBS at 37 °C and incubated 45 min at 37 °C with 95 μL chloromethyl-2′,7′-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Molecular Probes) at a concentration of 
2 μg mL−1. The reagent was removed and cells incubated at 37 °C for 1 h with 150 μL GBMs 
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dispersed in PBS (1, 10, and 50 μg mL−1). Finally, 100 μL Triton 1% in PBS was added to each 
well and fluorescence (λex/em = 480/530 nm) read in a micro-plate reader spectrophotometer. 
Controls were performed with GBMs dispersed in PBS, for all concentrations tested, and 
incubated with the same amount of CM-H2DCFDA in wells without cells. PBS was used as a 
negative control and H2O2 (Merck) 100 mM as a positive control for intracellular ROS 
production. ROS levels were calculated as follows: ROS levels (%) = Fluorescence of the 
sample/Fluorescence of negative control x 100. All assays were performed in triplicate and 
repeated 3 times. 
4.3.3.5 Transmission electron microscopy (TEM) 
After 72 h of incubation, cells exposed to 100 μg mL−1 GBMs in a Lab-Tek-II were fixed in 2% 
glutaraldehyde (Electron Microscopy sciences, Hatfield, USA) and 4% PFA in cacodylate Buffer 
0.1 M (pH 7.4), dehydrated and embedded in Epon resin (TAAB, Berks, England). Ultrathin 
sections (40–60 nm thickness) were prepared on a Leica Reichert SuperNOVA Ultramicrotome 
(Germany) using diamond knives (DDK, Wilmington, DE, USA). The sections were mounted on 
200 mesh copper or nickel grids, stained with uranyl acetate and lead citrate for 15 min each, and 
examined under a JEOL JEM 1400 TEM (Tokyo, Japan). Images were digitally recorded using a 
CCD digital camera Orious 1100 W (Tokyo, Japan) at the HEMS − Institute for Molecular and 
Cell Biology (IBMC) of the University of Porto. 
4.3.4 Statistical analysis 
Statistical analysis was performed using the software SPSS20 (IBM) performing Kruskal–Wallis 
one-way analysis of variance. The resazurin assays were analysed by performing parametric 
analysis of variance (ANOVA) followed by Tamhane, Dunnett, and Games-Howell post hoc tests. 
Multiple means comparisons were performed between samples to identify significant differences, 
which were considered for p < 0.05. 
 
4.4 Results 
4.4.1 Physical-chemical characterization 
 
Figure 4.1 shows particle size distributions obtained after GBMs dispersion in water. GNP-C 
exfoliates effectively in water, originating two populations of platelets with sizes below 2 μm 
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(approximately 0.5 and 2 μm). Dispersion after treatment with PEG, PVP, CON, GLU and HA 
does not increase particle size. However, it increases for GNP-C-PVA (approximately 25 μm) and 
GNP-C-HEC (approximately 8 μm), indicating significant formation of platelet agglomerates due 
to interaction with these two polymers. GNP-C is composed of platelets with length below 2 μm 
and small wrinkled flakes with folded edges (< 0.5 μm) that tend to form agglomerates. 
 
 
Figure 4.1: A) Particle size distributions of GBMs dispersed in water at a concentration of 
100 μg mL−1. B) Particle size distributions for a narrower size range than in image A, to 
allow comparison between GBMs with smaller size distribution. 
 
Polymer presence at the GNP-C surface was confirmed and quantified by XPS, Raman 
spectroscopy, and TGA (Figure B2 – Appendix B). The presence of these polymers increased O 
(at.%) in the final products in all cases, this increment being above 10% for GNP-C-PVA and 
HEC. The morphology of GNP-C before and after surface adsorption of the polymers was 
observed by SEM (Figure B1). 
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4.4.2 Biocompatibility evaluation 
4.4.2.1 Hemolysis evaluation 
 
Figure 4.2 shows that the hemolysis ratio seems to be decreased with surface adsorption of most 
polymers, except for HA, despite significant differences (p < 0.05) only being observed between 
GNP-C (1.7%), GNP-C-PVA (0.05%) and HEC (0%) at the higher concentration (500 μg mL−1). 
 
Figure 4.2: Percentage of RBCs lysis after 3 h incubation at 37 °C with PBS (negative 
control) and different concentrations of GBMs (100, 200 and 500 μg mL−1). The positive 
control (Triton 1% in PBS) resulted in 100% hemolysis (data not shown). The results are 
presented as the mean and standard deviation (n = 3). Greek symbols represent statistically 
significant differences between samples within the same concentration (p < 0.05). 
 
Because PVA and HEC presented the best performance at reducing hemolysis, these polymers 
were selected for testing in further biocompatibility assays, presented next. 
 
4.4.2.2 Biocompatibility with fibroblasts 
After verifying that the materials do not show relevant toxic effects towards RBCs, further assays 
were performed to evaluate their effect when in direct contact with human foreskin fibroblasts 
(HFF-1). Phase contrast images were obtained for each time and concentration tested, and 
representative images are shown in (Fig. B1). Further characterization was performed and 
described below. 
 
4.4.2.3 Cytotoxicity 
Considering that, if metabolic activity is reduced to less than 70% compared to the negative 
control for mitochondrial metabolic activity decrease (cells incubated with DMEM+), a sample 
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has cytotoxic potential [ISO 10993-5:2009(E)], it can be observed from Figure 4.3 (A) that GNP-
C is potentially non-toxic up to a concentration of 20 μg mL−1 until 72 h. GNP-C is toxic at 24 h 
at concentrations above 20 μg mL−1, however, the cell mitochondrial metabolic activity recovers 
over time until 72 h. For GNP-C-HEC, no improvements in biocompatibility are observed 
compared to pristine GNP-C. GNP-C-PVA is toxic at 24 h only above 50 μg mL−1, which 
constitutes an improvement in biocompatibility compared with GNP-C. Moreover, at 48 and 72 h, 
it also presents higher viability than GNP-C, revealing no toxicity until the highest concentration 
tested of 100 μg mL−1. Controls performed with materials dispersed in DMEM+ without cells, for 
all concentrations tested, presented similar values to DMEM+, suggesting that the materials tested 
did not interfere with fluorescence determination. 
Figure B4 (Appendix B) shows representative images of HFF-1 cells, with and without contact 
with GBMs, after labelling for LIVE/DEAD assay. As expected, the positive control for cell death 
(cells incubated with 0.1 wt.% Triton in DMEM+ for 72 h) unveiled 100% cell death. A negative 
control was performed incubating cells with DMEM+, presenting mostly live cells with scarce 
dead fibroblasts. Fig. 4.3(B) shows that cell death was below 5% for all materials tested. At 20 
and 50 μg mL−1, cell death was significantly lower (p < 0.05) for modified GNP-C-PVA 
compared to pristine GNP-C. 
Fig. 4.3(C), shows that for 50 μg mL−1 at 1 h, GNP-C increases ROS production by 4.4-fold 
compared with the negative control (PBS). For GNP-C-PVA and HEC it also increases by 3.3- 
and 5.2-fold, respectively. Despite no significant differences being observed between materials 
(p > 0.05), there is a trend toward surface adsorption of HEC increasing and PVA reducing ROS 
production compared to unmodified GNP-C (Figure 4.3(C)). All materials are different from the 
negative control (PBS) at 10 and 50 μg mL−1 (p < 0.05). Controls performed with GBMs 
dispersed in PBS, incubated with CM-H2DCFHDA in wells without cells, present similar values 
to PBS only, incubated with the indicator. Thus, GBMs do not interfere in the ROS quantification 
method used. 
 
4.4.2.4 Cell interaction with GBMs 
TEM images (Figure 4.4(C)) show that GNP-C is almost completely exfoliated, interacting with 
plasma membrane, being internalized without causing membrane damage, and being found inside 
vesicles in fibroblast cytoplasm (Fig. 4.4(D)). GNP-C is found often in cytoplasm, being able to 
interact with mitochondria (Fig. 4.4(C, D)), which may induce ROS production (Fig. 4.4(C)). 
GNP-C also contacts the nucleus (Fig. 4.4(C)), despite apparently causing no damage. 
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Figure 4.3: A) HFF-1 cell viability after incubation with GBMs in DMEM+, at 24, 48 and 
72 h. Cell mitochondrial metabolic activity is represented as a percentage in comparison 
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with cells cultured in DMEM+ (100%). The results are presented as the mean and standard 
deviation (n = 6). The red line at 70% marks the toxicity limit according to ISO 10993-
5:2009(E). The statistical analysis is presented in Table B1) Percentage of HFF-1 cell death 
after 72 h of incubation with GBMs. Cell death percentage was corrected by subtraction of 
the value for cells cultured in DMEM+ (negative control for cell death). The results are 
presented as the mean and standard deviation (n = 3). Statistically significant differences 
(p < 0.05) analysed within each concentration between all GBMs are represented by Greek 
symbols. C) Intracellular reactive oxygen species levels (ROS) induced by GBMs (1, 10, 
50 μg mL−1) when incubated with HFF-1 cells for 1 h. The negative control for ROS 
production is PBS (considered 100%) and the positive control is H2O2 100 mM. The results 
are presented as the mean and standard deviation (n = 3). No statistically significant 
differences (p > 0.05) were observed between samples within each concentration. 
 
GNP-C-PVA was more agglomerated, presenting larger volume than GNP-C (Fig. 4.4(E)), being 
found more often outside the plasma membrane (Fig. 4.4(F)) than in cytoplasm. Internalized 
GNP-C-HEC particles presented smaller length (0.5–1.5 μm) than GNP-C-PVA or GNP-C (0.5–
3 μm), being often found spread in cytoplasm (Fig. 4.4(G)). GNP-C-HEC was also observed in 
contact with mitochondria (Fig. 4.4(H)). For all materials, the internalized particles ranged in size 
from hundreds of nanometres to 3 μm. 
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Figure 4.4: TEM images of HFF-1 cells incubated for 72 h with 100 μg mL−1 GBMs. 
DMEM+ − A [33], B (cyt − cytoplasm, nc − nucleus); GNP-C − C (a − particle interacting 
with pm − plasma membrane, b − particles inside cytoplasm, c − particle in contact with 
nucleus), D (particles inside cytoplasm, vs- vesicles); GNP-C-PVA − E (agglomerated 
particles inside cytoplasm), F (particle outside plasma membrane); GNP-C-HEC − G 
(particles spread in cytoplasm), H (particles interacting with mitochondria − mt). Scale bar 
represents 0.5 μm, except for A − 2 μm. 
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4.5 Discussion 
 
To the best of our knowledge, the in vitro biological effects of GBMs modified by the polymers 
evaluated in this work have not been completely characterized to date. Polymer presence at the 
GNP-C surface was confirmed by several methods and quantified by TGA (Figure B2 – 
Appendix B). The presence of these polymers increased O (at.%) in the final products in all cases, 
this increment being above 10% for GNP-C-PVA and HEC. This higher hydrophilicity 
contributed to more stable dispersion in water and culture medium despite the increased particle 
size. The morphology of the GBMs was qualitatively evaluated by SEM (Fig. B1). Particle size 
distributions after dispersion in aqueous medium were determined by dynamic light scattering to 
evaluate the agglomeration state in conditions similar to those used in the biocompatibility assays. 
After sonication, GNP-C yields a bimodal distribution with narrow peaks at 0.5 and 2 μm, 
indicating very good deagglomeration into primary nanoplatelets. 
Similar results are obtained when treating with the selected materials except for HEC and PVA. In 
the first case, the final hydrodynamic diameter (HD) is approximately 8 μm, while for PVA HD it 
is approximately 25 μm. The increased platelet agglomeration when combined with HEC or PVA 
can be explained by the affinity of this polymer towards the GNP-C surface together with an 
inter-particular bridging effect due to hydrogen bonding between the polymer's hydroxyl groups. 
This effect appears to be dominant over steric stabilization and therefore leads to agglomeration. 
As shown in supplemental material (Fig. B3), it was observed by optical microscopy that over 
time all the materials sediment on the bottom of the wells, contacting the cells. Despite 
agglomerates with considerable size being present, TEM images show that only small platelets 
and agglomerates with diameter below 3 μm are internalized into fibroblasts. 
Hemolysis in the presence of GNP-C (1.7%) was significantly decreased with surface adsorption 
of PVA (0.05%) and HEC (0%) for the higher concentration tested (500 μg mL−1) with 3 h of 
incubation. The published literature on this topic is scarce and shows that haemocompatibility is 
dependent on the particular GBMs considered because interactions depend on the materials’ 
physicochemical properties (e.g., size, shape, chemical composition). [33] Due to having small size 
and sharp edges that may damage erythrocytes, GNP-C causes some hemolysis, but to a low 
extent (1.7%). Surface adsorption of PVA and HEC reduced this value even further, rendering the 
material almost completely nonhaemolytic. Adsorption of polymers that present low chemical 
affinity for GNP-C resulted in no significant differences (p > 0.05) in hemolysis, as for example 
HA, whose percentage in relation to polymer is only 5.1 wt.% and hemolysis 1.6%. For the 
purpose of discussion, comparisons can be made with Sasidharan et al. [34], who reported pristine 
bilayer graphene (p-G) obtained by chemical oxidation of graphite and thermal exfoliation, to be 
nonhaemolytic (hemolysis ≈ 0.2%) up to a tested concentration of 75 μg mL−1 with incubation of 
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3 h. However, Liao et al. [35] showed that GS − graphene sheets obtained from GO by 
hydrothermal treatment caused about 15% hemolysis at the higher concentration tested of 
200 μg mL−1 for the same incubation time. Because there are no in vitro studies regarding the 
haemocompatibilty of GBMs modified with polymers, a comparison can be made with Yang et 
al. [36], who observed nanographene sheets (NGS) functionalized with polyethylene glycol (PEG) 
to be non-toxic to Balb/c mice over a period of 3 months at a concentration of 20 mg kg−1 injected 
intravenously. Due to the reduced number of studies in this area, further testing is needed to better 
understand GBMs biocompatibility. 
GNP-C for 24 h is toxic at concentrations above 20 μg mL−1, however cell mitochondrial 
metabolic activity recovers over time until 72 h, in line with our previous work. [37] For GNP-C-
HEC, no improvements in biocompatibility are observed compared to pristine GNP-C. GNP-C-
PVA is toxic at 24 h only above 50 μg mL−1, which constitutes an improvement in 
biocompatibility compared with GNP-C. Moreover, at 48 and 72 h, it also presents better 
performance than GNP-C, revealing no toxicity until the highest concentration tested of 
100 μg mL−1. Feng et al. [23] had previously modified GO by surface adsorption 
(ultrasounds + centrifugation) of PEI. GO (thickness ≈ 1 nm, length < 100 nm) entered HeLa cells 
and caused a viability decrease of 32% (MTT assay) at a concentration of 100 μg mL−1 for 24 h. 
GO-PEI (thickness ≈ 4 nm, length < 100 nm) only reduced viability by 20% under the same 
conditions. Additionally, Wojtoniszak et al. [22] modified reduced GO − rGO (thickness ≈ 4 
layers, length ≈ 100 nm) with PEG by simple mixing in PBS. rGO caused L929 fibroblast 
viability decreases (WST-1 test) of 22% at 12.5 μg mL−1 for 24 h. For rGO-PEG, viability 
decreases were reduced to 14% employing equal circumstances. Interestingly, at higher 
concentrations, PEG was shown to not be as effective. Unfortunately, no further assays are 
available to unveil the toxicity mechanisms. For this reason, we performed complementary tests. 
LIVE/DEAD assays revealed that cell death is lower for GNP-C-PVA compared to pristine GNP-
C. It was already observed in resazurin assays that GNP-C-PVA presented better biocompatibility 
than pristine GNP-C. Additionally, cell death is below 5% for all materials. These values are 
inferior to the higher viability decreases observed in resazurin assays. A possible explanation for 
the difference is that metabolic activity is decreased in some cells despite presenting intact 
membranes and not being stained by propidium iodide, which only penetrates cells with 
compromised membrane integrity. For this reason, Fig. 4.3(B) is also an evaluation of membrane 
damage to HFF-1 cells. Generally, it shows that membrane damage increases with concentration 
being low for all materials. For GNP-C, the highest value was 4.7%, with PVA and HEC surface 
adsorption preventing membrane damage, presenting values of 1.4 and 1.2%, respectively. 
Because low membrane damage is observed, GNP-C probably has mainly a non-membrane 
disruptive internalization mechanism and intracellular toxicity. For this reason, ROS levels were 
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determined. Despite no significant differences being observed between materials (p > 0.05), there 
is a trend toward ROS production increasing with surface adsorption of HEC and decreasing with 
adsorption of PVA compared to unmodified GNP-C. These findings may explain the reduced 
membrane damage and early reversible metabolic activity decreases observed (respectively) in the 
LIVE/DEAD and resazurin assays. To clarify membrane and cell interactions with GBMs, 
imaging techniques were used. 
GNP-C is almost completely exfoliated in liquid medium, interacting with plasma membrane and 
being internalized without causing membrane damage. TEM images show that GNP-C-PVA was 
more agglomerated, presenting larger size, and it was found more often outside the plasma 
membrane than in cytoplasm. Internalized GNP-C-HEC particles presented smaller length (0.5–
1.5 μm) than GNP-C-PVA and GNP-C (0.5 − 3 μm), being often found spread in cytoplasm. 
Thus, we can assume that surface adsorption of PVA increases particle size, decreasing 
internalization, and HEC favours internalization of small particles compared with GNP-C. For 
these reasons, GNP-HEC could have had higher interaction with mitochondria, inducing higher 
ROS production and earlier toxicity. The same applies to GNP-C compared with GNP-C-PVA. 
These phenomena were already reported by Lamel et al. [38] They observed that graphene oxide 
(GO) and carboxyl graphene nanoplatelets (CXYG) penetrate through the plasma membrane of 
Hep G2 (human hepatocellular carcinoma) cells into the cytosol, concentrating and becoming 
encapsulated in intracellular vesicles. They also reported that exposure to GO (HD ≈ 0.4 μm) and 
CXYG (HD ≈ 1.7 μm) nanoplatelets results in high intracellular ROS levels from perturbation of 
mitochondrial structure and function. 
 
4.6 Conclusions 
 
GNP-C was modified by surface adsorption of PVA, HEC, PEG, PVP, chondroitin, 
glucosamine and hyaluronic acid, leading to an increase of oxygen content on the 
nanoplatelets' surface and, in the case of GNP-C-PVA and GNP-C-HEC, increasing apparent 
particle size in aqueous medium.  
All of the materials caused low hemolysis (<1.7%) up to 500 μg mL−1, usually decreasing 
after polymer adsorption, with PVA and HEC leading to the best results.  
GNP-C-PVA is non-cytotoxic at concentrations up to 100 μg mL−1, whereas GNP-C can 
only be used at a maximum concentration of 50 μg mL−1. This difference can be explained 
by PVA encapsulating and agglomerating GNP-C platelets, thereby decreasing the 
internalization and interaction with HFF-1 cells that lead to ROS production.  
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HEC favoured internalization of small GNP-C particles, having the opposite effect regarding 
ROS levels. For these reasons, modification with HEC, in contrast to PVA, was counter-
productive regarding increasing the biocompatibility of GNP-C with fibroblasts. 
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5 PLA/CARBON-BASED NANOMATERIALS 
COMPOSITES – LITERATURE REVIEW  
5.1 Scope 
 
Poly(lactic acid) (PLA) is a green alternative to petrochemical commodity plastics, used in 
packaging, agricultural products, disposable materials and textiles, and automotive. It also is 
approved by regulatory authorities for several biomedical applications. However, for some uses it 
is required that some of its properties are improved, namely thermo-mechanical and electrical 
properties. The incorporation of nanofillers is a common approach to attain this goal. The 
outstanding properties of carbon-based nanomaterials (CBNs), caused a surge on research works 
on PLA/CBNs composites. Since there is a great amount of information on these materials, it was 
gathered, compared and conclusions withdraw from it. This chapter is focused on PLA/CNTs 
(carbon nanotubes) and GBMs (graphene-based materials) composites production methods, and 
the effects of CBNs on PLA properties, namely mechanical, thermal, electrical and biological 
properties. 
 
5.2 State of the art 
5.2.1 Introduction 
 
The growing environmental awareness and new rules and regulations are forcing the industries to 
seek more ecologically friendly materials for their products. [1] In the last two decades, industrial 
and academic research on polymer composites was pursued to provide added value properties to 
the neat polymer without sacrificing its processability or adding excessive weight. [2] 
Poly(lactic acid) (PLA) has had significant demand due to its versatile applications in packaging, 
pharmaceutical, textiles, engineering, chemical industries, automotive, biomedical and tissue 
engineering fields. [3] However, the relatively low glass transition temperature, low thermal 
dimensional stability, and mechanical ductility limit the number of its applications. A significant 
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body of research has dealt with the use of fillers for improving the properties of PLA. [4-6] In this 
context, carbon based nanomaterials (CBNs), offer the potential to combine PLA properties with 
several of their unique features, such as high mechanical strength, electrical conductivity, thermal 
stability and bioactivity. [7-12] Carbon nanotubes (CNTs) and graphene-based materials (GBMs) 
are state of the art and very promising representatives of these materials. CNTs have exceptional 
mechanical properties, aspect ratio, electrical and thermal conductivities, and chemical stability. 
However, their production methods are usually complex and expensive, often leaving toxic metal 
residues. [13-16] Hence, GBMs provide an alternative option to produce functional composites due 
to their excellent properties and the natural abundance of their precursor, graphite. Moreover, 
GBMs can be produced by simple and inexpensive physico-chemical methods (Figure 5.1). [17-20] 
In the last years there has been a surge of research works on PLA/CNTs and PLA/GBMs 
composites. Due to the large amount of information available, there is the need to congregate, 
compare and withdraw conclusions. 
Several recent reviews have addressed PLA [3, 21-26] and CBNs [26-43] synthesis/production, 
applications and properties, however, there is no such work available focused on PLA/CBNs 
composites. This reason, this work presents some introductory information about PLA and CBNs, 
namely CNTs and GBMs, followed by a comprehensive comparison and discussion on the current 
progress regarding the production of PLA/CBNs composites and the resulting properties, namely 
mechanical, electrical, thermal and biological. 
 
5.2.2 Materials 
5.2.2.1 Poly (lactic acid) 
 
PLA is a thermoplastic aliphatic polyester commonly produced by polymerization of lactic acid 
monomer. As lactic acid is a chiral molecule, existing in l and d isomers, the term “poly(lactic 
acid)” refers to a family of polymers: poly-l-lactic acid (PLLA), poly-d-lactic acid (PDLA), and 
poly-d,l-lactic acid (PDLLA). PLA can be polymerized by diverse methods, like 
polycondensation, ring opening polymerization, azeotropic dehydration condensation, and 
enzymatic polymerization. Direct polymerization and ring opening polymerization are the most 
used. Controlling polymerization parameters is important, since PLA properties vary with isomer 
composition, temperature, and reaction time used. [3, 21, 24, 25, 44-47] 
The increasing interest on PLA has to do with aspects that lack in other polymers for the same 
applications, regarding renewability, biocompatibility, processability, and energy saving. [25] PLA 
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is derived from renewable and biodegradable resources such as corn and rice, and its degradation 
products are non-toxic. Thus, PLA finds application as biodegradable matrix for surgical implants 
and in drug delivery systems. [3] Furthermore, PLA is a green alternative to petrochemical 
commodity plastics, used in packaging, agricultural products, disposable materials and textiles, 
and automotive. [21] 
The use of PLA has some shortcomings, related to poor chemical modifiability, mechanical 
ductility, slow degradation [45], and relatively high price [24]. To overcome some of these issues, 
some approaches are commonly used, like blending with other polymers [48-55], functionalization 
[56-60], and addition of nanofillers [5, 6, 47, 61-66]. The last is an interesting choice, since with small 
filler amounts it is possible to enhance desired features, keeping PLA’s key properties intact. The 
most used nanofillers are nanoclays [4, 67-76], nanosilicas [5, 64, 65, 69, 77, 78], and carbon 
nanomaterials [6, 73, 79-84]. 
 
3.2.2.2. Carbon-based nanomaterials 
 
There are several types of carbon-based nanomaterials (carbon nanotubes, graphene-based 
materials, fullerenes, nanodiamonds) and most have been tested to improve PLA properties. This 
review is focused on the most widely tested and available: CNTs and GBMs. The high specific 
area of these materials allows for low loadings to be sufficient to tune key properties concerning 
mechanical, thermal, and electrical performance. 
 
3.2.2.2.1. CBNs production methods and modifications 
 
Graphene is the elementary structure of graphite, being a one carbon atom thick sheet, composed 
of sp2 carbon atoms arranged in a flat honeycomb structure composed of two equivalent sub-
lattices of carbon atoms bonded together with σ bonds (in plane) and a π bond (out-of-plane), 
which contributes to a delocalized network of electrons. [36, 43, 85] These unique characteristics 
explain its unmatched electronic, mechanical, optical and thermal properties. For that reason, this 
material has been studied to be applied in many fields, such as electronics [86-91], energy [92-95], 
membrane [96-99], composite [17, 18, 20, 100], and biomedical technology [10, 101-103]. 
The intrinsic properties of graphene, and GBMs in general, are affected by the production or 
modification methods. For example, structural integrity of graphene sheets is disrupted by 
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oxidation and some other chemical modifications. The dimensions (diameter and thickness) of the 
final GBMs also depend on the raw materials and methods employed. [10, 30, 31, 43, 86] Thus, those 
should be chosen according to desired applications. 
GBMs can be obtained by top-down and bottom-up approaches. [100] The first involves exfoliating 
graphite to obtain few or single layer graphene sheets. [35, 104] The second, consists in assembling 
graphene from deposition of carbon atoms from other sources. [105, 106] The main difficulty in top-
down methods is to overcome the van der Waals forces that hold the graphene layers together in 
graphite, preventing reagglomeration and avoiding damages in the honeycomb carbon structure. 
[107, 108] 
Some examples of such methods are micromechanical exfoliation, direct sonication, 
electrochemical exfoliation, and superacid dissolution. Figure 5.1 summarizes the paths for 
obtaining different GBMs from top-down approaches. Bottom-up methods include chemical 
vapor deposition (CVD), arc discharge, and epitaxial growth on silicon carbide. [100]  
 
Figure 5.1: Evolution Scheme showing the relation between different types of GBMs and 
their top-down production methods. 
 
The structure of CNTs can be conceptualized by wrapping graphene into a cylinder. Typically, 
CNTs are classified as either single-walled carbon nanotubes (SWCNTs) or multi-walled carbon 
nanotubes (MWCNTs). SWCNTs exhibit better electrical properties, while MWCNTs display 
better resistance to chemicals. [109] 
CNTs can be produced using different methods, which mainly involve gas phase processes [110, 
111], like CVD, arc discharge, and laser ablation [112]. The most commonly used and efficient 
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methods are the ones involving CVD, in which a carbon source is deposited on a catalyst that 
causes it to decompose into carbon atoms forming CNTs. This method has the advantages of 
allowing mild and controllable synthesis in large scale, with reduced costs. [113] CNTs are strong, 
flexible, electrically conductive, and can be functionalized. [114] Potential applications of CNTs 
have been reported such as in composite materials [115], electrochemical devices [116], hydrogen 
storage [117], field emission devices [118], nanometer-sized electronic devices, sensors and probes 
[119]. Determining the toxicity of CNTs has been one of the most pressing questions in 
nanotechnology. [120] There is still some controversy on this subject, thus continued research is 
needed to assure that these materials are safe for biomedical applications. [121, 122] Parameters 
such as structure, size distribution, surface area, surface chemistry, surface charge and 
agglomeration state, as well as the sample purity, have considerable impact on CNTs properties. 
[114] 
In the research works reported in this review, CBNs are both commercial products or lab-made by 
the authors. Most CNTs are commercial, because their main production method is CVD, which 
requires expensive equipment. The suppliers often make available the dimensions of the materials 
and sometimes the type of CVD used. On the other hand, GBMs are usually produced by 
researchers from graphitic precursors, using top-down methods involving chemical oxidation and 
exfoliation, namely the Saudenmaier and modified Hummers methods (Figure 5.2). Commercial 
GBMs are also used, with suppliers giving information about dimensions, and sometimes 
production methods. These involve chemical oxidation and exfoliation processes, using 
sonication and microwaves. Commercial products offer insured reproducibility and widespread 
availability. Moreover, with the optimization of the production processes, the costs of GBMs are 
coming closer to its precursor, graphite. [10] 
CBNs have been extensively used in polymer composites. In order to take advantage of their large 
surface area maximizing its effectiveness as filler, the degree of dispersion must be the highest 
possible, leading to attainment of reasonable quantities of deagglomerated single units. 
Functionalization is often used to improve compatibility with the polymer matrix. However, this 
can disrupt the sp2 hybridisation of the graphene sheets and subsequently hinder their properties. 
[123] Some examples of CBNs modifications used on the research works reported in this review 
are compiled in Figure 5.3. Some of these involve simple chemical oxidation, prior to surface 
modification with isocyanates, polymers (ethylene glycol, poly(caprolactone), methyl 
methacrylate, poly(vinyl pyrrolidone), and PLA)), polyols, silanes or amines. The impact of these 
on the composite properties is discussed in section 5.2.4. 
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Figure 5.2: Scheme showing the different types of modifications performed on CBNs prior 
to incorporation in PLA. 
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Figure 5.3: Scheme showing the different production methods of PLA/CBNs composites. 
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5.2.3 Production of PLA/CBNs composites 
 
Three methods are most frequently used to obtain a dispersion of CBNs into a polymer matrix: 
solution mixing, melt blending, and in situ polymerization. [18, 100] 
 
5.2.3.1 Solution mixing 
 
Solution mixing is a simple procedure, requiring no special equipment, and allowing for 
straightforward scale-up. This method typically consists of three steps: i) dispersion of the 
nanomaterial in a suitable solvent using sonication or mechanical stirring, ii) dissolution of the 
polymer in the previous dispersion, under appropriate stirring, and iii) removal of the solvent by 
distillation or lyophilization. Often the dispersion is cast into a flat mold, and then the solvent is 
evaporated. Flat composite slabs are therefore obtained. For this reason, the procedure is often 
called “solvent casting”. As an alternative, the dispersion may be cast onto a low surface energy 
material (e.g. PTFE coated surface) using a blade applicator. After solvent evaporation, thin 
composite films are obtained. The viscosity of the dispersion needs to be adjusted for this 
procedure, which can be done by changing the concentration of polymer. [124] If production of 
fibers is desired, the third step can be replaced by electrospinning. This technique allows 
obtaining fibers that are much smaller in diameter (ranging from micrometers to nanometers) than 
those produced by conventional techniques. The basis of electrospinning is to charge the polymer 
solution in the spinneret tip with a high voltage, so that the induced charges cause the polymer 
solution to eject and travel towards the ground collector. [23] 
Complete solvent removal is a critical issue when using solution mixing to prepare composites, 
since toxicity concerns may arise when organic solvents are used. In addition, presence of residual 
solvent induces plasticization of the polymer matrix, which may alter significantly its mechanical 
properties. [125-127] 
PLA is soluble in organic solvents such as chlorinated solvents, benzene, tetrahydrofuran (THF), 
dimethyl formamide (DMF) and dioxane, but insoluble in ethanol, methanol, and aliphatic 
hydrocarbons. CBNs are hydrophobic, thus not being easily dispersed in polar solvents, however, 
they can be oxidized or modified with hydrophilic groups, in order to allow dispersion in this sort 
of solvents. Solubility limitations can also be overcome to a certain point by using ultrasonication 
to produce short-time metastable dispersions of CBNs in organic solvents, which can then be 
mixed with polymer solutions. [128] 
 PLA/carbon-based nanomaterials composites – literature review 
Artur M. Pinto – Jan 2017                                                                                                                                113 
Chloroform is the most used solvent to prepare PLA/CNTs composites. [129-134] McCullen et al. 
[135] concluded that a combination of chloroform and DMF is beneficial. Some authors obtained 
good results with THF [84, 136],  and dichloromethane [137, 138]. Sometimes the introduction of new 
functional groups may originate incompatibility with the polymer matrix. To elude this problem, 
improvement of CNTs dispersion by surfactant addition (e.g., polyoxyethylene 8 lauryl, dodecyl 
octaethylene) may be used, which allows preserving the chemical structure of the nanofiller. [139] 
GBMs have been often incorporated in PLA by solution mixing using chloroform [126, 140-142] or 
DMF [143-149] as solvents. Agglomeration of CBNs may take place during solvent evaporation. 
Composite formation by electrospinning allows minimizing this problem, but leads to formation 
of fibers and not films. [23, 135] 
 
5.2.3.2 Melt-blending 
 
Melt blending is an economically attractive, environmentally friendly and highly scalable method 
for preparing nanocomposites. This strategy involves direct addition of the nanomaterial into the 
molten polymer, allowing optimization of the state of dispersion by adjusting operating 
parameters such as mixing speed, time and temperature. Due to the absence of solvent, the only 
compatibility issue is placed in terms of the nanofiller towards the polymer matrix. [23, 47] The 
drawbacks of this procedure are the low bulk density of CBNs, that makes the feeding of the 
melt-mixer a troublesome task and the lower degree of dispersion that is usually attained when 
compared to solvent mixing. [128, 150] 
Most published research works use a lab-scale melt mixer to melt PLA and mix it with the 
nanofillers. Typical processing conditions correspond to temperatures between 160 and 180 ºC 
[151-157], mixing times of 5 to 10 minutes [151-153, 155, 156, 158], and rotation speeds between 50 and 
100 rpm [151-155, 157-160]. After mixing, the composite materials are almost always moulded into 
flat sheets with controlled thickness in a hot press, however, other methods are also used (e.g., 
injection moulding and piston spinning). Typically, the pressing is performed between 160 and 
190 ºC for 2 to 5 minutes, under 110 to 150 Kgf cm-2 pressure. [151, 156-161] 
In addition to melt blending not being as effective as the solution mixing method or in situ 
polymerization in terms of the ability to achieve good filler dispersion, damage to the nanofillers 
or polymer may occur under severe conditions. Some studies have shown that processing 
conditions can have an impact on the molecular weight of PLA. [162] This can be mainly attributed 
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to the presence of impurities such as acidic species, peroxide groups, metallic ions or other 
residual products that can increase the degradation of PLA during melt mixing. [163] 
 
5.2.3.3 In situ polymerization 
 
In situ polymerization for production of polymer composites generally involves mixing the filler 
in neat monomer, or a solution of monomer, in the presence of catalysts and under proper reaction 
conditions. [164] The polymer chains grow on the filler surface, forming covalently bonded grafts. 
In situ polymerization generally results in more homogeneous particle dispersion than melt 
blending. [165] Contrary to CNTs, that usually are post-treated, graphene and GBMs already 
present some chemical groups that can be used in further functionalization, such as grafting 
polymer chains via atom transfer radical polymerization. Examples of in situ polymerization on 
GBMs include polymers such as polyaniline (PANI), polyurethane (PU), polystyrene (PS), 
poly(methyl methacrylate) (PMMA) and polydimethylsiloxane (PDMS). [20] 
Concerning PLA in situ polymerization, only a few approaches have been presented in the 
literature. Ring opening polymerization of l-lactide in presence of GBMs has been reported by 
Yang et al. [166] and Promoda et al [167]. No significant studies were found for PLA/CNTs 
composites. 
The abovementioned methods can be used both for GBMs and CNTs, for that reason, the methods 
used in the research works reported in this review were congregated in Figure 5.3. Since the 
methods were already discussed, further details are only given in Tables 5.1-4 and described on 
the discussion of the results in those presented, in section 5.2.4, for studies that show important 
achievements in PLA properties improvement. 
 
5.2.4 Properties of PLA/CBNs Composites 
 
As mentioned above, PLA has potential to replace petrochemical plastics if its mechanical and 
thermal properties are improved. Also, its bio-origins can be an advantage, when considering 
biomedical applications. For those reasons, numerous researchers have studied the different 
properties and applications of PLA alone and in combination with other materials that are able to 
tune key properties regarding its specific applications. [47] Here the effect of the incorporation of 
some of those materials in PLA will be discussed, namely CNTs which are known for two 
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decades with established large scale production methods, and GBMs, which present a growing 
interest from scientific community, and are cheaper and comparable in properties to CNTs. [167] 
 
5.2.4.1 Mechanical Properties 
 
CBNs present remarkable mechanical properties and when well dispersed in polymer matrices 
often improve their mechanical performance. Physico-chemical interactions between fillers and 
polymer phase contribute to load transfer and distribution along the CBNs network. Table 5.1 
shows that solution mixing is the most commonly reported method for incorporation of CBNs in 
PLA. The most frequently used solvents are chloroform, DMF and THF. The filler concentrations 
most often tested are between 0.1 – 2 wt.%. Maximum improvements in Young’s modulus (E), 
storage modulus (E’), and tensile strength (σmax) are found for concentrations between 0.25 - 5 
wt.% for CNTs, and between 0.1 - 1 wt.% for GBMs. The larger observed improvement in E, 
relative to unfilled PLA, was of 372%, obtained with 0.25 wt.% MWCNTs incorporated by 
sonication in a PLA/chloroform dispersion, followed by compression moulding of the dried 
mixture. [129] For GBMs, the best performance was an increase of 156 % with incorporation of 0.4 
wt.% GNP-M, also by sonication, but followed by film casting by doctor blading. [126] The 
maximum increase on E’ was of 1500 %, and was achieved with incorporation of 0.5 wt.% rGO-
KH792 in PLLA, by simple stirring, casting on PTFE mould, and vacuum drying the resultant 
films at 120 °C for 48h. [149] However, this increase only occurs around PLA transition 
temperature (60-65 °C). At ambient temperature, the best result was an increase of 67 % with 
incorporation of 3 wt.% A-SWCNTs-Si (acid treated and grafted with 3-isocyanatoporpyl 
triethoxysilane) in PLA by sonication, followed by drying and compression moulding at 190 °C. 
[136] The maximum increase in σ was of 129 wt.%, obtained with incorporation of 0.4 wt.% GNP-
M in PLA by sonication and film casting by doctor blading. [126] For CNTs the best result was an 
increase of 47 % obtained with MWCNT grafted with PLA, and then incorporated at a loading of 
1 wt.% in PLA by sonication in chloroform, separation, drying and compression moulding at 180 
ºC. [132] When considering CNTs without modification, the best result reported is an increase of 
9% for 1.2 wt.% MWCNTs incorporated in PLA by solution mixing, followed by drying and 
compression moulding at 180 ºC with a pressure of 1000 Kg. [133] 
Melt-blending is less frequently reported than solution mixing for production of PLA/CBNs 
composites, probably due to the lower availability of the necessary equipment. Results show that 
it tends to be not as effective improving mechanical properties, as solution mixing. The best 
performance in terms of E (↑88%) and E’ (↑76%) was reported by Lin et al. [151] for an 
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incorporation of 3 wt.% MWCNT grafted with stearyl alcohol (MWCNT-C18OH) in PLA by melt 
blending (180 °C, 5 min, 50 rpm), using Ti(OBu)4 for transesterification, followed by 
compression moulding at the same temperature. When PLA was not transesterified, E and E’ 
increases were of 74 and 44 %, respectively. The maximum increase in σmax (40 %) was obtained 
incorporating 0.08 wt.% rGO using a twin-screw mixer (175 °C, 8 min, 60 rpm), followed by 
compression moulding at 180 °C. [159] 
In-situ polymerization is the least used technique. It has been reported by Pramoda et al. [167], who 
performed PLA ring-opening polymerization in presence of 1 wt.% of GO functionalized with 
butanediol and GO modified with POSS silsesquioxane. In the first case, improvements of 1 % 
and 14 % in E and hardness were obtained, respectively. In the second, the performance was 
increased by 33 % and 45 %, in the same order. 
Comparing the results for CNTs and GBMs, we can conclude that both can effectively improve 
PLA mechanical properties, whether by solution mixing and melt blending. However, use of 
GBMs usually implies lower amounts of GBMs than of CNTs. Several chemical modifications 
have been tried to improve compatibility with the polymer matrix, with ineffective results is some 
cases. Functionalization with carboxyl groups is the most common and effective procedure to 
improve CNTs compatibility with PLA matrix. [138] On the other hand, no relation has been 
observed between CBNs morphological properties (size, length, and diameter) and the mechanical 
performance of the composites. 
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Table 5.1: Mechanical properties of PLA/CBNs composites in comparison with non-modified PLA. Production methods and CBNs characteristics. 
Method Procedure for composite preparation CBNs characteristics CBNs loading (wt.%) 
Mechanical properties 
relative to neat polymer 
E: maximum Young’s modulus improvement 
E’: maximum storage modulus improvement 
σmax: maximum tensile strength improvement 
References 
Solution mixing 
Sonication in chloroform and DMF, 
electrospinning 
Diameter (d) 15±5 nm 
Length (l) 5-20 µm 
95 % purity 
Produced by plasma enhanced 
CVD 
MWCNT: 0.25, 0.5, 1 ΔE↑372 (0.25 wt.%) [135] 
Sonication in chloroform, drying and 
compression moulding (200 ºC, 150 
Kgf/cm2, 15 min) 
d not given 
l ± 2000 µm 
MWCNT: 0.5, 3, 5, 10 ΔE↑50 (5 wt.%) [129] 
Sonication in chloroform, film casting. 
Unzipped CNTs 
Diameter 30 nm 
l = 10 µm 
95 % purity 
uCNT: 1, 2, 3, 4, 5 ΔE'↑4(3 wt.%) [130] 
PLA was modified with benzoyl chloride 
and pyridine (PLAm), then acid chloride 
groups were added by reaction with 
thionyl chloride and triethylamine, then 
fMWCNTs were added and the mixture 
centrifuged and filtered to remove excess 
filler and salts. Finally, sonication in 
chloroform and film casting was 
performed. 
MWCNT functionalized with 
COOH using Fenton reactant 
and then reacted with SOCl2 
and ethylene glycol 
(fMWCNT). 
d = 9.5 nm 
l = 1.5 µm 
95 % purity 
Not clear ΔE↑17, σmax↑8 % (comparing to PLAm) [131] 
Sonication in chloroform, coagulation 
with methanol, filtration, vacuum drying, 
and compression moulding (180 ºC) 
MWCNT (thermal CVD, d = 
10-15 nm, l = 10-20 µm, 95 % 
purity) 
 
MWCNT carboxyl-
functionalized (MWCNT-
COOH) by H2SO4 1:3 HNO3, 
3h, 120 °C 
 
MWCNT grafted with PLA 
(MWCNT-g-PLA): MWCNTs-
COOH + l-lactide, 12 h, 150 
°C, + tin(II) chloride, 20h, 180 
°C, under vacuum, filtration, 
MWCNT: 1 
MWCNT-COOH: 1 
MWCNT-g-PLA:0.1, 0.2, 
0.5, 1, 5 
MWCNT-g-PLA: ΔE↑32Δσmax↑47 % (1 
wt.%) 
 
[132] 
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vacuum drying 
Solution mixing in chloroform, drying 
and compression molding (180 ºC). 
MWCNT, 
MWCNT grafted with PLLA 
after reaction with SOCl2 and 
ethylene glycol (MWCNT-g-
PLLA) 
Dimensions not given 
95 % purity 
MWCNT and MWCNT-g-
PLLA: 0.1, 0.2, 0.4, 0.6, 
0.8, 1.2 
MWCNT: ΔE↑46Δσmax↑9 % (1.2 wt.%) 
MWCNT-g-PLLA: ΔE↑86Δσmax↑13 % (1.2 
wt.%) 
[133] 
Solution mixing in chloroform, filtered, 
washed, dried under vacuum, and 
compression moulded (180 ºC, 500 psi). 
MWCNT, MWCNT-COOH 
(both as in [101]), and 
MWCNT grafted with PLA 
chains of 122-530 g mol-1 by 
ring open polymerization 
(MWCNT-g-PLA530). 
d = 10-15 nm 
l = 10-20 µm 
95 % purity 
MWCNT-COOH: 1 
MWCNT-g-PLA530: 1 
MWCNT-COOH: ΔE↑4Δσmax = 9 % 
MWCNT-g-PLA530: ΔE↑44 Δσmax = 44 % 
[134] 
Solution mixing in THF, vacuum drying, 
thermal compression 
SWCNT (d < 2 nm, l = 5-15 
µm, 95 % purity) treated with 
3:1 H2SO4/HNO3 (A-
SWCNT), and functionalized 
(1:2 v/v) with 3-
isocyanatoporpyl 
triethoxysilane (IPTES) - A-
SWCNT-Si 
SWCNT, A-SWCNT and 
A-SWCNT-Si: 0.1, 0.3, 
0.5, 1, 3 
SWCNT: ΔE'↑20 % 
A-SWCNT: ΔE'↑33 % 
A-SWCNT-Si: ΔE'↑67 % 
(3 wt.% for all conditions) 
[136] 
Sonication in dichloromethane and THF, 
vacuum drying, and compression molding 
(190 ºC) 
MWCNT (d = 9-20 nm, l = 5 
µm) functionalized with 3:1 
H2SO4/HNO3 (MWCNT-
COOH) 
MWCNT-COOH: 0.5, 1, 
2.5 
MWCNT: 2.5 
 
MWCNT-COOH: ΔE↑80 %, ΔE'↑35%, Δσmax
↑28% (2.5 % wt.%) 
MWCNT: ΔE↑25 %, ΔE'↓6%, Δσmax (not 
reported) 
(2.5 wt.%) 
[138] 
Melt blending 
Internal mixer (180 ºC, 50 rpm, 5 min) 
with and without transesterification with 
Ti(OBu)4, compression molding (180 ºC) 
MWCNT (l = 1-10 µm) 
functionalized with HNO3 (120 
ºC, 40 min) - MWCNT-
COOH, and modified with 
DCC and stearyl alcohol 
(MWCNT-C18OH) 
PC: MWCNT/PLA 
PC-18: MWCNT-
C18OH/PLA 
PC-18T: MWCNT-
C18OH/PLA 
transesterified 
0.5, 1.5, 3 
(3 wt.%) 
PC: ΔE↑73%, ΔE'↑34% 
PC-18: ΔE↑74%, ΔE'↑44% 
PC-18T: ΔE↑88%, ΔE'↑76% 
 
[151] 
Twin-screw extrusion (150-190 ºC, 100 
rpm), injection molding (160-190 ºC) 
High-crystalline PLA (HC-PLA) and 
low-crystalline PLA (LC-PLA) were 
tested 
MWCNT (l = 5-20 µm, d = 40-
60 nm) fuctionalized with 
maleic anhydride (MWCNT-g-
MA) at 80 ºC, 4h, + benzoyl 
peroxide 
LC-PLA/MWCNT, HC-
PLA/MWCNT and 
MWCNT-g-MA: 0.25, 0.5, 
0.75, 1, 2, 4 
LC-PLA/MWCNT: σmax↑23 % 
HC-PLA/MWCNT: σmax↑13 % 
MWCNT-g-MA: σmax↑27 % 
(4 wt.% for all conditions) 
[154] 
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Twin-screw extrusion (180 ºC, 150 rpm, 5 
min), compression molding at 180 ºC 
d = 6-13 nm, l = 2.5-20 µm, 
specific surface area = 220 
m2g-1 
produced by CVD 
MWCNT: 1.5, 3, 5 MWCNT: E'↑28 %, σmax↑27% (5 wt.%) [156] 
Twin-screw extrusion (160 ºC-190 ºC) 
Carboxyl-functionalized  
d = 10-11 nm, l = 12-15 µm 
MWCNT-COOH: 1 E andσmax↑8(1 wt.%) [168] 
 
Method Procedure for composite preparation CBNs characteristics CBNs loading (wt.%) 
Mechanical properties 
relative to neat polymer 
E: maximum Young’s modulus improvement 
E’: maximum storage modulus improvement 
σmax: maximum tensile strength improvement 
References 
Solution mixing 
Sonication in chloroform, casting and 
doctor blading 
GO was pre-dispersed in acetone while 
GNP was directly dispersed in 
chloroform 
GNP grade M (commercial 
product) 
t = 6-8 nm, d ≈ 5 µm. 
GO (MHM) 
d ≈ 100 nm 
GO and GNP: 0.2, 0.4, 0.6 
GO: E↑115σmax↑95 % (0.3 wt.%) 
GNP: E↑156σmax↑129 % (0.4 wt.%) 
[126] 
Sonication in chloroform, filtration, 
vacuum drying, compression moulding 
(170 ºC, 10 min) 
GO (from natural graphite, MHM 
+ lyophilization) d ≈ 300 nm 
GO-g-PLLA (GO + l-lactide 
(Sn(oct)2), filtration, vacuum 
drying) 
GO and GO-g-PLLA: 0.5 
GO: σmax↑51 % 
GO-g-PLLA: σmax↑106 % 
[141] 
Stirring and sonication in DMF, 
coagulation with methanol, filtration, 
and vacuum drying 
GO (MHM) from expandable 
graphite, chemically reduced with 
hydrazine, and lyophilized (GNSs 
– solvent free graphene 
nanosheets) 
t < 1 nm, d < 50 nm. 
GNSs: 0.2 E’↑18 %σmax↑26 % [143] 
Sonication in DMF, coagulation with 
methanol, drying, compression 
moulding (185 ºC) 
TRG (commercial product, t = 
few layer, d = hundreds of nm) 
TRG/PLA/Py-PLA: Py-PLA-OH 
(1-Pyrenemethanol + l-lactide, 
Sn(oct)2) + TRG (10:1) – 
sonication + PLA – coagulation 
and drying 
TRG and TRG/Py-PLA-
OH: 0.25, 1 
trGO: E’↑1-3 %σmax↑8 % 
trGO/Py-PLA: E’↑10-15 %σmax↑19 % 
[145] 
Solution mixing in DMF, film casting. 
GO prepared according to MHM, 
reduced to rGO and functionalized 
with N-(aminoethyl)-
aminopropyltrimethoxysilane 
(KH792). 
rGO-KH792: 0.1, 0.2, 0.5 E’↑1500 % around the Tg (0.5 wt.%) [149] 
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Melt blending 
Twin-screw mixer (175 ºC, 60 rpm, 8 
min), compression molding at 180 ºC 
GO prepared by MHM and 
reduced with hydrazine and 
ammonia (rGO) 
t = 0.4-0.6 nm, d 0.1-0.5 µm 
rGO: 0.02, 0.04, 0.08, 0.2, 
0.5, 1, 2 
E’↑27 %,σmax↑40 % (0.08 wt.%) 
E’↑54 %,σmax↓40 % (2 wt.%) 
[159] 
Internal mixer (160 ºC, 25 rpm, 10 
min), compression moulding (160 ºC, 
10 min) 
(Polymer was PLA/PEG 9:1 blend 
GNP grade M15 (commercial 
product) 
t = 6-8 nm, d ≈ 15 µm 
GNP-M15: 0.1, 0.3, 0.5, 
0.7, 1 
E’↑84 and 70σmax↑20 and 33 % (0.1 and 
0.3 wt.%) 
(relative to pristine PLA/PEG blend) 
[158] 
Internal mixer (180 ºC, 80 rpm, 10 min) 
GO (MHM) + SDS, ultrasounds, 
stirring 12h, 25 ºC 
Methylmethacrylate (MMA), 
stirring 12h + ammonium 
persulfate (APS) 12h, 80 ºC + 
reduction with dimethyl 
hydrazine, 100 ºC, 2h (PFG -
  polymer-functionalized graphene 
nanoparticles) 
t = 2.4 nm 
PFG: 1, 2, 3, 4, 5 E↑80 %σmax↑10 % (5 wt.%) [155] 
In-situ 
polymerization 
Sonication of l-lactide + filler in 
toluene, addition of Tin(II)-2-
ethylhexanoate under N2, stirring at 110 
°C, 3 days 
Expanded graphite (MHM) to GO 
GO-fuctionalized: GO + TDI 
+1,4-butanediol, 80 °C, 24h 
GO-g-POSS: GO + POSS – 
polyhedral oligomeric 
silsesquioxane + DMAP – 4-
(dimethylaminopyridine) + EDC – 
N-(3-dimethylamino-propyl-N’-
ethylcarbodiimide), 2 days, room 
temperature, N2 
(dimensions not given) 
GO-fuctionalized, GO-g-
POSS, GO+POSS 
(physical mixture): 1 
GO-fuctionalized: 
E’↑1 %Hardness ↑ 14 % 
GO-g-POSS: 
E’↑33 Hardness ↑ 45 % 
GO+POSS: 
E’↑29 %Hardness ↑ 36 % 
 
[167] 
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5.2.4.2 Electrical properties 
 
Neat PLA is electrically insulating with a low electrical conductivity (σ ≈ 1 x 10-16  S m-1), and 
high sheet resistance ρ□ ≈ 5 x 1012 Ω/sq). [136, 151] Since CNTs and reduced forms of GBMs 
present high electrical conductivity, they can be incorporated in PLA to improve its conductivity. 
These sort of composites have potential to be used as electrical stimulating implants, since PLA is 
used as a biodegradable matrix in orthopedic material. Other advantages of increasing PLA 
conductivity are the possibility of using it as antistatic coating/material or for electromagnetic 
shielding. [100] The minimum amount of filler required to form a conductive network within the 
polymer is called percolation threshold, and should be as low as possible in order to keep 
processing simple (relatively low viscosity of the melt) and low costs. Table 5.2 shows that, once 
again, the most used method to incorporate CBNs on PLA for electrical properties evaluation is 
solution mixing. The amount of fillers ranges from 0.01 to 10 wt.%. The best result, considering 
electrical conductivity (σ) with CNTs was 3.5 x 10-3 S m-1, obtained incorporating 10 wt.% 
MWCNT in PLA by sonication in chloroform, followed by drying and compression moulding at 
200 ºC during 15 min. [129] Results are also often presented in terms of sheet resistance (ρ□), being 
the lowest value reported by Shao et al. [169], of 1 x 102 Ω/sq achieved incorporating 5 wt.% 
MWCNTs previously oxidized (treated with HCl and HNO3) in PLA by solution mixing, 
followed by electrospinning of aligned nanofibers (d ≈ 250 nm). The alignment of the fibers 
slightly improved sheet resistance, comparing with random meshes. Interestingly, Yoon et al. [134] 
observed a considerable sheet resistance of 1 x 105 Ω/sq, with incorporation of 1 wt.% MWCNT-
COOH, also oxidized by treatment with strong acids (H2SO4 and HNO3). For GBMs, the 
maximum conductivity reported was 2.2 S m-1, higher than for CNTs, obtained incorporating 1.25 
wt.% rGO-g (reduced with ammonia) in PLA by sonication in DMF. Interestingly, the solvent 
used for dispersion of CNTs in PLA was always chloroform and for GBMs was always DMF. 
Melt-blending is the second most used approach to disperse CBNs in PLA in order to improve its 
electrical properties, being most often performed by twin-screw extrusion, followed by 
compression moulding. The highest σ considering CNTs was 50 S m-1, which was reported by 
Pötschke et al. [170]. These authors prepared MWCNTs mixtures by twin-screw extrusion, 
followed by piston spinning at different speeds. They concluded that non-spinned mixtures with 5 
wt.% MWCNTs in PLA presented the same conductivity as 3 wt.% mixtures after piston spinning 
at a speed of 20 m min-1. Considering ρ□, the best performance was obtained incorporating 3 wt.% 
MWCNT-C18OH (MWCNTs modified with DCC and stearyl alcohol) using and external mixer, 
followed by compression moulding at 180 ºC during 5 min, resulting in a ρ□ of 1 x 10-1 Ω/sq. [151] 
This was the most effective modification performed, considering the sheet resistance values 
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obtained with incorporation of the same amount of non-modified MWCNT, which was 3 x 105 
Ω/sq. For GBMs, the higher σ was 2.6 x 10-2 S m-1, resultant from dispersion using an internal 
mixer at 180 ºC, of 5 wt.% PFG (graphene nanoparticles functionalized with 
methylmethacrylate). [155] For rGO, a non-functionalized GBM, the best conductivity value was 
obtained for 2 wt.% incorporation in PLA using a twin-screw extruder and compression 
moulding. The value obtained was of 1 x 10-9 S m-1, being higher than for the other concentrations 
tested. It can be compared, for example, with a σ of 1 x 10-13 S m-1 for 0.2 wt.%. [159] In most 
works evaluated, electrical properties improve with the increase of filler amount. 
In-situ polymerization is the least explored technique, despite interesting results being obtained by 
Yang et al. [166], which incorporated 0.01 – 2 wt.% trGO (thermally reduced) in PLA by ring-
opening melt polymerization of l-lactide in presence of the filler. As example, σ obtained was 5 x 
10-6 and 1.6 x 10-2 S m-1 for 1.5 and 2 wt.%, respectively. 
An interesting study by Chiu et. al. [84], shows that purification of  MWCNT by sonication with 
strong acids improved fillers compatibility and dispersibility in PLA, resulting in better electrical 
conductivity. The values of σ for incorporations of 7 wt.% were 5 x 10-8 and 2 x 10-6 S m-1, 
respectively for non-purified and purified MWCNT. Purification introduced polar functional 
groups on the CNTs surface, allowing better dispersion, which resulted in more deagglomerated 
particles that formed a wider conductive network on PLA matrix. 
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Table 5.2: Electrical properties of PLA/CBNs composites in comparison with non-modified PLA. Production methods and CBNs characteristics. 
Method Procedure CBNs characteristics CBNs Content (wt.%) 
Electrical Properties 
σ: electrical conductivity 
ρ□: sheet resistance 
(PLA σ ≈ 1 x 10-16  S m-1, ρ□ ≈ 5 x 1012 
Ω/sq) [106, 122] 
References 
Solution mixing 
Sonication in chloroform, drying and 
compression moulding (200 ºC, 150 
Kgf/cm2, 15 min) 
Diameter (d) not given 
Length (l) = ± 2000 µm 
MWCNT: 0.5, 3, 5, 10 
σ = 1.8 x 10-3  and 3.5 x 10-3 S m-1 (3 and 10 
wt.%) 
[129] 
Sonication in chloroform, coagulation 
with methanol, filtration, vacuum 
drying, and compression moulding 
(180 ºC) 
MWCNT (thermal CVD, d 
= 10-15 nm, l = 10-20 µm, 
95 % purity) 
MWCNT carboxyl-
functionalized (MWCNT-
COOH) by H2SO4 1:3 
HNO3, 3h, 120 °C 
MWCNT grafted with PLA 
(MWCNT-g-PLA): 
MWCNTs-COOH + l-
lactide, 12 h, 150 °C, + 
tin(II) chloride, 20h, 180 
°C, under vacuum, 
filtration, vacuum drying 
MWCNT: 1 
MWCNT-COOH: 1 
MWCNT-g-PLA:0.1, 0.2, 
0.5, 1, 5 
MWCNT: ρ□ = 1 x 1012 Ω/sq (for 0.1 and 
0.2 wt.% is similar to PLA), 1 x 105 and 1 x 
104 Ω/sq (0.5 wt.%, and 1-5 wt.%) 
MWCNT-g-PLA: ρ□ = 1 x 1012 Ω/sq (0.1-5 
wt.% - always similar to PLA) 
[132] 
Solution mixing in chloroform, drying 
and compression molding (180 ºC). 
MWCNT, 
MWCNT grafted with 
PLLA after reaction with 
SOCl2 and ethylene glycol 
(MWCNT-g-PLLA) 
Dimensions not given 
95 % purity 
MWCNT and MWCNT-g-
PLLA: 0.1, 0.2, 0.4, 0.6, 
0.8, 1.2 
MWCNT: σ = 2 x 10-13 S m-1 (0.1-0.4 
wt.%), 3 x 10-9 S m-1 (0.6 wt.%), and 2 x 
10-5 S m-1 (1.2 wt.%) 
MWCNT-g-PLLA: σ = 2 x 10-13 S m-1 (0.1-
0.4 wt.%), 5 x 10-13 S m-1 (0.6 wt.%), and 3 
x 10-8 S m-1 (1.2 wt.%) 
Increases with filler amount 
[133] 
Solution mixing in chloroform, 
filtered, washed, dried under vacuum, 
and compression moulded (180 ºC, 
500 psi). 
MWCNT, MWCNT-COOH 
(both as in [101]), and 
MWCNT grafted with PLA 
chains of 122-530 g mol-1 
by ring open polymerization 
(MWCNT-g-PLA530). 
d = 10-15 nm 
l = 10-20 µm 
MWCNT-COOH: 1 
MWCNT-g-PLA122-530: 1 
MWCNT-COOH: ρ□ = 1 x 105 Ω/sq 
MWCNT-g-PLA112-530: ρ□ = 2 x 106, 2 x 
1012, and 1 x 1012 Ω/sq (122, 250, 530 g 
mol-1) 
[134] 
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95 % purity 
Sonication in THF, vacuum drying, 
thermal compression 
MWCNTs (d = 8-15 nm, l = 
50 µm) purified by 
sonication with H2SO4 and 
HNO3 at 50 ºC, filtration, 
and washing 
MWCNT purified/non-
purified: 1, 3, 5, 7 
MWCNT purified: σ = 4 x 10-9, 1 x 10-9, 
and 2 x 10-6 S m-1 (1, 5, and 7 wt.%) 
MWCNT non-purified: σ = 7 x 10-11, 2 x 
10-8, and 5 x 10-8 S m-1 (1, 5, and 7 wt.%) 
Increases with filler amount 
[84] 
Solution mixing in THF, vacuum 
drying, thermal compression 
SWCNT (d < 2 nm, l = 5-15 
µm, 95 % purity) treated 
with 3:1 H2SO4/HNO3 (A-
SWCNT), and 
functionalized (1:2 v/v) 
with 3-isocyanatoporpyl 
triethoxysilane (IPTES) - A-
SWCNT-Si 
SWCNT, A-SWCNT and 
A-SWCNT-Si: 0.1, 0.3, 0.5, 
1, 3 
SWCNT: σ = 2 x 10-16, 3 x 10-9, and 5 x 10-
8 S m-1 (0.3, 1, 3 wt.%) 
A-SWCNT-Si: σ = 5 x 10-15, 5 x 10-8, and 2 
x 10-6 S m-1 (0.3, 1, 3 wt.%) 
Increases with filler amount 
[136] 
MWCNTs-ox (HCl, 2h at 25°C + 
HNO3, 4h at 110 ºC) 
Nanofibers (MWCNTs-ox sonicated 
in DMF 2h + SDS, adding to PLA in 
dicloromethane, 1h sonication before 
electrospinning) 
MWCNTs (l = 10–20 µm, d 
= 10–20 nm) 
Nanofibers (PLA ≈ 400 nm, 
PLA/MWCNTs-ox ≈ 250 
nm) 
PLA/MWCNTs-ox (3 
wt.%) random (R) and 
aligned (A) nanofibers: 1, 2, 
3, 4, 5 wt.% 
PLA/MWCNTs-ox-R: ρ□ = 1 x 104, 5 x 102 
Ω/sq (3 and 5 wt.%) 
PLA/MWCNTs-ox-A: ρ□ = 5 x 103, 1 x 102 
Ω/sq (3 and 5 wt.%) 
Increases with both fillers amount 
[169] 
Melt blending 
Internal mixer (180 ºC, 50 rpm, 5 
min) with and without 
transesterification with Ti(OBu)4, 
compression molding (180 ºC) 
MWCNT (l = 1-10 µm) 
functionalized with HNO3 
(120 ºC, 40 min) - 
MWCNT-COOH, and 
modified with DCC and 
stearyl alcohol (MWCNT-
C18OH) 
PC: MWCNT/PLA 
PC-18: MWCNT-
C18OH/PLA 
PC-18T: MWCNT-
C18OH/PLA transesterified 
0.5, 1.5, 3 
PC: ρ□ = 2 x 107, 3 x 106, and 3 x 105 Ω/sq 
(0.5, 1.5, 3 wt.%) 
PC-18: ρ□ = 8 x 105, 9 x 104, and 1 x 10-1 
Ω/sq (0.5, 1.5, 3 wt.%) 
PC-18T: ρ□ = 5 x 1012, 9 x 105, and 9 x 10-2 
Ω/sq (0.5, 1.5, 3 wt.%) 
[151] 
Twin-screw extruder (180, 215 and 
250 ºC; 100, 200 and 500 rpm; 5 min) 
1st – masterbatch production 
2nd – dilution of masterbatches and 
composites production 
d = 9.5 nm 
l = 1.5 µm 
90 % purity 
MWCNT: 0.5, 0.75, 1, 2 
σ is below 2.5 x 10-1 S m-1 (0.5-2 wt.%) 
slightly decreasing with filler wt.% increase 
[153] 
Twin-screw extrusion (150-190 ºC, 
100 rpm), injection molding (160-190 
ºC) 
High-crystalline PLA (HC-PLA) and 
low-crystalline PLA (LC-PLA) were 
tested 
MWCNT (l = 5-20 µm, d = 
40-60 nm) fuctionalized 
with maleic anhydride 
(MWCNT-g-MA) at 80 ºC, 
4h, + benzoyl peroxide 
 
LC-PLA/MWCNT, HC-
PLA/MWCNT and 
MWCNT-g-MA: 0.25, 0.5, 
0.75, 1, 2, 4 
LC-PLA/MWCNT: ρ□ = 2 x 1013, 5 x 103, 
and 5 x 102 Ω/sq (0.5, 2, 4 wt.%) 
HC-PLA/MWCNT: ρ□ = 1 x 1014, 9 x 1010, 
and 8 x 1010 Ω/sq (0.5, 2, 4 wt.%) 
LC-PLA/MWCNT-g-MA: ρ□ = 3 x 102, 2 x 
102, and 7 x 101 Ω/sq (0.5, 2, 4 wt.%) 
[154] 
Twin-screw extrusion (180 ºC, 150 
rpm, 5 min), compression molding at 
d = 6-13 nm, l = 2.5-20 µm, 
specific surface area = 220 
MWCNT: 1.5, 3, 5 
σ = 1 x 10-9, 1 x 10-2, and 1 S m-1 (1.5, 3, 5 
wt.%) 
[156] 
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180 ºC m2g-1 
produced by CVD 
Twin-screw extruder (180-220 ºC, 
500 rpm) 
Piston spinning (20, 50, 100 m min-1) 
to produce micro-fibres (220 ºC, 3 
min) 
d = 9.5 nm 
l = 1.5 µm 
90 % purity 
MWCNT: 0.5, 1, 2, 3, 5 
Extruded composites: σ = 4, 14, and 50 S 
m-1 (2, 3, 5 wt.%) 
Fibres (3 wt.%): σ = 50, 40, and 1 S m-1 
(spinning speeds of 20, 50, and 100 m min-
1) 
[170] 
 
Method Procedure CBNs characteristics CBNs Content (wt.%) 
Electrical Properties 
ρ: electrical resistivity 
σ: electrical conductivity 
Rs: surface resistance 
R: surface resistivity 
References 
Solution mixing 
Sonication in DMF, coagulation 
with methanol, drying, compression 
moulding (185 ºC) 
TRG (commercial product, t = 
few layer, d = hundreds of nm) 
TRG/PLA/Py-PLA: Py-PLA-OH 
(1-Pyrenemethanol + l-lactide, 
Sn(oct)2) + TRG (10:1) – 
sonication + PLA – coagulation 
and drying 
TRG and TRG/Py-
PLA-OH: 0.25, 1 
TRG:  = 1x10-16 and 1x10-6 S m-1 (0.25 
and 1 wt.%) 
TRG/Py-PLA-OH:  = 1x10-16 and 1x10-7 
S m-1 (0.25 and 1 wt.%) 
[145] 
Sonication in DMF, coagulation 
with methanol, drying, and 
compression molding (210 ºC) 
GO: from graphite flakes 
(modified Staudenmeier method) 
rGO-p: GO + 
Polyvinylpyrrolidone (1:5), 
sonication at 60 ºC 
rGO-g: reduced by stirring with 
glucose in ammonia solution at 95 
ºC, 60 min 
Dimension not given. 
GO 
rGO-p 
rGO-g 
(0.5-2.5 vol.%) 
 
GO:  = ↑ 6.5 x 10 -13 S m-1 
rGO-p:  = ↑ 4.7 x 10 -8 S m-1 
rGO-g:  = 2.2 S m-1 
(for 1.25 vol.% for all) 
Increases with filler amount 
[146] 
Melt blending 
Twin-screw mixer (175 ºC, 60 rpm, 
8 min), compression molding at 180 
ºC 
GO prepared according to MHM 
and chemically reduced to rGO. 
Thickness 0.4-0.6 nm and lateral 
dimension 0.1-0.5 mm. 
rGO: 0.02, 0.04, 0.06, 
0.2, 0.5, 1, 2 
σ = 1 x 10-13 and 1 x 10-9 S m-1 (0.2 and 2 
wt.%) 
Increases with filler amount 
[159] 
Internal mixer (180 ºC, 80 rpm, 10 
min) 
GO (MHM) + SDS, ultrasounds, 
stirring 12h, 25 ºC 
Methylmethacrylate (MMA), 
stirring 12h + ammonium 
persulfate (APS) 12h, 80 ºC + 
reduction with dimethyl 
PFG: 1, 2, 3, 4, 5 
 = 2.6 x 10-2 and 1 x 10-12  Sm-1 (1 and 5 
wt.%) 
Increases with filler amount 
[155] 
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hydrazine, 100 ºC, 2h (PFG -
  polymer-functionalized graphene 
nanoparticles) 
t = 2.4 nm 
In-situ 
polymerization 
Ring-opening melt polymerization 
of lactide in presence of trGO 
GO prepared according to MHM 
and thermally reduced to trGO. 
Dimensions not given. 
TrGO: 0.01, 0.1, 0.5, 1, 
1.5, 2 
 = 5 x 10-6 and 1.6 x 10-2 S m-1. (1.5 and 2 
wt.%) 
Increases with filler amount 
[166] 
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5.2.4.3 Thermal properties 
 
Several works report changes on thermal properties of PLA by incorporation of CBNs. CNTs 
incorporations range from 0.01 to 15 wt.%, while for GBMs lower amounts are needed 0.01 - 2 
wt.% (Table 5.3). The most frequently used techniques to evaluate thermal properties in polymer 
composites are thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), and 
dynamic mechanical analysis (DMA). TGA allows determination of thermal degradation 
temperatures, and DSC and DMA phase transition temperatures (Tg – glass transition temperature, 
Tm – melting temperature, and Tc – cold crystallization temperature). 
When using solution mixing, the highest variation in terms of Tg was an increase of 10 °C, 
obtained using 1 wt.% MWCNT purified by treatment with strong acids. Comparing with non-
purified filler at the same loading, the increase was 5 °C higher. This is explained by purified 
MWCNT having stronger interfacial interactions with PLA matrix, imposing increased restriction 
to the mobility of macromolecular chains, and therefore rising Tg. Also, Td (decomposition 
temperature) presented an increase of 10 °C for purified materials. [84] For Tm, the higher increase 
was of 16 °C for 0.3 and 1 wt.% MWCNT-PCL (functionalized with poly(caprolactone)) 
incorporated in PLA aligned fibers by sonication in dichloromethane and electrospinning. Also, 
Tc decreased more than 10 °C, due to MWCNT inducing heterogeneous crystallization. [137] 
However, the higher decrease in Tc (< 20 °C), was obtained by Moon et al. [129], with the 
incorporation of 3 - 10 wt.% MWCNT, with a length of about 2000 µm. In literature, the 
degradation temperatures of the polymeric materials determined by TGA are presented in 
different terms. For example, as Tdi (beginning of thermal degradation), Td5 (decomposition 
temperature for 5 wt.% loss), and Td50 (decomposition temperature for 50% weight loss). For Tdi, 
the highest increase was of 20 °C, obtained incorporating 2.5 wt.% MWCNT-COOH 
(carboxylated with strong acids) by sonication in PLA dispersed in dicloromethane and THF, 
followed by vacuum drying and compression moulding. [138] Considering Td50, the best result was 
an increase of 1 - 3 °C, in a work above described. [137] 
GBMs incorporation also induces changes on thermal properties of PLA. For Tg, an increase of 7 
°C was obtained sonicating 0.4 wt.% GNP in PLA films prepared by solvent mixing. [126] The 
highest increases in Tm have been of 5 °C, for samples obtained by compression moulding of PLA 
with 0.5 wt.% GO grafted with PLA, produced by vacuum drying a dispersion in chloroform. [141] 
Significant decrease in Tc, of 20 °C, was observed for PLA with 2 wt.% GO, obtained by solvent 
mixing. [144] Thermal stability of PLA has been shown to improve with addition of GBMs. 2 
wt.% GONSs (graphene oxide nanosheets) increased Tdi by 16 ºC in samples produced by solvent 
mixing. [147] Also, Td5 was increased by 11 °C sonication of 0.2 wt.% GNSs (graphene 
nanosheets) in PLA dispersed in DMF, which was dried under vacuum. The authors explain these 
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increases by GNS forming a tortuous path, which delays the diffusion of oxygen and the escape of 
volatile degradation products. and also char formation. [143] Finally, Td max (T of maximum 
degradation rate) increased 33 °C PLA filled with TRG, produced by solution mixing. [145] 
Chemical modifications of MWCNT were reported to increase thermal properties of the 
composites. For example, directly comparing with PLA/MWCNT(non-modified), the 
incorporation of 1 wt.% MWCNT grafted with PLA in the same PLA matrix, resulted in increases 
of about 3 °C in Tg and decreases of 9 °C in Tc. [132] Treatment with strong acids followed by 
silanization of SWCNT, [136] which were incorporated in PLA at loading ranging from 0.1 and 3 
wt.% resulted in increases of about 5 °C in Tg. 
Concerning composites produced by melt-blending, the highest increases in Tg were of 5 - 6 ºC, 
reported for PLA micro-fibers with 3 wt.% MWCNT to PLA. [170] Also, Tc was observed to 
decrease at most 12 ºC with incorporation of 0.5 and 2 wt.% MWCNT. [161] Chieng et al. [158], 
studied the thermal properties of PLA/PEG (9:1) blends with addition of 0.1 – 1 wt.% GNP, 
which resulted in e variations on Tg, Tm, and Tc. However, Tdi, Tmax, and T50, increased by 56, 53, 
and 44 ºC, respectively, for 0.5 wt.% loadings.  
In-situ polymerization of l-lactide in presence of TRG in amounts from 0.01 to 2 wt.% resulted in 
considerable increases on Tg, Tm, and Tdmax. For example, at 2 wt.% loading, increases of 5, 14, 
and 18 ºC were obtained, respectively. [166] In a different work reporting in-situ polymerization of 
l-lactide, covalent functionalization of GO with both 1,4-butanediol, and polyhedral 
silsesquioxane resulted in increases in Tg (18, 20 °C), Tc (15, 8 °C), Tm (7, 5 °C), and Td5 (23, 11 
°C) comparing with PLA/GO composites at 1 wt.% loadings. [167]  
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Table 5.3: Thermal properties of PLA/CBNs composites in comparison with non-modified PLA. Production methods and CBNs characteristics. 
Method Procedure CBNs characteristics CBNs content (wt.%) Thermal properties relative to neat polymer References 
Solution mixing 
Sonication in chloroform, drying and 
compression moulding (200 ºC, 150 Kgf/cm2, 
15 min). 
Diameter (d) not given 
Length (l) ± 2000 µm 
MWCNT: 0.5, 3, 5, 10 
Tg (glass transition) ↓ 1-4 ºC (3, 5 wt.%) and = (10 
wt.%) 
Tc
 (crystallization) ↓ >20 ºC (3, 5, 10 wt.%) 
Tm (melting) = (3, 5, 10 wt.%) 
Td (degradation) ↑ 10-20 ºC (3, 5, 10 wt.%) 
[129] 
Sonication in chloroform, film casting. 
Unzipped CNTs 
d = 30 nm 
l = 10 µm 
95 % purity 
uCNT: 1, 2, 3, 4, 5 
Tg ↑ 7, 8 ºC (3, 5 wt.%) 
Tm ↑ 5, 3 ºC (3, 5 wt.%) 
[130] 
PLA was modified with benzoyl chloride and 
pyridine (PLAm), then acid chloride groups 
were added by reaction with thionyl chloride 
and triethylamine, then fMWCNTs were added 
and the mixture centrifuged and filtered to 
remove excess filler and salts. Finally, 
sonication in chloroform and film casting was 
performed. 
MWCNT functionalized with 
COOH using Fenton reactant 
and then reacted with SOCl2 
and ethylene glycol 
(fMWCNT). 
d = 9.5 nm 
l = 1.5 µm 
95 % purity 
Not clear 
Tg (tanδ) ↑ 9 ºC 
Tdi (beginning of thermal degradation) ↑ 80 ºC 
[131] 
Sonication in chloroform, coagulation with 
methanol, filtration, vacuum drying, and 
compression moulding (180 ºC) 
MWCNT (thermal CVD, d = 
10-15 nm, l = 10-20 µm, 95 % 
purity) 
MWCNT carboxyl-
functionalized (MWCNT-
COOH) by H2SO4 1:3 HNO3, 
3h, 120 °C 
MWCNT grafted with PLA 
(MWCNT-g-PLA): MWCNTs-
COOH + l-lactide, 12 h, 150 
°C, + tin(II) chloride, 20h, 180 
°C, under vacuum, filtration, 
vacuum drying 
MWCNT: 1 
MWCNT-COOH: 1 
MWCNT-g-PLA:0.1, 0.2, 0.5, 
1, 5 
No significant changes in Tm for all materials 
 
PLA/MWCNT: 
Tg ↑ 3, Tc ↓ 3 ºC (1 wt.%) 
PLA/MWCNT-COOH: 
Tg ↑ 2, Tc ↓ 3 ºC (1 wt.%) 
PLA/MWCNT-g-PLA: 
Tg ↑ 5-6 Tc ↑ 1 ↓ 2, 6, 12, 19 ºC (0.1, 0.2, 0.5, 1, 5 
wt.%) 
 
[132] 
Sonication in dichloromethane, 
electrospinning. 
MWCNTs (d = 8-15 nm, 
l - not given, 
95 % purity) were 
functionalized with –COOH by 
H2SO4 and HNO3 (3:1). Then, 
MWCNTs-NH2 were produced 
reacting MWCNTs-COOH with 
N,N’-dicyclohexylcarbodiimide 
(DCC). MWCNTs-PCL were 
produced reacting 1g 
MWCNTs-NH2, 10 g PCL, and 
20 g DCC. 
MWCNT-PCL(0.3, 0.5, 1, 
3)/PLA aligned composite 
fibers 
Td50 (50% weight loss) ↑ 1-3 °C (0.3, 1 wt.%) 
Tg = (0.3, 1 wt.%) 
Tm ↑ 16 ºC (0.3, 1 wt.%) 
Tc ↓ 13 ºC and 12 ºC (0.3, 1 wt.%) 
[137] 
Sonication in THF, vacuum drying, thermal 
compression 
MWCNTs (d = 8-15 nm, l = 50 
µm) purified by sonication with 
H2SO4 and HNO3 at 50 ºC, 
MWCNT purified/non-purified: 
1, 3, 5, 7 
MWCNT non-purified: Tg ↑ 5-6 ºC (1, 3, 5, 7 wt.%) 
MWCNT purified: Tg ↑ 10,7,5,5 ºC (1, 3, 5, 7 wt.%) 
MWCNT non-purified Vs purified: Td ↑ 10, 11, 7, 8 ºC 
[84] 
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filtration, and washing (1, 3, 5, 7 wt.%) 
Solution mixing in THF, vacuum drying, 
thermal compression 
SWCNT (d < 2 nm, l = 5-15 
µm, 95 % purity) treated with 
3:1 H2SO4/HNO3 (A-SWCNT), 
and functionalized (1:2 v/v) 
with 3-isocyanatoporpyl 
triethoxysilane (IPTES) - A-
SWCNT-Si 
SWCNT, A-SWCNT, and A-
SWCNT-Si: 0.1, 0.3, 0.5, 1, 3 
Td5 (5 wt.% loss) ↓ for SWCNT (poor interfacial 
interaction), = for A-SWCNT, and A-SWCNT-Si 
Tg: (higher that pure PLA) SWCNT < A-SWCNT < A-
SWCNT-Si (considering all loadings, increases are 
below 5 °C) 
[136] 
Sonication in dichloromethane and THF, 
vacuum drying, and compression molding 
(190 ºC) 
MWCNT (d = 9-20 nm, l = 5 
µm) functionalized with 3:1 
H2SO4/HNO3 (MWCNT-
COOH) 
MWCNT-COOH: 0.5, 1, 2.5 
MWCNT-COOH: 
Tdi ↑ 10-20 ºC (0.5-2.5 wt.%) 
Tg ↑ 0, 1, 2 ºC (0.5, 1, 2.5 wt.%) 
Tc ↑ 1, 2, 4 ºC 0.5, 1, 2.5 wt.%) 
Tm ↑ 3, 4, 5 ºC 0.5, 1, 2.5 wt.%) 
 
[138] 
Melt blending 
Internal mixer (180 ºC, 50 rpm, 5 min) with 
and without transesterification with Ti(OBu)4, 
compression molding (180 ºC) 
MWCNT (l 1-10 µm) 
functionalized with HNO3 (120 
ºC, 40 min) - MWCNT-COOH, 
and modified with DCC and 
stearyl alcohol (MWCNT-
C18OH) 
PC: MWCNT/PLA 
PC-18: MWCNT-C18OH/PLA 
PC-18T: MWCNT-
C18OH/PLA transesterified 
0.5, 1.5, 3 
PC, PC-18 - No change in Tm 
PC-18T – 2 melting peaks, 1 bellow Tm for pristine PLA 
(low Mw PLA from transesterification), other at the same 
Tm 
[151] 
Sonication in THF, vacuum drying + 
Microextruder (180 ºC, 50 rpm, 5 min) 
MWCNTs (d = 9.5 nm, l = 1.5 
µm) produced by catalytic 
carbon vapor deposition 
(CCVD) 
MWCNT: 0.1, 1 Tg
 ↑ 1 ºC (0.1, 1 wt.%) [152] 
Twin-screw extruder (180, 215 and 250 ºC; 
100, 200 and 500 rpm; 5 min) 
1st – masterbatch production 
2nd – dilution of masterbatches and composites 
production 
d = 9.5 nm 
l = 1.5 µm 
90 % purity 
MWCNT: 0.5, 0.75, 1, 2, 7.5, 
15 
Similar Tg (7.5, 15 wt.%) [153] 
Twin-screw extruder (210 ºC, 400 rpm), 
compression molding (210 ºC) 
d = 5-20 nm 
l = 10 µm 
Specific surface area = 100-700 
m2g-1 
CCVD 
MWCNT: 0.5, 1, 2, 3, 5 
Tg ↓ 1, 2 ºC (0.5, 1-5 wt.%) 
Tc ↓ 12, 10, 12, 7, 6 ºC (0.5, 1, 2, 3, 5 wt.%) 
Tm ↓ 1, 2 ºC (0.5-3, 5 wt.%) 
[161] 
Twin-screw extruder (180-220 ºC, 500 rpm) 
Piston spinning to produce micro-fibres (220 
ºC, 3 min) 
d = 9.5 nm 
l = 1.5 µm 
90 % purity 
MWCNT: 0.5, 1, 2, 3, 5 
Tg: pellet = (3 wt.%) 
Fibres ↑ 5-6 ºC (3 wt.%) 
[170] 
 
Method Procedure CBNs  characteristics CBNs content (wt.%) Thermal properties relative to neat polymer References 
Solution mixing 
Sonication in chloroform, casting and doctor 
blading 
GO was pre-dispersed in acetone while GNP 
was directly dispersed in chloroform 
GNP grade M (commercial product) 
t = 6-8 nm, d ≈ 5 µm. 
GO (MHM) 
d ≈ 100 nm 
GO and GNP: 0.2, 0.4, 0.6 
GO: Tg ↑ 3, 4, 3 ºC (0.2, 0.4, 0.6 wt.%) 
GNP: Tg ↑ 6, 7, 5 ºC (0.2, 0.4, 0.6 wt.%) 
Similar Tm for both GO and GNP 
[126] 
Sonication in chloroform, filtration, vacuum 
drying, compression moulding (170 ºC, 10 
min) 
GO (from natural graphite, MHM + 
lyophilization) d ≈ 300 nm 
GO-g-PLLA (GO + l-lactide 
(Sn(oct)2), filtration, vacuum drying) 
GO and GO-g-PLLA: 0.5 
PLA/GO: Tg ↑ 6 ºC 
Tm ↑ 3 ºC 
PLA/GO-g-PLLA: Tg ↑ 6 ºC 
Tm ↑ 5 ºC 
[141] 
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Stirring and sonication in DMF, coagulation 
with methanol, filtration, and vacuum drying 
GO (MHM) from expandable 
graphite, chemically reduced with 
hydrazine, and lyophilized (GNSs – 
solvent free graphene nanosheets) 
t < 1 nm, d < 50 nm. 
GNSs: 0.2 Td5 ↑ 11 ºC. [143] 
Sonication in DMF, film casting, vacuum 
drying 
GO prepared according to 
Staudenmaier method (H2SO4 + 
HNO3 + KClO3) 
(dimensions not given) 
GO: 0.5, 1, 2 
(0.5, 1, 2 wt.%) 
Tc ↓ 9, 15, 20 ºC 
Tg similar 
[144] 
Sonication in DMF, coagulation with 
methanol, drying, compression moulding 
(185 ºC) 
TRG (commercial product, t = few 
layer, d = hundreds of nm) 
TRG/PLA/Py-PLA: Py-PLA-OH (1-
Pyrenemethanol + l-lactide, Sn(oct)2) 
+ TRG (10:1) – sonication + PLA – 
coagulation and drying 
TRG and TRG/Py-PLA-OH: 
0.25, 1 
TRG/PLA: 
Td5 ↓ 32 ºC 
Td max (max. degradation) ↑ 33 ºC 
TRG/PLA/Py-PLA: 
Td5 ↓ 2 ºC 
Td max ↑ 25 ºC 
(loadings not clear) 
[145] 
Sonication in DMF, coagulation with water, 
vacuum drying, compression moulding (200 
ºC, 3 min) 
Graphene oxide nanosheets - GONSs 
(MHM) from expandable graphite 
(t = few layer, d = 5-20 µm) 
GONSs: 0.25, 0.5, 1, 2 
(0.25, 0.5, 1, 2 wt.%) 
Tm1
 ↓ 1, 4, 0, 1 ºC 
Tm2
 ↓ 0, 1, 1, 1 ºC 
Tc ↓ 3, 6, 2, 4 ºC 
Tdi ↑ 2, 6, 11, 16 ºC 
[147] 
Sonication in DMF, film casting, vacuum 
drying 
GNS (commercial product) 
t = 5-25 nm, d = 0.5-20 µm, specific 
surface area = 50 m2g-1 
GNS: 1 
Similar Tg and Tm1 and 2 
Tc ↑ 3ºC 
[148] 
Melt blending 
Internal mixer (160 ºC, 25 rpm, 10 min), 
compression moulding (160 ºC, 10 min) 
(Polymer was PLA/PEG 9:1 blend) 
GNP grade M15 (commercial 
product) 
t = 6-8 nm, d ≈ 15 µm 
GNP-M15: 0.1, 0.3, 0.5, 0.7, 1 
(relative to pristine PLA/PEG blend) 
(0.1, 0.3, 0.5, 1 wt.%) 
Tg ↓0, 0, 1, 1 
Tm ↑ 2, 4 ↓ 1, 1 
Tc ↑ 1, 2, 2, 1 
Tdi , Td max, T50 ↑ 56, 53, 44 ºC (0.5 wt.%) 
[158] 
In-situ polymeriztion 
Melt ring-opening polymerization of l-
lactide in presence of TRG (Sn(oct)2, 170 
°C, 4h), filtration, vacuum drying 
Natural graphite (MHM + 
lyophilization) - GO 
GO thermal reduction (1000 °C, 1 
min) to TRG 
t = few layers 
TRG: 0.01, 0.1, 0.5, 1, 1.5, 2 
(0.01, 0.1, 0.5, 1, 1.5, 2 wt.%) 
Tg = ↑ 9, 6, 6, 7, 8, 5 ºC 
Tm = ↑ 11, 12, 13, 14, 14, 14 ºC 
Td max = ↑ 4, 13, 10, 11, 16, 18 ºC 
[166] 
Sonication of l-lactide + filler in toluene, 
addition of Tin(II)-2-ethylhexanoate under 
N2, stirring at 110 °C, 3 days 
Expanded graphite (MHM) to GO 
GO-fuctionalized: GO + TDI +1,4-
butanediol, 80 °C, 24h 
GO-g-POSS: GO + POSS – 
polyhedral oligomeric silsesquioxane 
+ DMAP – 4-
(dimethylaminopyridine) + EDC – N-
(3-dimethylamino-propyl-N’-
ethylcarbodiimide), 2 days, room 
temperature, N2 
(dimensions not given) 
GO-fuctionalized, GO-g-
POSS, GO+POSS (physical 
mixture): 1 
PLA/GO-functionalized: 
Td5 ↑ 8, Tg ↓ 8, Tc ↑ 14, Tm ↓ 2 ºC 
PLA/ GO-g-POSS: 
Td5 ↑ 31, Tg ↑ 10, Tc ↑ 29,  Tm ↑ 5 ºC 
PLA/ GO+POSS: 
Td5 ↑ 19, Tg ↑ 12, Tc ↑ 22, Tm ↑ 3 ºC 
[167] 
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5.2.4.4 Biological properties 
 
Since CBNs generally present toxicity when isolated, i.e. when not incorporated in a polymer 
matrix, [37, 171] biocompatibility of the composite must be tested when considering uses as 
biomaterials. Table 5.4 shows that PLA/CBNs composites (films and nanofibers) do not tend to 
decrease in vitro metabolic activity of several cell types, or cause increases up to 40% until 72 h 
incubations. Also, the selection of production method used (spin coating, electrospinning, and 
solvent mixing followed by casting or doctor blading), does not seem to influence cell 
proliferation. For long term incubations, McCullen et al. [172] showed that scaffolds of PLA with 1 
wt.% MWNTs do not to influence metabolic activity of adipose-derived human mesenchymal 
stem cells (hMSCs) at 7 days. At 14 days, cells present increased metabolic activity and 
longitudinal alignment induced by the scaffolds. Sherrell et al. [173] reported that PLGA (1:1) with 
a surface layer of graphene applied by CVD to increase PC-12 cells average length of neurites by 
2.5 fold when electrical stimulated. Also, hemocompatibility improvements were reported with 
both incorporation of 0.4 wt.% GNP by solvent mixing followed by doctor blading [140] and 4 
wt.% MWCNTs by extrusion followed by injection moulding [174] in PLA. In the last case, 
MWCNTs alignment is associated with decreased platelet adhesion and activation. Thus, 
alignment seems to be generally benefic for biocompatibility. The effectiveness of electrical 
stimulation together with fiber alignment was confirmed by Shao et al. [169], which cultured 
osteoblasts at the surface of PLA/MWCNTs-ox (3 wt.%) produced by solution mixing followed 
by electrospinning. They observed maximum improvements, comparing with control PLA fibers 
(d ≈ 400 nm), in cell elongation (190 %) and metabolic activity (20 %) for random nanofibers (d 
≈ 250 nm) under DC 100 μA. For aligned fibers the previous values increased by 355 and 40 %, 
respectively. Finally, An et al. [175] found PLA/PU 3 wt.%/GO 5 wt.% films and nanofibers to 
completely suppress Escherichia coli and Staphylococcus aureus growth after 24h, not affecting 
MC3T3-E1 cells metabolic activity. 
In an in vivo study, Kanczler et al. [176] observed that PLA-CB 0.1 wt.% scaffolds seeded or not 
with fetal femur-derived cells, when implanted in a murine critical-size femur segmental defect 
model aided the regeneration of bone defect. 
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Table 5.4: Biological properties of PLA/CBNs composites in comparison with non-modified PLA. Production methods and CBNs characteristics. 
 
Production methods Materials characteristics CBNs content (wt.%) Biocompatibility properties References 
GO - MHM 
Nanofibers - electrospinning 
GO (thickness (t) = 1.5 nm, 
Length (l) ≈ 1 µm) 
Nanofibers (l = 11-14 µm) 
 
PLGA (1:1)/GO 1 and 2 wt.% nanofibers 
Cell metabolic activity (MA): (PLGA = 100%, 
PLGA/GO 1 wt.% ≈ 102%, PLGA/GO 2wt.% ≈ 108%, 
48h) 
(PC 12 cells) 
 
[177] 
GO - MHM 
Films – spin coating 
GO (not found) 
Films (t ≈ 5 μm) 
PLGA (1:1)/GO films 
Cell MA: Small increase (≈ 10%) comparing to PLGA 
for PLGA/GO 2wt.% (48h) (Hela cells) 
[178] 
GO - MHM 
Nanofibers - electrospinning 
GO (few layer) 
PLA/HA/GO (diameter (d) = 0.3-1.3 µm) 
PLA/HA(10 wt.)/GO nanofibers 
Cell MA: 1, 2 and 5 wt.% GO ↑, comparing to PLA/HA 
(24h) 
Only nanofibers with 5 wt.% GO presented higher MA 
than PLA/HA (48h) 
(MC3T3-E1 cells) 
[179] 
GO - MHM 
Films – solvent mixing + doctor 
blading 
d ≈ 500 nm 
Films (t = 25-65 µm) 
PLA/GO films 
(0.4 wt.%) 
Cell MA: No variations until 48h, except for PLA/GO 
after 24 h (more 13% than pristine PLA) (Mouse 
embryo fibroblasts 3T3 - ATCC CCL-164) 
Hemocompatibility: Less platelets activated in 
PLA/GNP comparing with PLA in presence of plasma 
proteins (Human platelets concentrate) 
[140] GNP–commercial product 
 
Films – solvent mixing + doctor 
blading 
GNP (t ≈ 6-8 nm, l ≈ 5 µm) 
Films (t = 25-65 µm) 
PLA/GNP films 
(0.4 wt.%) 
Graphene – CVD (chemical vapor 
deposition) 
Films – solvent casting over 
graphene 
Graphene (t = 2 layers) 
Films (t = 25-65 µm) 
PLGA(1:1)/graphene surface layer 
Cell MA: No significant changes until 4 days for PC-12 
cells (rat adrenal gland pheochromocytoma). 
 
Cell differentiation: with electrical stimulation the 
average length of neurites increased 2.5 fold 
[173] 
GO - MHM 
Films – solvent mixing + solvent 
casting 
Nanofibers - electrospinning 
GO (not found) 
Films (not found) 
Nanofibers (d ≈ 1 μm) 
PLA/PU (3 wt.)/GO (5 wt.%) films and 
nanofibers 
Cell proliferation: not decreased (MC3T3-E1 cells) 
Antibacterial effect: E. coli and S. aureus growth 
100% reduced at 24h 
[175] 
MWNTs - catalytic chemical vapor 
deposition 
Composites – extrusion + injection 
moulding 
Aligned composites – mechanical 
stretching at 90°C 
MWNTs (l = 10–30 mm, d = 20–40 nm) 
Composites (not found) 
 
PLA/MWNTs (5, 10, 15 wt.%) composites 
Hemolysis: bellow standard permissible (5%) in all 
cases, decreases with MWNTs incorporation and 
alignment 
Kinetic clothing time: increases with MWNTs 
incorporation and alignment (best was PLA/MWNTs 5 
wt.% which increased time by 480%) 
Platelet adhesion and activation: decreases with  
MWNTs incorporation and alignment 
[174] 
MWNTs - plasma chemical vapour 
deposition 
Scaffolds – electrospinning 
MWNTs (l = 5–20 mm, d = 5–15 nm) 
Scaffolds (d = 0.7 μm, average porosity = 
87%, void space = 89%) 
PLA/MWNTs (1 wt.%) scaffolds 
Cell MA: equal until day 7 and increased with  
MWNTs at day 14 (hMSCs) 
Cell morphology: MWNTs induced longitudinal 
alignment on cells at day 14 
[172] 
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MWCNTs-ox (HCl, 2h at 25°C + 
HNO3, 4h at 110 ºC) 
Nanofibers ( MWCNTs-ox sonicated 
in DMF 2h + SDS, adding to PLA in 
dicloromethane, 1h sonication before 
electrospinning) 
MWCNTs (l = 10–20 µm, d = 10–20 nm) 
Nanofibers (PLA ≈ 400 nm, 
PLA/MWCNTs-ox ≈ 250 nm) 
PLA/MWCNTs-ox (3 wt.%) random (R) and 
aligned (A) nanofibers 
Cell MA: increased for osteoblasts at day 3 for 
PLA/MWCNTs-ox (3 wt.%) R – 20 % and A – 40 %, 
under DC = 100 μA 
Cell morphology:  induced osteoblasts alignment at day 
3 for PLA/MWCNTs-ox (3 wt.%) R – 190 % and A – 
355 %, under DC = 100 μA 
Both increased with electrical stimulation for DC = 50 
and 100 μA 
[169] 
CB – not found 
Scaffolds - surface selective laser 
sintering 
(CB) Carbon black (d = 360 nm, surface area 
= 100 m2 g-1) 
Scaffolds – several shapes 
SSLS-PLA/CB 0.1 wt.% scaffolds 
SSLS-PLA/CB 0.1 wt.% scaffolds seeded or not with 
fetal femur-derived cells aided regeneration of murine 
bone defect 
[176] 
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5.3 Conclusions 
 
Both CNTs and GBMs nanofillers are effective at improving PLA thermo-mechanical and 
electrical properties, whether produced by solution mixing or melt blending. However, lower 
amounts of GBMs (0.1-1 wt.%) are usually needed, comparing with CNTs (0.25-5 wt.%). Melt-
blending is less frequently reported than solution mixing for production of PLA/CBNs 
composites, probably due to the lower availability of the necessary equipment. Moreover, results 
show that melt blending tends to be not as effective at improving PLA properties. In-situ 
polymerization is the least reported technique, with further research being needed to demonstrate 
possible advantages over the previous approaches. 
Several chemical modifications can be tried to improve compatibility with a polymer matrix. 
Functionalization with carboxyls is the most common and effective procedure to improve CNTs 
dispersibility and compatibility with PLA. Some authors refer that purification with strong acids 
introduces polar groups in the carbon surface, which introduces positive interaction with PLA. 
Besides simple chemical oxidation of CBNs, other chemical modifications include reaction with 
isocyanates, polymers (ethylene glycol, poly(caprolactone), poly(methyl methacrylate), 
poly(vinyl pyrrolidone), and PLA)), polyols, silanes or amines. 
No relation can be determined between CBNs morphological properties (size, length, and 
diameter) and the composites performance.  
The alignment of PLA/CBNs fibres, was reported to improve their conductivity. Also, in most 
works evaluated, electrical properties improved with the increase of the amount of CBNs 
incorporated. 
Production methods reported for PLA/CBNs composites for biomedical applications are spin 
coating, electrospinning (most used), and solvent mixing followed by casting or doctor blading. 
The process selection does not influence cell metabolic activity. Different studies reveal that 
PLA/GBM composites (films and nanofibers) do not decrease the metabolic activity of cell lines, 
and in some cases induce increases below 40% until 72 h incubations, comparing with non-filled 
PLA. Improvements in hemocompatibility were achieved with incorporation of both CNTs and 
GBMs. Also, both fiber alignment and electrical stimulation, improved cell metabolic activity and 
elongation. Incorporation of GO has lead to suppression of Escherichia coli and Staphylococcus 
aureus growth, without compromising the composite biocompatibility. However, there is still no 
information on antimicrobial activity of these composites on other types of microorganisms or 
with other types of GBMs. 
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Interesting fields for future work would be to further explore in-situ polymerization, since there 
are few studies focused on that approach. Also, it is important to better understand how the fillers 
physico-chemical properties, and their alignment inside a polymer matrix, affect the composites 
properties. Emerging technologies, like 3D printing, will surely contribute for the conception of 
materials with the desired properties for the broad potential applications of PLA/CBNs 
composites.  
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6 PHYSICAL-CHEMICAL PROPERTIES AND 
BIOCOMPATIBILITY OF PLA/GBMS 
COMPOSITES - PRODUCTION BY 
SOLVENT-MIXING 
6.1 Scope 
 
There is a need to improve some of poly(lactic acid) (PLA) properties for several biomedical 
applications, being mechanical performance the most pressing. Due to its particular physical-
chemical properties, graphene-based materials (GBMs) are able to interact with polymer matrices 
when incorporated as fillers, even when used in low amounts, usually improving composites 
performance and leaving the base polymer key properties intact. This chapter, describes the 
preparation by solvent mixing followed by doctor blading, and characterization of PLA films and 
composite PLA films incorporating two GBMs – graphene oxide (GO) and graphene 
nanoplatelets (GNP). The materials were prepared and characterized regarding not only 
biocompatibility, but also surface topography, chemistry, and wettability.  
 
6.2 State of the art 
 
Aliphatic polyesters with reactive groups have attracted attention because of the demand of 
synthetic biopolymers with tuneable properties, including features such as hydrophilicity, 
biodegradation rates, bioadhesion, drug/targeting moiety attachment, etc. Poly(lactic acid) (PLA) 
has been widely investigated for biomedical applications because it is biodegradable, 
bioresorbable, and biocompatible. [1, 2] This polymer has several applications in tissue and 
surgical implant engineering, like production of: bioresorbable artificial ligaments, hernia repair 
meshes, scaffolds, screws, surgical plates, and suture yarns. [3, 4] PLA is also used in production of 
nano/microparticles for drug delivery, and in packaging of pharmaceutical products. [5] To make 
this material more attractive for some applications, as an effective alternative to petrochemical 
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plastics, some properties should be improved, namely mechanical performance. [6] To attain these 
objectives different approaches have been tried according to the required applications. Some 
commonly used strategies are adjustment of crystallinity [7], incorporation of plasticizers [8], 
blends with other polymers [6] and addition of nanofillers. The latter is an interesting option, since 
with the addition of small weight percentages (wt.%) target properties can, in principle, be 
improved, while maintaining other key PLA properties intact. Good dispersion and interfacial 
interaction with the polymer matrix is paramount in order for these improvements to be 
significant. Most of the nanofillers reported are nanoclays [9], carbon nanotubes [10], and 
nanosilicas [11]. 
Graphene, the elementary structure of graphite, is an atomically thick sheet composed of 
sp2 carbon atoms arranged in a flat honeycomb structure. It possesses remarkable mechanical 
strength and an extremely high surface area. [12] Since graphene is hydrophobic, stable dispersions 
in water can only be obtained with addition of proper surfactants. [13] Graphene oxide (GO) is 
similar to graphene, but presents oxygen-containing functional groups. The presence of these 
polar groups reduces the thermal stability of the nanomaterial, but may be important to promote 
interaction and compatibility with a particular polymer matrix. [12, 14] 
GO and graphene have been reported as efficient drug carriers [15, 16], as well as PLA [17]. 
Development of hybrid vehicles for drug targeting can take advantage of both materials properties 
and originate synergistic effects. [18] In addition, several graphene based biosensors are being 
developed. [19] Recent studies show that graphene substrates promote adherence of human 
mesenchymal stromal cells and osteoblasts [20], which can lead to better performance on tissues 
regeneration using scaffolds containing graphene and graphene oxide. Due to their great potential, 
several approaches are under study for future applications of these nanomaterials in biomedical 
engineering and biotechnology. [21] 
There are only a few studies regarding the biological effects of graphene and graphene 
derivatives. [22-28] Moreover, in some cases contradictory results are reported. [22, 28] Some of the 
materials tested have identical designations, but in fact are obtained from different products and 
by different methods, leading to divergent conclusions. Most studies refer concentration 
dependent toxicity. [23-26] Effective mechanical reinforcement of polymeric materials using very 
small loadings of GO and graphene nanoplatelets (GNP) has been described by several authors. 
[29-31] Therefore, toxicological effects may not occur if the amount of nanofillers exposed or 
released from the polymer is sufficiently low to avoid attaining toxic concentrations. 
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The synthesis of GNP and GO does not require metal catalysis, contrarily to the production of 
carbon nanotubes, a chemically similar material that has attracted significant interest. Thus, 
cytotoxicity and inflammation caused by residual metals does not occur for GNP and GO. [32] 
An appropriate cellular response to implanted surfaces is essential for tissue regeneration and 
integration. It is well described that implanted materials are immediately coated with proteins 
from blood and interstitial fluids, and it is through this adsorbed layer that cells sense foreign 
surfaces. Although several studies have been made, it is not yet clear which material properties 
(e.g. topography, chemical composition, wettability, surface charge) favor in vitro protein 
adsorption and cell adhesion and proliferation. [33] Graphene and graphene oxide can affect 
protein adsorption and cell adhesion and proliferation, according to their intrinsic morphology and 
wettability. The adhesion and activation of platelets is also affected by the abovementioned 
factors. Presence of carbon nanotubes at the surface of PLA films was reported to decrease 
thrombogenicity. [34] In addition, the starting materials and methods used in the production of 
graphene-based materials, as well as the presence of toxic functional groups and contaminants, 
can affect biocompatibility. 
In a previous study [35], we showed that incorporation of small amounts (0.4 wt.%) of GO and 
GNP in PLA significantly increases tensile strength and Young's modulus. Thus, this type of 
composites have a potential use in the production of surgical implants with improved mechanical 
performance. However, it is paramount to assure that these biomaterials do not present toxicity 
problems. In this work surface properties of PLA/GO and PLA/GNP thin films are characterized. 
Biocompatibility of the composite films is evaluated through cytotoxicity and cell proliferation 
assays. Platelet adhesion and activation studies are used to assess hemocompatibility of the films. 
6.3 Materials and methods 
6.3.1 Materials 
Poly(lactic acid) (PLA) 2002 D (4% d-lactide, 96% l-lactide content, molecular weight 
121,400 g mol−1), was obtained from Natureworks (Minnetonka, USA). Graphene nanoplatelets 
(GNP) grade M5, were purchased from XG Sciences (Lansing, USA), with the following 
characteristics: average thickness of 6–8 nm, maximum length 5 μm, and surface area between 
120 and 150 m2 g−1. GNP production is based on exfoliation of sulfuric acid-based intercalated 
graphite by rapid microwave heating, followed by ultrasonic treatment. [36, 37] 
Carbon graphite micropowder, with purity above 99% and a diameter between 7 and 11 μm was 
purchased from American Elements, Los Angeles, USA. 
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6.3.2 Preparation of GO 
Graphene oxide (GO) was prepared according to a modified Hummer's method. Briefly, 100 mL 
of H2SO4 were added to 3 g of graphite at room temperature and the solution was cooled using an 
ice bath, followed by gradual addition of 14 g of KMnO4. Then 300 mL of distilled water were 
added, followed by addition of H2O2 (to reduce KMnO4 excess) until oxygen release stopped. The 
solid was filtered and washed with water. After overnight resting, the resultant solution was 
decanted and the remaining product was centrifuged at 2000 rpm, during 5 min (this process was 
repeated four times). The solid was recovered and dried at 110 °C for 48 h. [38] 
6.3.3 Preparation of PLA/GO films 
Nanocomposite thin films with GO and GNP were prepared by doctor blade casting of solvent 
dispersions, as described in our previous work. [35] GO was dispersed in acetone using an 
ultrasonic bath (Bandelin Sonorex RK 512 H) during 5 h and then added to a PLA/chloroform 
solution and again sonicated for 15 min. Concentration of GO relative to PLA was 0.4 wt.%, 
since in a previous work we have verified that this was the optimum loading for mechanical 
performance improvement in terms of tensile strength and Young's modulus. [35] Thin films (25–
65 μm) were made by spreading the PLA/GO dispersion on a PTFE coated plate using a blade 
applicator. Solvent was completely removed by drying in a vacuum oven. 
6.3.4 Preparation of PLA/GNP films 
GNP were dispersed in chloroform using ultrasound sonication during 2 h and then dispersed in a 
PLA/chloroform solution. Concentration of GNP relative to PLA was 0.4 wt.%, for the 
abovementioned reason. Thin films (25–65 μm) were prepared and dried according to same 
procedures as the PLA/GO nanocomposites. 
6.3.5 Films surface characterization 
6.3.5.1 Contact angle and surface free energy measurements 
A OCA 20 (Dataphysics) goniometer was used to measure the contact angles of ultrapure water, 
ethane-1,2-diol and hexadecane on pristine PLA, PLA/GO and PLA/GNP films, by sessile drop 
method. Data were collected with SCA 20 v2 software. Equilibrium contact angles (considered at 
60 s) were measured for 5 μL droplet volumes. Determinations were made on 3 different locations 
for each condition. The total surface free energy and the polar and dispersive components of the 
films were evaluated by the OWRK Method using SCA 20 software. Polar and dispersive 
components of the surface tension of the liquids that were used are 46.80 and 26.00 mN m−1 for 
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water, 21.30 and 26.30 mN m−1 for ethane-1,2-diol and 0.00 and 27.47 mN m−1 for hexadecane, 
respectively. 
6.3.5.2 Reflected light microscopy 
Reflected light microscopy images of PLA, PLA/GO and PLA/GNP films were obtained with a 
Zeiss axiophot microscope, equipped with a Zeiss axiocam ICc 3. The specified spatial resolution 
is 370 nm. 
6.3.5.3 X-ray photoelectron spectroscopy (XPS) 
PLA, PLA/GO and PLA/GNP thin films and GNP, graphite and GO powders were analyzed with 
an Escalab 200 VG Scientific spectrometer working in ultra-high vacuum (1 × 10−6 Pa) and using 
achromatic Al Kα radiation (1486.6 eV). The analyzer pass energy was 50 eV for survey spectra 
and 20 eV for high-resolution spectra. The spectrometer was calibrated using (Au 3d5/2 at 
368.27 eV). The core levels for O 1s and C 1s were analyzed. The photoelectron take-off angle 
(the angle between the surface of the sample and the axis of the energy analyzer) was 90°. The 
electron gun used focused on the specimen in an area close to 100 mm2. Analyzed samples were 
not conductive, for these reason spectra energy was displaced and a corrective shift based on the 
C 1s peak (285 eV) was performed. Curve fitting of the spectra was performed with the software 
XPS peak version 4.1. 
6.3.5.4 Topography characterization 
A stylus profilometer Hommel T8000, equipped with a pick-up-set taster TKL 300/17, was used 
to obtain a three-dimensional characterization of the topography of rectangular surface areas with 
1.5 mm × 1.5 mm of PLA, PLA/GO and PLA/GNP films. Determinations were made on 3 
different locations for each film. Roughness parameters determined were: Sa – arithmetic average 
height of the surface (Sa=1/A∬a|Z(x,y)|dxdy, A – area) and Sp, Sv, and Sz which are parameters 
evaluated from the absolute highest and lowest points found on the surface, being: Sp – the 
maximum peak height, which is the height of the highest point; Sv – the maximum valley depth – 
which is the depth of the lowest point (expressed as a negative number); Sz– the maximum height 
of the surface. Thus, Sz = Sp − Sv (ISO 25178-2). [39, 40] The specified space resolution is 100 nm 
in x, y and z. 
6.3.6 In vitro biocompatibility assays 
 
In vitro assays were performed using mouse embryo fibroblasts 3T3 (ATCC CCL-164), grown in 
Dulbecco's modified Eagle's media supplemented with 10% newborn calf serum (Invitrogen) and 
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penicillin/streptomycin (1 mg mL−1) (Sigma–Aldrich) [DMEM+], at 37.0 °C, in a fully 
humidified air containing 5% CO2 (Infrared auto Flow). The cells were fed every 2–3 days. The 
cells were detached when 90% confluence was reached using a 0.25% (w/v) trypsin-EDTA 
solution (Sigma) and resuspended in culture medium at cellular density according to the assay. 
All assays were performed in triplicate and repeated at least 3 times. Results are presented as 
mean and standard deviation (SD). 
6.3.6.1 Cell adhesion and proliferation at the surface of PLA, PLA/GO, 
and PLA/GNP films 
Films (Ø 13 mm) constituted by PLA, PLA/GO and PLA/GNP were sterilized by immersion in 
ethanol (70%, v/v) and then washed with PBS (Phosphate Buffered Saline) before cells seeding at 
5 × 104 cells/well and incubated. Polystyrene disc (PS) was used as positive control. Fibroblasts 
proliferation was evaluated using 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT, 
Sigma), a colorimetric assay that gives a measure of the mitochondrial metabolic activity. Before 
the addition of MTT solution (0.5 mg mL−1 in PBS) films were changed to a new plate containing 
new medium. MTT assays were performed at 24, 48 and 72 h after cell seeded. The absorbance 
was measured at 570 nm and the cell proliferation inhibition index (CPII) was calculated as 
follows: CPII = 100 – (OD 570 nm of test culture/ OD 570 nm of control culture (PS) x 100). 
6.3.6.2 Direct contact assay 
A fibroblast suspension containing 3 × 104 cells mL−1 was plated into each well of a six-well 
plate. After reaching a state of subconfluence (after 24 h), samples of PLA, PLA/GO and 
PLA/GNP films (Ø 13 mm) were placed on the wells, in direct contact with cells. After 48 h 
incubation, the cell morphology and viability was assessed, using the 
LIVE/DEAD®Viability/Cytotoxicity Kit for mammalian cells fluorescence (Invitrogen) labeling. 
Positive and negative controls (discs of latex and agar gel) were also used. 
6.3.6.3 Platelet adhesion and activation 
The adhesion of platelets to the surface of Ø 14 mm disks of PLA, PLA/GO and PLA/GNP films 
were evaluated by counting and observation of morphological features using scanning electron 
microscopy (SEM). Wells of 24-well plates were blocked by adding BSA (bovine serum albumin) 
1% (w/v) in each well followed by 1 h incubation at 37 °C, and then rinsing with PBS (0.01 M, 
pH 7.4). Films were sterilized in ethanol 70% (v/v) for 20 min, and then rinsed with PBS. To 
evaluate the effect of serum proteins in platelet adhesion and activation, the samples, PS 
[poly(styrene)] – control, PLA, PLA/GO and PLA/GNP were first incubated with two different 
pre-immersion solutions: PBS or human plasma 1% (provided by the Portuguese Blood Institute) 
in a 24-well plate for 30 min at 37 °C, and afterwards rinsed with PBS. The human platelets 
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concentrate (PC) (obtained from the Immunohemotherapy service – Hospital S. João, Porto, 
Portugal) was diluted in PBS to a concentration of 3 × 108 platelets mL−1. Samples were 
incubated with the freshly prepared PC in the previously blocked 24-well plates for 30 min at 
37 °C under 90 rpm. Finally, the samples were rinsed with PBS. Adherent platelets were fixed 
with freshly prepared solution of 1.5% glutaraldehyde (Merk) in 0.14 M sodium cacodylate buffer 
(Merk) for 30 min at room temperature and then rinsed with PBS. Afterwards, the samples were 
dehydrated with a growing ethanol/water gradient, for 10 min each: 50, 60, 70, 80, 90 and 99% 
(v/v). Next, 100 μL of hexamethyldisilazane (Sigma–Aldrich) were added to each well and the 
samples were left to dry in the hoot overnight. Finally, the samples were sputtered with a 
conductive gold/palladium layer and observed by SEM (FEI Quanta 400FEG) at CEMUP – 
Centro de Materiais da Universidade do Porto. The degree of activation was evaluated by 
qualitative observation of the platelets morphology. Two degrees were considered: (a) non-
activated and (b) activated (see Figure 6.1). Platelets were considered activated if they had more 
than one pseudopod or were fully spread ((Fig. 6.1(C, D)). Samples were pre-immersed in PBS or 
plasma. At least 10 samples were used to calculate mean and standard deviation for each material 
in each pre-immersion condition. 
 
 
Figure 6.1: Activation degree of platelets at the surface of the films. Representative images 
of non-activated (A and B) and activated (C and D) platelets, at 20,000× magnification. 
 
Chapter 6 
156                                                                                                       Artur M. Pinto – Jan 2017 
6.3.7 Statistical analysis 
 
Statistical analysis was made by analysis of variance (ANOVA). Multiple means comparison was 
performed between samples to identify significant differences, which were considered 
for p < 0.05. In suitable cases independent two samples Student's t-test was used. Significant 
differences were also considered for p < 0.05. 
 
6.4 Results and discussion 
6.4.1 Topographical characterization 
 
The 3D topography images shown in Figure 6.2 compare the surfaces of pristine PLA films with 
PLA/GO and PLA/GNP composite films surfaces. The peaks seen in Fig. 6.2(B) correspond to 
agglomerates (1–2 μm), since individual GO sheets are too small to be detected by this technique 
(sizes in the order of tenths of micron). [35] On the other hand, GNP particles have nominal 
lengths close to 5 μm, allowing for the observation of both individual and agglomerated particles 
Fig. 6.2(C). The peaks are distributed throughout the entire surface. A grooved pattern was 
observed on the surfaces of all samples. Reflected light microscopy was used to identify the cause 
of this pattern (discussed next). 
Table 6.1 shows that films with GO and GNP incorporation present higher positive values 
of Sp and St than pristine PLA films, due to presence of fillers at the surface. PLA/GNP films 
presented negative values of Sv higher than PLA/GO films. This may be an indication of GNP 
having less compatibility with the polymer matrix than GO, thus being less embedded in it, 
existing more pronounced depressions surrounding GNP than GO particles. GO has more 
functional groups with oxygen than GNP (shown in Section 6.4.2), which form hydrogen bonds 
with similar groups in PLA. Differences in Sa between samples are not considerable because only 
a very small weight percentage of nanofillers are dispersed in the films. 
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Figure 6.2: Representative 3D images of the topography of the surface of pristine PLA (A), 
PLA/GO (B) and PLA/GNP (C) films. 
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Table 6.1: Roughness parameters for PLA, PLA/GO and PLA/GNP films. Sa – arithmetic 
average height of the surface, Sp – maximum peak height, Sv – maximum valley depth, Sz – 
maximum height of the surface. Results are presented as mean and standard deviation (in 
parenthesis) for n = 3. 
 
Roughness parameters 
Samples Sa / nm Sp / nm Sv / nm Sz / nm 
PLA 43 (11) 730 (124) -711 (427) 1441 (346) 
PLA/GO 43 (6) 1623 (370) -816 (203) 2439 (565) 
PLA/GNP 37 (6) 1211 (476) -1797 (963) 3008 (1424) 
 
Reflected light microscopy images (Figure 6.3) show that the surface of the films presents 
grooves with pitches between 0.5 and 2 μm for all conditions. These grooves are in the same 
direction as the spreading of the films. This might occur due to imprinting of a micropattern 
present in the doctor blade during spreading. Rapid solvent evaporation in these thin films hinders 
surface leveling and originates this morphology. GO and GNP are visible in Fig. 6.3(B,C) as dark 
and bright spots, respectively. 
6.4.2 Chemical characterization 
 
Chemical properties of nanofillers used in a composite are relevant in two important contexts: (i) 
compatibility with the polymer matrix, and (ii) biological effects when exposed at the film surface 
or released due to matrix biodegradation. XPS results (Figure 6.4 and Table 6.2) show that, both 
graphite and GNP present a low degree of oxidation (atomic percentage of oxygen – O 1s 
(at.%) < 9%). This was expected since graphite is mainly constituted by carbon atoms and GNP is 
obtained from graphite by microwave and ultrasonic treatment (see Section 6.3.1). XPS data also 
reveal that oxidation of graphite by modified Hummer's method, to produce graphene oxide, 
increases the O 1s (at.%) in the final product (GO) by about 15%. The most ubiquitous oxygen 
functional groups identified in GO are ethers. 
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Figure 6.3: Reflected light microscopy of the surface of PLA (A), PLA/GO (B) and 
PLA/GNP (C) films. 
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Figure 6.4: XPS spectra for the core level C 1s (after fitting) of graphite, GO and GNP 
powders. 
 
Concerning the composite films, the C and O 1s (at.%) at the surface of PLA, PLA/GO and 
PLA/GNP films are similar for every condition (Table 6.3). Major oxygen containing functional 
groups identified for the three cases were ethers and carbonyls. Again there were no considerable 
differences between the films. This might happen because the contribution of the filler (at a 
loading of only 0.4 wt.%) to the final C and O 1s (at.%) cannot be detected by XPS. 
 
Table 6.2: Atomic composition of graphite, GNP and GO, determined by XPS. Results are 
presented as mean and standard deviation (in parenthesis). 
 
Sample C 1s / at. % O 1s / at. % 
GNP 92.4 7.6 
Graphite 91.7 8.3 
GO 78.3 21.7 
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Table 6.3: Atomic composition analysis by XPS of the surface of PLA, PLA/GO and PLA/GNP 
films. Results are presented as mean and standard deviation (in parenthesis) for n = 3. 
 
Sample C 1s / at. % O 1s / at. % 
PLA 62.1 (2.36) 37.9 (2.36) 
PLA/GNP 63.7 (2.73) 37.8 (2.63) 
PLA/GO 61.7 (0.74) 38.3 (0.74) 
 
6.4.3 Wettability of the films surface 
 
Contact angle measurements (Table 6.4) show that the water contact angle of PLA/GO films 
decreased about 9° comparing with pristine PLA films. This shows that the presence of GO at the 
film surface increases its hydrophilicity. Hydrogen bond interactions between oxygen-containing 
groups in GO and water can explain this behavior. Hexadecane completely wetted the surface of 
PLA/GO films (Figure 6.5(E)), while at the surface of pristine PLA films it presented a contact 
angle close to 27°. Hydrophobic interactions with hexadecane might be established with the 
honeycomb sp2 carbon atoms. This suggests that the presence of GO particles induces an 
amphiphilic behavior of the surface. 
 
Table 6.4: Contact angles at 60 s of H2O, ethane-1,2-diol and hexadecane on PLA, PLA/GO 
and PLA/GNP films. Results are presented as mean and standard deviation (in parenthesis) 
for n = 3. 
 
Samples 
Contact angles / ⁰ 
H2O 
Ethane-1,2-
diol 
Hexadecane 
PLA 87.2 (0.36) 56.9 (2.14) 26.7 (3.37) 
PLA/GO 78.1 (2.06) 55.2 (3.38) 0 (0.00) 
PLA/GNP 89.6 (0.97) 65.3 (0.94) 0 (0.00) 
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Figure 6.5: Contact angle images for: A – water on PLA, B – ethane-1,2-diol on PLA, C – 
hexadecane on PLA, D – hexadecane on PLA/GO and E – hexadecane on PLA/GNP film 
surface. 
 
The water contact angle of PLA/GNP film increased 2.3°, comparing to pristine PLA films, 
showing a small hydrophobic effect. As occurred for PLA/GO films, hexadecane completely 
wetted the surface of PLA/GNP films (Fig. 6.5(D)). However, the contact angle for ethane-1,2-
diol increased, probably due to the presence of much less oxygen functional groups in GNP 
particles than in GO sheets at the film surface. 
All the above-mentioned findings suggest that the presence of the fillers at the film surface, 
despite not changing the surface composition significantly (shown in Section 6.4.2), affect its 
wettability. This might occur because of direct interaction of the liquids with partially exposed 
fillers at the PLA surface. Wang and co-workers measured water contact angles on poly(vinyl 
alcohol)/graphene dry films and observed that 0.5 wt.% graphene loading increased the contact 
angle from 36° to 93°. [41] 
Figure 4.6 shows surface free energy values computed from the contact angle measurements. The 
total surface free energy of PLA increases about 12% with the incorporation of 0.4 wt.% GO. 
However, for the same incorporated amount of GNP, no changes are observed. Additionally, as 
expected, the polar component of PLA films increases about 59% with addition of GO and 
decreases 56% with incorporation of GNP. These results are in accordance with the discussion 
presented above for the contact angles. 
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Figure 6.6: Dispersive and polar components of the total surface free energy of PLA, 
PLA/GO and PLA/GNP films. 
 
6.4.4 In vitro biocompatibility assessment 
 
In order to evaluate the cytotoxicity of the films, we have studied the effects of these materials in 
a mouse embryo fibroblast culture, namely in terms of cell adhesion and proliferation on the 
films, morphological features and cell death. 
After 24 h of culture, fibroblasts adhesion and proliferation on the PLA/GO films (CPII ca. 17%) 
was significantly higher than for pristine PLA (CPII ca. 31%) ones (p < 0.05) (Figure 6.7). This 
can be due to the presence of GO at the surface increasing its hydrophilicity or creating a more 
suitable surface morphology for protein adsorption and cell adhesion. Higher surface 
hydrophilicity favors vitronectin adhesion and allows the maintenance of fibronectin 
functionality. Furthermore, cell proliferation requires the reorganization of surface-adsorbed 
fibronectin, which occurs in hydrophilic surfaces and is often impaired in more hydrophobic 
surfaces. Increase in surface roughness may lead to higher fibronectin adsorption due to the 
increase of surface area. Interestingly, Ruiz et al. [28] observed that mammalian colorectal 
adenocarcinoma HT-29 cells attached and proliferated more efficiently in GO coated glass slides, 
than in control (glass slides). After 48 and 72 h, the proliferation rate at the surface of PLA/GO 
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films seems to decrease and no significant differences are observed comparing to PLA films 
(p > 0.05). Also, no significant differences (p > 0.05) are observed in CPII between PLA and 
PLA/GO comparing to PLA/GNP films, until 72 h. Thus, the presence of GNP at films surface 
does not seem to affect cell adhesion and proliferation. 
 
 
Figure 6.7: Cell proliferation inhibition index for mouse embryo fibroblasts, cultured on 
PLA, PLA/GO and PLA/GNP films. Results are presented as mean and error bars 
represent SD. *Significantly different (p < 0.05). 
 
Yoon et al. [42] reported that the proliferation and viability of neuronal cells (PC 12) on poly(d,l-
lactic-co-glycolic acid) [PLGA]/GO (2 wt.%) nanocomposite scaffolds increased by 8% in 
comparison to pristine PLGA scaffolds. However, Lahiri et al. [25], showed that the viability of 
osteoblasts (ATCC, Manassas, VA, USA) grown at the surface of ultra-high molecular weight 
poly (ethylene)–GNP nanocomposite films (0.1 wt.%) decreased about 6, 14 and 17% comparing 
to pristine polymer after, respectively, 1, 3 and 5 days of incubation. 
The cytotoxicity of the films was also assessed using a direct contact method. For that purpose, 
the films were used together with a positive and negative control (latex rubber and agar, 
respectively). Each sample was placed on top of a sub-confluent cellular layer on a six-well plate, 
as described in the material and methods section. 
Figure 6.8 shows the results obtained with the fluorescence labeling of the cell layers. As 
expected, the latex rubber is cytotoxic. Thus, the majority of cells were floating in the medium 
and some of those that remained attached were also dead (red labeled – Fig. 6.8(B)). No 
differences in morphology were found for the cells on the films surface and on the negative 
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control (agar – Fig. 6.8(A)). Moreover, all of the cells remained alive, as shown by the green 
fluorescence (Fig. 6.8(A, C–F)). These results suggest that films can be considered non-toxic. 
 
 
 
Figure 6.8: Fluorescence microscopy of mouse embryo fibroblasts after 48 h incubation in 
the direct contact assay: A – Agar (negative control); B – positive control (latex rubber); C 
and D – PLA; E – PLA/GO and F – PLA/GNP.  
 
6.4.5 Platelet adhesion and activation 
 
Since PLA is a biomaterial commonly used in surgery (e.g. orthopedy, dental medicine, hernia 
repair meshes), it should present low thrombogenicity in order to prevent the formation of post-
operative blood cloths. [5] Adhesion and activation of platelets at the surface of PLA, PLA/GO 
and PLA/GNP films were evaluated by counting and qualitative observation of morphological 
features using SEM (see Section 6.3.6.4). To evaluate the effect of serum proteins on platelet 
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adhesion and activation the samples were pre-immersed either in PBS or human plasma 
1%. Figure 6.9 shows that significantly less (p < 0.05) platelets adhered to PLA and PLA/GNP 
when samples were previously treated with human plasma comparing to those pre-immersed in 
PBS. This may occur due to adsorption of non-thrombogenic proteins, such as albumin, at the 
surface of the films preventing platelet adhesion. Moreover, when in presence of plasma proteins, 
the number of activated platelets in PLA/GNP films is significantly lower (p < 0.05) than that in 
PLA and PLA/GO films (Figure 6.9 and 6.10). This can be explained by the presence of 
hydrophobic GNP (see Section 6.4.3) at the surface of the films, favoring protein adsorption at the 
material surface. This blocks platelet activation in case of these proteins being albumin, which is 
generally the first to adhere because of its abundance in plasma and its small size. [44] 
A decrease of platelet adhesion and activation after pre immersion in plasma has been previously 
described for surfaces that preferentially adsorb albumin over other plasma proteins. [45, 46] Also, 
Koh et al. observed decreases in platelet adhesion and activation in (PLGA) poly(lactic-co-
glycolic-acid) films pre-immersed in fibrinogen and non-stimulated rich plasma, whose surface 
was coated with multi-walled nanotubes, comparing to PLGA films without MWCNTs at the 
surface. 
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Figure 6.9: Platelet adhesion on PLA, PLA/GO and PLA/GNP films surface, pre-immersed 
in PBS or plasma. Degree of activation of the platelets adhered to the surface of the films 
pre-immersed in PBS or in plasma. A – activated, NA – non activated. Results are presented 
as mean and error bars represent standard deviation. *Significantly different (p < 0.05). 
 
Chapter 6 
168                                                                                                       Artur M. Pinto – Jan 2017 
 
 
Figure 6.10: Platelets adherent on the surface of PLA (A), PLA/GO and (B) PLA/GNP films 
pre-immersed in plasma (images of the films pre-immersed in PBS are not shown). 
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6.5 Conclusions 
 
Incorporation of 0.4 wt.% loadings of GO and GNP changed the surface topography and 
wettability of PLA composite films. However, no considerable variation in cell proliferation 
at the surface of the films was observed, except for those containing GO after 24 h 
incubation, which presented a CPII inferior to pristine PLA films (p < 0.05). 
 The presence of GO on the films surface may favor cell adhesion and proliferation due to 
creation of a more suitable surface morphology or to the increase in surface hydrophilicity. 
In the direct contact assay differences in morphology were not found for cells on the films 
surfaces or on the negative control (agar) surfaces. Moreover, all cells remained alive. Thus, 
it can be concluded that the films showed no cytotoxicity. 
The number of activated platelets in PLA/GNP films is significantly lower than for pristine 
PLA films (p < 0.05) in the presence of plasma. 
These results indicate that small amounts of GO and GNP can be safely incorporated in PLA 
to improve its mechanical properties for biomedical applications. Additionally, GO has 
apparently a positive effect on cell adhesion and proliferation, leading to faster tissue 
regeneration. GNP incorporation, on the other hand, decreases thrombogenicity, which might 
reduce post operative complications caused by blood clots formation. 
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7 PHYSICAL-CHEMICAL PROPERTIES AND 
BIOCOMPATIBILITY OF PLA/GBMS 
COMPOSITES - PRODUCTION BY MELT-
BLENDING 
7.1 Scope 
 
Melt-blending is a commonly used method for polymer processing and fillers incorporation in 
polymer matrices. Comparing with solvent mixing followed by doctor blading, this method 
presents the advantage of not requiring the use of potentially toxic solvents. As mentioned in the 
previous chapter, there is the need to improve PLA mechanical properties for biomedical 
applications, as for example orthopaedical uses. In this chapter, graphene nanoplatelets are 
investigated as reinforcement filler for PLA. The parameters for production of PLA/GNP 
composites by melt-blending were optimized regarding mechanical performance, namely the 
effect of varying filler loading, mixing temperature, time, and intensity. Electron microscopy 
observations and Raman spectroscopy studies were used to understand why changing those 
variables affect mechanical properties. The biocompatibility of the composites was studied using 
human fibroblasts as an in vitro model.  
 
7.2 State of the art 
 
The biointeractions of graphene-based materials depend on their physico-chemical properties. In 
the last two decades, polymer composites have been studied as a strategy to provide added value 
properties to neat polymer without sacrificing its processability or adding excessive weight. 
Particular attention has been given to reinforcement with nanosized materials, which have the 
potential to present improved or even new properties when compared to conventional filled 
polymers. [1] 
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Poly(lactic acid) (PLA) has great worldwide demand due to versatile applicability in packaging, 
pharmaceutical, textiles, automotive, biomedical, and tissue engineering. [2] It has been widely 
investigated for biomedical applications due to its biodegradability, bioresorbability, and 
biocompatibility. [3, 4] Several applications have been described in tissue and surgical implant 
engineering, for production of bioresorbable artificial ligaments, hernia repair meshes, scaffolds, 
screws, surgical plates, and suture yarns. [5] PLA is also used in production of nano/microcapsules 
for drug delivery, and in packaging of pharmaceutical products. [6] Improvement and tuning of its 
properties has been reported by incorporation of plasticizers, blending with other polymers, and 
addition of nanofillers. [7-9] 
Carbon-based fillers offer the potential to combine several unique properties, such as mechanical 
strength, electrical conductivity, thermal stability, and physical and optical properties, required for 
a spectrum of applications. [10-12] Graphene, in particular, has been playing a key role in modern 
science and technology. Its remarkable properties and the natural abundance of its precursor, 
graphite, make it an interesting option for production of functional composites. [13] Graphene is a 
one-atom-thick planar sheet of sp2-bonded carbon atoms densely packed in a honeycomb crystal 
lattice. It possesses very high mechanical strength, surface area per unit mass, and thermal and 
electrical conductivities. In the last years, there has been a surge in research work involving this 
material, with reported applications in diverse fields, including biomedical engineering and 
biotechnology. [14-20] On the other hand, not many studies are yet available concerning 
biocompatibility of graphene and graphene-based materials (GBM). These often show 
contradictory results. [21-26] In our recent study, graphene nanoplatelets with smaller size (GNP-C) 
revealed to be biocompatible with human fibroblasts (HFF-1) until a concentration of 50 μg mL−1, 
opposing to larger GNP-M, which are toxic above 20 μg mL−1. [27] Since several authors have 
shown that effective reinforcement of polymeric matrices can be obtained with small loadings of 
GBM [28-32], toxic concentrations achievement can be prevented. Additionally, graphene oxide 
(GO) and graphene nanoplatelets (GNP), grade M (GNP-M), have shown not to affect mouse 
embryo fibroblasts metabolic activity when incorporated in PLA at a loading of 0.4 wt.%. [33] 
Many graphene-related materials have been reported in literature as potentially interesting fillers 
for polymer reinforcement. One commercial product that has been receiving particular attention, 
and is the object of study in this paper, is GNP: stacks of few graphene layers obtained by rapid 
heating of intercalated graphite. The platelets surface consists of mostly defect-free graphene, 
while oxygen is present in the sheet edges, in the form of, for instance, hydroxyl or carboxyl 
groups. Even though different grades are available for this material, grade M, with average 
platelet thickness of 6–8 nm and maximum length of 5 μm, is the most often tested in the 
available literature. [31] 
Physical-chemical properties and biocompatibility of PLA/GBMs composites – production by melt-blending 
Artur M. Pinto – Jan 2017                                                                                                                                177 
Several studies exist on reinforcement of PLA with GBM. Even though performance 
improvements are reported, quantitative results are usually distinct, owing mainly to differences 
in chemical and morphological nature of GBM, filler incorporation and processing methods, and 
filler loadings. Cao et al. observed an 18% increase in Young's modulus with addition of only 0.2 
wt.% of reduced graphene oxide. [30] The composite was prepared by solution mixing, followed 
by flocculation and drying. Pinto et al. showed that small loadings of GO and GNP-M (0.4 wt.%) 
in PLA thin films produced by solvent evaporation significantly improved mechanical and gas 
permeation barrier properties. [31] Tensile strength and Young's modulus were increased by about 
15% and 85%, respectively. Chieng et al. investigated PLA/PEG melt blends with GNP-M 
loadings of 0.3 wt.%, obtaining increases of 33%, 69%, and 22% in tensile strength, Young's 
modulus, and elongation at break. [34] Bao et al. prepared PLA/graphene composites by melt 
blending and observed 58% improvement in storage modulus at 0.2 wt.% loading. [35] Yang et al. 
prepared poly(l-lactic acid) (PLLA)/thermally reduced graphene oxide composites via in situ ring-
opening polymerization of lactide. The composite materials obtained, with loadings up to 2 wt.%, 
showed improved thermal stability, electrical conductivity, and crystallization rate. [36] In the 
work of Kim and Jeong, exfoliated graphite was incorporated in PLLA at different loadings by 
melt blending. [37] At 2 wt.% loading, tensile strength increased by about 13% and Young's 
modulus by 33%. Wenxiao et al. studied PLLA composites containing different low-dimensional 
carbonaceous fillers, with constant filler content of 0.5 wt.%. The fillers were pristine and 
silanized multiwalled carbon nanotubes (MWNTs) and exfoliated graphene. [38] All composites 
were prepared by solution mixing. It was found that tensile strength, elongation at break, and 
Young's modulus showed similar improvements when using carbon nanotubes or graphene (about 
20%, 39%, and 33%, respectively). Silane modification of both fillers further improved 
elongation at break and Young's modulus, without sacrificing tensile strength. More recently, 
Wenxiao et al. successfully grafted GO with PLLA by in situ polycondensation. [39] This material 
was incorporated in PLLA by solution mixing, and the composite with 0.5 wt.% loading showed 
improvements in flexural and tensile strengths of 114% and 106%, respectively. 
In this study, a recently made available commercial grade of GNP (grade C), made of thinner and 
shorter platelets than existing grades, is investigated for the first time as reinforcement filler for 
PLA. Melt blending is used for preparing the composite material as this is an economically 
attractive and industrially scalable method for efficiently dispersing nanofillers in thermoplastic 
polymers. The effects of blending conditions (mixing time, intensity, and temperature) and filler 
loading on the composite properties are analyzed, and the best conditions identified. This is an 
important aspect since results are often dependent on processing conditions, and this type of 
analysis is often absent from the literature. Melt blending is an environmentally friendly method 
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for filler incorporation that does not involve use of solvents. It avoids concerns with human health 
during processing and with toxicity of remaining solvent residues. 
The quality of filler dispersion in the PLA matrix is investigated by SEM and Raman 
spectroscopy, and is seen to have a major influence on mechanical properties. For the first time, 
the biocompatibility of PLA/GNP-C composites is studied, namely, in terms of effects on cell 
metabolic activity and morphology. 
 
7.3 Materials and methods 
7.3.1 Materials 
Poly(lactic acid) (PLA) 2003D (4% d-lactide, 96% l-lactide content) was purchased from 
Natureworks (Minnetonka, USA). 
GNP, grade C750 (GNP-C), was acquired from XG Sciences (Lansing, USA), with the following 
characteristics, according to the manufacturer: average thickness lower than 2 nm and surface area 
of 750 m2g−1. The platelet diameters have a distribution that ranges from tenths of micrometer up 
to 1–2 μm. GNP production is based on exfoliation of sulphuric acid-based intercalated graphite 
by rapid microwave heating, followed by ultrasonic treatment. [64] 
 
7.3.2 Preparation of PLA/GNP composites 
The PLA/GNP composites were prepared by melt blending in a Thermo Haake Polylab internal 
mixer (internal mixing volume 60 cm3) at different temperatures (180, 200, 225, and 250 °C) 
mixing times (10, 15, and 20 min) and rotor speeds (25, 50, and 75 rpm). The GNP contents 
tested were 0.1, 0.25, and 0.5 wt.%. After removal from the mixer, the composites were molded 
in a hot press at 190°C for 2 min, under a pressure of 150 kg cm-2, into sheets with approximately 
0.5 mm thickness. After pressing, the sheets were rapidly cooled in water at room temperature. 
Samples with different dimensions were cut from these sheets, depending on the characterization 
test. 
7.3.3 X-ray photoelectron spectroscopy (XPS) 
GNP-C powder was analyzed with an Escalab 200 VG Scientific spectrometer working in 
ultrahigh vacuum (1 × 10−6 Pa) and using achromatic Al Kα radiation (1486.6 eV). The analyzer 
pass energy was 50 eV for survey spectra and 20 eV for high-resolution spectra. The spectrometer 
Physical-chemical properties and biocompatibility of PLA/GBMs composites – production by melt-blending 
Artur M. Pinto – Jan 2017                                                                                                                                179 
was calibrated using (Au 3d5/2 at 368.27 eV). The core levels for O 1s and C 1s were analyzed. 
The photoelectron takeoff angle (the angle between the surface of the sample and the axis of the 
energy analyzer) was 90°. The electron gun focused on the specimen in an area close to 100 mm2. 
7.3.4 Fourier transform Infrared Spectroscopy (FTIR) 
PLA and PLA/GNP-C FTIR spectra were obtained between 600 and 4000 cm−1, with 100 scans 
and a resolution of 4 cm−1, using a spectrometer ABB MB3000 (ABB, Switzerland) equipped 
with a deuterated triglycine sulphate detector and using a MIRacle single reflection horizontal 
attenuated total reflectance (ATR) accessory (PIKE Technologies, USA) with a diamond/Se 
crystal plate. 
7.3.5 Tensile properties 
Tensile properties of the composites (dimensions of 60 × 15 mm, thickness of 300–500 μm) were 
measured using a Mecmesin Multitest-1d motorized test frame, at room temperature. Loadings 
were recorded with a Mecmesin BF 1000N digital dynamometer at a strain rate of 10 mm min−1. 
The test parameters were in agreement with ASTM D 882-02. At least 10 samples were tested for 
each composite. 
7.3.6 Thermal analysis 
Glass transition temperatures (Tg) and melting temperatures (Tm) of samples were determined 
with a Setaram DSC 131 device. The thermograms were recorded between 30 and 200 °C at a 
heating range of 10°C min−1 under nitrogen flow. Only the second heating thermograms were 
collected. Sample amounts ranged from 10 to 12 mg. 
Thermal stability of samples was determined with a Netzsh STA 449 F3 Jupiter simultaneous 
thermal analysis device. Sample amounts ranged from 10 to 12 mg. The thermograms were 
recorded between 25 and 800 °C at a heating rate of 10°C min−1 under nitrogen flow. 
The degree of crystallinity was determined as follows: , where 
ΔHc is the cold crystallization enthalpy, ΔHm is the melting enthalpy, and Δ  is the melting 
enthalpy of purely crystalline poly(l-lactide). [65] 
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7.3.7 Scanning Electron Microscopy (SEM) 
The morphology of the PLA/GNP composites was observed using SEM (FEI Quanta 400FEG, 
with acceleration voltage of 3 kV) at Centro de Materiais da Universidade do Porto. Composites 
selected for SEM analysis were fractured transversely under liquid nitrogen, applied on carbon 
tape, and sputtered with Au/Pa (10 nm film). The number of agglomerates per unit of area (mm2) 
as a function of agglomerate length, for different GNP-C loadings, was evaluated by direct 
measurements from 5 SEM images collected for each material, using ImageJ 1.45 software. 
7.3.8 Raman spectroscopy 
The unpolarized Raman spectra of GNP-C powder, PLA, and PLA/GNP-C composites were 
obtained under ambient conditions, in several positions for each sample. The linear polarized 
514.5 nm line of an Ar+ laser was used as excitation. The Raman spectra were recorded in a 
backscattering geometry by using a confocal Olympus BH-2 microscope with a 50× objective in a 
volume of 10 μm3. The spatial resolution is about 2 μm. The laser power was kept below 15 mW 
on the sample to avoid heating. The scattered radiation was analyzed using a Jobin–Yvon T64000 
triple spectrometer, equipped with a charge-coupled device. The spectral resolution was better 
than 4 cm−1. 
The spectra were quantitatively analyzed by fitting a sum of damped oscillator to the experimental 
data, according to the equation [66]: 
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Here n(ω,T) is the Bose-Einstein factor: Aoj, Ωoj, and τoj are the strength, wave number, and 
damping coefficient of the jth oscillator, respectively, and B(ω) is the background. In this work, 
the background was well simulated by a linear function of the frequency, which enables us to 
obtain reliable fits of Eq. (1) to the experimental data. 
The fitting procedure was performed for all Raman bands collected from the same sample, but in 
different positions. This procedure allows us to determine the average and standard deviation 
(SD) values of the phonon parameters, namely, the wave number and intensity. 
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7.3.9 Biocompatibility assays 
Human foreskin fibroblasts HFF-1 (from ATCC) were grown in DMEM+ (Dulbecco's modified 
Eagle's medium (DMEM, Gibco) supplemented with 10% (V/V) newborn calf serum (Gibco) and 
1% (V/V) penicillin/streptomycin (biowest) at 37 °C, in a fully humidified air containing 5% 
CO2. The media were replenished every 3 days. When reaching 90% confluence, cells were rinsed 
with PBS (37°C) and detached from culture flasks (TPP®) using 0.25% (w/V) trypsin solution 
(Sigma Aldrich) in PBS. All experiments were performed using cells between passages 10–14. 
Biocompatibility of the materials was evaluated using HFF-1 cells cultured at the surface of PLA 
and PLA/GNP-C 0.25 wt.% films (Ø = 5.5 mm). Cells were seeded at a density of 2 × 104 cells 
mL−1. Resazurin (20 μL) solution was added at 24, 48, and 72 h and incubated for 3 h, 
fluorescence (λex/em = 530/590 nm) read and metabolic activity evaluated (metabolic activity 
(%) = Fsample/FPLA × 100). All assays were performed in sextuplicate and repeated 3 times. Cell 
morphology was evaluated by immunocytochemistry at 72 h. Cells were washed with PBS and 
fixation was performed with paraformaldehyde (PFA, Merck) 4 wt.% in PBS for 15 min. PFA 
was removed, cells were washed with PBS, and stored at 4 °C. Cell membrane was permeabilized 
with Triton X-100 0.1 wt.% at 4°C for 5 min. Washing was performed with PBS and incubation 
performed with phalloidin (Alexa Fluor 488; Molecular Probes) solution in PBS in a 1:80 dilution 
for 20 min in the dark, to stain cell cytoskeletal filamentous actin. After rinsing with PBS, 4′,6-
diamidino-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich) solution at 3 μg mL−1 was 
added to each well and incubated for 15 min in the dark to stain the cell nucleus. Finally, cells 
were washed and kept in PBS to avoid drying. Plates with adherent cells were observed in an 
inverted fluorescence microscope (Carl Zeiss – Axiovert 200). For both assays, negative control 
for toxicity were cells cultured at the surface of PLA incubated in DMEM+, for positive control 
cells at PLA surface were incubated in DMEM+ with Triton 0.1 wt.%. 
7.4 Results and discussion 
7.4.1 GNP-C physico-chemical characterization 
XPS results (Figure 7.1(a)) show that GNP-C presents a low degree of oxidation (atomic 
percentage of oxygen, O 1s = 4%), as expected for a graphene-based material that should present 
oxygen-containing functional groups mostly at the platelet edges. Thermogravimetry results (Fig. 
7.1(b)) show that most of the thermal degradation of GNP-C occurs above 450 °C, the initial 
slight decrease in weight being associated with desorption of impurities. About 9% weight 
decrease is observed between 450 and 800 °C, probably due to loss of oxygen-containing groups. 
In many works, GBM with single or few layers are obtained by exfoliation of graphite through 
oxidative processes, which lead to obtainment of materials with high oxygen content. [40] On the 
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other hand, GNP-C is exfoliated by rapid microwave heating, followed by ultrasonic treatment; 
therefore, oxygen content is only associated to structural defects at the edges of basal planes. For 
comparison, Haubner et al. observed that pristine graphite presents an oxygen content of 1.4% 
and weight loss below 5% when heated until 800°C. [41] 
 
Figure 7.1: (a) XPS spectrum for atomic composition of GNP-C powder; (b) TGA curve for 
GNP-C powder. 
 
7.4.2 FTIR analysis 
Figure 7.2 shows the spectra typical for PLA presenting peaks from 3000 to 2850 cm−1, 
correspondent to alkyl C-H stretches. The C=O stretching region appears around 1750 cm−1. A 
band at 1450 cm−1attributed to CH3 is found. The C-H deformation and asymmetric bands are 
present at 1380 and 1355 cm−1. The C-O stretching modes of the ester groups are present around 
1178 cm−1. A band correspondent to C-O-C asymmetric stretching is present around 1078 cm−1, 
and C-O alkoxy stretching vibration mode is at 1060 cm−1. Also, a band correspondent to C-
CH3 vibrations is present around 1041 cm−1. Bands at 865 and 754 cm−1 are attributed to the 
amorphous and crystalline phase of PLA, respectively. [42, 43] 
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Figure 7.2: FTIR spectra for PLA and PLA/GNP-C 0.25 wt.% (180 °C, 20 min, and 50 
rpm). 
 
FTIR spectra for PLA and PLA/GNP-C 0.25 wt.% are similar. The low filler content makes it 
difficult to detect characteristic bands. Kong et al. also observed that incorporation of small 
amounts (0.3–3 wt.%) of carbon fillers (MWNTs) in the polyester poly(caprolactone) did not 
change the pristine polymer FTIR spectra. [44] 
 
7.4.3 Mechanical characterization 
By adjusting operation parameters in melt blending, one can try to obtain a compromise between 
maximizing filler exfoliation and minimizing thermal/oxidative PLA degradation. In the 
literature, typical conditions for PLA melt processing correspond to temperatures of 160–180 °C, 
mixing times of 10–20 min, and rotation speeds around 50 rpm. [3, 34, 45] In this work, PLA/GNP-
C blends were initially prepared by mixing at 180°C during 20 min and at 50 rpm. The resulting 
composites were characterized in terms of Young's modulus, tensile strength, and toughness (area 
under stress–strain curve, AUC). Figure 7.3 shows that Young's modulus and tensile strength are 
maximum for a loading of 0.25 wt.%, with 20% increase in tensile strength, 12% increase in 
Young's modulus, and 16% increase in toughness. In comparison, Chartarrayawadee et al. [46] 
observed an increase of 32% in tensile strength with the incorporation of 1 wt.% graphene oxide 
and stearic acid (1:1 ratio) in PLA. Also, Li et al. [47] reported an increase in tensile strength of 
39% with the incorporation of 1 wt.% graphene sheets in PLA. On the other hand, Narimissa et 
al. [48] observed PLA/GNP-M 1 wt.% composites to have similar tensile strength and Young's 
modulus as pristine PLA, becoming brittle at 3 wt.% loading. 
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Figure 7.3: Effect of increasing nanofiller content on mechanical properties of PLA/GNP-C 
composites under the same processing conditions (180 °C, 20 min, and 50 rpm): (a) Young's 
modulus; (b) tensile strength; (c) toughness. Error bars represent standard deviations 
computed from measurements on at least 10 samples. 
 
Figure 7.3 shows the decrease in mechanical performance when loading is raised to 0.5 wt.%, 
which can be attributed to increased platelet agglomeration introducing defects in the polymer 
matrix. The relation between agglomeration and loading level will be discussed further below. 
Toughness improves for 0.1 and 0.25 wt.% loadings, when compared to pristine PLA, but the two 
results are undistinguishable. Elongation at break results was of about 3.8%, with no significant 
differences observed between PLA and its composites. 
The effects of varying mixing time and rotation speed were analyzed for the optimal loading of 
0.25 wt.%. Figure 7.4 compares the results obtained for mixing times of 10, 15, and 20 min, and 
rotation speeds of 25 and 50 rpm. At 75 rpm, a brittle material was obtained, probably due to PLA 
degradation under high shear. The results show that the best processing conditions correspond to 
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20 min and 50 rpm. Lower mixing time or rotation speed probably yield worse GNP dispersion 
and hence lower mechanical performances. A higher mixing temperature of 200 °C was tested, 
but yielded very brittle materials, probably due to thermoxidative degradation of PLA. These 
results show that tuning of melt blending operation conditions can have an impact on the final 
properties of the nanocomposite, as it directly affects the quality of nanofiller dispersion and then 
possibility of polymer degradation. 
Since the best processing conditions for PLA and PLA/GNP-C were determined to be 180 °C, 20 
min, and 50 rpm, only the materials produced using these conditions were further characterized on 
physicochemical and biological studies. 
 
7.4.4 Thermal analysis 
Differential scanning calorimetry (DSC) was performed for all PLA/GNP-C loadings tested. The 
results are shown in Fig. 7.5. Glass transition occurs in the range 60–65 °C, followed by a small 
hysteresis peak, associated with physical relaxation. Melting takes place at around 155 °C, 
preceded by a broad cold-crystallization peak. It is interesting to note that PLA presents two 
combined melting peaks, which can be ascribed to differences in crystal morphology (e.g., 
lamellar thickness). [49] As GNP-C content increases, the higher temperature peak diminishes in 
intensity, indicating that polymer–nanoplatelet interaction leads to crystallinity uniformization. 
Table 7.1 shows the estimated values of glass transition temperature (Tg) and melting temperature 
(Tm) for all samples tested. As the material is loaded with GNP-C, both Tg and Tm do not change 
significantly in relation to pristine PLA. An increase in Tg is often expected as a consequence of 
segment mobility being restricted due to filler-induced chain confinement. However, other studies 
have reported similar behavior for PLA loaded with nanofillers, concomitantly with observation 
of mechanical reinforcement. [35, 39] A decrease in Tm would be observed if phase separation had 
occurred. [50, 51] 
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Figure 7.4: Effect of mixing time and rotation speed on mechanical properties of PLA/GNP-
C composites processed at 180 °C, for a filler content of 0.25 wt.%: (a) Young's modulus; (b) 
tensile strength; (c) toughness. Error bars represent standard deviations computed from 
measurements on at least 10 samples. 
 
Physical-chemical properties and biocompatibility of PLA/GBMs composites – production by melt-blending 
Artur M. Pinto – Jan 2017                                                                                                                                187 
 
Figure 7.5: DSC thermograms for PLA and PLA/GNP-C (180 °C, 20 min, and 50 rpm) 
composites with different filler contents. 
 
The computed degree of crystallinity (χc) is also shown in Table 7.1. Crystallinity seems to 
increase with GNP addition, but the differences are very small and are not expected to have a 
significant influence on the mechanical properties of the material. Interestingly, for the condition 
that resulted in better dispersion and mechanical performance (PLA/GNP-C 0.25 wt.%, 180 °C, 
20 min, and 50 rpm), Tc is decreased by 3 °C, ΔHcincreased by 3 J g−1, and crystallinity increased 
by 3%. This probably occurs because GNP-C particles cause heterogeneous nucleation, 
anticipating and increasing crystallization, as proposed by Kong et al. [52] for MWNTs, and 
similarly observed by Wang et al. [53] for GO. 
Figure 7.6(a) shows the thermogravimetric curves obtained for pristine PLA and PLA/GNP-C. 
Thermal degradation is very similar for all samples: a single step between 300 °C and 370 °C, as 
expected for PLA. [54]  
 
Table 7.1: Glass transition temperature (Tg) and melting temperature (Tm) for PLA and 
PLA/GNP-C composites (180 °C, 20 min, and 50 rpm) with different filler contents. 
 
Samples 
(wt.%) 
Tg 
(ºC) 
Tm 
(ºC) 
Tc 
(ºC) 
ΔHc 
(J/g) 
ΔHm 
(J/g) 
Χc 
(%) 
PLA 63.2 155.7 125.4 25.3 22.0 3.57 
GNP-C 0.10 63.6 155.5 126.0 25.4 22.1 3.50 
GNP-C 0.25 63.4 154.8 122.5 28.2 22.1 6.42 
GNP-C 0.50 63.6 155.9 126.1 26.0 21.6 4.75 
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Fig. 7.6(b), which represents the weight loss derivative (dTG) curves, allows a better 
differentiation between the results. The peak maximum values increase with graphene loading, 
indicating faster degradation rates. Similar behavior has been reported by Bao et al. [35] for 
PLA/graphene composites, which was attributed to the high thermal conductivity of graphene 
being the dominant contribution at low loadings. As a consequence, facilitated heat transfer 
overcomes the mass transfer barrier effect that often leads to improved thermal stabilities when 
lamellar fillers are used. In our particular case, the relatively small diameter of the GNP-C 
platelets may contribute to it being a less effective barrier, as the effect of path tortuosity is small. 
For a loading of 0.5 wt.%, the onset of degradation is shifted toward higher temperatures, which 
may indicate that at this concentration, diffusion of pyrolysis products is more effectively 
restrained. 
 
Figure 7.6: (a) TGA; (b) −dTG curves for PLA and PLA/GNP-C composites with different 
filler contents (180 °C, 20 min, and 50 rpm). 
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7.4.5 Scanning electron microscopy 
SEM imaging was performed on PLA/GNP-C composites fractured under liquid nitrogen. Figure 
7.7 shows the original GNP-C powder (Fig. 7.7(a)) and platelets found in fracture surfaces 
(Fig. 7.7(b–d)). Figure 7.7(a) shows that the powder is composed of flat platelets, lower than 2 
μm in length, and smaller flake agglomerates. Figure 7.7(b) displays one of the largest 
agglomerates found in the fractured PLA matrix, which is seen to be composed of small 
aggregated flakes. Planar GNP can also be found embedded in the matrix (Fig. 7.7 (c, d)), 
showing that platelet individualization was achieved in the melt dispersion process. 
 
 
Figure 7.7: (a) SEM images of GNP-C powder at 100,000× magnification; (b) fracture 
surfaces (under liquid nitrogen) of PLA/GNP-C composites (180 °C, 20 min, and 50 rpm), 
showing GNP-C agglomerates at 40,000× magnification; (c, d) individualized platelets at 
200,000× magnification, for loadings of 0.25 and 0.5 wt.% in PLA (180 °C, 20 min, and 50 
rpm), respectively. 
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As previously discussed, agglomeration at the higher loadings is the probable cause for the 
observed degradation of mechanical properties above 0.25 wt.% GNP-C content. To obtain a 
better notion of the incidence of agglomeration in these composites, different SEM images of 
fracture surfaces (at 5,000× magnification) were inspected, and the number of agglomerates with 
different average sizes was computed per unit area of sample section, for the three loadings tested. 
Figure 7.8 shows the cumulative plots obtained and representative images. Very few agglomerates 
were found with sizes above 0.8 μm, and therefore these were ignored in the calculations. From 
Fig. 7.8, the composites with 0.1 and 0.25 wt.% loadings show similar results. However, for 0.5 
wt.%, there is a noticeably higher concentration of agglomerates of all sizes. This is consistent 
with the observed decrease in mechanical performance. At this loading interplatelet interactions 
promote higher agglomeration, which cannot be efficiently overcome by melt mixing. The 
agglomerates work as defects in the polymer matrix, facilitating crack initiation during 
mechanical deformation. [55] 
 
Figure 7.8: (a) Cumulative plots of number of agglomerates per unit of area (mm2) as a 
function of agglomerate length, for different GNP-C loadings (180 °C, 20 min, and 50 rpm); 
(b) SEM images of fracture of surfaces for 5,000× magnification. 
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7.4.6 Raman spectroscopy 
As observed in Figure 7.9, the Raman spectrum of pristine PLA exhibits a well-defined band at 
1458 cm−1, in the 1200–1700 cm−1 spectral range. The Raman spectrum of the “as-received” 
GNP-C powder exhibits the strong D- and G-bands, located at 1345 cm−1 and at 1575 cm−1, 
respectively, as well as the weak D′-band at 1615 cm−1. [56, 57] The G-band is assigned to the in-
plane TO and LO vibrations of the carbon lattice, while the D and D′ bands arise from double 
resonance processes involving the in-plane TO phonon with defects and edge structure of the 
graphene sheets. The Raman spectrum of PLA/GNP-C 0.5 wt.%, presented here as representative 
example, exhibits a band at 1458 cm−1, from PLA matrix, and two sets of bands located at the left 
and right sides of this one, which deserve detailed attention. 
 
 
 
Figure 7.9: Representative unpolarized Raman spectra for PLA, GNP-C powder, and 
PLA/GNP-C 0.5 wt.% 20 min, recorded at ambient conditions. 
 
Figure 7.10 shows the best fit of Eq. (1) to the spectrum of PLA/GNP-C 0.5 wt.%. Both low and 
high frequency sets can be deconvoluted into three main bands. The existence of several bands in 
the spectral range where the D-band is expected and where the PLA matrix does not exhibit any 
Raman band, evidencing structural disorder in the samples due to the exfoliation degree of GNP. 
In fact, the width of the D bands increases in the composites, evidencing disorder, as reported by 
Ramirez et al. [56] The two bands, not presented in pristine GNP-C or PLA matrix spectra, appear 
in the composite sample: peak 3 at 1390 cm−1and peak 5 at 1525 cm−1. The existence of these 
bands is an evidence of physical interaction between polymer matrix and GNP-C, originating new 
modes in the system. Moreover, the frequency upshifts, of about 5 and 10 cm−1 observed for 
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peaks 2 and 6, respectively, when GNP-C is incorporated in PLA, corroborates the filler–matrix 
interaction and compression of the filler by the polymer matrix upon cooling. [58] 
 
 
 
Figure 7.10: Example of Raman spectrum fitting according to Eq. (1) to PLA/GNP-C 0.5 
wt.% 20 min. Bands 1–3 are attributed to D band and 5–6 to G band of GNP-C, while band 
4 arises from PLA matrix. 
 
Figure 7.11 shows the representative Raman spectra of PLA and PLA/GNP-C composites with 
different filler amounts, mixed during 10 (Fig. 7.11 (a)) and 20 min (Fig. 7.11 (b)). In both cases, 
as the graphene concentration increases, the intensity of Raman bands assigned to GNP-C 
increases. The Raman signals recorded for different sample positions did not show significant 
differences, pointing out the homogeneity of the graphene distribution within the polymer matrix, 
considering both individualized platelets and agglomerates. 
From the fitting procedure, we have calculated the intensity of the observed Raman bands. It is 
well established that the ratio between the intensities of the D- and G-bands, ID/IG, is widely used 
for characterizing the level of defect in graphene. [59] Moreover, the intensity of a Raman band 
depends on the scattering cross-section of the corresponding mode and on the number of scatters 
per unit volume. Therefore, the ratio between the intensities of two aforementioned modes gives 
qualitative information regarding the ratio between the corresponding scatters concentration. [60] 
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Figure 7.11: Unpolarized Raman spectra of PLA and PLA/GNP-C 0.1, 0.25, and 0.5 wt.% 
for (a) 10 and (b) 20 min mixing times.  
 
Figure 7.12 shows the ratio between the intensities relative to the D and G bands (peaks 2 and 6), 
for the as-received GNP-C powder and to the PLA/GNP-C composites, for 10 and 20 min mixing 
times. In both cases, as the GNP-C concentration increases, the ratio I2/I6 tends to increase, which 
is interpreted as an evidence for the increasing disorder in graphene, associated with defects 
arising from the interaction between graphene sheets and the polymeric matrix, and from the 
agglomerates of graphene in the matrix, as it is well evidenced by the SEM images. For a 
sufficiently high filler loading (0.5 wt.%), the content of agglomerated material introduces defects 
that can have a negative impact on the mechanical performance of the composite. This 
detrimental action surpasses the reinforcement effect, in agreement with the results of mechanical 
testing. This interpretation of the ID/IG ratio is consistent with the fact that, for the same GNP-C 
initial concentration, the ratio decreases with increasing mixing time, evidencing that longer 
mixing induces more efficient deagglomeration of the nanoplatelets within the PLA matrix. 
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Figure 7.12: Intensity ratios of the D and G bands of monolayer GNP-C (peak 2/peak 6) for 
GNP-C powder and PLA/GNP-C 0.1, 0.2, and 0.5 wt.% for 10 and 20 min mixing times. 
Results are presented as average values and error bars represent standard deviation (n > 3). 
 
7.4.7 Biocompatibility with fibroblasts 
Biocompatibility was studied by culturing cells at materials' surface, evaluating cell metabolic 
activity and morphology. For providing a negative control for cell death, cells were cultured at the 
surface of PLA, presenting the typical “spindle”-like shape of fibroblasts. This was expected, as 
PLA is generally a biocompatible material. [61] For positive control of cell death, PLA cultured in 
DMEM+ with Triton 0.1%, metabolic activity was close to 0% and cytoskeleton was 
disassembled. Since the best mechanical results were obtained for PLA/GNP-C 0.25 wt.% (180 
°C, 20 min, and 50 rpm), only these materials were tested on biological assays. 
HFF-1 cell metabolic activity at PLA/GNP-C 0.25 wt.% surface never decreased below 97%, in 
comparison with PLA (Figure 7.13). Also, immunocytochemistry images show no morphological 
differences between PLA and PLA/GNP-C 0.25 wt.%. Thus, filler incorporation has no impact on 
cell growth at materials surface. The fact that a small amount of GNP-C is used, together with the 
platelets being well encapsulated in the polymer may be on the base of the lack of toxicity 
observed. [26] Yoon et al. [62] observed that the incorporation of 2 wt.% GO in poly(d, l-lactic-co-
glycolic acid) matrix by solvent mixing improved neuronal cell metabolic activity. However, 
Lahiri et al. [63] observed ultrahigh molecular weight polyethylene/GNP-M 1 wt.% composites 
produced by electrostatic spraying to be toxic to osteoblasts. Toxicity can be caused by filler 
leaching [26], which suggests that electrostatic spraying may not promote effective embedding of 
GBM in polymer matrix. Solvent mixing and melt blending seem to be more effective in this 
sense, therefore, avoiding toxicity effects. 
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Figure 7.13: Metabolic activity of HFF-1 cells cultured at the surface of PLA/GNP-C 0.25 
wt.% (180 °C, 20 min, and 50 rpm) in DMEM+, at 24, 48, and 72 h. Cell metabolic activity is 
represented as percentage in comparison with cells cultured at PLA surface in DMEM+ 
(100%). Results are presented as mean and standard deviation (n = 6). The red line at 70% 
marks the toxicity limit, according to ISO 10993-5:2009(E). For positive control of cell 
death, cells were cultured at PLA surface in DMEM+/Triton 0.1%, with metabolic activity 
being close to 0% (data not shown). For representative immunofluorescence images of HFF-
1 at 72 h, cells were stained with DAPI (nuclei) blue and phalloidin (F-actin in cytoskeleton) 
green. Bottom line presents the phase-contrast images of materials surface. Scale bar 
represents 100 μm. 
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7.5 Conclusions 
 
The purpose of this chapter was to evaluate the mechanical and thermal properties of PLA 
filled with GNP-C, which presents particularly small platelet diameters and thicknesses. The 
effects of blending conditions (mixing time, intensity, and temperature) and nanofiller 
loading on the composite properties were analyzed. Both factors were observed to have a 
major effect on the material's performance.  
The best processing conditions were found to be mixing for 20 min at 50 rpm and 180 °C. 
The optimum loading was 0.25 wt.%, resulting in 20% increase in tensile strength, 12% 
increase in Young's modulus, and 16% increase in toughness. At higher loadings, defects due 
to filler agglomeration cause decay in mechanical performance. The higher incidence of 
agglomeration at 0.5 wt.% loading was demonstrated by SEM and Raman analysis, in what 
we believe are novel approaches for the use of these techniques in composite 
characterization. 
Thermal analysis (DSC and TGA) showed no differences in glass transition or degradation 
temperature between pristine PLA and the composites. However, an increase in rate of 
thermal degradation with GNP-C loading was identified, which was interpreted in terms of a 
dominant effect of enhanced heat transfer over mass transfer barrier, in agreement with other 
reported works. 
Melt mixing intensity and duration were found to have an impact on the mechanical 
properties of PLA/GNP-C composites.  
Raman spectroscopy analysis, based on intensity ratios of D and G bands, confirmed that 
longer mixing times yield better dispersion of GNP. Evidence of effective interaction 
between the nanofiller and the polymer matrix was found in the form of frequency shifts and 
appearance of new Raman bands. 
HFF-1 cells metabolic activity and morphology were not affected by the incorporation of 
0.25 wt.% GNP-C in PLA. 
The increased mechanical performance of these composites, achieved at low filler loadings, 
associated with their biocompatibility, provides interesting perspectives for use in 
biomaterial applications. 
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8 PHYSICAL-CHEMICAL PROPERTIES AND 
BIOCOMPATIBILITY OF PLA/GBMs 
COMPOSITES - EFFECT OF 
BIODEGRADATION 
8.1 Scope 
 
Physico-chemical characterization of biomaterials is important because it can impact on its 
performance, both by leading to “undesirable effects” or changing/preventing “the clinically 
relevant performance”. In the case of poly(lactic acid) PLA, this characterization is of outmost 
relevance, since it is a biodegradable polymer, so its properties considerably change after 
implantation. PLA has potential to be used for several biomedical applications, as for example 
orthopaedical uses, in which mechanical properties are relevant. For that reason, it is important to 
assure that they do not decrease at an excessive rate, hampering the implants clinical function. 
Graphene nanoplatelets (GNP) potential to be used as fillers to improve PLA mechanical 
performance has already been demonstrated in the previous chapters and their lack of adverse 
effects on cell lines proliferation at PLA/GNP composites surface shown. However, along 
biodegradation toxic products can be released, as well as GNP particles. The last were shown to 
have potential to be toxic in high concentrations, which will be hardly achieved by leaching from 
the polymer matrix, since the filler loading required to improve mechanical properties is very low. 
Despite that, two different grades of GNP were incorporated in PLA using the conditions that 
resulted in better mechanical performance, as described in Chapter 7. The produced composites 
were characterized after being subject to hydrolytic degradation in physiological conditions. 
Materials were analyzed by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction 
(XRD), size exclusion chromatography (GPC-SEC), scanning electron microscopy (SEM), 
thermogravimetric analysis (TGA), tensile testing, creep-recovery testing, and biocompatibility 
assays.  
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8.2 State of the art 
 
Poly(lactic acid) (PLA) has been widely investigated for biomedical applications because it is 
biodegradable, bioresorbable, biocompatible and easily processable. [1,3] In addition, PLA-based 
products are approved for biomedical applications and contact with body fluids by Food and Drug 
Administration (FDA). [3] This polymer has several applications in bioengineering, like the 
production of bioresorbable artificial ligaments, hernia repair meshes, scaffolds, screws, surgical 
plates, and suture yarns. [4, 5] PLA can also be used in the production of drug delivery systems, 
and in the packaging of pharmaceutical products. [6] To make this material more effective in 
several applications, namely orthopaedic, some properties can be improved, being mechanical 
performance usually the most relevant. [7] Approaches like adjustment of crystallinity [8], 
incorporation of plasticizers [9], blends with other polymers [7] and addition of nanofillers have 
been tested. Reinforcement with small amounts of nanofillers is an interesting option because it 
allows improvement of target properties without changing PLA’s main characteristics. The most 
frequently reported nanofillers are nanoclays [10], carbon nanotubes [11], and nanosilicas [12]. 
Graphene is a single layer of sp2 carbon atoms arranged in a honeycomb structure and possesses 
extraordinary mechanical strength and an extremely high specific surface area. [13] Graphene 
nanoplatelets (GNPs) are a commercial product with reduced cost when compared to single layer 
graphene. GNPs are constituted by few stacked graphene layers, possessing oxygen-containing 
functional groups along the edges. [14] They present high aspect ratio, thus being able to form a 
percolated network with large interfacial interaction between nanoplatelets and polymer matrix, 
resulting in effective load transfer and increased strength. [15] In a previous study, we have shown 
that GNPs, at loadings below 1 wt.%, can provide effective mechanical reinforcement of PLA. [16] 
However, in that work the composite films were prepared by solvent-mixing technique, which 
may raise issues related to the toxicity of solvent residues that may remain in the materials, which 
are often difficult to remove, and to occupational health concerns in industrial production. [17] 
Melt blending, on the other hand, is a solvent-free and easily up-scalable processing method, 
which has been adopted for the current work. Several authors have used this technique for 
production of PLA composites filled with GNP or other graphene-related materials in recent 
years, reporting improvements in mechanical performance at loadings below 1 wt.%. [18-21] 
Narimissa et al. [22] observed that higher loadings are unbeneficial and the composites become 
brittle. 
To our knowledge, there are no studies regarding the behaviour of PLA filled with graphene-
based materials along biodegradation time. This is a pertinent issue when use as implanted 
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medical devices is intended. PLA biodegrades mainly by simple hydrolysis of the ester linkages, 
forming monomeric lactic acid that is eliminated through the Krebs cycle. [23] Poly (l-lactide) acid 
(PLLA), which presents better mechanical properties, degrades more slowly than the d-
lactide, with complete degradation occurring between 10 months to 4 years, depending on factors 
like molecular weight, crystallinity, material geometry and location in the body. Degradation 
leads to gradual decreases in molecular weight and mechanical performance. [24] For some 
orthopaedic applications, like prosthetic ligaments, one important concern regarding PLA is to 
maintain mechanical properties for long time periods, preventing rupture by fatigue and excessive 
laxity due to creep, while the natural ligament is rebuilding itself. [25] 
A study by Wan et al. compared PLA loaded with carbon fibre to pristine PLA, and reported that 
the composite material had better mechanical properties along degradation than the unloaded 
polymer. [26] However, not all fillers are able to improve the mechanical performance of PLA 
along degradation time. [27] Since this subject has not been addressed for graphene-based 
materials (GBMs), the current work focuses on characterization of the mechanical and thermal 
behaviour of PLA filled with two grades of graphene nanoplatelets (GNP-M and GNP-C) along 
6 months degradation. In addition, the biocompatibility of the composites and of their degradation 
products is studied in terms of effects on metabolic activity, cell death and morphology of human 
fibroblasts (HFF-1). 
 
8.3 Materials and methods 
8.3.1 Materials 
 
Poly(lactic acid) (PLA) 2003D (4% d-lactide, 96% l-lactide content), was purchased from 
Natureworks (Minnetonka, USA). 
Graphene nanoplatelets (GNP), grade C750 (GNP-C) and M-5 (GNP-M) were acquired from XG 
Sciences (Lansing, USA). The manufacturer reports the following characteristics. GNP-C: 
average thickness lower than 2 nm and surface area of 750 m2 g−1; the platelet diameters have a 
distribution that ranges from tenths of micrometer up to 1–2 μm. GNP-M: average thickness of 6–
8 nm, diameter of about 5 μm and surface area between 120 and 150 m2 g−1. Production of these 
GNP grades is based on exfoliation of sulphuric acid-based intercalated graphite by rapid 
microwave heating, followed by ultrasonic treatment. [28] 
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8.3.2 Preparation and degradation of PLA and PLA/GNP 
composites 
 
Composites of PLA filled with GNP-M and GNP-C at 0.25 wt.% loadings were prepared by melt 
blending in a Thermo Haake Polylab internal mixer (internal mixing volume 60 cm3) at 180 °C, 
with 20 min mixing time and with a rotor speed of 50 rpm. The conditions used had been 
previously optimized in terms of filler loading, mixing temperature and duration, and rotor 
speed. [29] After removal from the mixer, the composites were moulded in a hot press at 190 °C 
for 2 min, under a pressure of 150 kg cm-2, into sheets with approximately 0.5 mm thickness. 
After pressing, the sheets were rapidly cooled in water at room temperature. PLA without GNP 
addition was processed in the same way to be used as a control. Samples with different 
dimensions were cut from these sheets, depending on the characterization test. 
Samples with dimensions of 60 × 15 mm and thickness of approximately 0.5 mm, were immersed 
in 50 mL PBS in sterile conditions in plastic flasks (3 per flask) and incubated for 2, 4 and 
6 months at 37 °C under 100 rpm. 
 
8.3.3 Physico-chemical characterization 
8.3.3.1 Scanning Electron Microscopy (SEM) 
 
The morphology of the samples was observed using SEM (FEI Quanta 400FEG, with an 
acceleration voltage of 3 kV) at Centro de Materiais da Universidade do Porto. Composites 
selected for SEM analysis were fractured transversely under liquid nitrogen, applied on carbon 
tape and sputtered with Au/Pa (10 nm film). 
 
8.3.3.2 Fourier transform infrared spectroscopy (FTIR) 
 
FTIR was used to evaluate the effect of fillers incorporation and biodegradation on materials’ 
chemical composition. Spectra were obtained between 600 and 4000 cm−1, with 100 scans and a 
resolution of 4 cm−1, using a spectrometer ABB MB3000 (ABB, Switzerland) equipped with a 
deuterated triglycine sulphate detector and using a MIRacle single reflection horizontal attenuated 
total reflectance (ATR) accessory (PIKE Technologies, USA) with a diamond/Se crystal plate. 
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8.3.3.3 X-ray diffraction analysis (XRD) 
 
XRD was used to evaluate the effect of fillers incorporation and biodegradation on materials’ 
crystalline structure. Samples were scanned using a Philips X́Pert diffractometer in the range of 
diffraction angle 2θ, according to a Bragg-Brentano geometry. The anticathode used was cobalt 
with a wavelength of 0.178896 nm. Samples in the form of films were analysed as they were, and 
GNP-M and C powders were gently placed in an aluminium sample holder. 
 
8.3.3.4 Gel permeation chromatography and size exclusion 
chromatography (GPC-SEC) 
 
In order to evaluate materials degradation along 6 months in PBS, samples were dried in an oven 
at 50 °C during 48 h and stored in a desiccator. Samples were dispersed in chloroform during 24 h 
(in a fridge at 4 °C), at a concentration of 5 mg mL−1, sonicated for 5 min, filtered and 300 μL 
injected for GPC-SEC analysis. Calibration was performed with Shodex SM-105 set of 
polystyrene standards (1.27 × 103 < Mw < 3.04 × 106), at the same concentration as the studied 
samples. Data were processed using the program Multioffline (Polymer Laboratories) and 
molecular weight (Mw) determined. At least 3 replicates were performed for each sample. The 
equipment used was the PLA-GPC 50 Plus with a chloroform flow of 1 mL min−1, oven 
temperature of 30 °C, using a column Viscotek T4000 Org GPC/SEC (300 × 8.0 mm) and a pre-
column Viscotek Tguard Org Guard (10 × 4.6 mm). 
 
8.3.3.5 Thermal analysis 
 
Thermal stability of samples was determined with a Netzsh STA 449 F3 Jupiter device. Sample 
amounts ranged from 10 to 12 mg. The thermograms were recorded between 30 and 800 °C at a 
heating rate of 10 °C min−1 under nitrogen flow. 
 
8.3.4 Mechanical properties characterization 
 
Tensile properties of the samples (60 × 15 × 0.5 mm) were measured using a Mecmesin Multitest-
1d motorized test frame, at room temperature. Loadings were recorded with a Mecmesin BF 
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1000 N digital dynamometer at a strain rate of 10 mm min−1. The test parameters were in 
agreement with ASTM D 882-02. At least five samples were tested for each composite. 
Creep/recovery tests were performed with a DMA 242 E Artemis (Netzsch) equipment in tension 
mode at 37 °C. Samples (12 × 6 × 0.5 mm) were subjected to a static force of 6.0 N during 10 min 
with a recovery mode also lasting 10 min. Multi-cycle measurements were carried out using the 
same conditions for 10 cycles of creep/recovery, each with the duration of 10 min. 
 
8.3.5 Biocompatibility evaluation 
 
Human foreskin fibroblasts HFF-1 (from ATCC) were grown in DMEM (Dulbecco’s modified 
Eagle’s medium (DMEM, Gibco) supplemented with 10% (V/V) newborn calf serum (Gibco) and 
1% (V/V) penicillin/streptomycin (biowest) at 37 °C, in a fully humidified air containing 5% 
CO2. The media were replenished every 3 days. When reaching 90% confluence, cells were rinsed 
with PBS (37 °C) and detached from culture flasks (TPP®) using 0.25% (w/V) trypsin solution 
(Sigma Aldrich) in PBS. 
Biocompatibility of the materials was evaluated by the direct contact test, and by the elution test 
method. In the direct contact test, cells were cultured on the surface of PLA, PLA/GNP-M and C 
0.25 wt.% films (Ø = 5.5 mm). For the elution test method a monolayer of cells, after 24 h cell 
growth, was exposed to materials’ extracts obtained after 6 months incubation in PBS (50 μL in 
150 μL DMEM) at 37 °C and 100 rpm, as described in 8.3.2. In both assays, cells were seeded in 
96 well plates (7500 cells per well). All experiments were performed using cells between 
passages 10–14. 
Negative control (DMEM) for metabolic activity decrease, toxicity or changed morphology, for 
all biocompatibility assays was performed incubating cells in DMEM. Positive control for 
metabolic activity decrease, toxicity or changed morphology, was performed incubating cells in 
DMEM with 0.1% Triton X-100 (Triton 0.1%). For the elution test method, performed to test 
degradation products biocompatibility, DMEM control consists in replacing culture media by 
50 μL PBS incubated 6 months in the same conditions as other samples (PBS 6 M), in 150 μL 
DMEM+. 
 
8.3.5.1 Cytotoxicity 
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For cell metabolic activity evaluation, at 24, 48, and 72 h incubation with materials or materials 
extracts, 20 μL resazurin solution were added and incubated for 3 h, fluorescence 
(λex/em = 530/590 nm) read, and values determined as follows: Metabolic activity 
(%) = Fsample/FDMEM × 100. All assays were performed in sextuplicate and repeated 3 times. 
Cell viability/membrane integrity was evaluated by LIVE/DEAD assay. Hoechst 33342 permeates 
membrane and stains nucleic acids. Calcein also permeates the membrane and is metabolized in 
the cytoplasm by intracellular esterases originating a green highly fluorescent derivative. The cell 
membrane has a residual permeability to propidium iodide, which only enters cells whose 
membrane integrity is compromised, staining nucleic acids. After cells being incubated for 72 h 
on the surface of the materials or in presence of extracts from the materials, DMEM was removed 
and cells incubated with Hoechst 33342 (Molecular Probes) and Calcein (Molecular Probes), both 
at 2.5 μg mL−1in PBS for 15 min, at 37 °C in the dark. Then, propidium iodide (PI) (Sigma 
Aldrich) in PBS was added to each well to a final concentration of 1.25 μg mL−1 and images 
acquired in an inverted fluorescence microscope (Carl Zeiss – Axiovert 200). 
 
8.3.5.2 Immunocytochemistry 
 
Cell morphology was evaluated by immunocytochemistry after cells being incubated for 72 h on 
the surface of the materials or in presence of extracts from the materials. Cells were washed with 
PBS and fixation was performed with paraformaldehyde (PFA - Merck) 4 wt.% in PBS for 
15 min. PFA was removed, cells washed with PBS and stored at 4 °C. Cell cytoskeletal 
filamentous actin can be visualized by binding of fluorescent phalloidin and the nucleus can be 
stained with 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) that intercalates with nucleic 
acids. Cell membrane was permeabilized with triton X-100 0.1 wt.% at 4 °C for 5 min. Washing 
was performed with PBS and incubation performed with phalloidin (Alexa Fluor 488; Molecular 
Probes) solution in PBS in a 1:80 dilution for 20 min in the dark. After rinsing with PBS, DAPI 
(Sigma Aldrich) solution at 3 μg mL−1 was added to each well and incubated for 15 min in the 
dark. Finally, cells were washed and kept in PBS to avoid drying. Plates with adherent cells were 
observed in the Carl Zeiss – Axiovert 200. 
 
8.3.6 Statistical analysis 
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Statistical analysis was performed using the software SPSS20 (IBM) performing Kruskal–Wallis 
one-way analysis of variance. Multiple means comparison were performed between samples to 
identify significant differences, which were considered for p < 0.05. 
8.4 Results 
 
The main goal of this work was to investigate the effect of biodegradation on the mechanical and 
biological properties of PLA filled with low amounts (0.25 wt.%) of GNP-M and C. For that 
reason, materials were characterized by several techniques and results are presented next. 
 
8.4.1 Physical-chemical characterization 
8.4.1.1 Scanning electron microscopy 
 
Figure 8.1 shows that after 6 months degradation in PBS at 37 °C and 100 rpm, PLA and 
PLA/GNP-C present evidence of surface erosion, shown in the images within elliptical contours. 
In PLA/GNP-M 6 M, surface erosion does not seem to be so evident in SEM images. However, 
some voids are observed, mainly around nanoplatelets (Fig. 8.1(D)), which are not seen in the 
non-degraded sample and in PLA/GNP-C before and after degradation. 
Both GNP-M and GNP-C are well dispersed in PLA matrix, presenting mostly completely 
exfoliated particles and small agglomerates, as shown by SEM images and agglomerate size 
analysis in Figure C1 (Appendix C). 
 
8.4.1.2 FTIR and XRD 
 
FTIR and XRD spectra were performed and are presented in Appendix C. No differences were 
observed between samples in FTIR analysis, due to the low amount of fillers present (0.25 wt.%). 
However, XRD analysis, allowed identification of the fillers characteristic diffraction bands in the 
composites. No differences were seen between samples before and after 6 months degradation, 
indicating permanence of the fillers. 
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8.4.1.3 GPC-SEC 
 
Figure 8.2 presents average molecular weight (?̅?w) evolution along 6 months degradation for 
PLA, and for PLA/GNP-M and PLA/GNP-C at 0.25 wt.% loading. 
 
 
Figure 8.1: SEM images of PLA 0 M (A), PLA 6 M (B), PLA/GNP-M 0.25 wt.% 0 M (C), 
PLA/GNP-M 0.25 wt.% 6 M (D), PLA/GNP-C 0.25 wt.% 0 M (E), and PLA/GNP-C 
0.25 wt.% 6 M (F), broken under liquid nitrogen. Magnification is 4000×. Scale bar 
represents 30 μm. Elliptical contours point out surface erosion and possible bulk 
degradation. 
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Figure 8.2: Average ?̅? w evolution for PLA, PLA/GNP-M and C 0.25 wt.% along 
degradation time (0, 2, 4 and 6 months). Results are presented as mean and standard 
deviation (n = 3). 
 
8.4.1.4 Thermogravimetric analysis 
 
Figure 8.3 shows that thermogravimetric curves for PLA, PLA/GNP-M and C 0.25 wt.% 0 M and 
6 M are very similar, consisting of a single step between 300 °C and 370 °C, as expected for 
PLA. [30] Temperatures of onset of intense thermal degradation, Td (shown in a figure inset), are 
similar for undegraded samples, PLA/GNP-M showing a slightly higher value (2.6 °C more than 
PLA). After biodegradation, Td decreases by about 10 °C in all samples. 
8.4.2 Mechanical characterization 
8.4.2.1 Tensile tests 
 
Figure 8.4 shows that incorporation of 0.25 wt.% of GNP-C and M in PLA increased its Young’s 
modulus by 14%. Also, tensile strength is increased by 20% with GNP-C incorporation and by 
6% with GNP-M. Only with GNP-C is observed a considerable improvement in toughness (20%). 
Best performance of GNP-C probably arises from its smaller dimensions. This may allow for 
more effective dispersion and interaction with the polymer matrix.  
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Figure 8.3: TGA curves and temperatures of onset of intense thermal degradation (Td) for 
PLA and composites before and after 6 months degradation in PBS at 37 °C and 100 rpm. 
 
After 6 months degradation in PBS, no significant changes are observed in Young’s modulus for 
all materials tested. However, decreases in tensile strength, elongation at break, and toughness are 
considerably higher for PLA (2.6, 2.5, and 10-fold, respectively) comparing with PLA/GNP-M 
(1.6, 1.8, and 3.3-fold), and PLA/GNP-C (1.4, 1.4 and 1.7-fold). Thus, the incorporation of both 
fillers is improving PLA mechanical properties after 6 months degradation, being GNP-C the 
most effective material in this sense. 
 
8.4.2.2 Creep and recovery tests 
 
Figure 8.5 shows that the materials present similar behaviour, with a relatively large instantaneous 
increase of the strain upon load application, followed by a steady creep, and rapid strain recovery 
after load removal. PLA after 6 months biodegradation presents the highest permanent creep 
strain (ε∞), with a value of 0.029%, comparing with 0.016% for the non-degraded polymer. The 
GNP-filled samples display similar ε∞ before and after biodegradation, varying between 0.01 and 
0.014%. 
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Figure 8.4: Stress-strain curves and mechanical parameters for PLA and composites before 
and after 6 months degradation in PBS at 37 °C and 100 rpm. 
 
Figure 8.6 shows that, after 10 creep/recovery cycles, all non-degraded materials (0 M) show 
similar maximum creep strain - εmax (at 6 N), being of 0.118, 0.103, and 0.104% for PLA, 
PLA/GNP-M, and C 0.25 wt.%, respectively. After 6 months degradation in PBS, the PLA 
samples ruptured after 4 cycles (Fig. 8.6(A)), showing a very intense cumulative increase in 
permanent creep strain. Remarkably, on the other hand, PLA/GNP-M and C did not rupture after 
10 cycles (Fig. 8.6(B, C)) and presented only a slight increase in ε∞. 
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Figure 8.5: Creep and recovery curves for PLA, PLA/GNP-M and C 0 and 6 M at 37 °C. 
 
 
Figure 8.6: Multicycle creep-relaxation curves for PLA and composites before (0 M) and 
after 6 months (6 M) degradation in PBS at 37 °C. ε – strain. 
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8.4.3 Biocompatibility with human fibroblasts 
 
Biocompatibility of PLA, PLA/GNP-M, and C 0.25 wt.% composites, and of their degradation 
products after 6 months biodegradation in PBS at 37 °C at 100 rpm, was studied in terms of 
effects on metabolic activity, cell death and morphology of human fibroblasts (HFF-1). Results 
are presented below. 
 
8.4.3.1 Biocompatibility of PLA and PLA/GNP materials 
 
As presented in Figure 8.7(A), HFF-1 cells metabolic activity at PLA surface was 75% at 24 and 
48 h, and 94% at 72 h, comparing with negative control for metabolic activity decrease - cells 
incubated in DMEM. These differences are statistically significant (p < 0.05) at 24 and 48 h. 
Also, positive control for metabolic activity decrease - cells incubated with Triton 0.1% in 
DMEM, as expected presented almost no metabolic activity (<5% - data not shown). In 
comparison with PLA, cell metabolic activity was maintained for PLA/GNP-M and PLA/GNP-C 
(p > 0.05). Considering that a sample has cytotoxic potential if its metabolic activity is reduced to 
less than 70% comparing to negative control for metabolic activity ISO 10993-5:2009(E) [32], it 
can be observed from Fig. 8.7(A), that the incorporation of both fillers has no significant toxic 
impact on metabolic activity of cells cultured at material’s surface, because it is always higher 
than 70%. 
Fig. 8.7(B) shows representative images for HFF-1 cells fluorescently labelled for LIVE/DEAD 
assay. As expected, positive control of cell death (cells incubated with PLA/Triton 0.1 wt.% in 
DMEM + for 72 h) unveils cell death close to 100%. Negative control was performed incubating 
cells with DMEM, presenting mostly live cells with scarce dead cells. In agreement with 
metabolic activity results, no considerable differences are observed between DMEM and PLA at 
72 h (Fig. 8.7(B)). Also, there are no more dead cells at the surface of PLA/GNP-M and C than at 
PLA surface. 
Cells cultured at material’s surface were stained and observed after 72 h incubation in DMEM. 
Immunofluorescence images (Fig. 8.7(C)) show that toxicity positive control cells, which were 
incubated with triton 0.1%, presented disassembled cytoskeleton. Negative toxicity control, 
performed with cells cultured in DMEM, exhibiting the typical “spindle” like shape of fibroblasts. 
Also, cells incubated at the surface of PLA, PLA/GNP-M and C 0.25 wt.% had a normal 
morphology, similar to negative control. 
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Figure 8.7: (A) HFF-1 cells viability at the surface of PLA, PLA/GNP-M and C 0.25 wt.% 
cultured in DMEM, at 24, 48 and 72 h. Cell metabolic activity is represented as a percentage 
in comparison with negative control for metabolic activity decrease - DMEM (100%). 
Positive control for metabolic activity decrease – Triton 0.1% presented metabolic activity 
below 5% (data not shown). Results are presented as the mean and standard deviation 
(n = 6). The red line at 70%, marks the toxicity limit, according to ISO 10993-
5:2009(E). [31] * Statistically significantly different from the negative control (p < 0.05). All 
samples were different from positive control – Triton 0.1% (p < 0.05). (B) LIVE/DEAD 
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staining of HFF-1 cells incubated at the surface PLA, PLA/GNP-M and C 0.25 wt.% for 
72 h. Triton 0.1% in DMEM was used as toxicity positive control and DMEM as negative 
control. Cytoplasm is stained with calcein – green, all nuclei with Hoechst 33342, and cells 
with membrane integrity compromised were stained in the nucleus with propidium iodide 
(PI) – red. The bottom line presents a phase-contrast image of the materials surface. Scale 
bar represents 100 μm. (C) Immunofluorescence images of HFF-1 cells after 72 h culture at 
the surface of PLA, PLA/GNP-M and C 0.25 wt.%. Triton 0.1% in DMEM was used as 
positive control for changed morphology, and cells grown in DMEM as negative control. 
Cells were stained with DAPI (nuclei) - blue and Phalloidin (F-actin in cytoskeleton) - green. 
Scale bar represents 100 μm. 
 
 
8.4.3.2 Biocompatibility of the degradation products 
 
Negative control for metabolic activity decrease (DMEM 6 M) was performed with 50 μL PBS 
6 M (37 °C, 100 rpm, 6 months) in 150 μL DMEM presenting similar cell metabolic activity to 
degradation products of PLA after 6 months in PBS (PLA 6 M), tested in the same conditions, 
which shows that those are not toxic. Metabolic activity of cells exposed to PLA 6 M comparing 
with DMEM 6 M, were of 105, 96, and 100%, for 24, 48 and 72 h, respectively (Figure 8.8(A)), 
with no significant differences being found overtime (p > 0.05). Also, degradation products of 
PLA/GNP-M and C 0.25 wt.% 6 M are not toxic, comparing with DMEM 6 M (p > 0.05). For 
PLA/GNP-M and C 6 M, respectively, metabolic activities comparing with PLA 6 M were of 84 
and 93, 92 and 104, and 88 and 120%, for 24, 48 and 72 h, in the previous order. 
Fig. 8.8(B) shows example images for HFF-1 cells fluorescently labelled for LIVE/DEAD assay. 
Negative control for cell death (DMEM 6 M) was performed as described for metabolic activity 
assay and presented mostly live cells with few red stained dead cells (Fig. 8.8(B)). Comparing 
with cells incubated with 6 months degradation products of PLA 6 M, PLA/GNP-M and C 6 M 
0.25 wt.%, no more dead cells were observed. 
Cells morphology was evaluated by immunocytochemistry (Fig. 8(C)). Toxicity positive control 
cells (Triton 0.1%) cytoskeleton was disassembled (results not shown - similar to Fig. 8.8(C)). 
Negative control (DMEM 6 M), PLA 6 M, PLA/GNP-M and C 6 M 0.25 wt.% exhibited the 
typical “spindle” like shape of fibroblasts. 
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Figure 8.8: (A) HFF-1 cells viability after incubation with 6 months degradation products of 
PLA 6 M, PLA/GNP-M and C 6 M 0.25 wt.% cultured in DMEM+, at 24, 48 and 72 h. Cell 
metabolic activity is represented as percentage in comparison with negative control for 
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metabolic activity decrease (100%) – DMEM 6 M – cells exposed to 50 μL PBS 6 M 
(incubated 6 months at 37 °C at 100 rpm) in 150 μL DMEM. Positive control for metabolic 
activity decrease – Triton 0.1% presented a metabolic activity below 5% (data not shown). 
Results are presented as the mean and standard deviation (n = 6). The red line at 70%, 
marks the toxicity limit, according to ISO 10993-5:2009(E). [31] There are no statistically 
significant differences (p > 0.05) between samples, and between samples and negative 
control (DMEM). (B) LIVE/DEAD staining of HFF-1 cells incubated with 6 months 
degradation products of PLA 6 M, PLA/GNP-M and C 6 M 0.25 wt.% for 72 h. Triton 0.1% 
was used as toxicity positive control (images not shown – similar to Fig. 8.7(B)). Negative 
control was DMEM 6 M (50 μL PBS 6 M + 150 μL DMEM). Cytoplasm is stained with 
calcein – green, all nuclei with Hoechst 33342, and cells with membrane integrity 
compromised were stained in the nucleus with propidium iodide (PI) – red. Scale bar 
represents 100 μm. (C) Representative immunofluorescence images of HFF-1 cells after 
incubation for 72 h with PLA 6 M and PLA/GNP-M and C 6 M 0.25 wt.% degradation 
products. Triton 0.1% was used as positive control for changed morphology (images not 
shown – similar to Fig. 8.7(C)). Negative control was DMEM 6 M (50 μL PBS 6 M + 150 μL 
DMEM). Cells were stained with DAPI (nuclei) - blue and Phalloidin (F-actin in 
cytoskeleton) - green. Scale bar represents 100 μm. 
 
 
8.5 Discussion 
 
PLA and PLA/GNP-M and C 0.25 wt.% composites were studied in terms of chemical, physical, 
mechanical and biocompatibility characteristics, before and after 6 months degradation. This time 
period was considered because PLA is known to show an appreciable loss in strength during the 
first 6 months of hydrolytic degradation, even though significant changes in mass only are 
observed for much longer stages. [32] Maintaining the integrity of PLA mechanical properties 
within the first 6 months of degradation is important regarding its biomedical applications, 
namely orthopaedic, as discussed in the introduction. 
FTIR spectra for PLA and composites (shown in Appendix C), before and after degradation, were 
similar, indicating unchanged chemical structures. It must be noted that the low filler content does 
not allow the detection of characteristic bands of GNP. Kong et al. also observed that 
incorporation of small amounts (0.3–3 wt.%) of multiwalled carbon nanotubes in polyester 
poly(caprolactone) did not change the pristine polymer FTIR spectra. [33] On the other hand, XRD 
analysis of the composites revealed characteristic peaks corresponding to GNP-M and C. No 
differences were observed after degradation, indicating that the fillers remained in the material. 
SEM imaging of samples biodegraded for 6 months indicated evidence of surface erosion for 
PLA and PLA/GNP-C. PLA samples with very low thickness (e.g. fibres) are expected to exhibit 
Physical-chemical properties and biocompatibility of PLA/GBMs composites – effect of biodegradation 
Artur M. Pinto – Jan 2017                                                                                                                                221 
bulk hydrolytic erosion due to fast water diffusion within the material compared to water-
mediated hydrolysis. [24] However, for the 500 μm thickness of the slabs tested in our work, 
hydrolysis seems to have occurred more intensely near the surface. Effective polymer 
biodegradation in all materials was confirmed by GPC-SEC, in terms of ?̅?w decreased along time. 
The intense decrease in molecular weight observed between 2 and 4 months may be due to bulk 
erosion becoming more intense after water penetration in the material core. From this time range, 
samples containing GNP-M and C presented higher decreases in molecular weight than pristine 
PLA, which can be explained by defects caused by larger GNP agglomerates facilitating water 
diffusion within PLA and subsequent degradation. The fact that only GNP-M samples showed 
evidence of bulk degradation can be due to GNP-M agglomerates having larger sizes, resulting in 
larger voids inside PLA matrix. Kontou et al. observed that after 3 months biodegradation, 
PLA/montmorillonite and PLA/silica nanocomposites presented higher degradation rates than 
pristine PLA. [34] They also propose that filler agglomerates create voids and cracks in PLA where 
degradation can start. In contrast, Fukushima et al. [35, 36] observed that the addition of nanoclays 
Cloisite 30B and Sepiolite S9 delayed the degradation of PLA at 37 °C due to induction of 
polymer crystallization and/or by uptaking water, therefore preventing hydrolysis of the polymer 
matrix. 
Thermal properties of the materials are often influenced by fillers addition. It is interesting to note 
that, before degradation, PLA/GNP-M yielded slightly higher molecular weight and 
higher Td than PLA and PLA/GNP-C. One may hypothesize that this is due to GNP-M improving 
thermal homogenization of the melt, minimizing the occurrence of hot-spots and consequent 
polymer degradation during melt-blending and/or compression moulding. Liu et al. [37] reported a 
similar effect with the incorporation of hydroxyapatite in PLA. 
Tensile tests on the non-degraded materials revealed that the presence of the fillers improved 
mechanical properties: Young’s modulus increased by about 14% with both fillers, while tensile 
strength increased by 20% using GNP-C and by 6% using GNP-M. The smaller particle size of 
GNP-C in relation to GNP-M, and consequent higher concentration of peripheral oxygen-
containing groups per surface area, may play a key role in improving filler/matrix compatibility 
and thus providing the better mechanical performance observed at the same low loading. 
Reinforcement of PLA with small amounts (<1 wt.%) of GNP-M15, using melt-blending and 
adding epoxidized palm oil as a plasticizer, had been shown by Chienge et al. [38] to lead to 
increases of about 27% in tensile strength. In a previous work, we have reinforced thin films of 
PLA with GNP-M5. For a loading of 0.2 wt.%, close to the one used in the current work, Young’s 
modulus and tensile strength increased by 6% and 5%, respectively, in unplasticized films, and by 
7% and 21% in plasticized films. The optimal improvement was observed for 0.4 wt.% 
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loading. [17] However, solvent-mixing was used for preparing the composite, while melt-blending 
was used here, taking into account the focus on the development of biocompatible materials. 
An important finding in the current work is that incorporation of both GNP materials, at low 
loadings, prevents significant decrease of PLA mechanical properties after 6 months degradation, 
namely in terms of tensile strength, elongation at break and toughness. In addition, GNP-C 
incorporation seems to have a more beneficial effect than GNP-M, especially in terms of 
toughness. 
Materials under cyclic loading typically fail at lower stress than under static conditions. Also, this 
can induce physical ageing in viscoelastic materials like PLA. [39] Evaluation of mechanical 
properties under these circumstances may be particularly important when orthopaedic applications 
are considered, like bioabsorbable artificial ligaments. [25] The cyclic creep/recovery tests 
performed in this work showed a significant decay in PLA performance after 6 months 
degradation, while PLA/GNP-M and C displayed behaviours equivalent to the non-degraded 
samples. The GNP fillers are therefore significantly counteracting the very negative effect of 
biodegradation on PLA’s creep stability. This remarkable effect can be attributed to the fillers’ 
interaction with the PLA matrix, since the molecular weights have been observed to not be 
significantly different for all materials after degradation. This may provide a strategy for tuning 
PLA’s creep stability in biosorbable bioimplants. The effect of platelet-like fillers on improving 
polymer creep stability has already been described by Faraz et al. [39] for clay platelets. 
Zandiatashbar el al. [40] have also observed improvement in epoxy creep behaviour for graphene 
loadings between 0.1–0.5 wt.%. In addition, Rafiee et al. [41] observed that low loadings (0.05–
0.5 wt.%) of graphene prevented crack propagation in epoxy polymers, increasing fracture 
toughness. Interestingly, for the maximum number of cycles considered in our work, the 
beneficial effect of GNP addition is only evident after biodegradation. It is possible that a 
difference would be observable in non-degraded samples for a higher number of cycles. 
Often, when encapsulated in a polymer matrix, graphene-based materials are not toxic. [42] 
However, their biological effects should be studied to ensure safe use. Also, as the matrix 
degrades, filler leaching takes place. Since GNP-M and GNP-C can be toxic at high 
concentrations, respectively of 20 and 50 μg mL−1 [43], it is relevant to assure that no toxicity 
occurs in biological degradation conditions, despite the fact that the amount of GNP present in the 
composites is quite low (0.25 wt.%). The interaction of human fibroblasts with the materials’ 
surfaces was studied. In addition, cells were incubated with the degradation products resultant 
from 6 months incubation is PBS at 37 °C and 100 rpm. To our knowledge, there are no studies 
available simulating a prolonged extraction of these materials in physiological conditions, 
mimicking what occurs during clinical use, providing an assessment of the hazard potential. No 
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toxicity was observed since there are no statistically significant differences (p > 0.05) between 
samples (PLA 6 M, PLA/GNP-M and C 6 M), and between samples and negative control 
(DMEM 6 M). Moreover, for all conditions, cells present low cell death and normal morphology, 
when in contact with the degradation products. The same is observed for direct contact assay, in 
which cells incubated at the surface of non-degraded materials. PLA at 24 and 48 h, presented 
lower metabolic activity (p < 0.05) than negative control (DMEM), however, at 72 h both present 
similar values (p > 0.05). This can occur due to PLA surface presenting less favourable 
physicochemical properties (e.g. too hydrophobic) [44] than control surface, which is optimized for 
cell culture, allowing faster cell attachment and growth in the first 48 h. Since our goal is to 
compare PLA biological properties, before and after incorporation of the fillers, more important 
was the fact that no significant differences (p > 0.05) were found between PLA and PLA/GNP-M 
and C 0.25 wt.%. These results are similar to those we obtained for thinner PLA/GNP-M 
0.4 wt.% films produced by solvent mixing followed by doctor blading [17], except that in that 
case the effect of degradation was not studied. Yoon [45, 46] and Ma [47] et al. had already shown 
incorporation of graphene oxide in low amounts (<2 wt.%) not to decrease PLA or PLGA, and 
PLA/hydroxyapatite biocompatibility. Both latter authors used solvents to produce the 
composites. On the other hand, Lahiri et al. [15] used electrostatic deposition to produce ultra-high 
molecular weight polyethylene/GNP-M composites. Filler incorporation resulted in viability 
decreases of 14% at 72 h with the addition of 0.1 wt.% GNP-M5, and of 69% with the 
incorporation of 1 wt.%. The observed toxicity may have been caused by excessive GNP 
concentration at the surface and/or rapid leaching, as a result of the production method used. 
 
8.6 Conclusions 
 
It was shown that addition of graphene nanoplatelets (grades GNP-M and GNP-C) to PLA at 
low loadings (0.25 wt.%) by melt-mixing, not only produces composites with improved 
mechanical properties, but also leads to a much lower decay in performance after 6 months 
hydrolytic degradation when compared to unfilled PLA.  
GNP-C incorporation seems to have a more beneficial effect than GNP-M, especially when 
concerning the toughness of the composites after the degradation period. In addition, the 
composites revealed high stability under cyclic creep-recovery testing, while unfilled PLA 
exhibited a significant cumulative increase in permanent creep strain and ruptured after 4 
cycles. This result is particularly relevant in the context of use in orthopaedic implants and 
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suture yarns. The nano-fillers were shown not to impair the polymer degradation process, 
actually evidencing some acceleration of the molecular weight decrease. 
Comparing with unfilled PLA, PLA/GNP-M and PLA/GNP-C composites allow similar 
HFF-1 cell adhesion and growth at the surface before degradation, and after 6 months 
degradation in physiological conditions, do not release toxic products towards human 
fibroblasts. 
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9 GENERAL DISCUSSION 
9.1 Scope 
 
Despite results already have been discussed in each chapter of this thesis, a brief general 
discussion of the most relevant results is performed in this section, in the light of the most 
recently available literature reports. The points discussed are the effects of GBMs physical-
chemical properties on biocompatibility, the effect of their surface modification with polymers, 
and the effect of encapasulating them in a polymer matrix. The production methods, mechanical 
performance before and after degradation, and biocompatibility of PLA/GBMs composites are 
also discussed. Finally, pertinent questions, potential applications, and promising approaches are 
discussed taking into account the most recent reports found in literature. 
 
 
9.2 Discussion 
 
From the results presented on chapter 3 and 4, we can conclude that all GBMs (in powder form) 
tested caused low hemolysis (< 2.5 %) even when considering very high concentrations as 500 µg 
mL-1. Smaller size, oxidation, and surface adsorption of PVA and HEC further reduced the 
hemolysis ratio. This can be explained by those materials presenting less sharp edges to cause 
membrane damages on erythrocytes. Comparison was already performed with works that also 
state the low hemolytic potential of some GBMs [1] and its further reduction by introduction of 
oxygen-containing functional groups [2] or surface adsorption of a polymer [3] at their surface. A 
recent study presents an interesting approach to further evaluation of GBMs hemocompatibility. It 
reports the use of a microfluidic system for the evaluation of blood clot formation under dynamic 
flow. It reveals that both albumin and fibrinogen adsorb well on the surface of GO, and that GO 
can be functionalized with albumin to enhance its antithrombotic effect. [4] On chapter 6, it is 
demonstrated that when in presence of plasma proteins, the number of activated platelets in 
PLA/GNP-M films is significantly lower than that in PLA and PLA/GO films. This can be 
explained by the presence of hydrophobic GNP at the surface of the films, favoring protein 
adsorption at the material surface. This blocks platelet activation in case of these proteins being 
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albumin, which is generally the first to adhere because of its abundance in plasma and its small 
size. These results are supported by a recent study that states and demonstrates that mono or few 
layer graphene coated nitinol substrates, present a reduced fibrinogen/albumin ratio relative to 
pristine nitinol, which is correlated with low platelet adhesion and thrombus formation. [5] A 
different work reports that a mixed matrix membrane of GO-polyvinylpyrrolidone in a 
polyetherimide matrix, greatly enhances protein adsorption resistance, suppressing platelet 
adhesion, lowering complement activation, and prolonging clotting time. [6]  It was also reports 
that the incorporation of GO-g-2-methacryloyloxyethyl phosphorylcholine in polyurethane results 
in improved resistance to nonspecific protein adsorption and platelet adhesion. [7] These later 
works point out interesting strategies to further improve the antithrombotic properties of the 
PLA/GNP composites that we produced. 
Chapters 3 and 4 also show that GNP-C, which exhibits smaller sizes, is generally more 
biocompatible in vitro than GNP-M. The sharper and longer edges of GNP-M platelets cause 
membrane damages on cells, being cytotoxic above 20 μg mL−1. GNP-C, despite being 
internalized without causing membrane damages, increases ROS levels, being toxic above 
50 μg mL−1. The complete oxidation of GNP-M (GNP-M-ox-1:6) folds its sharp edges, assuring 
biocompatibility until the highest concentration tested (100 μg mL−1). GNP-M-ox-1:6 has an 
oxygen content of 24% (attributed mostly to carboxyls and hydroxyls) and is dispersible in water 
by sonication, revealing potential to be used for biomedical purposes. Generally, oxidation is 
more important than size, since more oxidized GNP-M performs better than smaller GNP-C. 
GNP-C-PVA can be used at concentrations up to 100 μg mL−1, whereas GNP-C can only be used 
up to concentrations of 50 μg mL−1. This difference can be explained by PVA encapsulating and 
agglomerating GNP-C platelets, thereby decreasing the internalization and interaction with HFF-1 
cells that lead to ROS production. HEC favours internalization of small GNP-C particles, having 
the opposite effect regarding ROS levels. For these reasons, modification with HEC, in contrast to 
PVA, is counter-productive regarding increasing the biocompatibility of GNP-C with fibroblasts. 
Comparison was already performed with related works in which it was also observed that 
oxidation [3] and adsorption of polymers [8, 9] at the surface of GBMs usually improve their 
biocompatibility. In Chapter 2, it was stated that “an interesting aspect that is lacking from 
existing studies has to do with the effect of particle size (length and thickness) on the 
biocompatibility of GBMs with similar chemical properties. In addition, there are no references in 
the literature regarding the effect of GBMs surface charge on biocompatibility.” Fortunately, new 
data has arisen more recently. A comprehensive study reports preparation of small (HD = 330 
nm), larger GO (HD = 2007 nm), and graphene coated with BSA (HD = 1179 nm) or pluronic 
(PF108) (HD = 2007 nm) to enable dispersion in aqueous solution. In vitro characterization 
revealed that none of the GBMs caused toxicity (reduction of cell viability below 70%), but both 
GOs triggered the production of inflammation mediators in cell lines. Also, all GBMs, except 
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graphene coated with PF108, induce pulmonary fibrosis when administered by oropharyngeal 
aspiration in mice at 2 mg Kg-1, with large GO providing the strongest response. [10] A different 
study also shows that small sized GO (hydrodynamic diameter (HD) = 243 nm) presents lower 
toxicity in mice for intravenous multiple-low-dose exposure, than large GO (HD = 914 nm). [11] 
In vitro studies revealed that GO with different sizes and thickness caused no toxicity when in 
contact with cells, up to the highest concentrations tested (80 µg mL-1 or higher). [12, 13] However, 
GNP with larger diameter, thickness, and lower surface charge, caused toxicity above 40 µg mL-1. 
Also, considerable increases were observed in ROS productions, being those higher for GOs, 
which presented smaller sizes than GNP. [12] The observations from abovementioned works, 
regarding lower toxicity of smaller GBMs, are consistent with what is observed in Chapter 3 and 
4, regarding lower toxicity of smaller sized GNP-C, in comparison with GNP-M. The finding that 
GBMs that are non-toxic to cell lines can induce inflammation, both in vitro and in vivo, [10] 
indicates that the GBMs that we tested should be evaluated in similar assays. 
Chapter 2 states that “encapsulation [of GBMs] in a polymer matrix modifies biological 
interactions”. This was studied on Chapter 6 by incorporating GO and GNP-M in PLA by solvent 
casting, with improvement of mechanical and biological properties of the polymer matrix being 
achieved, and no toxicity caused by the embed fillers being observed. Chapters 7 and 8 explore a 
melt-blending approach for production of PLA/GBMs composites, which does not require the use 
of potentially toxic solvents. Firstly, the best filler loading, mixing time, and mixing intensity are 
identified. Then, physical-chemical characterization of PLA/GNP-C and M 0.25 wt.% composites 
is performed, with focus on mechanical performance, before and after degradation in PBS at 37 
°C during 6 months, and biocompatibility of the biomaterials and their degradation products 
tested in vitro. It is observed that GBMs incorporation in PLA not only produces composites with 
improved mechanical properties, but also leads to a much lower decay in performance after 
6 months hydrolytic degradation when compared to unfilled PLA. GNP-C incorporation seems to 
have a more beneficial effect than GNP-M, especially when concerning the toughness of the 
composites after the degradation period. In addition, the composites reveal high mechanical 
stability under cyclic creep-recovery testing, while unfilled PLA exhibits a significant cumulative 
increase in permanent creep strain and ruptures after only 4 cycles. This result is particularly 
relevant in the context of use in orthopaedic implants and suture yarns. The nano-fillers are shown 
not to impair the polymer degradation process, actually evidencing some acceleration of the 
molecular weight decrease. Comparing with unfilled PLA, PLA/GNP-M and PLA/GNP-C 
composites allow similar HFF-1 cell adhesion and growth at the surface before degradation, and 
after 6 months degradation in PBS, do not release toxic products towards human fibroblasts. A 
recent study confirms that GNP-C improves PLA stiffness and elasticity. However, the 
composites are produced by solution mixing followed by compression moulding, and the amounts 
of fillers tested are much higher than those we used: 3 and 6 wt.%. Also, surface modification of 
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GNP-C with 12-aminododecanoic acid, a zwitterionic surfactant, enhances the composites 
performance by improving GNP-C dispersion and interaction with PLA matrix. [14] Thus, this is 
an approach to take in consideration for further improvement of the mechanical performance of 
our materials. Another work uses GNP-C, at 1 and 5 wt.% loadings, to improve the stiffness of 
Bioflex™, a commercial biodegradable polymer-blend based on PLA and a copolyester. [15] A 
different study shows that with the incorporation of low amounts of GNP-M (0.3 wt.%), the 
tensile strength of PLA plasticized with epoxidized palm oil (EPO) is increased. This occurs 
because GNP-M is uniformly dispersed in the PLA/EPO matrix, with no aggregation being 
observed. [16] The same authors show a slight reduction of the number of gram positive and 
negative bacteria at the composites surface, comparing with PLA. [17] This underlines the 
potential of GBMs as antibacterial fillers for PLA and other biopolymers, and reinforces the idea 
that we can do further work in this field. State of the art approaches report the production of 
polymer/graphene 3D printable composites. [18-20] One of those studies shows that 3D printed 
PLA/graphene 10 wt.% composites show improved mechanical and thermomechanical properties 
compared to PLA. This technology is promising regarding production of materials with tailored 
properties for several applications, including orthopedics and tissue engineering. [18] A 
comprehensive study demonstrates that a polylactide-co-glycolide/graphene (d = 5-20 µm, t = 3-8 
layers) 3D composite material is mechanically robust and flexible, presenting considerable 
electrical conductivity. These scaffolds support human mesenchymal stem cell (hMSC) adhesion, 
viability, proliferation, and neurogenic differentiation with significant upregulation of glial and 
neuronal genes. Also, in vivo experiments indicate that the materials are biocompatible until 30 
days implantation, with no evidence of graphene particles presence in the kidney, liver, or spleen. 
Surgical tests using a human cadaver nerve model revealed that the materials present exceptional 
handling characteristics, can be intraoperatively manipulated, and applied to fine surgical 
procedures. [19] An interesting question regarding biodegradable polymer/GBMs composites is the 
fate that GBMs might have after the polymer matrix is degraded. An in vivo study in mouse, 
developed until 3 months, reports biodegradation by macrophages of carboxyl-functionalized 
single layer graphene with a lateral size between 150 and 200 nm, which aggregates, 24 hours 
post injection, into larger clusters up to 10 µm. Despite this positive insight regarding the 
possibility of some GBMs being naturally degraded by the body, further studies are needed to 
understand the mechanisms that lead to biodegradation, which characteristics of the GBMs make 
them more prone to it, like for example, surface properties, dimensions, and concentrations. This 
knowledge would allow the selection and modification of GBMs properties to maximize their 
long-term biocompatibility, which would surely result in valuable outcomes, both regarding their 
potential applications as fillers of composite materials or when freely dispersed as particles. 
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Previously it was mentioned that GNP-C particles present less toxicity than GNP-M to human 
cells. Also, oxidation and surface modification of GNP-C with PVA was proposed for further 
reduction of its toxicity. Since PLA/GNP-C composites perform better in terms of mechanical 
properties than PLA/GNP-M ones, testing GNP-C-ox, and GNP-C-ox-PVA as fillers for PLA 
may be an interesting approach. Despite there being no evidence of in vitro toxicity of the 
PLA/GBMs composites that we produced, it is uncertain if the GBMs would trigger in vitro or in 
vivo inflammation after being released, while the matrix degrades. For that reason, it is always 
important to further improve the biocompatibility/biotolerability of the GBMs, while 
simultaneously conferring surface properties that allow good dispersibility within the polymer 
matrix. 
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10 CONCLUSIONS AND FUTURE WORK 
10.1 General conclusions 
 
• The effect of size and thickness on GBMs in vitro biocompatibility was evaluated using 
two different GNP grades. GNP-M platelets were larger and sharper, causing membrane 
damages on cells in concentrations higher than 20 mg mL-1. GNP-C is internalized due 
to its small size, inducing ROS production that leads to mild toxicity in concentrations 
higher than 50 mg mL-1, from which the cells can recover along time. GNP-M toxic 
effects can be avoided by extensive oxidation (GNP-M-ox-1:6), which folds its sharp 
edges, preventing membrane damages. GNP-M-ox-1:6 has an oxygen content of 24% 
(mostly carboxyls and hydroxyls) and is dispersible in water by sonication, revealing 
potential to be used for biomedical purposes. 
 
• All the GBMs tested cause low haemolysis (<2.5%) up to 500 μg mL−1. This decreases 
further after oxidation and polymer adsorption, the best results being obtained with 
PVA and HEC.  
 
• Surface adsorption of PVA to GNP-C platelets encapsulates and agglomerates them, 
thereby decreasing the internalization and interaction with cells that lead to ROS 
production and toxicity. When coated with HEC, small GNP-C particles present higher 
internalization, which increases ROS levels and toxicity. For these reasons, PVA 
surface adsorption improves GNP-C biocompatibility, while the use of HEC is counter-
productive. 
 
• A method for evaluation of GBMs degree of dispersion in PLA matrix by Raman 
spectroscopy was developed and implemented. 
 
• Incorporation of 0.4 wt.% loadings of GO and GNP-M in PLA by solvent mixing 
followed by doctor blading changes the surface topography, and wettability of the 
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composite films. Additionally, the incorporation of GO in PLA films, slightly increases 
the metabolic activity of cells adhered at their surface. GNP-M incorporation, on the 
other hand, decreases platelet activation at the films surface. This might be relevant for 
bioapplications that involve contact with blood. 
 
• The dispersion of GNP-M and C in PLA by melt-blending, in amounts as low as 0.25 
wt.%, improves its mechanical properties under cyclic creep-recovery testing after 
degradation under physiological conditions during 6 months. This is relevant for several 
PLA applications, as for example production of orthopaedic implants and suture yarns. 
PLA/GNP-C composites present a general better mechanical performance than 
PLA/GNP-M composites. 
 
• The incorporation of 0.25 wt.% loadings of GNP-M and C in PLA films, produced by 
melt-blending, does not cause toxiciy to HFF-1 cells in direct contact with their 
surfaces. Both before degradation, and after 6 months degradation in physiological 
conditions. Also, the degradation products of those composites are not toxic for human 
fibroblasts. 
 
10.2 Ongoing and Future work 
 
• Following the promising results obtained with PLA/GNP-M composites, in vivo 
biocompatibility studies in BALB/c mice have already been initiated at University of 
Washington in Prof. Buddy Ratner’s Lab. PLA, PLA/GNP-M and C 0.25 wt.% 
composites were implanted subcutaneously  in mice during 3 weeks. The materials were 
explanted and embed in paraffin. This work was not included in this thesis since the 
histological analysis is not yet available. After analyzing these results it will be decided 
if long term assays are needed to access biocompatibility of the composites, and 
particularly of GBMs that may eventually be released from PLA matrix as it degrades. 
 
• Since GNP-M complete oxidation improves its biocompatibility, it would be an 
interesting approach to apply on GNP-C. Also, modification with PVA, which is 
effective for GNP-C, could be tried after its oxidation for further improvement of its 
biocompatibility. If those materials prove non-toxic and non-inflammatory, they can be 
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tested as fillers of PLA. Despite there being no evidence of in vitro toxicity of the 
PLA/GBMs composites that we produced, it is uncertain if the GBMs would trigger in 
vitro or in vivo inflammation after being released, while the matrix degrades. For that 
reason, it is always important to further improve the biocompatibility/biotolerability of 
the GBMs, and if possible simultaneously conferring them surface properties that allow 
better dispersion and compatibility with the polymer matrix, which would reflect on 
increased mechanical performance. 
 
• GBMs have been described to have antibacterial effect, and a study reports that 
PLA/GNP-M plasticized with epoxidized palm oil has antibacterial activity against both 
gram negative and gram positive bacteria. Thus, testing the antibacterial properties of 
GBMs, and modifying them to increase it, as well as producing and optimizing 
PLA/GBMs composites for the same effect is one of our future goals. 
 
• Recent studies report the production of polymer/GBMs composite 3D printed 
structures. This technology is promising regarding production of materials with tailored 
properties for several applications, including in orthopedics and tissue engineering.  
 
• Since incorporation of GBMs has been described to confer electrical conductivity to 
PLA, development of electrically conductive PLA composites materials to stimulate 
tissue regeneration is an interesting perspective, even more so when associated with 3D 
printing of biomaterials. 
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APPENDIX A                                                                                                                                                        
SUPPLEMENTARY MATERIAL FOR CHAPTER 3         
GBMS BIOCOMPATIBILITY - EFFECT OF PARTICLE SIZE 
AND DEGREE OF OXIDATION 
 
A1. Hemolysis 
 
GNP-M and GNP-C were washed with 5 L distilled water by filtration, and these materials were 
designated as GNP-M-w and GNP-C-w. GNP-M and GNP-C were centrifuged at 4000 rpm 
during 15 min, the precipitate was recovered and tested. These materials are designated as GNP-
M-c and GNP-C-c. 
Figure A1 shows that both GNP-M (2.5 %) and GNP-C (1.7 %) induce low hemolysis up to 
concentrations of 500 µg mL-1. Materials were washed in order to assure removal of possible 
contaminants from production/storage. However, hemolysis is similar for “as received” and 
washed materials. Thus, washing is not necessary to reduce toxicity. Centrifugation of both 
materials and recovery of the precipitate was also tested to remove possible contaminants present. 
This treatment did not reduce hemolysis for both materials at 500 µg mL-1. 
 
 
Figure A1: Percentage of RBCs lysis after 3h incubation at 37°C with PBS (negative 
control), GNP-M and GNP-C “as received”, after washing (GNP-M-w and GNP-C-w), and 
after centrifugation (GNP-M-c and GNP-C-c). GBMs concentrations tested were 100, 200 
and 500 µg mL-1. Positive control for 100 % hemolysis was Triton 1% in PBS. Results are 
presented as mean and standard deviation (n=3). 
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A2. Cell morphology 
 
Phase contrast images were obtained for each incubation time and concentration. Examples 
images for 24, 48, 72h for 10 and 50 µg mL-1 are shown in Figure A2. Materials deposited in 
wells bottom and are in contact with the cells, however it is imperceptible whether they penetrate 
cell membrane or not. To clarify this question, HFF-1 cells incubated with materials were 
analysed by TEM (see section 3.4.1.2.2.2). The increase of materials concentration, leads to more 
accumulation at cell membrane (Fig. A2). GNP-C, possesses agglomerates with smaller size after 
sedimentation, than GNP-M. Also, GNP-M-ox-1:3 and GNP-M-ox-1:6 have larger agglomerates 
in well bottom and in contact with cells than GNP-M, with less isolated particles being observed. 
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Figure A2: Optical microscopy images of HFF-1 cells in DMEM+ and incubated with 10 
and 50 µg mL-1 (left and right column, respectively) of GNP-C, GNP-M, GNP-M-ox-1:3 and 
1:6 for 72h. Scale bar represents 100 µm. 
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A3. Cytotoxicity 
 
Figure A3: Fluorescence intensities from resazurin assay for HFF-1 cells incubated with 
DMEM+ (control) and GBMs from 1-100 µg mL-1 for 24, 48 and 72h. Results are presented 
as mean and standard deviation (n=6). PhC images show the density of cells incubated in 
DMEM+ at 24, 48, and 72h. Scale bar represents 100 µm. Immunofluorescence images show 
cell density for cells incubated with DMEM+ and 100 µg mL-1 GBMs at 24 and 72h. Scale 
bar represents 200 µm. 
 
Advances in GBMs and their composites with focus on biomedical applications 
Artur M. Pinto – Jan 2017                                                                                                                                251 
 
Figure A4: LIVE/DEAD staining of HFF-1 cells incubated with 100 µg mL-1 GBMs for 72h. 
Triton 0.1 wt.% in DMEM+ was used as toxicity positive control and cells cultured in 
DMEM+ as negative control. Cytoplasm is stained with calcein – green. Cells with 
membrane integrity compromised were stained in the nucleus with propidium iodide – red. 
Scale bar represents 200 µm. 
 
 
Figure A5: Ki-67 expression (Ki-67+ - positive) for HFF-1 cells incubated with GBMs in 
DMEM+ at 24, 48, and 72h. Results are presented as mean and standard deviation (n=3). 
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Significant differences (p < 0.05) comparing with control without GBMs (DMEM+) are 
represent by Ø. Example of the images used to calculate Ki-67 expression (Ki-67+ - green, all 
nuclei - red) for HFF-1 cells incubated with DMEM+ and respective negative control 
without primary antibody (- control) at 24, 48 and 72h. Scale bar represents 200 µm. 
 
 
Figure A6: Mitochondrial membrane potential (ΔΨm - MMP) as % of negative control for 
MMP decrease – HFF-1 cells cultured in DMEM+, for positive control for MMP decrease - 
cells exposed to CCCP 20 µM for 15 min (ΔΨm = 19.7%), and GBMs for concentrations 
between 10-100 µg mL-1, for 48h. Results are presented as mean and standard deviation 
(n=3). Statistically significant differences, analysed within each concentration are 
represented by c – GNP-C, m – GNP-M, 1:3 – GNP-M-ox-1:3, 1:6 – GNP-M-ox-1:6. 
Symbols represented above a sample concentration indicate that sample is different (p < 
0.05) from samples represented by the symbols for that concentration. Samples different 
from DMEM+ are signalled for each concentration as Ø (p < 0.05). Immunofluorescence 
images of HFF-1 cells incubated with controls performed with culture medium (DMEM+, 
48h) and CCCP 20 µM for 15 min. Nuclei are stained with Hoechst 33342. 
 
Figure A6, shows that only cells incubated with the protonophore carbonyl cyanide m-
chlorophenylhydrazone (CCCP) 20 µM for 15 min, present very low red staining, because CCCP 
uncouples mitochondrial electron transfer decreasing membrane potential. This compound 
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decreases mitochondrial membrane potential (MMP) to 19.7 % comparing with cells cultured 
with DMEM+. Both GNP-M and GNP-M-ox-1:3 present decreased MMP comparing with 
DMEM+ above a concentration of 10 µg mL-1 (p > 0.05). For GNP-C MMP only decreases above 
50 µg mL-1. GNP-M-ox-1:6 show no significant differences in MMP comparing with cells 
cultured in DMEM+ (p > 0.05). 
 
A4. Statistical analysis 
 
Table A1: Statistical analysis for resazurin assay (see section 3.4.1.2.2.1). p values are shown 
when differences were found between samples. 
Time Conc. Samples DMEM+ GNP-C GNP-M 
GNP-M-
ox-1:3 
GNP-M-
ox-1:6 
24h 
5
 µ
g
 m
L
-1
 DMEM+ x     
GNP-C 
 
x p < 0.01 
  
GNP-M 
 
p < 0.01 x 
  
GNP-M-ox-1:3 
   
x 
 
GNP-M-ox-1:6 
    
x 
1
0
 µ
g
 m
L
-1
 DMEM+ x p < 0.05 p < 0.05 p < 0.05 
 
GNP-C p < 0.05 x 
   
GNP-M p < 0.05 
 
x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.05 
  
x p < 0.05 
GNP-M-ox-1:6 
  
p < 0.01 p < 0.05 x 
2
0
 µ
g
 m
L
-1
 DMEM+ x 
    
GNP-C 
 
x 
   
GNP-M 
  
x 
  
GNP-M-ox-1:3 
   
x p < 0.05 
GNP-M-ox-1:6 
   
p < 0.05 x 
5
0
 µ
g
 m
L
-1
 DMEM+ x p < 0.01 p < 0.05 
  
GNP-C p < 0.01 x 
  
p < 0.05 
GNP-M p < 0.05 
 
x 
  
GNP-M-ox-1:3 
   
x 
 
GNP-M-ox-1:6 
 
p < 0.05 
  
x 
1
0
0
 µ
g
 m
L
-1
 DMEM+ x p < 0.01 p < 0.01 p < 0.05 p < 0.05 
GNP-C p < 0.01 x p < 0.05 
  
GNP-M p < 0.01 p < 0.05 x 
  
GNP-M-ox-1:3 p < 0.05 
  
x 
 
GNP-M-ox-1:6 p < 0.05 
   
x 
48h 
1
 µ
g
 m
L
-1
 DMEM+ x     
GNP-C 
 
x 
   
GNP-M 
  
x p < 0.01 
 
GNP-M-ox-1:3 
  
p < 0.01 x 
 
GNP-M-ox-1:6 
    
x 
5
 µ
g
 m
L
-1
 DMEM+ x   
p < 0.05 
 
GNP-C 
 
x 
 
p < 0.01 
 
GNP-M 
  
x 
  
GNP-M-ox-1:3 p < 0.05 p < 0.01 
 
x p < 0.01 
GNP-M-ox-1:6 
   
p < 0.01 x 
1
0
 µ
g
 m
L
-1
 DMEM+ x 
  
p < 0.01 
 
GNP-C 
 
x 
   
GNP-M 
  
x 
  
GNP-M-ox-1:3 p < 0.01 
  
x p < 0.01 
GNP-M-ox-1:6 
   
p < 0.01 x 
2
0
 µ
g
 m
L
-1
 
DMEM+ x 
 
p < 0.05 p < 0.01 
 
GNP-C 
 
x p < 0.01 
  
GNP-M p < 0.05 p < 0.01 x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.01 
  
x 
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GNP-M-ox-1:6 
  
p < 0.01 
 
x 
5
0
 µ
g
 m
L
-1
 DMEM+ x 
 
p < 0.01 p < 0.01 
 
GNP-C 
 
x p < 0.01 
  
GNP-M p < 0.01 p < 0.01 x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.01 
  
x 
 
GNP-M-ox-1:6 
  
p < 0.01 
 
x 
1
0
0
 µ
g
 m
L
-1
 DMEM+ x p < 0.05 p < 0.01 p < 0.01 
 
GNP-C p < 0.05 x 
   
GNP-M p < 0.01 
 
x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.01 
  
x p < 0.01 
GNP-M-ox-1:6 
  
p < 0.01 p < 0.01 x 
72h 
1
 µ
g
 m
L
-1
 DMEM+ x     
GNP-C 
 
x p < 0.05 
  
GNP-M 
 
p < 0.05 x p < 0.05 p < 0.01 
GNP-M-ox-1:3 
  
p < 0.05 x 
 
GNP-M-ox-1:6 
  
p < 0.01 
 
x 
5
 µ
g
 m
L
-1
 DMEM+ x p < 0.05    
GNP-C p < 0.05 x p < 0.01 
  
GNP-M 
 
p < 0.01 x 
 
p < 0.05 
GNP-M-ox-1:3 
   
x 
 
GNP-M-ox-1:6 
  
p < 0.05 
 
x 
1
0
 µ
g
 m
L
-1
 DMEM+ x 
 
p < 0.05 p < 0.05 
 
GNP-C 
 
x p < 0.05 
  
GNP-M p < 0.05 p < 0.05 x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.05 
  
x p < 0.01 
GNP-M-ox-1:6 
  
p < 0.01 p < 0.01 x 
2
0
 µ
g
 m
L
-1
 DMEM+ x 
    
GNP-C 
 
x 
   
GNP-M 
  
x 
 
p < 0.05 
GNP-M-ox-1:3 
   
x 
 
GNP-M-ox-1:6 
  
p < 0.05 
 
x 
5
0
 µ
g
 m
L
-1
 DMEM+ x 
 
p < 0.01 p < 0.01 p < 0.05 
GNP-C 
 
x p < 0.01 p < 0.05 p < 0.01 
GNP-M p < 0.01 p < 0.01 x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.01 p < 0.05 
 
x p < 0.01 
GNP-M-ox-1:6 p < 0.05 p < 0.05 p < 0.01 p < 0.01 x 
1
0
0
 µ
g
 m
L
-1
 DMEM+ x 
 
p < 0.01 p < 0.01 p < 0.05 
GNP-C 
 
x p < 0.01 p < 0.05 p < 0.05 
GNP-M p < 0.01 p < 0.01 x 
 
p < 0.01 
GNP-M-ox-1:3 p < 0.01 p < 0.05 
 
x p < 0.01 
GNP-M-ox-1:6 p < 0.05 p < 0.05 p < 0.01 p < 0.01 x 
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A5. Biocompatibility with HPMEC cells 
 
Figure A7: HPMEC cells viability after incubation with GBMs in M199+, at 24, and 72 h. 
Cell metabolic activity is represented as percentage in comparison with cells cultured in 
M199+ (100 %). Results are presented as mean and standard deviation (n=6). The red line 
at 70%, marks the toxicity limit, according to ISO 10993-5:2009(E). Statistically significant 
differences, analysed within each concentration between all GBMs are represented by c – 
GNP-C, m – GNP-M, 1:3 – GNP-M-ox-1:3 (differences were only found comparing with 
GNP-M-ox-1:6); Differences comparing with M199+ are represented by Ø. Significant 
differences were considered for p < 0.05. 
 
Considering that a sample has cytotoxic potential if its metabolic activity is reduced to less than 
70 % comparing to negative control for metabolic activity decrease - cells incubated with M199+ 
[ISO 10993-5:2009(E)], it can be observed from Figure A7 that GNP-C is toxic at 24 h for 
concentrations above 20 µg mL-1. However, cell metabolic activity recovered over time, and at 72 
h toxicity is only observed above 50 µg mL-1. For GNP-M and GNP-M-ox-1:3, toxicity occurs at 
24 h above 10 µg mL-1. At 72 h, toxicity is observed above 20 µg mL-1 for GNP-M-ox-1:3 and at 
10 µg mL-1 for GNP-M. GNP-M-ox-1:6 reveals no toxicity until the higher concentration tested 
of 100 µg mL-1 (p < 0.05). These results are in agreement with results from resazurin assay for 
HHF-1 cells, since GNP-M and GNP-M-ox-1:3 are the most toxic materials, while GNP-M-ox-
1:6 shows no toxicity. Also, GNP-C shows initial mild toxicity which is almost recovered over 
time. 
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Figure A8: Optical microscopy images of HPMEC cells in culture medium (M199+) at 24 
and 72h, and incubated for 72h with 10 and 50 µg mL-1 (left and right column, respectively) 
of GNP-C, GNP-M, GNP-M-ox-1:3 and 1:6. Scale bar represents 100 µm. 
Advances in GBMs and their composites with focus on biomedical applications 
Artur M. Pinto – Jan 2017                                                                                                                                257 
APPENDIX B                                                                                                                                                        
SUPPLEMENTARY MATERIAL FOR CHAPTER 4         
GBMS BIOCOMPATIBILITY - EFFECT OF POLYMER 
SURFACE ADSORPTION 
 
B1. Materials and methods 
 
X-ray photoelectron spectroscopy (XPS) The XPS analysis of GBMs powders tablets (d = 10 
mm) was performed at CEMUP (Centro de Materiais da Universidade do Porto) using a 
ESCALAB 200A, VG Scientific (UK) with PISCES software for data acquisition and analysis. 
For analysis, an achromatic Al (K) X-ray source (1486.6 eV) operating at 15kV (300 W) was 
used, and the spectrometer, calibrated with reference to Ag 3d5/2 (368.27 eV), was operated in 
constant analyser energy mode with a pass energy of 20 eV for regions of interest, and 50 eV in 
survey. The core levels for O 1s and C 1s were analysed. The photoelectron take-off angle (the 
angle between the surface of the sample and the axis of the energy analyser) was 90°. The 
electron gun used focused on the specimen in an area close to 100 mm2. Data acquisition was 
performed with a pressure lower than 1x106 Pa.  The effect of the electric charge was corrected by 
the reference of the carbon peak (285 eV). The deconvolution of spectra was performed with the 
XPSPEAK41 program, in which a peak fitting was performed using Gaussian-Lorentzian peak 
shape and Shirley type background subtraction. 
Raman spectroscopy The unpolarized Raman spectra of GBMs powders were obtained under 
ambient conditions, in several positions for each sample. The linear polarized 514.5 nm line of an 
Ar+ laser was used as excitation. The Raman spectra were recorded in a backscattering geometry 
by using a confocal Olympus BH-2 microscope with a 50x objective. The spatial resolution is 
about 2 μm, and laser power was 15 mW. The scattered radiation was analysed using a Jobin–
Yvon T64000 triple spectrometer, equipped with a charge-coupled device. The diameter of 
analysis was 10 µm and the spectral resolution better than 4 cm–1. 
The spectra were quantitatively analysed by fitting a sum of damped oscillator to the experimental 
data, according to the equation: 
 (1)
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Here n(ω,T) is the Bose-Einstein factor: Aoj, Ωoj, and τoj are the strength, wave number and 
damping coefficient of the j-th oscillator, respectively, and B(ω) is the background. In this work, 
the background was well simulated by a linear function of the frequency, which enable us to 
obtain reliable fits of the equation (1) to the experimental data. The fitting procedure was 
performed for all Raman bands collected from the same sample, but in different positions. This 
procedure allows us to determine the average and standard deviation (SD) values of the phonon 
parameters, namely the wave number and intensity. [1] 
Thermogravimetric analysis (TGA) The thermal stability of the samples was determined with a 
Netzsh STA 449 F3 Jupiter device. Sample amounts ranged from 10 to 12 mg. The thermograms 
were recorded between 50 and 800 °C at a heating rate of 10 °C min-1 under nitrogen flow. 
Scanning electron microscopy (SEM) The morphology of GBMs was observed at CEMUP 
using SEM (FEI Quanta 400FEG, with an acceleration voltage of 3 kV). Powders of the 
nanomaterials were applied on conductive carbon strips for visualization. 
Immunocytochemistry Cells in each well exposed to 50 µg mL-1 of GBMs (at 100 µg mL-1 
GBMs interfere with staining and images had worse quality) were washed with PBS. Then, 
fixation was performed with paraformaldehyde (PFA - Merck) 4 wt.% in PBS for 15 minutes. 
PFA was removed, the cells washed with PBS and stored at 4 °C. Cell cytoskeletal filamentous 
actin can be visualized by binding of fluorescent phalloidin and the nucleus can be stained with 
4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) that intercalates with nucleic acids. Cell 
membrane was permeabilized with triton X-100 0.1 wt.% at 4 °C for 5 min. Washing was 
performed with PBS and incubation performed with a phalloidin (Alexa Fluor 488; Molecular 
Probes) solution in PBS in a 1:80 dilution, during 20 min in the dark. After rinsing with PBS, a 
DAPI (Sigma Aldrich) solution at a concentration of 3 µg mL-1 was added to each well and 
incubated for 15 min in the dark. Finally, the cells were washed and kept in PBS to avoid drying. 
Plates with adherent cells were observed in an inverted fluorescence microscope (Carl Zeiss – 
Axiovert 200). 
 
B2. Results 
B2.1. Physical-chemical characterization 
Figure B1(A) shows a nanoplatelet of pristine GNP-C. After adsorption of PVA or HEC, platelet 
agglomerates become more evident, as shown in Fig. B1(B, C), for GNP-C-PVA and GNP-C-
HEC, respectively. Polymer presence on the GNP-C surface was confirmed by other methods as 
shown below. 
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Figure B1: SEM images of dry powder of GNP-C (A – 100 000x), GNP C-PVA (B – 40 
000x), and GNP-C-HEC (C – 20 000x). 
 
XPS results (Figure B2(A)) reveal that treatment of GNP-C (which has atomic percentage of 
oxygen – O (at.%) < 4 %) with polymers increases the final O (at.%). The highest increases are 
for GNP-C-PVA and HEC, being above 10 %. These results confirm the adsorption of all 
polymers onto the GNP-C surface. 
As seen in Figure B2(B), the Raman spectra obtained for the GBMs powders are similar. The D-
band, located between 1270–1450 cm−1, is assigned to the carbon lattice disorder typical of crystal 
edges and defects in the graphene network. The G-band close to 1580 cm-1 is associated with sp2 
hybridization. [2, 3] From the fitting procedure, we have calculated the intensity of the observed 
Raman bands. It is well established that the ratio between the intensities of the D- and G-bands, 
ID/G, can be used to characterize the defect degree in graphene materials and to evaluate 
multilayered graphene crystallite size. [2] Usually, the D band is absent or weak on the surface of 
graphene sheets and intense at their edges. [3] GNP modified with all polymers presents a less 
intense D-band than pristine GNP-C. This occurs because the latter is less agglomerated and is 
not covered with polymer, thus, more edges are present in the analysis site, which leads to a more 
intense signal. [3] This result further confirms the presence of polymers at the GNP-C surface, 
already evidenced before by laser diffraction, SEM and XPS. 
Thermograms for the GBMs are shown in Figure B2(C). GNP-C modified with polymers starts to 
lose weight at lower temperatures (approximately 250 °C) than pristine GNP-C, which presents 
little weight loss (GNP-C = 13.8 wt.%), mostly above 400 °C. These temperatures seem to be in 
the range of the temperature of onset of intense degradation for the polymers used. [4, 5] As an 
example, GNP-C-PVA and HEC lose, respectively, approximately 35 and 29 wt.% until 800 °C. 
Taking into account the mass lost by pristine GNP-C up to that temperature, it can be concluded 
that the total amount of PVA and HEC polymers on the GNP-C surface is 21 % and 15 %, 
respectively. 
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Figure B2: A) XPS spectra and atomic composition of GBMs powders for the core level C 
1s. B) Representative unpolarized Raman spectra and intensity ratio of the (D/G) bands for 
GBMs powders. The results are presented as the mean and standard deviation (n=3). C) 
TGA curves and weight loss for GBMs powders. 
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B2.2. GBMs dispersion in culture medium 
Phase contrast images were obtained for each incubation time and concentration tested. Example 
images for DMEM+ at 24 and 72 h, and for all GBMs at 72 h for concentrations of 10 and 50 µg 
mL-1 are shown in Figure B3. The materials deposited in well bottoms and are in contact with the 
cells, however it is imperceptible whether they penetrate the cell membrane or not. To clarify this 
question, HFF-1 cells incubated with materials were analyzed by TEM (Figure 4.4 – Chapter 4). 
An increase of materials concentration leads to more accumulation at the cell membrane (Fig). 
GNP-C possesses agglomerates with smaller size after sedimentation than GNP-C-PVA or HEC. 
Moreover, GNP-C-PVA has larger agglomerates than GNP-C-HEC, and both results are in 
agreement with laser scattering results (Fig. 4.1 – Chapter 4). 
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Figure B3: Optical microscopy images of HFF-1 cells in culture medium (DMEM+) at 24 
and 72 h, and incubated with GBMs at concentrations of 10 and 50 µg mL-1 (left and right 
column, respectively) for 72 h. The scale bar represents 100 µm. 
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S 3. Cytotoxicity 
 
Figure B4: LIVE/DEAD staining of HFF-1 cells incubated with 100 µg mL-1 GBMs for 72 h. 
Triton 0.1 wt.% in DMEM+ was used as a toxicity positive control and cells cultured in 
DMEM+ as a negative control. Cytoplasm is stained with calcein – green. Cells with 
compromised membrane integrity were stained in the nucleus with propidium iodide – red. 
The scale bar represents 200 µm. 
 
B2.4 Cell morphology 
After the resazurin assays, cells in each well exposed to 50 µg mL-1 of GBMs were stained and 
observed (at 100 µg mL-1 GBMs interfere with staining and images had lower quality). 
Immunofluorescence images (Figure B5) show that for toxicity positive controls (triton 0.1 % and 
DMSO 10 % in DMEM+), the cell cytoskeleton was disassembled. A control was performed with 
cells cultured in DMEM+, which exhibited typical “spindle” like shape of fibroblasts. After 72 h 
of incubation with 50 µg mL-1 GNP-C, GNP-C-PVA or HEC, cells exhibit normal morphology 
similar to the negative control. These results are in agreement with those observed in the 
cytotoxicity assays (see Chapter 4) at 72 h for all materials because in these conditions, no 
considerable metabolic decrease or cell death is observed. 
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Figure B5: Representative immunofluorescence images of HFF-1 cells after 72 h incubation 
with 50 µg mL-1 GBMs. Triton 0.1 % and DMSO 10 % in DMEM+ were used as a positive 
control and cells grown in DMEM+ as a negative control. Cells were stained with DAPI 
(nucleus) blue and Phalloidin (F-actin in cytoskeleton) - green. The scale bar represents 200 
µm. 
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B2.5. Statistical analysis 
Table B1: Statistical analysis for resazurin assay. p values are shown when differences were 
found between samples. 
 
Time Conc. Samples DMEM+ GNP-C 
GNP-C-
PVA 
GNP-C-
HEC 
24h 
1
0
 µ
g
 m
L
-  DMEM+ x p < 0.05 
 
p < 0.01 
GNP-C p < 0.05 x 
  
GNP-C-PVA  
 
x  
GNP-C-HEC p < 0.01 
  
x 
2
0
 µ
g
 m
L
-1
 
DMEM+ x 
   
GNP-C 
 
x 
  
GNP-C-PVA 
  
x p < 0.05 
GNP-C-HEC 
  
p < 0.05 x 
5
0
 µ
g
 m
L
-1
 
DMEM+ x p < 0.01 
 
p < 0.01 
GNP-C p < 0.01 x p < 0.05  
GNP-C-PVA 
 
p < 0.05 x p < 0.01 
GNP-C-HEC p < 0.01 
 
p < 0.01 x 
1
0
0
 µ
g
 m
L
-1
 
DMEM+ x p < 0.01 p < 0.05 p < 0.01 
GNP-C p < 0.01 x p < 0.01  
GNP-C-PVA p < 0.05 p < 0.01 x p < 0.01 
GNP-C-HEC p < 0.01 
 
p < 0.01 x 
48h 
1
0
0
 µ
g
 m
L
-1
 
DMEM+ x p < 0.05  p < 0.01 
GNP-C p < 0.05 x   
GNP-C-PVA  
 
x p < 0.01 
GNP-C-HEC p < 0.01 
 
p < 0.01 x 
72h 
5
0
 µ
g
 m
L
-1
 
DMEM+ x 
 
 p < 0.05 
GNP-C 
 
x  p < 0.05 
GNP-C-PVA   x  
GNP-C-HEC p < 0.05 p < 0.05  x 
1
0
0
 µ
g
 m
L
-1
 
DMEM+ x 
 
 p < 0.05 
GNP-C 
 
x  p < 0.05 
GNP-C-PVA   x  
GNP-C-HEC p < 0.05 p < 0.05  x 
 
B3. Polymer’s chemical structure 
Table B2: Chemical structure of the polymers studied for GBMs modification. 
Polymer Chemical Structure 
PVA 
 
HEC 
 
11 Appendices 
266                                                                                                       Artur M. Pinto – Jan 2017 
PEG 
 
PVP 
 
CON 
 
GLU 
 
HA 
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APPENDIX C                                                                                                                                                        
SUPPLEMENTARY MATERIAL FOR CHAPTER 8     
PHYSICAL-CHEMICAL PROPERTIES AND 
BIOCOMPATIBILITY OF PLA/GBMS COMPOSITES - 
EFFECT OF BIODEGRADATION 
 
 
C1. Fillers distribution in PLA matrix 
Figure C1 shows the number of agglomerates per unit of area (mm2) as a function of apparent 
particle sizes, for different PLA/GNP-M and C 0.25 wt.%, evaluated by direct measurements on 
several SEM images collected for each material, using ImageJ software. [1] Both GNP-C and M 
are well exfoliated in PLA matrix. GNP-C presents apparent particle sizes mostly bellow 2 µm, in 
agreement with the maximum nanoplatelet diameters reported by the manufacturer. GNP-M 
presents a fraction of material with sizes above 2.5 µm, corresponding to the visible nanoplatelets 
with lateral dimensions of about 5 µm and some small agglomerates. 
 
Figure C1. Example of SEM images of samples broken under liquid nitrogen, showing 
fillers distribution on PLA matrix. Number of agglomerates per unit of area (mm2) as a 
function of agglomerate length, for PLA/GNP-C and M 0.25 wt.%. 
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C2. Fourier Transform Infrared Spectroscopy 
 
Figure C2, shows spectra typical for PLA, with peaks correspondent to alkyl C-H stretches being 
observed from 3000-2850 cm-1, and the C=O stretching region appearing around 1750 cm-1. A 
band at 1450 cm-1 attributed to CH3 is found. The C-H deformation and asymmetric bands are 
present at 1380, and 1355 cm-1. The C-O stretching modes of the ester groups are present around 
1178 cm-1. A band correspondent to C-O-C asymmetric stretching is present around 1078 cm-1, 
and C-O alkoxy stretching vibration mode is at 1060 cm-1. Also, a band correspondent to C- CH3 
vibrations is present around 1041 cm-1. Bands at 865, and 754 cm-1 are attributed to the 
amorphous and crystalline phase of PLA, respectively. [2] FTIR spectra for PLA, and composites 
before and after degradation are similar. 
 
Figure C2: FTIR spectra for PLA and composites before and after degradation during 6 
months in PBS at 37 °C and 100 rpm. 
 
 
C3. X-ray Diffraction 
 
X-ray diffraction analysis, confirmed the presence of GNP in the PLA matrix. Figure C3 shows 
that GNP-M and C powders present similar XRD spectra, typical of graphitic materials [3], with 
an intense peak around 31°, and two broad peaks around 50° and 65°. GNP-M presents a more 
intense peak at 31º because it has a higher number of stacked graphene sheets per platelet than 
GNP-C, thus having different planes contributing to the same diffraction. [4] PLA, before (0M) 
and after the 6 months (6M) biodegradation period, presents similar typical spectra, with two 
broad peaks. The first, around 20°, is more intense than the second, around 35°. [5] PLA/GNP-M 
0.25 wt.% 0M and 6M present similar spectra, with PLA and GNP-M peaks being observed, 
Advances in GBMs and their composites with focus on biomedical applications 
Artur M. Pinto – Jan 2017                                                                                                                                269 
which confirms the presence of filler in the polymer matrix. For PLA/GNP-C 0.25 wt.% 0M and 
6M, the two spectra are also similar, however the GNP-C peak is much less intense than GNP-M 
peak, as expected since the pristine powders also show the same intensity disparity. 
 
 
 
Figure C3. XRD spectra for GNP-M and C powders (A), PLA 0M and 6M (B), PLA/GNP-M 
0.25 wt.% 0M and 6M (C) and PLA/GNP-C 0.25 wt.% 0 and 6M (D). 
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